data_2lek_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lek _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptp . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.5 tp -80.54 100.7 8.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.626 0.77 . . . . 0.0 108.972 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.401 HG11 HG12 ' A' ' 50' ' ' VAL . 17.3 m -123.02 137.33 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.565 0.746 . . . . 0.0 110.515 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 26.5 m -73.44 97.26 2.51 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.455 0.702 . . . . 0.0 109.623 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 62.8 mt -95.17 108.21 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.112 0.565 . . . . 0.0 109.629 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 62.85 28.73 16.51 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.244 1.018 . . . . 0.0 111.277 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.56 -6.53 65.31 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 113.84 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -105.47 113.02 26.35 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.712 0.805 . . . . 0.0 109.626 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 47.7 mt-30 -64.78 103.11 0.66 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 173.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -118.7 127.75 53.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.356 1.062 . . . . 0.0 109.795 -170.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -86.08 102.63 14.01 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.876 1.27 . . . . 0.0 109.415 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -105.36 168.9 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.899 0.88 . . . . 0.0 111.064 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -110.57 -4.52 15.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.577 0.751 . . . . 0.0 111.776 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -91.71 129.99 37.58 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.581 0.753 . . . . 0.0 111.88 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.46 -6.25 37.7 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.334 1.053 . . . . 0.0 112.557 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 42.5 t -123.52 147.29 47.38 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.108 0.963 . . . . 0.0 109.173 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.3 -34.67 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.145 0.978 . . . . 0.0 111.269 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.73 -52.04 67.1 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 -29.16 69.19 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.9 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.42 -52.89 22.59 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.84 0.856 . . . . 0.0 110.32 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.426 ' HE2' HG22 ' A' ' 58' ' ' ILE . 91.2 mmm -62.94 -34.44 77.47 Favored 'General case' 0 CA--C 1.554 1.1 0 O-C-N 123.72 0.637 . . . . 0.0 109.979 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -70.9 -36.08 72.58 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.238 0.615 . . . . 0.0 110.895 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.73 -35.11 76.71 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.073 0.949 . . . . 0.0 110.433 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.519 HD13 HD13 ' A' ' 5' ' ' ILE . 76.9 mt -93.32 -0.81 56.53 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.885 0.874 . . . . 0.0 112.006 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.3 t70 69.74 15.03 8.09 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.079 0.952 . . . . 0.0 112.189 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' A' ' 58' ' ' ILE . 27.6 m . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 124.331 1.052 . . . . 0.0 111.902 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.17 160.86 40.79 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.024 1.33 . . . . 0.0 108.491 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.571 HG23 HG23 ' A' ' 56' ' ' ILE . 7.7 p -115.56 136.69 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.291 0.637 . . . . 0.0 109.493 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -118.24 99.89 7.15 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.1 tp -88.98 107.64 19.14 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 62.3 38.74 13.01 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.114 0.966 . . . . 0.0 110.11 -172.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 72.89 -5.86 1.81 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 125.407 1.483 . . . . 0.0 112.463 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -92.02 111.37 22.88 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -67.65 122.85 19.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 O-C-N 123.516 0.51 . . . . 0.0 111.033 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.452 ' HB ' HG12 ' A' ' 33' ' ' VAL . 60.9 t -90.66 119.23 69.05 Favored Pre-proline 0 C--O 1.247 0.939 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.85 144.93 64.35 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.576 2.184 . . . . 0.0 111.178 171.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.404 ' HD3' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -57.22 -31.33 65.39 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.943 0.777 . . . . 0.0 112.7 -175.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.404 ' N ' ' HD3' ' A' ' 42' ' ' ARG . . . -70.39 -2.36 41.48 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-O 119.384 -0.675 . . . . 0.0 114.11 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -119.16 -3.64 10.58 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.102 0.961 . . . . 0.0 112.228 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -55.0 -41.03 70.77 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.227 0.611 . . . . 0.0 112.239 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.01 -35.16 66.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.356 0.662 . . . . 0.0 110.817 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.55 -26.64 64.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.732 0.813 . . . . 0.0 111.488 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.3 m -97.0 117.58 65.67 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 84.7 Cg_endo -81.58 161.87 19.3 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.388 2.059 . . . . 0.0 111.783 168.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.401 HG12 HG11 ' A' ' 3' ' ' VAL . 13.7 t -90.29 147.15 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 p -124.09 133.74 53.54 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.736 0.814 . . . . 0.0 109.593 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.15 127.49 32.41 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.703 0.801 . . . . 0.0 111.985 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.83 7.64 74.29 Favored Glycine 0 N--CA 1.472 1.073 0 O-C-N 123.798 0.686 . . . . 0.0 113.637 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.21 167.32 16.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.429 0.691 . . . . 0.0 109.559 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -114.98 101.55 9.12 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.184 0.593 . . . . 0.0 109.939 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.571 HG23 HG23 ' A' ' 33' ' ' VAL . 2.7 mp -97.88 97.83 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 124.37 1.068 . . . . 0.0 108.919 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 41.9 tt0 -91.43 108.92 20.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.328 0.651 . . . . 0.0 109.467 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.426 HG22 ' HE2' ' A' ' 21' ' ' MET . 68.9 mt -78.13 109.72 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 123.198 0.599 . . . . 0.0 110.969 178.26 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 120.842 0.353 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 47.1 tp -79.02 113.44 17.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.606 0.763 . . . . 0.0 109.345 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.04 179.64 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.206 1.002 . . . . 0.0 109.236 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 25.2 m -120.64 101.66 7.89 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 118.775 0.716 . . . . 0.0 110.092 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.524 HD13 HD13 ' A' ' 24' ' ' LEU . 71.5 mt -95.71 117.2 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 123.624 0.769 . . . . 0.0 109.887 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 61.74 22.07 12.69 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.894 1.278 . . . . 0.0 112.567 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.84 1.49 65.5 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-O 120.072 -0.293 . . . . 0.0 113.713 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.78 126.71 50.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.696 0.798 . . . . 0.0 109.8 172.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 42.9 mt-30 -69.84 135.79 50.0 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.971 0.415 . . . . 0.0 111.354 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -146.95 136.4 22.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.402 1.081 . . . . 0.0 108.519 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 45.4 tt0 -81.5 123.0 28.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.468 0.707 . . . . 0.0 109.442 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.92 160.01 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.931 0.892 . . . . 0.0 109.324 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.55 -2.3 9.98 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.713 0.405 . . . . 0.0 111.006 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.5 p -66.21 107.97 2.13 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.604 0.762 . . . . 0.0 110.252 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.26 60.2 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.676 0.79 . . . . 0.0 112.874 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.6 p -112.03 150.03 31.21 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.435 ' O ' ' HG2' ' A' ' 21' ' ' MET . 72.7 t -67.61 -33.4 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.247 0.619 . . . . 0.0 110.368 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.42 -46.18 90.95 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.973 0.509 . . . . 0.0 110.84 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -59.14 -44.31 92.07 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 124.167 0.917 . . . . 0.0 110.525 177.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.8 tp -63.94 -44.45 92.82 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.935 0.772 . . . . 0.0 111.674 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.445 ' HE2' HG21 ' A' ' 58' ' ' ILE . 95.0 mmm -63.31 -28.04 69.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.851 0.46 . . . . 0.0 110.598 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -74.56 -39.07 62.52 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.188 0.595 . . . . 0.0 111.496 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 10.6 mm-40 -63.84 -38.86 92.68 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.503 0.668 . . . . 0.0 110.36 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.524 HD13 HD13 ' A' ' 5' ' ' ILE . 79.4 mt -91.32 -1.87 57.53 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.598 -176.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.19 28.86 14.05 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.829 1.252 . . . . 0.0 113.179 171.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.6 m . . . . . 0 CA--C 1.545 0.753 0 C-N-CA 124.47 1.108 . . . . 0.0 110.726 178.29 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.468 0.434 0 CA-C-O 121.756 0.789 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 59' ' ' LEU . . . -133.45 -176.39 4.13 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.937 168.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.423 HG11 HG12 ' A' ' 17' ' ' VAL . 8.5 p -146.56 158.25 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -132.52 110.3 10.39 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.193 0.597 . . . . 0.0 110.529 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.9 tp -89.31 109.27 20.18 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 52.28 65.86 1.38 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.958 1.303 . . . . 0.0 111.866 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 68.43 1.16 2.82 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 124.941 1.296 . . . . 0.0 112.696 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -119.35 116.64 26.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.002 0.921 . . . . 0.0 109.532 -171.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 58.0 t -70.62 119.87 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 123.764 0.665 . . . . 0.0 111.06 -174.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -92.52 124.16 59.93 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.064 0.946 . . . . 0.0 108.813 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.95 154.7 66.72 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.364 2.043 . . . . 0.0 111.412 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -56.11 -41.38 75.17 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.298 1.039 . . . . 0.0 112.473 -171.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.63 14.17 5.89 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 114.361 0.504 . . . . 0.0 114.361 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -17.48 6.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.092 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -46.34 -41.86 14.0 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 123.902 0.751 . . . . 0.0 112.492 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.54 -48.5 77.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.547 1.139 . . . . 0.0 111.327 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.52 -0.48 57.27 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.849 0.86 . . . . 0.0 112.253 -175.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.7 m -96.89 120.85 60.84 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.66 146.74 9.48 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.298 1.999 . . . . 0.0 113.636 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.9 t -86.87 130.49 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 109.071 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 54' ' ' ASP . 10.6 m -103.99 146.99 27.89 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.767 0.827 . . . . 0.0 110.043 -173.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.97 116.73 8.95 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.321 0.648 . . . . 0.0 110.973 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.91 33.73 49.85 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.612 0.57 . . . . 0.0 112.659 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.524 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 27.8 p30 -83.87 -165.27 1.08 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.686 0.394 . . . . 0.0 110.779 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -134.85 94.66 3.2 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 37.5 mt -95.04 100.63 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.519 0.727 . . . . 0.0 109.977 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.26 114.1 25.85 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.701 0.801 . . . . 0.0 109.316 177.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.445 HG21 ' HE2' ' A' ' 21' ' ' MET . 62.1 mt -77.65 129.85 36.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.445 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 90.4 mt . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.116 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.479 0.181 . . . . 0.0 111.09 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 9' ' ' GLN . 40.6 tp -86.59 127.42 34.91 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.52 0.728 . . . . 0.0 109.464 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.73 138.02 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.528 1.131 . . . . 0.0 109.267 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 28.4 m -78.33 97.71 5.69 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.174 0.443 . . . . 0.0 109.861 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.8 mt -94.22 104.25 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 67.0 t30 62.04 36.2 15.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.63 1.172 . . . . 0.0 111.145 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.94 10.83 82.4 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.517 -0.765 . . . . 0.0 113.496 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -130.19 108.88 10.38 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.869 0.867 . . . . 0.0 108.98 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.518 ' HB3' HD11 ' A' ' 2' ' ' LEU . 98.3 mt-30 -64.92 119.77 11.33 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.539 0.736 . . . . 0.0 110.457 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -126.59 158.11 37.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.844 0.858 . . . . 0.0 110.327 -177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -97.59 113.79 25.58 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.172 0.989 . . . . 0.0 109.741 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.6 m -120.16 147.25 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.832 0.853 . . . . 0.0 110.85 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -119.01 22.2 12.02 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.74 0.781 . . . . 0.0 109.389 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 p -75.97 -49.84 16.56 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.91 1.284 . . . . 0.0 112.418 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 67.21 0.4 2.05 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.676 1.19 . . . . 0.0 113.669 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 39.7 m -154.33 153.6 31.93 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.132 1.373 . . . . 0.0 109.106 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.422 ' CG1' HG11 ' A' ' 33' ' ' VAL . 58.3 t -69.95 -34.36 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 O-C-N 124.297 0.998 . . . . 0.0 112.506 -172.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.23 -53.24 39.48 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 -33.15 70.37 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.137 0.898 . . . . 0.0 111.238 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.615 HD21 HG22 ' A' ' 56' ' ' ILE . 42.0 tp -61.54 -59.88 4.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.194 1.398 . . . . 0.0 111.817 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 60.6 mtp -73.63 -19.92 60.72 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.477 0.485 . . . . 0.0 111.256 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.1 m -70.97 -41.72 70.67 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 121.159 0.504 . . . . 0.0 110.061 168.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.84 -35.96 70.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.508 1.123 . . . . 0.0 111.312 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.3 mt -80.22 -5.93 56.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.531 0.732 . . . . 0.0 110.707 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.2 t70 65.55 24.62 11.77 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.352 1.461 . . . . 0.0 110.819 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.444 ' SG ' HD13 ' A' ' 58' ' ' ILE . 35.0 t . . . . . 0 CA--C 1.554 1.108 0 C-N-CA 124.609 1.163 . . . . 0.0 111.467 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 121.146 0.498 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.81 175.45 9.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.537 1.135 . . . . 0.0 108.467 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.525 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 6.4 p -134.71 144.2 35.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 123.983 0.913 . . . . 0.0 109.649 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . . . -117.77 100.14 7.4 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.4 tp -97.37 112.01 24.02 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 54.47 55.94 7.45 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.588 1.155 . . . . 0.0 111.49 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 62.86 34.85 14.01 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.434 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -152.06 126.39 9.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.039 0.536 . . . . 0.0 109.898 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 t -73.72 126.03 33.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 O-C-N 123.674 0.609 . . . . 0.0 110.38 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.08 117.39 66.8 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.91 152.69 79.67 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.579 2.186 . . . . 0.0 111.059 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -61.37 -38.64 87.76 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -167.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.9 -1.71 33.9 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 123.481 0.488 . . . . 0.0 114.118 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -114.44 -9.35 12.74 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.73 0.812 . . . . 0.0 112.156 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -51.47 -41.03 60.62 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 123.396 0.678 . . . . 0.0 111.399 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -70.96 -38.32 72.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.468 1.107 . . . . 0.0 111.802 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -77.39 -14.84 59.62 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.1 m -106.27 119.58 51.51 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 88.2 Cg_endo -81.77 167.76 16.37 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.396 2.064 . . . . 0.0 112.316 172.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.421 HG12 HD12 ' A' ' 56' ' ' ILE . 63.0 t -118.73 140.85 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.429 1.092 . . . . 0.0 108.271 171.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.1 m -123.24 154.35 38.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.415 1.086 . . . . 0.0 108.815 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.78 126.93 29.55 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.468 0.707 . . . . 0.0 110.662 175.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 -2.96 52.42 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.959 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -76.42 138.72 40.54 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.447 0.624 . . . . 0.0 111.205 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -92.39 110.48 21.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.655 0.782 . . . . 0.0 109.11 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.615 HG22 HD21 ' A' ' 20' ' ' LEU . 56.4 mt -107.26 98.28 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.054 0.942 . . . . 0.0 109.829 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 41.3 tt0 -96.67 117.06 30.19 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.444 HD13 ' SG ' ' A' ' 26' ' ' CYS . 75.2 mt -76.3 141.45 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 N--CA 1.47 0.549 0 C-N-CA 123.457 0.703 . . . . 0.0 110.522 -177.611 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mtp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 9' ' ' GLN . 4.4 tt -79.18 105.22 10.35 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.54 178.02 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.365 1.066 . . . . 0.0 109.021 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.6 m -122.63 100.52 6.96 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.6 mt -95.14 110.04 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.72 0.808 . . . . 0.0 108.982 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.471 HD22 HG13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER 65.23 34.01 8.8 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.166 1.386 . . . . 0.0 110.86 175.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.32 2.52 85.33 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.524 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -115.76 120.2 38.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.163 0.585 . . . . 0.0 110.51 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.466 ' HB3' HD22 ' A' ' 2' ' ' LEU . 47.9 mt-30 -64.11 113.65 3.67 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.406 0.683 . . . . 0.0 110.351 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -125.08 133.56 52.84 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.285 1.034 . . . . 0.0 109.965 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -85.18 114.99 22.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.414 1.086 . . . . 0.0 108.993 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.9 m -125.12 168.55 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.445 1.098 . . . . 0.0 109.089 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -124.83 5.53 8.08 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.453 0.701 . . . . 0.0 109.5 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.4 m -78.58 105.21 9.7 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 123.296 0.638 . . . . 0.0 110.576 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.88 2.47 34.21 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.172 0.589 . . . . 0.0 111.106 171.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.7 t -124.52 133.89 53.18 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.431 1.093 . . . . 0.0 109.261 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.591 HG12 HG11 ' A' ' 33' ' ' VAL . 66.8 t -63.41 -43.05 98.31 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 O-C-N 123.743 0.652 . . . . 0.0 110.046 174.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -50.39 68.49 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 0.0 111.415 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.06 92.11 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 124.047 0.842 . . . . 0.0 111.207 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.0 tp -60.78 -45.94 92.4 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.968 0.792 . . . . 0.0 111.685 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.0 mmm -71.77 -24.31 61.73 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.214 0.606 . . . . 0.0 111.25 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -69.58 -41.07 76.32 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.901 0.481 . . . . 0.0 110.119 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.44 -37.58 77.45 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.085 0.954 . . . . 0.0 111.51 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -82.81 -4.7 58.34 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.563 0.745 . . . . 0.0 111.145 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.2 t70 69.08 12.25 8.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.491 1.116 . . . . 0.0 111.506 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 124.19 0.996 . . . . 0.0 110.423 -175.058 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 121.076 0.465 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' A' ' 59' ' ' LEU . . . -119.69 167.85 11.63 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.698 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.591 HG11 HG12 ' A' ' 17' ' ' VAL . 9.8 p -122.82 156.41 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 57' ' ' GLU . . . -131.14 100.86 5.35 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -89.84 108.84 19.94 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 59.71 39.75 20.65 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.763 1.225 . . . . 0.0 109.889 -169.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 73.91 -9.28 1.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.99 1.716 . . . . 0.0 113.297 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -77.97 108.94 11.6 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.8 t -67.57 121.72 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 123.6 0.562 . . . . 0.0 109.904 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.449 HG22 HG23 ' A' ' 48' ' ' THR . 67.9 t -105.69 132.56 20.78 Favored Pre-proline 0 C--O 1.245 0.818 0 C-N-CA 124.124 0.97 . . . . 0.0 108.827 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.11 149.83 59.01 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.465 2.11 . . . . 0.0 111.256 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -63.48 -34.2 77.24 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -165.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.96 -29.06 67.12 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 123.384 0.427 . . . . 0.0 112.773 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -95.09 -4.21 46.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.718 0.807 . . . . 0.0 112.718 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -57.9 -29.99 65.52 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 118.495 0.589 . . . . 0.0 110.625 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.24 -39.6 82.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.395 1.078 . . . . 0.0 110.888 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -79.47 -24.84 42.1 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.122 0.969 . . . . 0.0 112.131 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.449 HG23 HG22 ' A' ' 40' ' ' VAL . 56.6 m -92.9 110.98 49.24 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.835 0.854 . . . . 0.0 109.464 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -81.03 171.59 13.93 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.8 2.333 . . . . 0.0 112.439 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.405 HG11 HD12 ' A' ' 56' ' ' ILE . 58.0 t -121.85 138.82 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.209 1.004 . . . . 0.0 108.388 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.2 p -128.69 150.85 50.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.567 1.147 . . . . 0.0 108.294 173.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.63 122.39 15.17 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.522 0.729 . . . . 0.0 110.705 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.01 -13.94 19.43 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.191 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -67.18 139.49 57.44 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 117.198 0.499 . . . . 0.0 111.986 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.68 99.45 12.35 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.405 HD12 HG11 ' A' ' 50' ' ' VAL . 62.4 mt -98.3 96.28 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.714 0.805 . . . . 0.0 109.289 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.544 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 34.5 tt0 -93.67 119.96 33.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.808 0.843 . . . . 0.0 109.726 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.471 HG13 HD22 ' A' ' 6' ' ' ASN . 88.5 mt -87.73 136.42 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.54 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 80.0 mt . . . . . 0 N--CA 1.467 0.385 0 C-N-CA 124.245 1.018 . . . . 0.0 109.763 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.553 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 1.3 pmm? . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.91 0.386 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 tt -79.93 118.56 21.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 m -131.0 142.56 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.524 1.129 . . . . 0.0 110.415 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 m -79.75 98.92 7.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.793 0.837 . . . . 0.0 109.437 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.6 HD13 HD12 ' A' ' 24' ' ' LEU . 74.1 mt -104.38 110.77 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.408 HD22 ' HB ' ' A' ' 58' ' ' ILE . 88.9 m-20 64.13 22.42 12.88 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.605 1.162 . . . . 0.0 111.494 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.66 -15.1 64.06 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-O 119.72 -0.489 . . . . 0.0 113.535 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -86.09 133.08 33.91 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 117.401 0.601 . . . . 0.0 109.72 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -75.08 100.16 4.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -105.17 146.2 29.55 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.059 0.944 . . . . 0.0 109.973 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -109.61 104.29 13.29 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 m -113.33 165.14 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.569 0.748 . . . . 0.0 110.156 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -128.1 9.12 6.21 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.661 0.784 . . . . 0.0 109.627 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -57.0 -49.1 76.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.803 1.241 . . . . 0.0 112.799 -170.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 61.78 9.36 2.85 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.179 0.992 . . . . 0.0 112.802 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.2 t -162.05 141.48 9.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.152 1.381 . . . . 0.0 108.109 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.452 HG12 HG11 ' A' ' 33' ' ' VAL . 94.6 t -72.05 -33.39 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.335 0.654 . . . . 0.0 111.461 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.88 -53.6 51.7 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.641 0.376 . . . . 0.0 110.275 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.65 -44.83 73.59 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.66 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.7 tp -58.81 -56.02 27.59 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.273 1.029 . . . . 0.0 111.886 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.426 ' HE2' ' O ' ' A' ' 26' ' ' CYS . 77.2 mtp -68.95 -19.27 64.17 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.027 0.531 . . . . 0.0 111.2 -175.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.7 m -73.27 -46.28 50.8 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.795 0.438 . . . . 0.0 110.663 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -70.1 -34.57 73.3 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.282 1.033 . . . . 0.0 111.604 -175.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.6 HD12 HD13 ' A' ' 5' ' ' ILE . 89.5 mt -79.09 -12.23 60.0 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.522 0.729 . . . . 0.0 111.25 175.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 63.54 24.57 14.08 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.576 1.15 . . . . 0.0 111.027 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.436 ' HB3' HG21 ' A' ' 58' ' ' ILE . 88.3 m . . . . . 0 N--CA 1.47 0.57 0 C-N-CA 125.473 1.509 . . . . 0.0 110.566 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 120.801 0.334 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.427 ' HB1' ' HB2' ' A' ' 59' ' ' LEU . . . -138.54 177.96 7.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.088 1.355 . . . . 0.0 108.466 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.452 HG11 HG12 ' A' ' 17' ' ' VAL . 11.1 p -138.17 148.41 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.227 0.537 . . . . 0.0 110.824 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -129.9 105.53 8.05 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.129 1.372 . . . . 0.0 108.037 172.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.0 tp -86.83 105.79 17.27 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 54.74 52.88 11.36 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.266 1.427 . . . . 0.0 110.725 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 74.89 -16.8 0.53 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 125.765 1.626 . . . . 0.0 113.761 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.03 107.71 19.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 75.4 t -69.96 117.49 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.371 0.669 . . . . 0.0 110.874 -176.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.23 119.45 65.59 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 123.853 0.861 . . . . 0.0 109.157 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.33 154.47 74.11 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.421 2.081 . . . . 0.0 112.159 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -59.39 -33.94 71.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.087 0.955 . . . . 0.0 112.115 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.44 1.31 7.21 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.994 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -127.88 -9.82 5.48 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 117.976 -1.011 . . . . 0.0 112.334 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -49.46 -42.33 42.77 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 119.072 0.851 . . . . 0.0 111.685 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -68.09 -41.72 81.42 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.379 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.44 -19.03 60.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.772 0.829 . . . . 0.0 111.812 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.0 m -96.06 115.35 65.51 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.45 169.91 20.98 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.475 2.117 . . . . 0.0 112.832 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.26 104.72 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.802 1.241 . . . . 0.0 108.499 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 p -97.97 166.64 11.35 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.158 0.983 . . . . 0.0 110.678 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 1' ' ' MET . . . -64.22 116.52 6.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.783 0.833 . . . . 0.0 112.003 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.66 26.78 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 119.315 -0.714 . . . . 0.0 114.479 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -74.09 140.52 45.36 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.023 0.912 . . . . 0.0 111.841 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -89.89 92.56 9.07 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 64.3 mt -96.19 100.91 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.79 0.836 . . . . 0.0 109.861 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -88.92 104.47 16.99 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 26' ' ' CYS . 50.6 mm -78.56 106.69 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.427 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 61.1 mt . . . . . 0 C--N 1.323 -0.552 0 C-N-CA 123.298 0.639 . . . . 0.0 110.538 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.453 ' HG2' HG13 ' A' ' 3' ' ' VAL . 1.5 pmm? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.371 0.129 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 44.9 tp -77.86 116.71 18.57 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 173.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.453 HG13 ' HG2' ' A' ' 1' ' ' MET . 32.7 m -120.33 -176.46 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.762 1.225 . . . . 0.0 109.273 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 58.7 m -126.67 101.65 6.73 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 172.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.4 mt -96.29 115.6 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.757 0.823 . . . . 0.0 110.006 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 t30 50.42 52.74 14.21 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.851 1.26 . . . . 0.0 111.243 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.07 -0.8 61.74 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 114.62 -1.173 . . . . 0.0 114.429 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -107.56 109.67 21.38 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.817 0.847 . . . . 0.0 110.155 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 27.2 pt20 -66.32 102.03 0.81 Allowed 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.746 0.784 . . . . 0.0 109.774 176.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -137.34 136.97 38.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.506 0.722 . . . . 0.0 109.392 -171.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 36.7 tt0 -84.67 130.83 34.66 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.239 0.616 . . . . 0.0 109.595 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.41 177.04 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.713 1.205 . . . . 0.0 108.933 171.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -119.67 7.38 11.05 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.8 m -68.33 112.2 5.07 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 123.441 0.697 . . . . 0.0 110.618 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.97 -16.49 43.91 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.374 0.669 . . . . 0.0 110.728 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.3 t -121.28 141.34 50.99 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.319 1.048 . . . . 0.0 109.432 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.3 t -69.77 -30.19 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 123.535 0.522 . . . . 0.0 110.371 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.74 64.21 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.456 0.702 . . . . 0.0 110.368 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.39 90.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.544 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.6 tp -61.77 -54.58 40.43 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.626 0.578 . . . . 0.0 110.888 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.3 mmm -61.57 -32.31 72.39 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.044 0.84 . . . . 0.0 110.905 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -70.03 -40.94 74.87 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.212 0.605 . . . . 0.0 110.887 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.52 -20.77 59.85 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.097 0.559 . . . . 0.0 111.376 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.8 mt -87.29 -6.43 58.53 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.056 0.543 . . . . 0.0 110.081 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.5 t70 62.03 31.47 17.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.147 1.379 . . . . 0.0 110.564 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.5 t . . . . . 0 CA--C 1.553 1.063 0 C-N-CA 125.223 1.409 . . . . 0.0 109.286 -177.852 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 121.111 0.482 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.1 179.54 9.05 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.82 1.248 . . . . 0.0 108.784 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.42 HG12 ' NE1' ' A' ' 45' ' ' TRP . 7.3 p -147.06 119.09 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.246 0.546 . . . . 0.0 110.299 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . . . -80.32 97.48 7.03 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 171.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.412 HD11 HG12 ' A' ' 56' ' ' ILE . 46.5 tp -92.11 120.49 32.77 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.4 m120 63.45 25.72 14.62 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.69 1.196 . . . . 0.0 110.071 -173.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 74.47 8.31 4.46 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 126.256 1.822 . . . . 0.0 112.644 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -106.04 126.91 52.77 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.49 124.16 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.564 0.746 . . . . 0.0 111.094 -171.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.5 116.69 57.38 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.536 1.135 . . . . 0.0 109.063 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.536 ' HD2' ' HD3' ' A' ' 44' ' ' LYS . 57.4 Cg_endo -70.23 164.26 35.65 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.858 2.372 . . . . 0.0 112.135 173.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -56.53 -43.42 79.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.081 0.952 . . . . 0.0 112.66 -172.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.8 -30.18 74.32 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 123.804 0.69 . . . . 0.0 113.301 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.536 ' HD3' ' HD2' ' A' ' 41' ' ' PRO . 28.2 mtpp -82.01 -25.92 34.28 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.328 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.42 ' NE1' HG12 ' A' ' 33' ' ' VAL . 51.9 m0 -49.19 -36.34 19.43 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 123.76 0.824 . . . . 0.0 111.65 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.73 -54.23 38.62 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.012 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -86.03 2.78 45.12 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.092 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.7 m -108.37 114.67 59.05 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.1 166.12 12.9 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.579 2.186 . . . . 0.0 113.29 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.1 t -95.17 147.75 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.884 0.873 . . . . 0.0 108.839 172.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 m -123.51 149.16 45.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.848 0.859 . . . . 0.0 110.119 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.29 113.76 3.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.462 0.305 . . . . 0.0 111.243 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.83 39.3 24.95 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.448 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -94.39 164.84 12.84 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.823 0.449 . . . . 0.0 111.386 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -101.15 86.99 3.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.566 0.698 . . . . 0.0 110.204 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.412 HG12 HD11 ' A' ' 35' ' ' LEU . 82.5 mt -86.19 144.2 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.026 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 33.8 tt0 -147.48 136.25 22.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mm -83.29 134.73 26.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.1 mt . . . . . 0 C--N 1.323 -0.546 0 C-N-CA 124.013 0.925 . . . . 0.0 109.543 178.038 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.502 ' SD ' HG12 ' A' ' 50' ' ' VAL . 23.8 ptp . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 121.064 0.459 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.9 tt -85.43 107.27 17.32 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.465 HG21 HG13 ' A' ' 5' ' ' ILE . 28.6 m -118.69 162.04 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.396 1.079 . . . . 0.0 109.449 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.3 m -94.12 101.52 13.53 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.121 0.569 . . . . 0.0 109.711 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.634 HD12 HD13 ' A' ' 24' ' ' LEU . 69.1 mt -100.02 107.85 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.2 m120 68.26 22.21 8.19 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.917 1.287 . . . . 0.0 112.399 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.17 4.91 66.22 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.455 -0.339 . . . . 0.0 112.66 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -119.99 111.57 18.07 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.143 0.977 . . . . 0.0 108.488 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -60.2 111.28 1.47 Allowed 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.953 0.406 . . . . 0.0 110.287 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -119.94 131.34 55.17 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.626 1.17 . . . . 0.0 108.872 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -80.65 124.42 28.99 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 170.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.43 163.3 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.311 1.044 . . . . 0.0 108.973 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -114.73 -2.22 13.07 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.862 0.465 . . . . 0.0 111.539 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -70.77 117.3 12.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.718 0.407 . . . . 0.0 110.851 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.55 14.27 19.34 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.196 0.998 . . . . 0.0 110.931 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 p -142.38 141.57 32.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.501 1.12 . . . . 0.0 108.702 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.476 HG11 HG11 ' A' ' 33' ' ' VAL . 98.7 t -67.74 -31.73 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 124.027 0.829 . . . . 0.0 112.033 -172.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.5 -45.87 78.14 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.46 0.304 . . . . 0.0 110.521 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -61.29 -38.12 85.63 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.076 0.86 . . . . 0.0 111.092 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.1 tp -62.63 -50.57 70.7 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.902 0.881 . . . . 0.0 111.438 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.5 mtp -72.84 -16.8 61.59 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.65 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.2 m -69.54 -45.84 67.84 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 166.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 22.2 mm-40 -65.89 -30.6 71.23 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.243 0.617 . . . . 0.0 112.217 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.634 HD13 HD12 ' A' ' 5' ' ' ILE . 60.7 mt -99.6 -0.82 39.62 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.634 0.774 . . . . 0.0 111.675 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t70 62.4 25.45 15.18 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.076 1.35 . . . . 0.0 111.503 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.9 m . . . . . 0 CA--C 1.547 0.851 0 C-N-CA 124.434 1.094 . . . . 0.0 110.622 178.232 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 . . . . . 0 C--O 1.237 0.429 0 CA-C-O 121.093 0.473 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.67 134.64 54.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.476 HG11 HG11 ' A' ' 17' ' ' VAL . 11.0 p -106.05 137.92 33.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.43 100.56 8.86 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.408 HD13 HG12 ' A' ' 56' ' ' ILE . 28.5 tp -87.01 108.64 18.94 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 60.39 39.45 18.57 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.232 0.957 . . . . 0.0 110.182 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 68.21 13.87 9.14 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.28 1.432 . . . . 0.0 113.184 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -111.7 116.99 31.67 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.8 t -67.15 126.97 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.247 0.619 . . . . 0.0 111.181 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.7 t -103.8 127.86 28.53 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.544 1.137 . . . . 0.0 108.333 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.68 161.39 33.85 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.947 2.431 . . . . 0.0 111.836 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -59.18 -41.72 89.12 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.476 0.71 . . . . 0.0 112.864 -169.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.45 -29.13 70.81 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 123.373 0.421 . . . . 0.0 112.899 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -88.74 -14.89 36.11 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-O 117.936 -1.031 . . . . 0.0 112.177 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -53.88 -43.37 69.55 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.96 0.8 . . . . 0.0 111.701 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.1 -42.14 85.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.669 0.788 . . . . 0.0 110.432 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -75.77 -21.18 57.65 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.46 1.104 . . . . 0.0 112.445 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 83.8 m -95.0 116.81 66.73 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.27 169.81 16.05 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.409 2.073 . . . . 0.0 112.744 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.502 HG12 ' SD ' ' A' ' 1' ' ' MET . 98.2 t -121.91 134.62 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 169.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.8 p -128.0 155.69 43.89 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.118 0.967 . . . . 0.0 108.753 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.9 134.08 55.66 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.613 0.571 . . . . 0.0 111.67 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.1 -13.04 57.44 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-O 118.979 -0.901 . . . . 0.0 114.393 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -60.25 137.8 58.05 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -82.43 82.04 8.04 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 62.2 mt -88.58 95.41 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.87 106.13 16.64 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -174.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.8 mt -93.04 100.93 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.539 0.685 . . . . 0.0 109.44 -174.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.1 mt . . . . . 0 C--N 1.325 -0.478 0 C-N-CA 124.286 1.035 . . . . 0.0 110.746 176.834 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.594 0.235 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.551 HD13 ' HB3' ' A' ' 9' ' ' GLN . 48.1 tp -89.24 128.15 35.82 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.9 m -140.25 158.33 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.591 1.156 . . . . 0.0 109.325 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -92.29 98.78 11.72 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 62.1 mt -106.61 120.33 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.9 m120 64.01 21.27 12.54 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.692 1.197 . . . . 0.0 111.945 -176.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.75 0.51 78.47 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 119.721 -0.488 . . . . 0.0 114.12 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -115.21 161.11 18.89 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.778 0.789 . . . . 0.0 110.0 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.551 ' HB3' HD13 ' A' ' 2' ' ' LEU . 2.0 mp0 -81.6 118.75 23.03 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -127.64 125.75 40.73 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.685 1.194 . . . . 0.0 109.605 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -95.1 113.51 25.21 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.26 157.38 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.697 0.799 . . . . 0.0 110.775 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.15 -2.29 15.0 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.744 0.818 . . . . 0.0 110.607 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 m -60.55 -44.66 95.89 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.76 1.224 . . . . 0.0 112.972 -168.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 75.45 -43.17 0.49 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.245 1.418 . . . . 0.0 113.227 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -97.18 146.51 25.0 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.496 HG11 HG11 ' A' ' 33' ' ' VAL . 54.9 t -67.91 -31.67 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 123.687 0.617 . . . . 0.0 110.457 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.26 -50.25 72.46 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.668 0.387 . . . . 0.0 110.539 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.84 72.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.602 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.2 tp -68.42 -49.24 61.38 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.794 0.838 . . . . 0.0 111.384 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.447 ' HE3' HG22 ' A' ' 58' ' ' ILE . 92.6 mmm -68.49 -22.49 64.55 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.368 0.667 . . . . 0.0 110.325 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -81.67 -39.39 24.43 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.552 0.341 . . . . 0.0 111.493 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.65 -42.62 98.09 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.696 0.798 . . . . 0.0 110.26 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -88.18 -0.09 56.68 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.983 0.913 . . . . 0.0 111.436 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.0 t70 64.31 20.84 12.33 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.04 1.336 . . . . 0.0 112.437 173.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.0 m . . . . . 0 CA--C 1.553 1.09 0 C-N-CA 124.318 1.047 . . . . 0.0 111.884 -178.135 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.92 153.26 24.76 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.496 HG11 HG11 ' A' ' 17' ' ' VAL . 9.3 p -105.13 146.01 12.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -126.87 101.83 6.76 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.13 116.92 24.63 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.411 ' N ' HD21 ' A' ' 36' ' ' ASN . 0.8 OUTLIER 65.02 28.44 12.46 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 124.604 1.19 . . . . 0.0 110.276 -172.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 68.92 22.2 7.21 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.473 1.509 . . . . 0.0 112.751 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -114.58 115.79 27.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.932 0.893 . . . . 0.0 108.91 172.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.1 t -66.65 120.77 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.906 0.882 . . . . 0.0 112.109 -170.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.446 ' HB ' HG12 ' A' ' 33' ' ' VAL . 91.7 t -95.52 126.6 45.03 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.981 1.312 . . . . 0.0 109.248 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.45 157.19 59.44 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 123.111 2.54 . . . . 0.0 112.475 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.448 ' HA ' ' CE2' ' A' ' 45' ' ' TRP . 74.7 ttt180 -59.05 -40.59 85.59 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.921 0.889 . . . . 0.0 112.695 -171.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.41 -17.97 54.48 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.885 0.741 . . . . 0.0 114.349 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -102.89 -8.28 20.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.448 ' CE2' ' HA ' ' A' ' 42' ' ' ARG . 50.7 m0 -55.35 -37.19 67.15 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 120.991 0.424 . . . . 0.0 111.866 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.21 -50.03 71.88 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.343 1.057 . . . . 0.0 111.445 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.1 2.28 40.14 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.594 0.758 . . . . 0.0 112.515 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.3 m -104.53 122.52 43.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.412 0.685 . . . . 0.0 109.517 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.96 161.36 18.38 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.711 2.274 . . . . 0.0 114.584 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.2 94.59 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.7 p -104.36 142.74 34.03 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.03 127.42 31.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.4 1.08 . . . . 0.0 113.319 -167.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.03 12.92 75.78 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-O 119.397 -0.668 . . . . 0.0 114.455 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.96 147.06 25.91 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.869 0.835 . . . . 0.0 111.119 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -84.86 81.75 8.75 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.918 1.287 . . . . 0.0 109.842 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 72.7 mt -88.37 96.43 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.911 0.884 . . . . 0.0 109.158 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 10.4 tp10 -93.65 111.14 22.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.447 HG22 ' HE3' ' A' ' 21' ' ' MET . 55.7 mt -100.55 104.02 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.728 0 C-N-CA 124.304 1.042 . . . . 0.0 110.389 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.403 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.722 0.296 . . . . 0.0 111.213 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 40.8 tp -90.82 116.51 28.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.178 0.991 . . . . 0.0 110.012 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -129.66 140.6 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.406 0.682 . . . . 0.0 110.495 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 59.9 m -71.33 104.58 3.21 Favored 'General case' 0 C--O 1.216 -0.674 0 C-N-CA 123.915 0.886 . . . . 0.0 110.295 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 46.6 mt -102.32 105.45 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 122.825 0.45 . . . . 0.0 109.955 175.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.8 m120 65.62 31.78 9.64 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.09 1.356 . . . . 0.0 112.308 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.13 1.5 81.77 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.944 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -122.4 115.13 21.74 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.745 0.818 . . . . 0.0 109.112 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 1.2 mp0 -68.9 146.01 53.17 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.101 0.56 . . . . 0.0 110.143 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -150.92 139.57 20.66 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.564 0.346 . . . . 0.0 111.267 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.49 99.91 9.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.572 1.149 . . . . 0.0 109.098 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.3 m -121.61 158.73 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.188 0.995 . . . . 0.0 110.259 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -112.14 9.85 20.21 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.635 0.774 . . . . 0.0 110.075 172.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.0 m -73.37 94.04 2.01 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.576 0.75 . . . . 0.0 110.489 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.77 -3.25 37.24 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.432 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.0 t -129.49 148.69 51.42 Favored 'General case' 0 C--O 1.247 0.958 0 C-N-CA 124.616 1.166 . . . . 0.0 109.62 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.469 HG11 HG13 ' A' ' 33' ' ' VAL . 53.5 t -66.32 -33.37 63.07 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.779 0.832 . . . . 0.0 110.623 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.25 -51.62 68.77 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.5 0.72 . . . . 0.0 111.147 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.74 79.93 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.85 0.719 . . . . 0.0 111.301 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.17 -53.71 18.64 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 123.819 0.699 . . . . 0.0 111.462 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.575 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 65.8 mtp -69.79 -34.34 73.61 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.442 0.297 . . . . 0.0 111.498 -175.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.2 m -68.41 -36.09 78.6 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.523 0.329 . . . . 0.0 110.762 175.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.67 -47.31 84.23 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.204 0.526 . . . . 0.0 110.219 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.7 mt -75.79 -8.14 56.14 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.442 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.0 t70 61.42 54.62 3.08 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.145 1.378 . . . . 0.0 110.384 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.7 m . . . . . 0 CA--C 1.544 0.735 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.801 179.038 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.931 0.396 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.43 -175.26 2.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.762 1.225 . . . . 0.0 108.991 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.575 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.1 p -144.96 156.08 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.163 0.585 . . . . 0.0 110.132 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -132.28 102.16 5.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.954 0.901 . . . . 0.0 109.011 176.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.8 tp -86.66 114.99 23.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 56.52 36.29 27.34 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.078 0.951 . . . . 0.0 110.863 -170.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 74.02 -2.03 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.97 1.708 . . . . 0.0 113.106 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -95.87 122.11 38.31 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 59.0 t -70.3 132.75 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.559 0.744 . . . . 0.0 111.799 -170.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.57 124.44 40.77 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -64.61 154.89 69.82 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.71 2.273 . . . . 0.0 111.703 170.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -64.41 -44.14 92.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.694 0.798 . . . . 0.0 112.202 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.61 -3.99 29.84 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.252 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -113.34 -9.45 13.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.147 0.979 . . . . 0.0 113.033 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -52.04 -39.78 60.08 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 119.011 0.823 . . . . 0.0 111.157 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -71.28 -41.9 69.42 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.956 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.95 -12.31 60.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.403 1.081 . . . . 0.0 112.683 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -105.1 115.15 62.78 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -176.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.51 159.14 32.42 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.602 2.201 . . . . 0.0 112.957 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.47 HG11 HD11 ' A' ' 56' ' ' ILE . 84.9 t -119.06 139.19 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.54 1.136 . . . . 0.0 108.004 174.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.8 p -126.26 165.61 18.65 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.256 1.022 . . . . 0.0 109.206 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 1' ' ' MET . . . -61.7 129.97 43.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.965 0.906 . . . . 0.0 112.244 -176.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.52 2.05 68.09 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.218 -0.768 . . . . 0.0 114.164 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.31 147.14 44.76 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 117.897 0.848 . . . . 0.0 111.755 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -94.28 92.39 7.19 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.47 HD11 HG11 ' A' ' 50' ' ' VAL . 3.1 mp -84.93 95.02 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 172.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 36.0 tt0 -96.47 100.39 11.99 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.4 mt -73.95 103.55 2.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.2 mt . . . . . 0 N--CA 1.448 -0.539 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.528 178.562 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptp . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.584 0.231 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 52.4 tp -82.18 114.53 20.76 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.31 -180.0 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.276 1.03 . . . . 0.0 110.57 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.6 m -117.74 100.3 7.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.138 0.575 . . . . 0.0 109.655 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.522 HD13 HD11 ' A' ' 24' ' ' LEU . 69.5 mt -102.41 122.27 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.62 0.768 . . . . 0.0 108.98 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 58.92 30.39 20.13 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.274 1.03 . . . . 0.0 111.927 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.06 -2.74 87.08 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 120.028 -0.318 . . . . 0.0 113.64 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.3 136.0 46.8 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.099 0.96 . . . . 0.0 109.929 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -77.92 113.14 15.54 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -132.1 136.61 47.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.545 1.138 . . . . 0.0 109.512 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.95 131.85 35.36 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.81 155.26 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.632 0.773 . . . . 0.0 110.449 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -93.63 -43.34 8.72 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.041 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 m -58.83 120.99 10.02 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.857 0.863 . . . . 0.0 112.353 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.54 -0.37 57.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.985 0.914 . . . . 0.0 111.261 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.5 t -116.17 141.39 48.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.384 1.073 . . . . 0.0 108.891 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.64 -33.62 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.497 0.719 . . . . 0.0 110.993 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.73 -53.01 61.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.525 0.33 . . . . 0.0 110.308 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.465 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -60.19 -39.45 86.56 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.065 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.2 tp -66.0 -48.1 72.32 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.842 0.457 . . . . 0.0 111.255 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.483 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 83.0 mtp -67.94 -25.68 65.58 Favored 'General case' 0 C--O 1.211 -0.955 0 O-C-N 123.372 0.42 . . . . 0.0 110.238 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.1 m -69.45 -40.95 76.85 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 118.16 0.436 . . . . 0.0 110.343 172.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 18.2 mm-40 -65.93 -37.5 86.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.943 0.497 . . . . 0.0 111.105 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.522 HD11 HD13 ' A' ' 5' ' ' ILE . 95.5 mt -82.0 -12.86 58.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.02 0.928 . . . . 0.0 111.314 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 63.62 51.13 2.57 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.105 1.362 . . . . 0.0 110.553 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.3 m . . . . . 0 CA--C 1.55 0.947 0 C-N-CA 125.339 1.456 . . . . 0.0 110.443 -178.271 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.0 147.8 52.27 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.207 1.003 . . . . 0.0 109.115 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 5.6 p -106.82 135.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -116.46 100.98 8.24 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.0 tp -88.71 113.72 24.57 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 56.9 42.85 25.78 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.74 1.275 . . . . 0.0 110.072 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 68.04 21.15 8.89 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.385 1.474 . . . . 0.0 112.328 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -124.59 115.44 20.82 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.804 0.842 . . . . 0.0 108.868 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 58.8 t -63.82 127.96 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.55 0.74 . . . . 0.0 111.144 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.433 ' HB ' HG12 ' A' ' 33' ' ' VAL . 98.4 t -96.02 126.64 43.77 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.401 1.081 . . . . 0.0 109.612 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.38 146.22 68.01 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.44 2.093 . . . . 0.0 112.47 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -48.02 -48.55 32.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.892 1.677 . . . . 0.0 113.315 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.1 -15.65 60.99 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 123.749 0.655 . . . . 0.0 114.561 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -106.68 -10.04 16.28 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 117.922 -1.037 . . . . 0.0 112.34 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -46.8 -40.55 13.92 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 123.646 0.778 . . . . 0.0 112.554 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -70.08 -41.01 74.67 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.955 0.902 . . . . 0.0 110.64 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -76.72 -11.91 59.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.595 1.158 . . . . 0.0 111.418 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.0 m -92.78 118.12 67.82 Favored Pre-proline 0 C--O 1.243 0.722 0 C-N-CA 123.515 0.726 . . . . 0.0 109.55 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -82.14 156.73 17.42 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.207 1.938 . . . . 0.0 113.021 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.3 t -96.99 138.64 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.748 1.219 . . . . 0.0 107.867 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.9 m -130.02 139.37 51.03 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.228 1.011 . . . . 0.0 109.461 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.66 114.6 2.82 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.96 0.346 . . . . 0.0 111.392 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.74 20.68 42.82 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-O 119.371 -0.683 . . . . 0.0 114.253 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -84.73 165.69 17.64 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.004 0.902 . . . . 0.0 110.229 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.74 85.5 2.24 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.861 0.464 . . . . 0.0 110.117 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 82.8 mt -88.01 97.32 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 36.6 tt0 -103.99 102.52 12.29 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.211 0.605 . . . . 0.0 109.974 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 64.3 mt -97.88 105.77 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.474 0.739 0 C-N-CA 124.52 1.128 . . . . 0.0 110.508 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.5 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 120.718 0.294 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 9' ' ' GLN . 59.2 tp -79.65 119.08 22.1 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.954 0.902 . . . . 0.0 110.324 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.47 162.97 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.344 1.058 . . . . 0.0 109.069 176.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 m -105.02 99.99 9.6 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.611 HD13 HD13 ' A' ' 24' ' ' LEU . 32.9 mt -101.5 108.96 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.732 0.813 . . . . 0.0 109.321 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.4 m120 63.48 22.73 13.36 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.249 1.02 . . . . 0.0 112.999 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.94 8.75 72.1 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.358 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -103.91 131.27 51.3 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.729 0.811 . . . . 0.0 108.834 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.47 ' HB3' HD12 ' A' ' 2' ' ' LEU . 24.9 mt-30 -80.05 113.84 18.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 172.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -137.3 130.56 30.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.146 0.578 . . . . 0.0 110.225 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -82.52 129.52 34.93 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.751 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.99 159.56 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.764 0.826 . . . . 0.0 110.136 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -112.32 -12.69 13.53 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.877 0.871 . . . . 0.0 110.371 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 p -66.16 105.47 1.4 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.128 0.971 . . . . 0.0 110.973 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.95 -17.56 62.07 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.813 0.845 . . . . 0.0 111.748 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.7 t -105.03 143.24 33.49 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.01 0.924 . . . . 0.0 110.097 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.16 -33.63 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.62 95.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.843 0.457 . . . . 0.0 110.511 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.08 79.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.084 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.1 tp -69.42 -43.13 74.02 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.659 0.599 . . . . 0.0 110.695 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.411 ' HE2' HG22 ' A' ' 58' ' ' ILE . 91.8 mmm -67.44 -29.12 68.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.915 0.486 . . . . 0.0 109.988 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 m -79.99 -29.25 39.46 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.682 0.393 . . . . 0.0 110.663 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -68.48 -37.52 80.2 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.759 0.824 . . . . 0.0 109.931 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.611 HD13 HD13 ' A' ' 5' ' ' ILE . 57.4 mt -98.26 8.62 44.56 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.349 1.06 . . . . 0.0 110.851 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 p30 51.03 23.78 1.63 Allowed 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 125.814 1.646 . . . . 0.0 113.389 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.8 m . . . . . 0 CA--C 1.555 1.14 0 C-N-CA 124.749 1.219 . . . . 0.0 110.655 177.899 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.556 0.693 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.59 168.32 22.3 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.764 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG12 ' HB ' ' A' ' 40' ' ' VAL . 12.8 p -130.91 147.98 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -126.56 104.96 8.4 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.477 1.111 . . . . 0.0 108.447 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 tp -88.35 109.82 20.29 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 57.06 52.22 9.42 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 124.662 1.226 . . . . 0.0 111.191 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 71.18 -2.1 2.49 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.507 1.523 . . . . 0.0 112.988 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -103.7 110.26 22.28 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.78 0.832 . . . . 0.0 108.943 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 78.0 t -69.92 115.76 9.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 122.896 0.479 . . . . 0.0 110.404 -175.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.457 ' HB ' HG12 ' A' ' 33' ' ' VAL . 58.4 t -87.23 122.39 70.94 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.23 1.012 . . . . 0.0 108.637 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.9 159.17 53.42 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 122.767 2.311 . . . . 0.0 111.145 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -61.56 -34.05 74.91 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.621 0.576 . . . . 0.0 111.985 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.87 -5.85 21.13 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.792 -0.64 . . . . 0.0 114.066 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -119.46 -6.86 10.24 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 117.655 -1.164 . . . . 0.0 112.827 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -55.86 -46.47 78.21 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 120.132 1.333 . . . . 0.0 111.454 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.51 -39.45 67.61 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.782 0.433 . . . . 0.0 110.108 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.77 -22.37 65.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.713 0.805 . . . . 0.0 112.617 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.5 m -99.56 127.88 32.99 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 123.554 0.742 . . . . 0.0 109.596 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -83.34 167.25 13.79 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.558 2.172 . . . . 0.0 113.429 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 56' ' ' ILE . 67.7 t -115.45 125.59 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.278 1.031 . . . . 0.0 108.37 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.5 p -123.8 160.65 26.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.098 0.559 . . . . 0.0 110.207 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' A' ' 1' ' ' MET . . . -64.29 142.02 58.57 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.824 1.249 . . . . 0.0 112.588 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.28 -13.2 60.53 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-O 119.71 -0.495 . . . . 0.0 114.01 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.82 145.16 40.86 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.73 0.765 . . . . 0.0 112.049 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -93.14 99.67 12.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.207 1.003 . . . . 0.0 110.127 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 61.6 mt -97.89 97.51 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.901 0.881 . . . . 0.0 108.924 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -96.83 107.11 19.54 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.707 0.803 . . . . 0.0 109.536 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.411 HG22 ' HE2' ' A' ' 21' ' ' MET . 58.9 mt -94.96 114.84 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.414 HD12 ' H ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.634 0 C-N-CA 123.455 0.702 . . . . 0.0 110.414 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.52 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 24.3 ptp . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.653 0.264 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 36.2 tp -81.49 112.32 18.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.39 165.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.955 0.902 . . . . 0.0 110.087 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.7 m -111.64 100.73 9.21 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.972 0.509 . . . . 0.0 109.871 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 20' ' ' LEU . 70.7 mt -108.35 117.8 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 124.109 0.964 . . . . 0.0 109.203 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 65.41 24.49 11.99 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.517 1.127 . . . . 0.0 112.644 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.18 -3.08 84.18 Favored Glycine 0 N--CA 1.47 0.908 0 CA-C-N 116.445 -0.343 . . . . 0.0 113.156 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -105.78 154.97 19.76 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.613 1.165 . . . . 0.0 108.42 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -105.27 136.12 45.38 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.074 0.397 . . . . 0.0 110.07 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -141.3 130.97 24.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.293 1.037 . . . . 0.0 109.503 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.15 124.96 29.68 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.3 m -135.99 161.92 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.212 1.005 . . . . 0.0 110.724 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.82 24.08 5.0 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.781 1.232 . . . . 0.0 108.884 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.3 m -55.98 -48.11 76.44 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.932 1.293 . . . . 0.0 113.705 -171.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 77.02 -50.33 0.55 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.953 1.701 . . . . 0.0 111.701 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -108.19 151.55 25.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.033 0.933 . . . . 0.0 109.301 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 21' ' ' MET . 87.6 t -66.43 -24.97 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 O-C-N 124.056 0.848 . . . . 0.0 110.754 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.63 -56.73 15.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.73 0.812 . . . . 0.0 110.512 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.12 -30.32 68.03 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.465 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.426 HD11 HD12 ' A' ' 5' ' ' ILE . 48.3 tp -64.49 -54.74 27.68 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.752 0.821 . . . . 0.0 110.703 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.508 ' HE2' HG22 ' A' ' 58' ' ' ILE . 97.6 mmm -64.78 -26.43 68.35 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.005 0.522 . . . . 0.0 111.527 -177.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.8 m -75.02 -38.49 61.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.66 0.784 . . . . 0.0 110.936 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.91 -45.13 93.93 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.695 HD11 HD12 ' A' ' 58' ' ' ILE . 48.1 mt -72.65 -12.27 60.97 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.569 1.147 . . . . 0.0 111.828 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 63.62 14.36 8.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.936 1.294 . . . . 0.0 111.626 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.2 m . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 124.886 1.274 . . . . 0.0 109.098 179.23 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 121.516 0.674 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.54 154.3 50.11 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.422 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 8.8 p -123.1 150.33 27.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.86 99.32 5.7 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.511 HD11 HG12 ' A' ' 56' ' ' ILE . 18.3 tp -90.08 121.12 31.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.73 23.04 8.73 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.635 1.174 . . . . 0.0 108.734 -170.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.464 ' CE2' ' HB3' ' A' ' 55' ' ' GLU . 59.3 m-85 68.96 3.96 4.28 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.848 1.659 . . . . 0.0 113.059 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -92.63 127.17 38.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.282 0.633 . . . . 0.0 109.39 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.9 t -66.27 114.27 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.748 0.819 . . . . 0.0 111.024 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.402 ' HB ' HG12 ' A' ' 33' ' ' VAL . 80.2 t -87.61 120.41 71.03 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.1 143.36 99.55 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.096 2.531 . . . . 0.0 110.739 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -57.8 -40.07 79.07 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.96 -24.19 62.47 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 123.803 0.689 . . . . 0.0 114.173 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -103.13 2.39 34.53 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -50.79 -41.93 57.5 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 118.13 0.423 . . . . 0.0 111.031 175.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.25 -49.42 60.76 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.578 0.751 . . . . 0.0 110.884 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.15 -26.02 67.24 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.826 0.85 . . . . 0.0 111.694 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.2 m -95.52 119.56 65.04 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.73 167.88 23.28 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.856 2.371 . . . . 0.0 113.504 176.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.6 t -104.29 145.76 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.609 1.163 . . . . 0.0 109.305 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.1 m -108.58 148.57 30.12 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.579 0.752 . . . . 0.0 109.683 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HA ' ' HB2' ' A' ' 1' ' ' MET . . . -65.67 115.34 5.74 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.735 0.814 . . . . 0.0 110.741 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.86 41.1 73.99 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 123.365 0.415 . . . . 0.0 112.551 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.95 149.03 28.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.084 0.554 . . . . 0.0 110.364 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.464 ' HB3' ' CE2' ' A' ' 37' ' ' TYR . 2.9 mp0 -84.63 81.71 8.74 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 121.854 0.835 . . . . 0.0 109.586 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.511 HG12 HD11 ' A' ' 35' ' ' LEU . 32.4 mt -99.04 153.65 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.729 1.212 . . . . 0.0 109.637 -177.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -151.17 125.01 9.12 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.469 0.708 . . . . 0.0 109.14 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.695 HD12 HD11 ' A' ' 24' ' ' LEU . 66.8 mt -80.37 105.36 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.4 mt . . . . . 0 C--O 1.221 -0.44 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.282 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtm . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.62 103.52 9.59 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.64 152.13 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.363 1.065 . . . . 0.0 109.118 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 38.9 m -86.37 106.44 17.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.156 0.582 . . . . 0.0 109.577 176.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 70.2 mt -100.22 106.2 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.986 0.515 . . . . 0.0 110.733 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 t30 66.5 23.61 10.44 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.709 1.204 . . . . 0.0 110.708 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.4 -15.58 62.58 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.354 -174.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -98.18 110.31 22.91 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.38 0.672 . . . . 0.0 109.314 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 18.5 mt-30 -71.94 114.5 10.11 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 120.786 0.326 . . . . 0.0 110.15 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.466 ' NH1' HG12 ' A' ' 12' ' ' VAL . 61.1 ttt-85 -131.23 143.87 50.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.419 1.088 . . . . 0.0 109.265 -176.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.3 137.98 35.74 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.466 HG12 ' NH1' ' A' ' 10' ' ' ARG . 33.1 m -114.81 152.94 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 122.841 0.456 . . . . 0.0 111.261 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.92 -38.43 11.7 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 168.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -66.44 120.05 12.69 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.938 0.895 . . . . 0.0 111.849 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.35 -0.88 52.24 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.787 0.835 . . . . 0.0 111.529 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.7 p -122.14 148.11 45.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.059 0.944 . . . . 0.0 109.093 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.6 t -68.61 -31.43 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 123.478 0.711 . . . . 0.0 111.486 -176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.34 -52.8 63.13 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.896 0.478 . . . . 0.0 110.88 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.63 -30.65 71.67 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.137 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.4 tp -71.16 -44.92 64.55 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 124.0 0.812 . . . . 0.0 111.483 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.504 ' HE3' HG22 ' A' ' 58' ' ' ILE . 98.8 mmm -70.03 -24.38 63.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.719 0.408 . . . . 0.0 110.681 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -74.38 -43.01 58.27 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.764 0.426 . . . . 0.0 110.413 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.12 -37.87 86.76 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.719 1.208 . . . . 0.0 110.895 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.548 HD11 HD12 ' A' ' 58' ' ' ILE . 71.3 mt -88.65 -7.73 55.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.306 1.042 . . . . 0.0 111.367 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.5 t70 59.78 42.68 16.33 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.027 1.331 . . . . 0.0 110.933 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.471 0.615 0 C-N-CA 124.386 1.074 . . . . 0.0 110.769 176.505 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 121.425 0.631 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.416 ' HA ' ' HZ2' ' A' ' 45' ' ' TRP . . . -136.02 -177.84 4.88 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.412 1.485 . . . . 0.0 108.226 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.405 HG13 ' NE1' ' A' ' 45' ' ' TRP . 7.9 p -149.8 159.61 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.543 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . . . -133.15 109.86 9.76 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.013 0.525 . . . . 0.0 109.737 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.3 tp -88.59 113.02 23.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 59.48 36.44 23.03 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.154 0.982 . . . . 0.0 110.614 -172.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 72.0 13.18 5.97 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.061 1.344 . . . . 0.0 112.217 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -102.02 112.07 24.58 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.922 0.889 . . . . 0.0 109.247 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.4 t -62.93 111.03 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.557 0 O-C-N 123.921 0.763 . . . . 0.0 110.73 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -90.41 121.36 68.54 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.41 151.84 75.71 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.538 2.159 . . . . 0.0 111.053 173.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -58.24 -38.09 76.18 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.916 0.886 . . . . 0.0 113.053 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.67 3.55 25.83 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 114.567 0.587 . . . . 0.0 114.567 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -121.73 -9.96 8.8 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.882 0.873 . . . . 0.0 112.026 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.416 ' HZ2' ' HA ' ' A' ' 32' ' ' ALA . 40.9 m0 -49.66 -39.69 37.12 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.124 0.57 . . . . 0.0 112.23 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -70.06 -43.07 71.96 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.772 0.829 . . . . 0.0 110.819 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -73.08 -14.59 61.43 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 112.303 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.6 m -100.45 120.37 56.38 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.478 0.711 . . . . 0.0 109.324 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -83.99 166.81 12.88 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.897 2.398 . . . . 0.0 113.278 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.6 129.22 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.019 1.328 . . . . 0.0 107.855 175.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.9 p -125.22 149.53 47.89 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.99 126.88 29.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.842 0.857 . . . . 0.0 111.4 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.56 -4.05 39.89 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 119.564 -0.576 . . . . 0.0 113.358 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -78.11 154.64 31.11 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 117.443 0.622 . . . . 0.0 111.366 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -110.09 90.91 3.45 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.778 0.831 . . . . 0.0 109.387 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 4.0 mp -88.13 97.45 6.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HG3' ' HB2' ' A' ' 34' ' ' ALA . 8.2 pt-20 -99.1 125.44 44.63 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.69 0.757 . . . . 0.0 109.231 175.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.548 HD12 HD11 ' A' ' 24' ' ' LEU . 70.2 mt -84.74 126.22 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.453 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 C--N 1.328 -0.366 0 C-N-CA 123.687 0.795 . . . . 0.0 109.724 -177.859 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 47.3 tp -79.11 96.88 5.95 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.92 139.03 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.41 1.084 . . . . 0.0 109.642 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 8.7 m -84.5 99.66 10.86 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -176.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 65.9 mt -98.6 108.31 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.626 0.77 . . . . 0.0 109.707 -177.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.485 HD21 ' N ' ' A' ' 6' ' ' ASN . 0.7 OUTLIER 67.66 34.09 4.66 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.9 1.28 . . . . 0.0 110.899 176.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.53 10.16 84.64 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.441 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -125.68 110.99 14.43 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.502 1.121 . . . . 0.0 108.244 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 79.6 mt-30 -66.44 143.89 56.84 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -151.43 128.34 11.0 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.815 1.246 . . . . 0.0 108.595 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.83 116.32 22.1 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.67 155.78 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.286 1.035 . . . . 0.0 109.607 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -109.44 -12.6 14.7 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.846 0.859 . . . . 0.0 109.506 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.2 m -57.46 100.07 0.05 OUTLIER 'General case' 0 C--N 1.353 0.731 0 C-N-CA 124.651 1.18 . . . . 0.0 110.672 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.69 -13.98 60.0 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.631 0.773 . . . . 0.0 111.967 -177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 t -114.42 142.01 46.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 109.46 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 33' ' ' VAL . 94.9 t -69.65 -27.07 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.437 0.695 . . . . 0.0 110.435 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.32 -54.32 42.25 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.79 -31.7 71.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.186 0.594 . . . . 0.0 111.474 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.2 -51.97 46.89 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.491 0.716 . . . . 0.0 111.195 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.545 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 76.4 mtp -75.02 -18.8 60.29 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.782 0.433 . . . . 0.0 111.425 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -67.1 -45.23 77.87 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 166.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -67.1 -41.05 86.92 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.277 1.031 . . . . 0.0 111.613 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 5' ' ' ILE . 80.9 mt -80.4 -11.55 59.68 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.835 0.854 . . . . 0.0 110.609 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.3 t70 62.81 35.14 13.94 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.138 1.375 . . . . 0.0 110.817 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.606 ' SG ' HD13 ' A' ' 58' ' ' ILE . 59.8 m . . . . . 0 CA--C 1.545 0.753 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.394 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 121.401 0.619 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -153.29 168.97 24.23 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.272 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.545 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 6.6 p -128.76 139.03 52.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 C-N-CA 124.057 0.943 . . . . 0.0 108.855 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.427 ' HB1' ' HB2' ' A' ' 57' ' ' GLU . . . -108.08 104.19 13.57 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.0 tp -90.11 107.02 18.87 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 173.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.16 37.8 14.16 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.65 1.18 . . . . 0.0 110.42 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 71.98 11.85 6.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.084 1.754 . . . . 0.0 112.86 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.84 109.32 21.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 84.7 t -71.2 122.91 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.127 0.571 . . . . 0.0 109.937 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.47 126.97 48.2 Favored Pre-proline 0 C--O 1.246 0.917 0 C-N-CA 124.293 1.037 . . . . 0.0 109.322 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.81 145.69 59.92 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.087 2.525 . . . . 0.0 112.389 170.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -60.33 -42.19 95.13 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.843 0.857 . . . . 0.0 112.277 -173.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.15 11.7 11.33 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-N 116.317 -0.401 . . . . 0.0 113.14 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -126.32 -6.93 6.44 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.243 1.017 . . . . 0.0 110.611 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 52.5 m0 -54.24 -33.74 59.11 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.19 0.596 . . . . 0.0 111.358 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -71.39 -39.58 71.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.983 0.913 . . . . 0.0 110.471 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.29 -17.9 63.1 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.083 0.953 . . . . 0.0 111.773 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 m -96.41 114.5 64.48 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.981 0.512 . . . . 0.0 109.84 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.74 155.85 53.66 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.214 1.943 . . . . 0.0 112.471 168.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.9 t -101.02 129.33 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -127.17 135.75 51.11 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.116 0.566 . . . . 0.0 109.831 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.49 133.69 56.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.657 1.183 . . . . 0.0 112.598 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.41 -6.1 71.18 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.351 -0.694 . . . . 0.0 114.372 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.29 164.23 15.02 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 117.872 0.836 . . . . 0.0 112.108 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -97.05 108.57 21.33 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.666 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 73.8 mt -111.38 96.96 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.94 0.896 . . . . 0.0 109.535 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.427 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -91.33 145.37 24.7 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.427 0.691 . . . . 0.0 109.242 177.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.606 HD13 ' SG ' ' A' ' 26' ' ' CYS . 99.6 mt -120.81 114.51 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.403 HD23 ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.312 0 C-N-CA 124.498 1.119 . . . . 0.0 108.641 -174.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 120.932 0.396 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 9' ' ' GLN . 8.5 tt -85.55 114.57 22.66 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.4 HG21 HG13 ' A' ' 5' ' ' ILE . 9.7 m -132.8 139.46 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.246 1.018 . . . . 0.0 110.568 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.9 m -67.79 100.43 0.93 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 55.7 mt -104.19 104.57 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.44 0.696 . . . . 0.0 109.328 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 62.45 31.43 17.13 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 122.375 1.083 . . . . 0.0 110.28 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.44 -6.52 83.25 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 121.649 -0.657 . . . . 0.0 113.402 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -106.31 105.59 15.7 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.502 ' HB3' HD22 ' A' ' 2' ' ' LEU . 27.0 mt-30 -61.21 107.23 0.72 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB3' HD13 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -118.72 121.53 40.33 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -169.177 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -81.42 112.78 19.0 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.921 0.888 . . . . 0.0 109.031 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.77 169.65 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.59 1.156 . . . . 0.0 109.85 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -129.59 17.77 5.82 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.383 0.673 . . . . 0.0 110.847 175.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.0 p -94.96 108.65 20.71 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.336 0.654 . . . . 0.0 109.311 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.79 -0.38 47.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.813 0.845 . . . . 0.0 112.035 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.0 t -110.34 135.62 50.78 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.153 0.981 . . . . 0.0 108.916 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.8 t -68.66 -26.69 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.153 0.581 . . . . 0.0 110.451 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.67 -55.2 18.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.086 0.554 . . . . 0.0 109.999 172.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.2 -30.1 69.15 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.65 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -69.11 -54.66 13.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.786 0.834 . . . . 0.0 110.867 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.588 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 78.8 mtp -70.04 -21.5 63.18 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.3 m -75.18 -37.89 61.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.638 0.375 . . . . 0.0 110.021 171.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.6 -40.92 98.45 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.854 0.861 . . . . 0.0 110.389 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.472 HD13 HD12 ' A' ' 5' ' ' ILE . 64.4 mt -86.89 -3.68 59.1 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.387 -176.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.49 19.67 10.52 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.245 1.418 . . . . 0.0 112.682 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.506 ' SG ' HG21 ' A' ' 58' ' ' ILE . 56.2 m . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 125.018 1.327 . . . . 0.0 111.237 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.995 0.426 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.71 159.67 40.92 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.46 1.104 . . . . 0.0 109.333 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.588 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 11.1 p -118.49 148.01 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.523 0.729 . . . . 0.0 110.103 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.507 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . . . -129.55 102.53 6.42 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.625 0.77 . . . . 0.0 110.221 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.472 HD12 HG12 ' A' ' 56' ' ' ILE . 64.3 tp -89.67 123.07 33.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.0 m120 64.38 39.13 7.3 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.555 1.142 . . . . 0.0 111.079 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 66.48 21.31 10.82 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.456 1.502 . . . . 0.0 112.0 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -131.89 123.53 27.67 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.946 0.899 . . . . 0.0 108.66 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 59.4 t -66.12 126.27 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.302 0.641 . . . . 0.0 111.07 -176.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.422 ' HB ' HG12 ' A' ' 33' ' ' VAL . 61.2 t -88.7 125.93 61.41 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.057 0.943 . . . . 0.0 109.085 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.06 146.56 91.11 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.605 2.203 . . . . 0.0 112.031 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -59.78 -39.17 84.01 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.37 -14.64 57.56 Favored Glycine 0 CA--C 1.532 1.095 0 O-C-N 123.752 0.657 . . . . 0.0 113.051 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -104.74 -16.67 14.88 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 117.73 -1.129 . . . . 0.0 112.676 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -46.61 -42.82 16.75 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 118.994 0.815 . . . . 0.0 111.908 -176.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -67.43 -42.72 82.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.566 1.146 . . . . 0.0 112.052 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -90.05 -2.98 58.2 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.917 0.487 . . . . 0.0 112.302 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.3 m -89.53 115.61 64.23 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.82 153.99 33.76 Favored 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 122.364 2.043 . . . . 0.0 112.785 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.3 t -105.22 119.27 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.561 1.144 . . . . 0.0 108.754 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 p -120.63 148.2 44.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.85 0.86 . . . . 0.0 109.88 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.72 131.81 49.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.139 0.976 . . . . 0.0 112.478 -171.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.62 -0.54 82.97 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-O 119.287 -0.729 . . . . 0.0 114.92 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.46 155.37 24.65 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 117.657 0.728 . . . . 0.0 111.561 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -87.77 92.41 9.1 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.594 1.158 . . . . 0.0 109.177 -173.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 62.1 mt -97.83 97.49 6.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 45.0 mt-10 -93.08 116.77 29.35 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.506 HG21 ' SG ' ' A' ' 26' ' ' CYS . 45.8 mm -98.16 118.1 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 123.169 0.588 . . . . 0.0 109.977 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.405 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 21.3 ptp . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 57.9 tp -79.2 107.11 11.71 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -110.74 179.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.043 0.937 . . . . 0.0 108.879 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 25.2 m -116.43 110.52 18.75 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -106.76 114.14 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.247 0.619 . . . . 0.0 109.603 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 65.35 26.97 12.04 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.054 1.342 . . . . 0.0 111.645 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.37 3.74 74.86 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.121 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -122.9 114.85 21.01 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.21 1.004 . . . . 0.0 109.232 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 13.9 pt20 -67.73 130.03 41.73 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.058 0.456 . . . . 0.0 111.193 -178.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 42.6 ttm105 -150.59 141.94 23.32 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.2 1.0 . . . . 0.0 109.045 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -80.82 137.78 36.22 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -124.11 144.71 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.114 0.483 . . . . 0.0 110.187 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -93.28 -23.17 18.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.348 1.059 . . . . 0.0 108.984 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.1 p -76.73 110.15 11.09 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.786 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.49 26.14 2.39 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.752 0.821 . . . . 0.0 110.938 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 57.7 m -146.48 149.41 33.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.917 0.887 . . . . 0.0 109.703 173.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.03 -36.51 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.138 0.975 . . . . 0.0 111.998 -174.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.05 -54.33 39.83 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 120.759 0.314 . . . . 0.0 110.495 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.82 -31.68 69.95 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.442 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.42 HD21 HG21 ' A' ' 56' ' ' ILE . 60.4 tp -67.25 -53.31 31.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.843 0.857 . . . . 0.0 111.135 177.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.526 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 71.5 mtp -69.71 -23.37 63.41 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.155 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.4 m -76.0 -35.22 59.64 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.74 -32.31 70.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.288 0.635 . . . . 0.0 110.762 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.35 2.93 56.04 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.477 0.711 . . . . 0.0 111.963 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 65.14 21.69 12.19 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.646 1.178 . . . . 0.0 111.859 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.598 ' SG ' HG21 ' A' ' 58' ' ' ILE . 60.6 m . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 124.596 1.158 . . . . 0.0 110.628 -177.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . . . -124.9 171.92 9.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.981 0.912 . . . . 0.0 108.65 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.526 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.2 p -135.38 140.33 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -110.73 105.71 14.67 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 170.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.3 tp -92.68 115.37 28.05 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 57.83 37.78 27.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.947 1.299 . . . . 0.0 111.734 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 72.49 30.68 1.89 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.93 1.292 . . . . 0.0 112.193 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -137.38 128.77 28.14 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.718 0.807 . . . . 0.0 109.489 169.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.0 t -72.27 116.76 14.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 123.096 0.559 . . . . 0.0 110.842 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.422 ' HB ' HG12 ' A' ' 33' ' ' VAL . 33.7 t -86.79 120.65 71.86 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.82 155.63 68.03 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.656 2.237 . . . . 0.0 111.302 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -60.14 -32.29 70.88 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.951 0.901 . . . . 0.0 112.808 -173.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.27 -5.22 26.94 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 123.857 0.723 . . . . 0.0 114.502 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -109.06 -25.96 10.41 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.694 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -48.39 -45.69 36.15 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -167.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.49 -47.78 77.63 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.05 0.54 . . . . 0.0 110.371 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.55 -11.34 60.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.298 1.039 . . . . 0.0 112.345 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.6 m -101.6 112.4 65.13 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 98.0 Cg_endo -77.59 171.44 17.51 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.025 1.816 . . . . 0.0 113.081 175.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.3 t -119.32 130.64 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.112 1.365 . . . . 0.0 107.825 172.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.4 p -120.13 156.44 31.05 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.82 0.848 . . . . 0.0 108.932 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' A' ' 1' ' ' MET . . . -56.21 135.57 53.27 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.593 0.757 . . . . 0.0 111.69 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.15 -16.59 58.06 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.689 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -60.37 127.8 33.56 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.681 0.741 . . . . 0.0 111.991 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -79.82 86.57 5.36 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.42 HG21 HD21 ' A' ' 20' ' ' LEU . 55.6 mt -89.52 149.73 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.721 1.208 . . . . 0.0 108.878 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 35.2 tt0 -147.33 137.15 22.98 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.598 HG21 ' SG ' ' A' ' 26' ' ' CYS . 36.9 mm -103.31 111.0 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 57.6 mt . . . . . 0 C--O 1.238 0.451 0 C-N-CA 123.747 0.819 . . . . 0.0 110.404 172.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 111.23 0.085 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 9' ' ' GLN . 7.7 tt -82.06 113.46 19.95 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -109.07 -179.68 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.098 1.359 . . . . 0.0 110.539 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.0 m -129.23 101.97 6.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.202 0.601 . . . . 0.0 109.719 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.9 mt -103.4 120.38 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.609 0.764 . . . . 0.0 109.177 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.62 30.42 18.59 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.917 1.287 . . . . 0.0 112.141 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.07 -1.66 88.68 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.595 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -113.5 132.29 55.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.436 1.094 . . . . 0.0 108.293 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.526 ' HB3' HD22 ' A' ' 2' ' ' LEU . 1.5 mp0 -80.11 121.98 26.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.209 0.604 . . . . 0.0 111.038 -175.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -128.2 145.96 50.87 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.418 1.087 . . . . 0.0 108.138 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 39.9 tt0 -93.12 117.5 30.14 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 173.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -113.61 174.19 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.742 0.817 . . . . 0.0 109.999 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -149.89 18.16 0.89 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.003 0.921 . . . . 0.0 109.642 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.8 m -64.17 -31.54 72.77 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.086 0.954 . . . . 0.0 112.644 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 75.79 -46.69 0.56 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.605 1.562 . . . . 0.0 112.427 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.6 t -103.52 146.92 27.82 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.124 0.97 . . . . 0.0 109.914 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.03 -30.67 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 123.618 0.767 . . . . 0.0 110.723 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.3 -55.81 21.69 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.931 0.492 . . . . 0.0 110.098 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.45 65.28 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 124.341 1.026 . . . . 0.0 111.506 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.73 -59.86 3.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.786 0.834 . . . . 0.0 111.34 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.472 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 81.2 mtp -70.7 -21.35 62.58 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.816 0.446 . . . . 0.0 111.651 -174.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 m -70.01 -43.9 70.43 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.152 0.581 . . . . 0.0 110.122 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -73.63 -31.82 63.72 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.002 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.76 -10.89 59.84 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.532 0.733 . . . . 0.0 110.882 175.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 62.83 33.18 15.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.544 1.138 . . . . 0.0 111.404 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.1 m . . . . . 0 N--CA 1.477 0.878 0 C-N-CA 125.276 1.43 . . . . 0.0 110.001 179.968 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.77 -179.38 3.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.466 0.706 . . . . 0.0 109.525 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.472 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.1 p -140.54 146.14 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.053 0.541 . . . . 0.0 109.666 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -117.51 98.99 6.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.3 tp -90.97 118.86 30.69 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 56.62 33.25 22.43 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.904 0.882 . . . . 0.0 111.465 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 68.97 15.3 8.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.036 1.334 . . . . 0.0 112.185 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -109.24 115.81 30.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 40.7 t -77.17 121.0 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.139 0.576 . . . . 0.0 109.988 -175.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.42 129.54 25.87 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.514 0.725 . . . . 0.0 109.599 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.72 160.07 28.0 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.942 2.428 . . . . 0.0 112.009 174.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -52.87 -43.47 66.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.689 0.795 . . . . 0.0 112.179 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.37 -21.58 48.58 Favored Glycine 0 C--N 1.345 1.065 0 O-C-N 123.81 0.694 . . . . 0.0 114.237 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -103.75 -22.27 13.57 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.357 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -46.64 -42.21 15.93 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 123.623 0.769 . . . . 0.0 112.641 -174.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -61.13 -49.53 76.9 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.971 0.908 . . . . 0.0 111.335 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -77.82 -15.22 59.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.809 0.844 . . . . 0.0 111.923 -176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.5 m -91.18 117.63 67.99 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -83.84 158.3 13.85 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.784 2.323 . . . . 0.0 112.948 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.59 135.93 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.192 0.997 . . . . 0.0 108.311 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.4 m -121.05 147.62 45.27 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.725 0.81 . . . . 0.0 111.232 -168.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.54 114.01 3.66 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.219 0.608 . . . . 0.0 111.334 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.2 32.75 34.39 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 113.137 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.9 p30 -81.24 175.37 10.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.838 0.455 . . . . 0.0 110.891 174.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.06 82.91 1.78 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.629 0.372 . . . . 0.0 110.447 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 75.2 mt -84.82 141.31 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.629 0.772 . . . . 0.0 109.166 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 42.0 tt0 -141.53 112.2 7.12 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.5 mm -77.22 105.44 6.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 CA--C 1.533 0.303 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.206 178.114 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' HG11 ' A' ' 50' ' ' VAL . 17.7 ptp . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 120.973 0.416 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.6 tp -80.05 97.35 6.78 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.01 0.924 . . . . 0.0 108.557 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.7 m -110.84 145.66 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.944 0.897 . . . . 0.0 109.821 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 6.8 m -83.77 99.44 10.28 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 58.6 mt -95.76 108.53 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 60.73 36.07 19.47 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.739 1.215 . . . . 0.0 111.238 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.54 -3.89 86.65 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.519 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -118.04 110.95 18.28 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.055 0.942 . . . . 0.0 108.743 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 94.5 mt-30 -66.03 118.74 10.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.267 0.627 . . . . 0.0 110.845 -178.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -121.91 139.98 52.98 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.472 1.509 . . . . 0.0 108.768 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -81.87 125.18 30.41 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.81 155.25 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.816 0.847 . . . . 0.0 110.55 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -91.52 -25.64 19.16 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.182 0.593 . . . . 0.0 110.957 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.0 m -70.98 114.99 9.59 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.181 0.592 . . . . 0.0 111.918 -175.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.89 13.04 26.1 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.328 1.051 . . . . 0.0 111.439 173.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.8 t -128.44 138.1 52.15 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.983 1.313 . . . . 0.0 108.403 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.499 HG12 HG11 ' A' ' 33' ' ' VAL . 76.1 t -68.06 -34.16 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 123.722 0.639 . . . . 0.0 110.839 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.48 -56.68 18.95 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.01 0.524 . . . . 0.0 110.394 174.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.36 75.32 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 124.211 0.944 . . . . 0.0 111.491 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.9 tp -64.32 -55.64 19.9 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 123.732 0.645 . . . . 0.0 110.074 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.545 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 72.0 mtp -69.52 -25.84 64.23 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 122.679 0.392 . . . . 0.0 111.098 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -67.35 -39.57 85.78 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 117.938 0.336 . . . . 0.0 110.549 172.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -69.02 -39.14 79.44 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.081 0.953 . . . . 0.0 110.599 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 81.8 mt -86.93 5.89 34.81 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.067 0.947 . . . . 0.0 111.987 -175.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.3 t70 58.29 44.41 18.68 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.757 1.265 . . . . 0.0 110.868 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 CA--C 1.548 0.873 0 C-N-CA 125.473 1.509 . . . . 0.0 110.473 179.22 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 121.246 0.546 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.71 170.85 15.2 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.456 1.103 . . . . 0.0 108.485 173.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.545 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 9.1 p -130.08 151.71 36.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' ' 57' ' ' GLU . . . -125.25 100.42 6.52 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 174.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.2 tp -88.86 108.8 19.73 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 55' ' ' GLU . 50.2 m-20 54.71 47.43 22.51 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.607 1.163 . . . . 0.0 110.034 -173.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 73.44 -9.88 1.12 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.48 1.512 . . . . 0.0 113.252 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -84.22 116.59 23.03 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.9 t -73.76 117.55 17.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 122.925 0.49 . . . . 0.0 110.1 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.4 t -102.04 119.77 55.74 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.079 0.952 . . . . 0.0 108.627 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.53 165.83 29.76 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.105 2.537 . . . . 0.0 112.345 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -53.07 -41.53 64.96 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.818 1.247 . . . . 0.0 113.38 -173.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.67 -21.05 60.15 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 123.853 0.721 . . . . 0.0 113.934 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -109.42 -7.6 15.17 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.01 -0.995 . . . . 0.0 112.088 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -52.27 -40.88 62.32 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.073 0.851 . . . . 0.0 110.616 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.69 -41.39 98.14 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.755 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -84.18 -11.06 57.18 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.375 1.07 . . . . 0.0 112.529 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.8 m -102.36 112.45 65.52 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -76.33 173.86 13.78 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.409 2.072 . . . . 0.0 112.615 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.546 HG11 ' SD ' ' A' ' 1' ' ' MET . 86.4 t -124.69 143.73 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.918 1.287 . . . . 0.0 108.643 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.5 m -142.62 149.39 38.9 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.866 0.866 . . . . 0.0 109.804 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.14 126.58 26.68 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.576 0.75 . . . . 0.0 111.135 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.54 -22.07 17.95 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 119.011 -0.883 . . . . 0.0 114.259 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -69.13 141.92 54.53 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.024 0.912 . . . . 0.0 112.518 -173.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 36' ' ' ASN . 9.9 mp0 -80.52 80.53 6.96 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.751 1.22 . . . . 0.0 109.353 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 63.1 mt -91.03 96.36 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 39.5 tt0 -98.65 106.43 18.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.038 0.935 . . . . 0.0 108.669 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.447 HG22 ' HE1' ' A' ' 21' ' ' MET . 70.0 mt -76.56 105.06 5.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.235 0.328 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.217 179.92 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.417 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 pmm? . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.669 -0.123 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.624 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 5.0 tt -83.0 122.64 28.57 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.01 145.25 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.098 0.959 . . . . 0.0 110.42 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 18.4 m -78.69 102.1 7.86 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.033 0.533 . . . . 0.0 110.088 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 24.1 mt -101.35 105.61 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.061 0.544 . . . . 0.0 109.947 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 60.41 41.82 15.51 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.514 1.126 . . . . 0.0 110.708 173.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.39 -18.35 57.15 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 114.595 -1.184 . . . . 0.0 114.027 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -108.79 116.39 31.89 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.626 0.77 . . . . 0.0 110.093 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 48.1 mt-30 -70.89 131.49 43.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.857 0.463 . . . . 0.0 109.782 174.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.52 ' NH2' HD21 ' A' ' 24' ' ' LEU . 65.1 ttp85 -152.87 142.9 22.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.34 0.656 . . . . 0.0 109.727 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.624 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 38.5 tt0 -83.66 127.05 33.48 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.4 m -120.14 164.15 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.046 0.938 . . . . 0.0 111.069 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -102.89 -1.72 29.09 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.668 1.187 . . . . 0.0 109.744 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.1 m -67.07 99.37 0.65 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 124.304 1.042 . . . . 0.0 111.003 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.69 -14.51 58.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.115 0.566 . . . . 0.0 110.822 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.2 t -127.57 154.35 45.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.102 0.961 . . . . 0.0 109.753 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.431 ' O ' ' HG2' ' A' ' 21' ' ' MET . 95.2 t -65.7 -38.56 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.661 0.785 . . . . 0.0 110.774 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.51 95.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.473 0.309 . . . . 0.0 110.882 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.04 80.21 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.708 0.803 . . . . 0.0 111.318 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 5' ' ' ILE . 28.1 tp -64.98 -45.94 83.55 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.84 0.713 . . . . 0.0 111.358 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 83.0 mmm -68.17 -24.86 65.02 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.726 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.0 m -74.95 -45.37 42.76 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.935 0.494 . . . . 0.0 110.721 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -57.69 -47.48 82.22 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.805 0.842 . . . . 0.0 110.675 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.52 HD21 ' NH2' ' A' ' 10' ' ' ARG . 80.8 mt -84.47 1.47 45.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.246 -175.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 61.73 20.44 11.37 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.574 1.15 . . . . 0.0 111.119 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.441 ' SG ' HG21 ' A' ' 58' ' ' ILE . 36.1 t . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 124.833 1.253 . . . . 0.0 111.321 -170.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 121.53 0.681 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.83 173.26 12.01 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.464 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -139.86 140.48 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.05 0.54 . . . . 0.0 109.834 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.99 100.33 7.48 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.151 0.98 . . . . 0.0 108.52 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 tp -92.56 113.81 26.19 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 64.29 37.14 8.77 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.365 1.041 . . . . 0.0 110.374 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 79.26 -17.04 0.62 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 126.584 1.954 . . . . 0.0 112.741 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -96.52 119.83 35.72 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -171.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 p -67.36 126.54 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.316 0.579 . . . . 0.0 110.756 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.44 119.35 65.48 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.43 156.25 42.39 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.394 2.063 . . . . 0.0 112.485 174.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -60.87 -39.27 88.54 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.089 0.555 . . . . 0.0 111.702 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.89 -19.97 59.38 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 123.72 0.638 . . . . 0.0 113.035 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -99.53 -20.16 16.54 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 117.83 -1.081 . . . . 0.0 111.593 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -49.73 -47.3 50.78 Favored 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 119.399 0.999 . . . . 0.0 110.999 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.98 -45.26 78.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.889 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -72.09 -15.16 62.0 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.488 1.115 . . . . 0.0 112.577 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 m -104.52 129.33 25.2 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.369 0.668 . . . . 0.0 110.28 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -84.58 174.77 7.51 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.698 2.266 . . . . 0.0 113.267 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.439 HG11 HD12 ' A' ' 56' ' ' ILE . 67.3 t -117.89 126.65 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.603 1.161 . . . . 0.0 108.766 173.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -108.91 145.11 35.91 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.384 1.074 . . . . 0.0 109.027 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.14 118.29 5.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.304 0.642 . . . . 0.0 111.388 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.87 -2.0 31.83 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.53 -0.595 . . . . 0.0 114.055 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.38 131.27 44.54 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.534 0.667 . . . . 0.0 112.156 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -84.77 92.56 8.25 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 39.4 mt -100.33 95.86 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.417 1.087 . . . . 0.0 108.676 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.75 120.3 37.89 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.71 -0.619 . . . . 0.0 110.086 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.441 HG21 ' SG ' ' A' ' 26' ' ' CYS . 76.6 mt -76.32 121.98 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.4 mt . . . . . 0 C--O 1.219 -0.532 0 C-N-CA 123.604 0.762 . . . . 0.0 109.753 177.633 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.503 ' SD ' HG12 ' A' ' 50' ' ' VAL . 49.5 ttm . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.2 tp -79.62 105.14 10.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.52 0.728 . . . . 0.0 109.51 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.0 m -125.32 139.39 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.294 1.038 . . . . 0.0 109.664 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.5 m -77.03 99.58 5.36 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.512 HD11 ' HD3' ' A' ' 10' ' ' ARG . 50.5 mt -97.55 114.27 34.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 123.148 0.579 . . . . 0.0 109.643 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 55.3 t30 59.87 35.57 21.85 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.671 1.588 . . . . 0.0 111.434 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.39 -3.36 83.85 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.978 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -109.37 130.98 55.48 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 117.464 0.632 . . . . 0.0 110.469 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -69.98 103.02 2.14 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 174.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' HD3' HD11 ' A' ' 5' ' ' ILE . 53.1 ttt180 -122.17 122.54 39.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.703 0.801 . . . . 0.0 110.113 -173.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -88.43 104.62 16.96 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.48 160.59 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.72 0.808 . . . . 0.0 109.94 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -105.44 -1.35 25.06 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.311 0.644 . . . . 0.0 111.011 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.2 p -77.18 117.28 18.56 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.829 0.852 . . . . 0.0 110.744 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.61 1.73 56.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.954 0.901 . . . . 0.0 111.73 174.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -125.65 142.98 51.23 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.366 1.066 . . . . 0.0 109.58 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.56 -28.23 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.236 0.614 . . . . 0.0 110.39 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.67 -54.41 39.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.759 0.424 . . . . 0.0 110.303 172.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.54 64.77 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.911 0.757 . . . . 0.0 111.679 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.02 -58.93 6.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 172.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.54 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 95.7 mmm -63.43 -32.62 74.12 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.106 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.2 m -66.62 -44.84 80.96 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.057 0.543 . . . . 0.0 110.059 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.95 -31.09 68.64 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.966 0.906 . . . . 0.0 110.382 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.6 mt -91.89 -0.69 57.51 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.754 0.822 . . . . 0.0 111.127 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 63.97 38.81 8.47 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.098 1.359 . . . . 0.0 112.942 171.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 CA--C 1.553 1.091 0 C-N-CA 125.118 1.367 . . . . 0.0 110.832 178.174 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 121.162 0.506 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 59' ' ' LEU . . . -127.01 167.31 16.08 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.225 1.01 . . . . 0.0 109.111 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.54 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 8.5 p -133.06 148.21 31.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.41 109.37 11.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.988 0.423 . . . . 0.0 109.916 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.9 tp -88.11 109.28 19.76 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 60.57 51.25 5.2 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 124.755 1.284 . . . . 0.0 110.62 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 72.02 6.74 5.66 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 125.374 1.47 . . . . 0.0 113.671 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -124.5 127.28 47.22 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.129 0.572 . . . . 0.0 109.926 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 p -64.49 135.15 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 124.191 0.932 . . . . 0.0 111.687 -175.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.13 122.48 57.94 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.92 152.61 63.1 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.393 2.062 . . . . 0.0 112.607 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -54.16 -52.53 60.86 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.423 1.089 . . . . 0.0 113.056 -170.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.59 -9.5 61.97 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 116.412 -0.358 . . . . 0.0 113.266 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HD2' ' HB2' ' A' ' 47' ' ' GLU . 54.8 tptt -96.54 -15.44 21.63 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.23 1.012 . . . . 0.0 110.057 -177.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -52.91 -44.41 66.94 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.176 0.591 . . . . 0.0 111.191 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.46 -38.18 80.86 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.002 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 44' ' ' LYS . 32.8 mt-10 -75.41 -21.41 58.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.796 0.838 . . . . 0.0 112.09 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.401 ' HG1' ' HG3' ' A' ' 44' ' ' LYS . 58.0 m -100.3 117.89 62.25 Favored Pre-proline 0 N--CA 1.47 0.544 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.93 165.98 27.56 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.079 1.853 . . . . 0.0 112.604 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.503 HG12 ' SD ' ' A' ' 1' ' ' MET . 61.7 t -99.79 141.21 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 167.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.9 m -134.44 139.72 45.73 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.09 144.24 56.82 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.692 0.797 . . . . 0.0 111.088 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 -10.98 71.3 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.554 -0.581 . . . . 0.0 112.893 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -87.13 162.45 17.52 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.364 0.602 . . . . 0.0 110.788 174.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -121.06 99.36 6.45 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.835 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 55.8 mt -103.24 153.51 5.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 C-N-CA 124.711 1.204 . . . . 0.0 109.154 -176.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -146.62 139.28 25.18 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 119.26 0.936 . . . . 0.0 109.441 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.1 mt -85.07 121.04 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.412 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 84.7 mt . . . . . 0 C--N 1.328 -0.353 0 C-N-CA 123.906 0.883 . . . . 0.0 109.448 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptp . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.5 tp -80.54 100.7 8.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.626 0.77 . . . . 0.0 108.972 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.401 HG11 HG12 ' A' ' 50' ' ' VAL . 17.3 m -123.02 137.33 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.565 0.746 . . . . 0.0 110.515 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 26.5 m -73.44 97.26 2.51 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.455 0.702 . . . . 0.0 109.623 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 62.8 mt -95.17 108.21 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.112 0.565 . . . . 0.0 109.629 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 62.85 28.73 16.51 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.244 1.018 . . . . 0.0 111.277 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.56 -6.53 65.31 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 113.84 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -105.47 113.02 26.35 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.712 0.805 . . . . 0.0 109.626 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 47.7 mt-30 -64.78 103.11 0.66 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 173.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -118.7 127.75 53.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.356 1.062 . . . . 0.0 109.795 -170.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -86.08 102.63 14.01 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.876 1.27 . . . . 0.0 109.415 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -105.36 168.9 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.899 0.88 . . . . 0.0 111.064 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -110.57 -4.52 15.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.577 0.751 . . . . 0.0 111.776 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -91.71 129.99 37.58 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.581 0.753 . . . . 0.0 111.88 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.46 -6.25 37.7 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.334 1.053 . . . . 0.0 112.557 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 42.5 t -123.52 147.29 47.38 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.108 0.963 . . . . 0.0 109.173 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.3 -34.67 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.145 0.978 . . . . 0.0 111.269 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.73 -52.04 67.1 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 -29.16 69.19 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.9 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.42 -52.89 22.59 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.84 0.856 . . . . 0.0 110.32 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.426 ' HE2' HG22 ' A' ' 58' ' ' ILE . 91.2 mmm -62.94 -34.44 77.47 Favored 'General case' 0 CA--C 1.554 1.1 0 O-C-N 123.72 0.637 . . . . 0.0 109.979 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -70.9 -36.08 72.58 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.238 0.615 . . . . 0.0 110.895 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.73 -35.11 76.71 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.073 0.949 . . . . 0.0 110.433 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.519 HD13 HD13 ' A' ' 5' ' ' ILE . 76.9 mt -93.32 -0.81 56.53 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.885 0.874 . . . . 0.0 112.006 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.3 t70 69.74 15.03 8.09 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.079 0.952 . . . . 0.0 112.189 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' A' ' 58' ' ' ILE . 27.6 m -92.48 38.17 1.01 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.331 1.052 . . . . 0.0 111.902 -176.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.1 p -108.38 -8.27 15.66 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -113.22 -173.81 2.33 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.078 0.551 . . . . 0.0 110.72 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.83 -103.67 0.35 Allowed Glycine 0 C--N 1.355 1.615 0 O-C-N 123.507 0.504 . . . . 0.0 112.467 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -154.78 86.1 1.12 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.729 0.775 . . . . 0.0 109.596 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -118.3 158.67 24.77 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 171.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.17 160.86 40.79 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.024 1.33 . . . . 0.0 108.491 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.571 HG23 HG23 ' A' ' 56' ' ' ILE . 7.7 p -115.56 136.69 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.291 0.637 . . . . 0.0 109.493 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -118.24 99.89 7.15 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.1 tp -88.98 107.64 19.14 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 62.3 38.74 13.01 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.114 0.966 . . . . 0.0 110.11 -172.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 72.89 -5.86 1.81 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 125.407 1.483 . . . . 0.0 112.463 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -92.02 111.37 22.88 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -67.65 122.85 19.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 O-C-N 123.516 0.51 . . . . 0.0 111.033 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.452 ' HB ' HG12 ' A' ' 33' ' ' VAL . 60.9 t -90.66 119.23 69.05 Favored Pre-proline 0 C--O 1.247 0.939 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.85 144.93 64.35 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.576 2.184 . . . . 0.0 111.178 171.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.404 ' HD3' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -57.22 -31.33 65.39 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.943 0.777 . . . . 0.0 112.7 -175.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.404 ' N ' ' HD3' ' A' ' 42' ' ' ARG . . . -70.39 -2.36 41.48 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-O 119.384 -0.675 . . . . 0.0 114.11 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -119.16 -3.64 10.58 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.102 0.961 . . . . 0.0 112.228 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -55.0 -41.03 70.77 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.227 0.611 . . . . 0.0 112.239 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.01 -35.16 66.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.356 0.662 . . . . 0.0 110.817 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.55 -26.64 64.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.732 0.813 . . . . 0.0 111.488 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.3 m -97.0 117.58 65.67 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 84.7 Cg_endo -81.58 161.87 19.3 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.388 2.059 . . . . 0.0 111.783 168.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.401 HG12 HG11 ' A' ' 3' ' ' VAL . 13.7 t -90.29 147.15 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 p -124.09 133.74 53.54 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.736 0.814 . . . . 0.0 109.593 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.15 127.49 32.41 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.703 0.801 . . . . 0.0 111.985 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.83 7.64 74.29 Favored Glycine 0 N--CA 1.472 1.073 0 O-C-N 123.798 0.686 . . . . 0.0 113.637 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.21 167.32 16.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.429 0.691 . . . . 0.0 109.559 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -114.98 101.55 9.12 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.184 0.593 . . . . 0.0 109.939 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.571 HG23 HG23 ' A' ' 33' ' ' VAL . 2.7 mp -97.88 97.83 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 124.37 1.068 . . . . 0.0 108.919 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 41.9 tt0 -91.43 108.92 20.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.328 0.651 . . . . 0.0 109.467 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.426 HG22 ' HE2' ' A' ' 21' ' ' MET . 68.9 mt -78.13 109.72 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.1 mt -89.93 142.99 27.17 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.198 0.599 . . . . 0.0 110.969 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.7 p -107.65 85.44 2.36 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.39 132.25 42.67 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.988 2.459 . . . . 0.0 113.039 -169.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -74.43 98.12 3.22 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.396 1.078 . . . . 0.0 109.163 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.81 21.13 5.47 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.244 1.018 . . . . 0.0 110.973 -176.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.86 -61.6 5.14 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.64 43.08 3.08 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 112.294 -0.323 . . . . 0.0 112.294 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 tt -113.18 119.66 38.55 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -52.06 -33.13 37.7 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.565 1.146 . . . . 0.0 113.739 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -71.57 -14.5 62.11 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.627 0.771 . . . . 0.0 111.428 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -49.27 -30.52 7.38 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 124.296 1.039 . . . . 0.0 112.014 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -160.74 118.13 2.42 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -134.83 118.38 16.93 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -59.61 131.6 51.41 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.043 0.537 . . . . 0.0 109.681 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 . . . . . 0 CA--C 1.57 1.725 0 O-C-N 124.539 1.149 . . . . 0.0 110.218 -175.118 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 120.842 0.353 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 47.1 tp -79.02 113.44 17.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.606 0.763 . . . . 0.0 109.345 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.04 179.64 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.206 1.002 . . . . 0.0 109.236 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 25.2 m -120.64 101.66 7.89 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 118.775 0.716 . . . . 0.0 110.092 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.524 HD13 HD13 ' A' ' 24' ' ' LEU . 71.5 mt -95.71 117.2 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 123.624 0.769 . . . . 0.0 109.887 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 61.74 22.07 12.69 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.894 1.278 . . . . 0.0 112.567 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.84 1.49 65.5 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-O 120.072 -0.293 . . . . 0.0 113.713 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.78 126.71 50.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.696 0.798 . . . . 0.0 109.8 172.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 42.9 mt-30 -69.84 135.79 50.0 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.971 0.415 . . . . 0.0 111.354 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -146.95 136.4 22.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.402 1.081 . . . . 0.0 108.519 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 45.4 tt0 -81.5 123.0 28.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.468 0.707 . . . . 0.0 109.442 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.92 160.01 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.931 0.892 . . . . 0.0 109.324 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.55 -2.3 9.98 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.713 0.405 . . . . 0.0 111.006 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.5 p -66.21 107.97 2.13 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.604 0.762 . . . . 0.0 110.252 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.26 60.2 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.676 0.79 . . . . 0.0 112.874 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.6 p -112.03 150.03 31.21 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.435 ' O ' ' HG2' ' A' ' 21' ' ' MET . 72.7 t -67.61 -33.4 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.247 0.619 . . . . 0.0 110.368 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.42 -46.18 90.95 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.973 0.509 . . . . 0.0 110.84 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -59.14 -44.31 92.07 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 124.167 0.917 . . . . 0.0 110.525 177.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.8 tp -63.94 -44.45 92.82 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.935 0.772 . . . . 0.0 111.674 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.445 ' HE2' HG21 ' A' ' 58' ' ' ILE . 95.0 mmm -63.31 -28.04 69.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.851 0.46 . . . . 0.0 110.598 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -74.56 -39.07 62.52 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.188 0.595 . . . . 0.0 111.496 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 10.6 mm-40 -63.84 -38.86 92.68 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.503 0.668 . . . . 0.0 110.36 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.524 HD13 HD13 ' A' ' 5' ' ' ILE . 79.4 mt -91.32 -1.87 57.53 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.598 -176.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.19 28.86 14.05 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.829 1.252 . . . . 0.0 113.179 171.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.6 m -115.27 21.25 14.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.47 1.108 . . . . 0.0 110.726 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 t -84.67 62.62 7.46 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 122.531 1.157 . . . . 0.0 110.493 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.526 ' HB3' ' HD1' ' A' ' 31' ' ' TYR . 19.4 t70 -139.91 158.43 44.1 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.715 -174.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.12 -24.06 76.8 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 114.428 0.531 . . . . 0.0 114.428 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -71.13 -25.37 62.55 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.602 0.361 . . . . 0.0 110.027 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.526 ' HD1' ' HB3' ' A' ' 28' ' ' ASP . 90.2 m-85 -92.09 158.72 16.05 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.756 0.789 . . . . 0.0 110.392 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 59' ' ' LEU . . . -133.45 -176.39 4.13 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.937 168.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.423 HG11 HG12 ' A' ' 17' ' ' VAL . 8.5 p -146.56 158.25 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -132.52 110.3 10.39 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.193 0.597 . . . . 0.0 110.529 177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.9 tp -89.31 109.27 20.18 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 52.28 65.86 1.38 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.958 1.303 . . . . 0.0 111.866 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 68.43 1.16 2.82 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 124.941 1.296 . . . . 0.0 112.696 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -119.35 116.64 26.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.002 0.921 . . . . 0.0 109.532 -171.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 58.0 t -70.62 119.87 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 123.764 0.665 . . . . 0.0 111.06 -174.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -92.52 124.16 59.93 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.064 0.946 . . . . 0.0 108.813 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.95 154.7 66.72 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.364 2.043 . . . . 0.0 111.412 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -56.11 -41.38 75.17 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.298 1.039 . . . . 0.0 112.473 -171.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.63 14.17 5.89 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 114.361 0.504 . . . . 0.0 114.361 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -17.48 6.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.092 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -46.34 -41.86 14.0 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 123.902 0.751 . . . . 0.0 112.492 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.54 -48.5 77.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.547 1.139 . . . . 0.0 111.327 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.52 -0.48 57.27 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.849 0.86 . . . . 0.0 112.253 -175.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 91.7 m -96.89 120.85 60.84 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.66 146.74 9.48 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.298 1.999 . . . . 0.0 113.636 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.9 t -86.87 130.49 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 109.071 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 54' ' ' ASP . 10.6 m -103.99 146.99 27.89 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.767 0.827 . . . . 0.0 110.043 -173.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.97 116.73 8.95 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.321 0.648 . . . . 0.0 110.973 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.91 33.73 49.85 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.612 0.57 . . . . 0.0 112.659 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.524 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 27.8 p30 -83.87 -165.27 1.08 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.686 0.394 . . . . 0.0 110.779 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -134.85 94.66 3.2 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 37.5 mt -95.04 100.63 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.519 0.727 . . . . 0.0 109.977 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.26 114.1 25.85 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.701 0.801 . . . . 0.0 109.316 177.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.445 HG21 ' HE2' ' A' ' 21' ' ' MET . 62.1 mt -77.65 129.85 36.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.445 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 90.4 mt -104.93 147.43 27.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.116 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.7 t -141.75 75.72 21.18 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.55 117.75 4.88 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.272 1.981 . . . . 0.0 111.168 -172.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 -57.28 -41.91 80.66 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.222 0.609 . . . . 0.0 109.999 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -71.38 86.49 0.83 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.176 171.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.93 63.63 0.28 Allowed Glycine 0 N--CA 1.474 1.217 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.79 -168.82 40.92 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.2 mt 51.39 54.88 10.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.483 1.113 . . . . 0.0 110.843 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -87.5 63.85 7.84 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.336 -172.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -73.61 -44.77 56.23 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.14 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -108.82 80.38 1.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 168.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -70.67 96.31 1.2 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.416 0.627 . . . . 0.0 109.864 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -77.15 106.11 8.66 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.218 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -94.65 142.05 27.9 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 174.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 174.344 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.479 0.181 . . . . 0.0 111.09 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 9' ' ' GLN . 40.6 tp -86.59 127.42 34.91 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.52 0.728 . . . . 0.0 109.464 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.73 138.02 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.528 1.131 . . . . 0.0 109.267 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 28.4 m -78.33 97.71 5.69 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.174 0.443 . . . . 0.0 109.861 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.8 mt -94.22 104.25 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 67.0 t30 62.04 36.2 15.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.63 1.172 . . . . 0.0 111.145 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.94 10.83 82.4 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.517 -0.765 . . . . 0.0 113.496 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -130.19 108.88 10.38 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.869 0.867 . . . . 0.0 108.98 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.518 ' HB3' HD11 ' A' ' 2' ' ' LEU . 98.3 mt-30 -64.92 119.77 11.33 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.539 0.736 . . . . 0.0 110.457 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -126.59 158.11 37.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.844 0.858 . . . . 0.0 110.327 -177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -97.59 113.79 25.58 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.172 0.989 . . . . 0.0 109.741 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.6 m -120.16 147.25 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.832 0.853 . . . . 0.0 110.85 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -119.01 22.2 12.02 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.74 0.781 . . . . 0.0 109.389 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 p -75.97 -49.84 16.56 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.91 1.284 . . . . 0.0 112.418 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 67.21 0.4 2.05 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.676 1.19 . . . . 0.0 113.669 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 39.7 m -154.33 153.6 31.93 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.132 1.373 . . . . 0.0 109.106 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.422 ' CG1' HG11 ' A' ' 33' ' ' VAL . 58.3 t -69.95 -34.36 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 O-C-N 124.297 0.998 . . . . 0.0 112.506 -172.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.23 -53.24 39.48 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 -33.15 70.37 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.137 0.898 . . . . 0.0 111.238 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.615 HD21 HG22 ' A' ' 56' ' ' ILE . 42.0 tp -61.54 -59.88 4.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.194 1.398 . . . . 0.0 111.817 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.525 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 60.6 mtp -73.63 -19.92 60.72 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.477 0.485 . . . . 0.0 111.256 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.1 m -70.97 -41.72 70.67 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 121.159 0.504 . . . . 0.0 110.061 168.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.84 -35.96 70.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.508 1.123 . . . . 0.0 111.312 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.3 mt -80.22 -5.93 56.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.531 0.732 . . . . 0.0 110.707 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.2 t70 65.55 24.62 11.77 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.352 1.461 . . . . 0.0 110.819 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.444 ' SG ' HD13 ' A' ' 58' ' ' ILE . 35.0 t -92.75 34.56 1.07 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.609 1.163 . . . . 0.0 111.467 -175.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.1 p -118.76 15.39 13.53 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.787 0.835 . . . . 0.0 110.45 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -80.77 0.28 35.47 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.736 0.814 . . . . 0.0 112.702 -175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.68 -151.52 6.6 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -90.54 61.55 4.94 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.426 0.69 . . . . 0.0 109.509 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -91.38 156.13 17.98 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.356 0.662 . . . . 0.0 110.935 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.81 175.45 9.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.537 1.135 . . . . 0.0 108.467 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.525 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 6.4 p -134.71 144.2 35.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 123.983 0.913 . . . . 0.0 109.649 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . . . -117.77 100.14 7.4 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.4 tp -97.37 112.01 24.02 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 54.47 55.94 7.45 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.588 1.155 . . . . 0.0 111.49 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 62.86 34.85 14.01 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.434 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -152.06 126.39 9.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.039 0.536 . . . . 0.0 109.898 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 t -73.72 126.03 33.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 O-C-N 123.674 0.609 . . . . 0.0 110.38 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.08 117.39 66.8 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.91 152.69 79.67 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.579 2.186 . . . . 0.0 111.059 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -61.37 -38.64 87.76 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -167.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.9 -1.71 33.9 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 123.481 0.488 . . . . 0.0 114.118 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -114.44 -9.35 12.74 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.73 0.812 . . . . 0.0 112.156 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -51.47 -41.03 60.62 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 123.396 0.678 . . . . 0.0 111.399 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -70.96 -38.32 72.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.468 1.107 . . . . 0.0 111.802 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -77.39 -14.84 59.62 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.1 m -106.27 119.58 51.51 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 88.2 Cg_endo -81.77 167.76 16.37 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.396 2.064 . . . . 0.0 112.316 172.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.421 HG12 HD12 ' A' ' 56' ' ' ILE . 63.0 t -118.73 140.85 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.429 1.092 . . . . 0.0 108.271 171.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.1 m -123.24 154.35 38.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.415 1.086 . . . . 0.0 108.815 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.78 126.93 29.55 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.468 0.707 . . . . 0.0 110.662 175.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 -2.96 52.42 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.959 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -76.42 138.72 40.54 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.447 0.624 . . . . 0.0 111.205 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -92.39 110.48 21.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.655 0.782 . . . . 0.0 109.11 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.615 HG22 HD21 ' A' ' 20' ' ' LEU . 56.4 mt -107.26 98.28 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.054 0.942 . . . . 0.0 109.829 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 41.3 tt0 -96.67 117.06 30.19 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.444 HD13 ' SG ' ' A' ' 26' ' ' CYS . 75.2 mt -76.3 141.45 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.2 mt -125.23 151.69 45.57 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.457 0.703 . . . . 0.0 110.522 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 64.1 p -122.9 84.6 50.23 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 168.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -65.12 114.97 3.04 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.174 1.916 . . . . 0.0 111.384 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -156.76 111.32 2.77 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 65.78 8.2 5.09 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.431 1.492 . . . . 0.0 113.052 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.515 ' HA3' ' NE2' ' A' ' 70' ' ' HIS . . . 104.47 10.77 32.76 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.46 -117.92 9.44 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 119.68 -0.511 . . . . 0.0 114.259 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 tt -74.38 -52.44 12.12 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.405 0.682 . . . . 0.0 109.975 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.98 140.53 45.58 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.188 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -114.02 -9.66 12.96 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.824 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -114.24 84.17 2.0 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.946 0.899 . . . . 0.0 108.647 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.515 ' NE2' ' HA3' ' A' ' 64' ' ' GLY . 96.7 m-70 -93.64 144.91 24.95 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.25 0.62 . . . . 0.0 110.547 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -122.18 -62.05 1.42 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 172.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -139.47 84.04 1.97 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 169.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 50.3 m80 . . . . . 0 C--O 1.252 1.215 0 C-N-CA 124.902 1.281 . . . . 0.0 109.855 -170.962 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mtp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 9' ' ' GLN . 4.4 tt -79.18 105.22 10.35 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.54 178.02 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.365 1.066 . . . . 0.0 109.021 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.6 m -122.63 100.52 6.96 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.6 mt -95.14 110.04 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.72 0.808 . . . . 0.0 108.982 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.471 HD22 HG13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER 65.23 34.01 8.8 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.166 1.386 . . . . 0.0 110.86 175.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.32 2.52 85.33 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.524 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -115.76 120.2 38.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.163 0.585 . . . . 0.0 110.51 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.466 ' HB3' HD22 ' A' ' 2' ' ' LEU . 47.9 mt-30 -64.11 113.65 3.67 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.406 0.683 . . . . 0.0 110.351 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -125.08 133.56 52.84 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.285 1.034 . . . . 0.0 109.965 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -85.18 114.99 22.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.414 1.086 . . . . 0.0 108.993 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.9 m -125.12 168.55 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.445 1.098 . . . . 0.0 109.089 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -124.83 5.53 8.08 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.453 0.701 . . . . 0.0 109.5 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.4 m -78.58 105.21 9.7 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 123.296 0.638 . . . . 0.0 110.576 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.88 2.47 34.21 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.172 0.589 . . . . 0.0 111.106 171.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.7 t -124.52 133.89 53.18 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.431 1.093 . . . . 0.0 109.261 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.591 HG12 HG11 ' A' ' 33' ' ' VAL . 66.8 t -63.41 -43.05 98.31 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 O-C-N 123.743 0.652 . . . . 0.0 110.046 174.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -50.39 68.49 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 0.0 111.415 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.06 92.11 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 124.047 0.842 . . . . 0.0 111.207 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.0 tp -60.78 -45.94 92.4 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.968 0.792 . . . . 0.0 111.685 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.0 mmm -71.77 -24.31 61.73 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.214 0.606 . . . . 0.0 111.25 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -69.58 -41.07 76.32 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.901 0.481 . . . . 0.0 110.119 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.44 -37.58 77.45 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.085 0.954 . . . . 0.0 111.51 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -82.81 -4.7 58.34 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.563 0.745 . . . . 0.0 111.145 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.2 t70 69.08 12.25 8.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.491 1.116 . . . . 0.0 111.506 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.8 m -95.5 33.52 1.59 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.19 0.996 . . . . 0.0 110.423 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.1 t -125.6 -13.77 6.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.735 0.814 . . . . 0.0 110.304 173.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.76 -68.39 0.34 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.734 0.814 . . . . 0.0 110.694 -175.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.04 -164.92 40.69 Favored Glycine 0 C--N 1.34 0.782 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.936 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -74.5 84.99 2.03 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 122.278 1.037 . . . . 0.0 110.154 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -123.69 150.09 44.7 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.415 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' A' ' 59' ' ' LEU . . . -119.69 167.85 11.63 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.698 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.591 HG11 HG12 ' A' ' 17' ' ' VAL . 9.8 p -122.82 156.41 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 57' ' ' GLU . . . -131.14 100.86 5.35 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -89.84 108.84 19.94 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 59.71 39.75 20.65 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.763 1.225 . . . . 0.0 109.889 -169.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 73.91 -9.28 1.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.99 1.716 . . . . 0.0 113.297 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -77.97 108.94 11.6 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.8 t -67.57 121.72 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 123.6 0.562 . . . . 0.0 109.904 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.449 HG22 HG23 ' A' ' 48' ' ' THR . 67.9 t -105.69 132.56 20.78 Favored Pre-proline 0 C--O 1.245 0.818 0 C-N-CA 124.124 0.97 . . . . 0.0 108.827 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.11 149.83 59.01 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.465 2.11 . . . . 0.0 111.256 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -63.48 -34.2 77.24 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -165.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.96 -29.06 67.12 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 123.384 0.427 . . . . 0.0 112.773 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -95.09 -4.21 46.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.718 0.807 . . . . 0.0 112.718 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -57.9 -29.99 65.52 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 118.495 0.589 . . . . 0.0 110.625 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.24 -39.6 82.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.395 1.078 . . . . 0.0 110.888 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -79.47 -24.84 42.1 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.122 0.969 . . . . 0.0 112.131 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.449 HG23 HG22 ' A' ' 40' ' ' VAL . 56.6 m -92.9 110.98 49.24 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.835 0.854 . . . . 0.0 109.464 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -81.03 171.59 13.93 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.8 2.333 . . . . 0.0 112.439 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.405 HG11 HD12 ' A' ' 56' ' ' ILE . 58.0 t -121.85 138.82 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.209 1.004 . . . . 0.0 108.388 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.2 p -128.69 150.85 50.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.567 1.147 . . . . 0.0 108.294 173.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.63 122.39 15.17 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.522 0.729 . . . . 0.0 110.705 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.01 -13.94 19.43 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.191 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -67.18 139.49 57.44 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 117.198 0.499 . . . . 0.0 111.986 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.68 99.45 12.35 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.405 HD12 HG11 ' A' ' 50' ' ' VAL . 62.4 mt -98.3 96.28 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.714 0.805 . . . . 0.0 109.289 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.544 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 34.5 tt0 -93.67 119.96 33.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.808 0.843 . . . . 0.0 109.726 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.471 HG13 HD22 ' A' ' 6' ' ' ASN . 88.5 mt -87.73 136.42 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.54 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 80.0 mt -120.07 152.45 37.53 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.245 1.018 . . . . 0.0 109.763 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 m -126.28 82.7 65.28 Favored Pre-proline 0 C--O 1.243 0.716 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 167.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -61.35 116.4 3.38 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.522 2.148 . . . . 0.0 112.152 -170.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 59.5 72.9 0.5 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.701 1.2 . . . . 0.0 110.603 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -84.08 -40.54 18.17 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.931 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.8 106.86 1.77 Allowed Glycine 0 C--N 1.354 1.53 0 O-C-N 124.079 0.862 . . . . 0.0 112.394 -177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.06 65.33 0.17 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.9 tp -51.46 -41.91 61.22 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.305 1.042 . . . . 0.0 111.258 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -106.06 -40.04 5.79 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.045 0.538 . . . . 0.0 110.309 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -72.89 9.41 1.16 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -53.94 -39.17 65.67 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 123.301 0.64 . . . . 0.0 110.67 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -87.54 95.79 10.16 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 169.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -83.31 -2.76 56.47 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.714 -170.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 85.4 t60 59.03 84.83 0.1 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.302 1.041 . . . . 0.0 110.469 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.8 p80 . . . . . 0 CA--C 1.56 1.331 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -177.562 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.553 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 1.3 pmm? . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.91 0.386 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 tt -79.93 118.56 21.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 m -131.0 142.56 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.524 1.129 . . . . 0.0 110.415 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 m -79.75 98.92 7.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.793 0.837 . . . . 0.0 109.437 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.6 HD13 HD12 ' A' ' 24' ' ' LEU . 74.1 mt -104.38 110.77 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.408 HD22 ' HB ' ' A' ' 58' ' ' ILE . 88.9 m-20 64.13 22.42 12.88 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.605 1.162 . . . . 0.0 111.494 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.66 -15.1 64.06 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-O 119.72 -0.489 . . . . 0.0 113.535 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -86.09 133.08 33.91 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 117.401 0.601 . . . . 0.0 109.72 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -75.08 100.16 4.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -105.17 146.2 29.55 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.059 0.944 . . . . 0.0 109.973 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -109.61 104.29 13.29 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 m -113.33 165.14 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.569 0.748 . . . . 0.0 110.156 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -128.1 9.12 6.21 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.661 0.784 . . . . 0.0 109.627 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -57.0 -49.1 76.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.803 1.241 . . . . 0.0 112.799 -170.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 61.78 9.36 2.85 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.179 0.992 . . . . 0.0 112.802 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.2 t -162.05 141.48 9.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.152 1.381 . . . . 0.0 108.109 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.452 HG12 HG11 ' A' ' 33' ' ' VAL . 94.6 t -72.05 -33.39 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.335 0.654 . . . . 0.0 111.461 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.88 -53.6 51.7 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.641 0.376 . . . . 0.0 110.275 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.65 -44.83 73.59 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.66 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.7 tp -58.81 -56.02 27.59 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.273 1.029 . . . . 0.0 111.886 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.426 ' HE2' ' O ' ' A' ' 26' ' ' CYS . 77.2 mtp -68.95 -19.27 64.17 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.027 0.531 . . . . 0.0 111.2 -175.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.7 m -73.27 -46.28 50.8 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.795 0.438 . . . . 0.0 110.663 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -70.1 -34.57 73.3 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.282 1.033 . . . . 0.0 111.604 -175.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.6 HD12 HD13 ' A' ' 5' ' ' ILE . 89.5 mt -79.09 -12.23 60.0 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.522 0.729 . . . . 0.0 111.25 175.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 63.54 24.57 14.08 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.576 1.15 . . . . 0.0 111.027 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.436 ' HB3' HG21 ' A' ' 58' ' ' ILE . 88.3 m -88.98 40.95 1.0 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.473 1.509 . . . . 0.0 110.566 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -138.46 25.48 2.64 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.369 1.067 . . . . 0.0 109.46 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -89.54 85.64 6.55 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.865 0.866 . . . . 0.0 110.112 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.67 -102.11 0.66 Allowed Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.59 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -75.85 77.81 2.77 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.94 0.896 . . . . 0.0 111.076 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.437 ' CE1' HG23 ' A' ' 60' ' ' THR . 27.3 m-85 -141.22 140.08 33.89 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.391 0.676 . . . . 0.0 110.196 174.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.427 ' HB1' ' HB2' ' A' ' 59' ' ' LEU . . . -138.54 177.96 7.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.088 1.355 . . . . 0.0 108.466 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.452 HG11 HG12 ' A' ' 17' ' ' VAL . 11.1 p -138.17 148.41 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.227 0.537 . . . . 0.0 110.824 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -129.9 105.53 8.05 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.129 1.372 . . . . 0.0 108.037 172.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.0 tp -86.83 105.79 17.27 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 54.74 52.88 11.36 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.266 1.427 . . . . 0.0 110.725 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 74.89 -16.8 0.53 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 125.765 1.626 . . . . 0.0 113.761 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.03 107.71 19.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 75.4 t -69.96 117.49 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.371 0.669 . . . . 0.0 110.874 -176.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.23 119.45 65.59 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 123.853 0.861 . . . . 0.0 109.157 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.33 154.47 74.11 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.421 2.081 . . . . 0.0 112.159 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -59.39 -33.94 71.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.087 0.955 . . . . 0.0 112.115 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.44 1.31 7.21 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.994 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -127.88 -9.82 5.48 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 117.976 -1.011 . . . . 0.0 112.334 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -49.46 -42.33 42.77 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 119.072 0.851 . . . . 0.0 111.685 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -68.09 -41.72 81.42 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.379 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.44 -19.03 60.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.772 0.829 . . . . 0.0 111.812 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.0 m -96.06 115.35 65.51 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.45 169.91 20.98 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.475 2.117 . . . . 0.0 112.832 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.26 104.72 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.802 1.241 . . . . 0.0 108.499 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 p -97.97 166.64 11.35 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.158 0.983 . . . . 0.0 110.678 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 1' ' ' MET . . . -64.22 116.52 6.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.783 0.833 . . . . 0.0 112.003 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.66 26.78 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 119.315 -0.714 . . . . 0.0 114.479 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -74.09 140.52 45.36 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.023 0.912 . . . . 0.0 111.841 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -89.89 92.56 9.07 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 64.3 mt -96.19 100.91 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.79 0.836 . . . . 0.0 109.861 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -88.92 104.47 16.99 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 26' ' ' CYS . 50.6 mm -78.56 106.69 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.427 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 61.1 mt -73.75 141.83 46.29 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.298 0.639 . . . . 0.0 110.538 176.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.437 HG23 ' CE1' ' A' ' 31' ' ' TYR . 81.4 p -119.0 67.84 8.52 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.617 0.767 . . . . 0.0 109.248 171.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.25 115.31 3.78 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 121.636 1.557 . . . . 0.0 110.203 -172.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -57.12 -44.8 83.63 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.184 0.994 . . . . 0.0 110.804 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -137.09 153.58 50.52 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.129 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.15 -163.89 35.09 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 112.338 -0.305 . . . . 0.0 112.338 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.8 108.77 0.46 Allowed Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -46.25 -36.31 6.04 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.666 1.186 . . . . 0.0 112.4 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -147.1 167.7 23.45 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 169.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -109.66 85.73 2.16 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.362 0.665 . . . . 0.0 109.308 174.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -75.35 128.06 34.54 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 165.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.5 p80 47.87 106.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.583 1.553 . . . . 0.0 111.425 -167.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -36.16 -58.26 0.68 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 125.541 1.536 . . . . 0.0 113.562 -167.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 54.34 93.53 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 O-C-N 124.688 1.243 . . . . 0.0 111.44 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 . . . . . 0 CA--C 1.553 1.063 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.996 -175.632 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HG2' HG13 ' A' ' 3' ' ' VAL . 1.5 pmm? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.371 0.129 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 44.9 tp -77.86 116.71 18.57 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 173.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.453 HG13 ' HG2' ' A' ' 1' ' ' MET . 32.7 m -120.33 -176.46 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.762 1.225 . . . . 0.0 109.273 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 58.7 m -126.67 101.65 6.73 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 172.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.4 mt -96.29 115.6 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.757 0.823 . . . . 0.0 110.006 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 t30 50.42 52.74 14.21 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.851 1.26 . . . . 0.0 111.243 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.07 -0.8 61.74 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 114.62 -1.173 . . . . 0.0 114.429 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -107.56 109.67 21.38 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.817 0.847 . . . . 0.0 110.155 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 27.2 pt20 -66.32 102.03 0.81 Allowed 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.746 0.784 . . . . 0.0 109.774 176.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -137.34 136.97 38.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.506 0.722 . . . . 0.0 109.392 -171.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 36.7 tt0 -84.67 130.83 34.66 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.239 0.616 . . . . 0.0 109.595 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.41 177.04 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.713 1.205 . . . . 0.0 108.933 171.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -119.67 7.38 11.05 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.8 m -68.33 112.2 5.07 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 123.441 0.697 . . . . 0.0 110.618 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.97 -16.49 43.91 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.374 0.669 . . . . 0.0 110.728 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.3 t -121.28 141.34 50.99 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.319 1.048 . . . . 0.0 109.432 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.3 t -69.77 -30.19 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 123.535 0.522 . . . . 0.0 110.371 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.74 64.21 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.456 0.702 . . . . 0.0 110.368 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.39 90.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.544 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.6 tp -61.77 -54.58 40.43 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.626 0.578 . . . . 0.0 110.888 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.3 mmm -61.57 -32.31 72.39 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.044 0.84 . . . . 0.0 110.905 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -70.03 -40.94 74.87 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.212 0.605 . . . . 0.0 110.887 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.52 -20.77 59.85 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.097 0.559 . . . . 0.0 111.376 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.8 mt -87.29 -6.43 58.53 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.056 0.543 . . . . 0.0 110.081 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.5 t70 62.03 31.47 17.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.147 1.379 . . . . 0.0 110.564 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.5 t -107.38 38.52 2.11 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.223 1.409 . . . . 0.0 109.286 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.424 HG22 ' HZ3' ' A' ' 45' ' ' TRP . 21.5 p -124.06 0.32 8.48 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.713 0.805 . . . . 0.0 112.551 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -81.33 -5.65 58.05 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -170.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.74 -146.64 5.17 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.706 -0.497 . . . . 0.0 112.726 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -77.14 94.6 4.09 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.992 0.901 . . . . 0.0 110.603 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -130.96 171.56 13.06 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.895 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.1 179.54 9.05 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.82 1.248 . . . . 0.0 108.784 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.42 HG12 ' NE1' ' A' ' 45' ' ' TRP . 7.3 p -147.06 119.09 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.246 0.546 . . . . 0.0 110.299 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . . . -80.32 97.48 7.03 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 171.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.412 HD11 HG12 ' A' ' 56' ' ' ILE . 46.5 tp -92.11 120.49 32.77 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.4 m120 63.45 25.72 14.62 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.69 1.196 . . . . 0.0 110.071 -173.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 74.47 8.31 4.46 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 126.256 1.822 . . . . 0.0 112.644 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -106.04 126.91 52.77 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.49 124.16 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.564 0.746 . . . . 0.0 111.094 -171.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.5 116.69 57.38 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.536 1.135 . . . . 0.0 109.063 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.536 ' HD2' ' HD3' ' A' ' 44' ' ' LYS . 57.4 Cg_endo -70.23 164.26 35.65 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.858 2.372 . . . . 0.0 112.135 173.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -56.53 -43.42 79.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.081 0.952 . . . . 0.0 112.66 -172.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.8 -30.18 74.32 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 123.804 0.69 . . . . 0.0 113.301 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.536 ' HD3' ' HD2' ' A' ' 41' ' ' PRO . 28.2 mtpp -82.01 -25.92 34.28 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.328 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.424 ' HZ3' HG22 ' A' ' 27' ' ' THR . 51.9 m0 -49.19 -36.34 19.43 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 123.76 0.824 . . . . 0.0 111.65 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.73 -54.23 38.62 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.012 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -86.03 2.78 45.12 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.092 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.7 m -108.37 114.67 59.05 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.1 166.12 12.9 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.579 2.186 . . . . 0.0 113.29 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.1 t -95.17 147.75 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.884 0.873 . . . . 0.0 108.839 172.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 m -123.51 149.16 45.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.848 0.859 . . . . 0.0 110.119 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.29 113.76 3.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.462 0.305 . . . . 0.0 111.243 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.83 39.3 24.95 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.448 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -94.39 164.84 12.84 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.823 0.449 . . . . 0.0 111.386 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -101.15 86.99 3.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.566 0.698 . . . . 0.0 110.204 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.412 HG12 HD11 ' A' ' 35' ' ' LEU . 82.5 mt -86.19 144.2 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.026 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 33.8 tt0 -147.48 136.25 22.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mm -83.29 134.73 26.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.1 mt -125.46 149.61 48.08 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.013 0.925 . . . . 0.0 109.543 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.5 p -126.02 89.77 51.64 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 171.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.23 143.9 32.52 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.379 2.052 . . . . 0.0 110.408 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 66.86 23.07 10.06 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.012 0.925 . . . . 0.0 111.305 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -73.29 135.88 44.47 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.971 0.908 . . . . 0.0 111.134 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.2 -18.0 46.59 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-O 119.071 -0.85 . . . . 0.0 112.894 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.72 123.34 12.96 Favored Glycine 0 C--N 1.357 1.721 0 C-N-CA 123.278 0.466 . . . . 0.0 113.713 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.0 mt -99.73 20.92 13.23 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.798 0.839 . . . . 0.0 111.536 -172.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.73 93.33 0.52 Allowed 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 122.285 1.04 . . . . 0.0 110.669 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 74.74 -77.19 0.05 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 125.836 1.654 . . . . 0.0 111.457 170.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -141.13 159.62 41.84 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.997 0.519 . . . . 0.0 110.923 -175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -109.21 106.31 16.12 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -79.85 76.04 6.54 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.266 0.555 . . . . 0.0 109.919 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -148.32 173.98 12.49 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.847 1.259 . . . . 0.0 109.402 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.8 p80 . . . . . 0 CA--C 1.561 1.37 0 C-N-CA 123.775 0.83 . . . . 0.0 109.393 -175.623 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.502 ' SD ' HG12 ' A' ' 50' ' ' VAL . 23.8 ptp . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 121.064 0.459 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.9 tt -85.43 107.27 17.32 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.465 HG21 HG13 ' A' ' 5' ' ' ILE . 28.6 m -118.69 162.04 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.396 1.079 . . . . 0.0 109.449 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.3 m -94.12 101.52 13.53 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.121 0.569 . . . . 0.0 109.711 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.634 HD12 HD13 ' A' ' 24' ' ' LEU . 69.1 mt -100.02 107.85 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.2 m120 68.26 22.21 8.19 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.917 1.287 . . . . 0.0 112.399 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.17 4.91 66.22 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.455 -0.339 . . . . 0.0 112.66 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -119.99 111.57 18.07 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.143 0.977 . . . . 0.0 108.488 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -60.2 111.28 1.47 Allowed 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.953 0.406 . . . . 0.0 110.287 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -119.94 131.34 55.17 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.626 1.17 . . . . 0.0 108.872 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -80.65 124.42 28.99 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 170.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.43 163.3 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.311 1.044 . . . . 0.0 108.973 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -114.73 -2.22 13.07 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.862 0.465 . . . . 0.0 111.539 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -70.77 117.3 12.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.718 0.407 . . . . 0.0 110.851 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.55 14.27 19.34 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.196 0.998 . . . . 0.0 110.931 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 p -142.38 141.57 32.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.501 1.12 . . . . 0.0 108.702 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.476 HG11 HG11 ' A' ' 33' ' ' VAL . 98.7 t -67.74 -31.73 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 124.027 0.829 . . . . 0.0 112.033 -172.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.5 -45.87 78.14 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.46 0.304 . . . . 0.0 110.521 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -61.29 -38.12 85.63 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.076 0.86 . . . . 0.0 111.092 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.1 tp -62.63 -50.57 70.7 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.902 0.881 . . . . 0.0 111.438 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.5 mtp -72.84 -16.8 61.59 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.65 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.2 m -69.54 -45.84 67.84 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 166.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 22.2 mm-40 -65.89 -30.6 71.23 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.243 0.617 . . . . 0.0 112.217 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.634 HD13 HD12 ' A' ' 5' ' ' ILE . 60.7 mt -99.6 -0.82 39.62 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.634 0.774 . . . . 0.0 111.675 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t70 62.4 25.45 15.18 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.076 1.35 . . . . 0.0 111.503 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.9 m -90.8 14.31 13.94 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.434 1.094 . . . . 0.0 110.622 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.4 t -110.19 -9.57 14.68 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.268 1.027 . . . . 0.0 109.643 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -67.73 -64.96 0.75 Allowed 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.026 0.93 . . . . 0.0 110.499 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.64 -158.43 33.87 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.819 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -90.69 98.29 11.69 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.936 0.495 . . . . 0.0 109.767 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -122.79 148.65 45.12 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.379 0.672 . . . . 0.0 110.177 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.67 134.64 54.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.476 HG11 HG11 ' A' ' 17' ' ' VAL . 11.0 p -106.05 137.92 33.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.43 100.56 8.86 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.408 HD13 HG12 ' A' ' 56' ' ' ILE . 28.5 tp -87.01 108.64 18.94 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 60.39 39.45 18.57 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.232 0.957 . . . . 0.0 110.182 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 68.21 13.87 9.14 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.28 1.432 . . . . 0.0 113.184 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -111.7 116.99 31.67 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.8 t -67.15 126.97 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.247 0.619 . . . . 0.0 111.181 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.7 t -103.8 127.86 28.53 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.544 1.137 . . . . 0.0 108.333 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.68 161.39 33.85 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.947 2.431 . . . . 0.0 111.836 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -59.18 -41.72 89.12 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.476 0.71 . . . . 0.0 112.864 -169.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.45 -29.13 70.81 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 123.373 0.421 . . . . 0.0 112.899 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -88.74 -14.89 36.11 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-O 117.936 -1.031 . . . . 0.0 112.177 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -53.88 -43.37 69.55 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.96 0.8 . . . . 0.0 111.701 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.1 -42.14 85.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.669 0.788 . . . . 0.0 110.432 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -75.77 -21.18 57.65 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.46 1.104 . . . . 0.0 112.445 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 83.8 m -95.0 116.81 66.73 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.27 169.81 16.05 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.409 2.073 . . . . 0.0 112.744 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.502 HG12 ' SD ' ' A' ' 1' ' ' MET . 98.2 t -121.91 134.62 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 169.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.8 p -128.0 155.69 43.89 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.118 0.967 . . . . 0.0 108.753 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.9 134.08 55.66 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.613 0.571 . . . . 0.0 111.67 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.1 -13.04 57.44 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-O 118.979 -0.901 . . . . 0.0 114.393 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -60.25 137.8 58.05 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -82.43 82.04 8.04 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 62.2 mt -88.58 95.41 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.87 106.13 16.64 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -174.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.8 mt -93.04 100.93 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.539 0.685 . . . . 0.0 109.44 -174.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.1 mt -80.1 153.58 28.63 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.286 1.035 . . . . 0.0 110.746 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.1 m -110.23 91.33 11.29 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 167.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.26 136.81 38.42 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.923 2.416 . . . . 0.0 111.797 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -73.44 121.24 20.2 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -67.36 103.34 1.26 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.571 0.748 . . . . 0.0 109.281 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.5 121.37 0.59 Allowed Glycine 0 C--N 1.348 1.25 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.06 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.53 -66.6 3.87 Favored Glycine 0 C--N 1.35 1.351 0 C-N-CA 123.088 0.375 . . . . 0.0 112.347 173.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.98 -60.96 2.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.579 0.752 . . . . 0.0 109.296 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -88.01 32.1 0.76 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.269 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -73.84 94.07 2.24 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -94.58 110.43 22.25 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -54.29 -38.27 65.72 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.966 0.906 . . . . 0.0 109.737 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -102.12 80.28 1.97 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.482 168.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -82.21 86.49 6.64 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.936 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 . . . . . 0 CA--C 1.551 1.008 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.237 179.81 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.594 0.235 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.551 HD13 ' HB3' ' A' ' 9' ' ' GLN . 48.1 tp -89.24 128.15 35.82 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.9 m -140.25 158.33 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.591 1.156 . . . . 0.0 109.325 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -92.29 98.78 11.72 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 62.1 mt -106.61 120.33 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.9 m120 64.01 21.27 12.54 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.692 1.197 . . . . 0.0 111.945 -176.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.75 0.51 78.47 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 119.721 -0.488 . . . . 0.0 114.12 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -115.21 161.11 18.89 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.778 0.789 . . . . 0.0 110.0 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.551 ' HB3' HD13 ' A' ' 2' ' ' LEU . 2.0 mp0 -81.6 118.75 23.03 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -127.64 125.75 40.73 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.685 1.194 . . . . 0.0 109.605 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -95.1 113.51 25.21 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.26 157.38 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.697 0.799 . . . . 0.0 110.775 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.15 -2.29 15.0 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.744 0.818 . . . . 0.0 110.607 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 m -60.55 -44.66 95.89 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.76 1.224 . . . . 0.0 112.972 -168.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 75.45 -43.17 0.49 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.245 1.418 . . . . 0.0 113.227 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -97.18 146.51 25.0 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.496 HG11 HG11 ' A' ' 33' ' ' VAL . 54.9 t -67.91 -31.67 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 123.687 0.617 . . . . 0.0 110.457 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.26 -50.25 72.46 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.668 0.387 . . . . 0.0 110.539 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.84 72.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.602 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.2 tp -68.42 -49.24 61.38 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.794 0.838 . . . . 0.0 111.384 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.447 ' HE3' HG22 ' A' ' 58' ' ' ILE . 92.6 mmm -68.49 -22.49 64.55 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.368 0.667 . . . . 0.0 110.325 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -81.67 -39.39 24.43 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.552 0.341 . . . . 0.0 111.493 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.65 -42.62 98.09 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.696 0.798 . . . . 0.0 110.26 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -88.18 -0.09 56.68 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.983 0.913 . . . . 0.0 111.436 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.0 t70 64.31 20.84 12.33 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.04 1.336 . . . . 0.0 112.437 173.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.0 m -83.08 21.39 1.08 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.318 1.047 . . . . 0.0 111.884 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.461 HG22 ' HZ3' ' A' ' 45' ' ' TRP . 51.4 p -96.85 -31.32 12.66 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.449 0.7 . . . . 0.0 109.875 173.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.09 -60.24 4.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.36 1.064 . . . . 0.0 112.182 -172.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.44 24.27 10.34 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-O 119.588 -0.562 . . . . 0.0 113.759 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 55.5 m80 52.23 64.0 2.02 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.336 1.055 . . . . 0.0 111.376 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -89.75 153.66 20.52 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -109.92 153.26 24.76 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.496 HG11 HG11 ' A' ' 17' ' ' VAL . 9.3 p -105.13 146.01 12.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -126.87 101.83 6.76 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.13 116.92 24.63 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.411 ' N ' HD21 ' A' ' 36' ' ' ASN . 0.8 OUTLIER 65.02 28.44 12.46 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 124.604 1.19 . . . . 0.0 110.276 -172.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 68.92 22.2 7.21 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.473 1.509 . . . . 0.0 112.751 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -114.58 115.79 27.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.932 0.893 . . . . 0.0 108.91 172.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.1 t -66.65 120.77 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.906 0.882 . . . . 0.0 112.109 -170.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.446 ' HB ' HG12 ' A' ' 33' ' ' VAL . 91.7 t -95.52 126.6 45.03 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.981 1.312 . . . . 0.0 109.248 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.45 157.19 59.44 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 123.111 2.54 . . . . 0.0 112.475 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.448 ' HA ' ' CE2' ' A' ' 45' ' ' TRP . 74.7 ttt180 -59.05 -40.59 85.59 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.921 0.889 . . . . 0.0 112.695 -171.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.41 -17.97 54.48 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.885 0.741 . . . . 0.0 114.349 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -102.89 -8.28 20.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.461 ' HZ3' HG22 ' A' ' 27' ' ' THR . 50.7 m0 -55.35 -37.19 67.15 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 120.991 0.424 . . . . 0.0 111.866 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.21 -50.03 71.88 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.343 1.057 . . . . 0.0 111.445 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.1 2.28 40.14 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.594 0.758 . . . . 0.0 112.515 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.3 m -104.53 122.52 43.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.412 0.685 . . . . 0.0 109.517 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.96 161.36 18.38 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.711 2.274 . . . . 0.0 114.584 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.2 94.59 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.7 p -104.36 142.74 34.03 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.03 127.42 31.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.4 1.08 . . . . 0.0 113.319 -167.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.03 12.92 75.78 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-O 119.397 -0.668 . . . . 0.0 114.455 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.96 147.06 25.91 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.869 0.835 . . . . 0.0 111.119 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -84.86 81.75 8.75 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.918 1.287 . . . . 0.0 109.842 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 72.7 mt -88.37 96.43 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.911 0.884 . . . . 0.0 109.158 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 10.4 tp10 -93.65 111.14 22.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.447 HG22 ' HE3' ' A' ' 21' ' ' MET . 55.7 mt -100.55 104.02 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.25 177.71 5.25 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.304 1.042 . . . . 0.0 110.389 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.499 ' HB ' ' HA3' ' A' ' 64' ' ' GLY . 21.2 m -106.97 113.95 62.03 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.09 117.58 4.9 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.133 1.888 . . . . 0.0 111.631 -175.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 70.66 115.99 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.59 1.556 . . . . 0.0 111.468 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 67.51 38.13 3.22 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.381 1.072 . . . . 0.0 111.303 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.499 ' HA3' ' HB ' ' A' ' 60' ' ' THR . . . -106.95 -7.15 33.75 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.609 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.26 -40.73 92.25 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 116.874 0.337 . . . . 0.0 112.954 172.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.58 42.4 1.71 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.127 0.971 . . . . 0.0 108.878 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.5 130.06 30.66 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.271 1.028 . . . . 0.0 109.842 175.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -87.75 80.6 7.85 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -56.62 102.52 0.08 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.618 1.167 . . . . 0.0 111.48 -174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -102.65 26.58 7.8 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.29 1.036 . . . . 0.0 109.533 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -63.11 131.96 50.26 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.313 1.045 . . . . 0.0 109.218 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -53.64 -44.38 69.52 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.268 0.627 . . . . 0.0 111.881 -174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 . . . . . 0 C--O 1.245 0.837 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.128 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.722 0.296 . . . . 0.0 111.213 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 40.8 tp -90.82 116.51 28.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.178 0.991 . . . . 0.0 110.012 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -129.66 140.6 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.406 0.682 . . . . 0.0 110.495 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 59.9 m -71.33 104.58 3.21 Favored 'General case' 0 C--O 1.216 -0.674 0 C-N-CA 123.915 0.886 . . . . 0.0 110.295 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 46.6 mt -102.32 105.45 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 122.825 0.45 . . . . 0.0 109.955 175.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.8 m120 65.62 31.78 9.64 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.09 1.356 . . . . 0.0 112.308 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.13 1.5 81.77 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.944 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -122.4 115.13 21.74 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.745 0.818 . . . . 0.0 109.112 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 1.2 mp0 -68.9 146.01 53.17 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.101 0.56 . . . . 0.0 110.143 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -150.92 139.57 20.66 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.564 0.346 . . . . 0.0 111.267 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.49 99.91 9.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.572 1.149 . . . . 0.0 109.098 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.3 m -121.61 158.73 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.188 0.995 . . . . 0.0 110.259 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -112.14 9.85 20.21 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.635 0.774 . . . . 0.0 110.075 172.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.0 m -73.37 94.04 2.01 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.576 0.75 . . . . 0.0 110.489 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.77 -3.25 37.24 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.432 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.0 t -129.49 148.69 51.42 Favored 'General case' 0 C--O 1.247 0.958 0 C-N-CA 124.616 1.166 . . . . 0.0 109.62 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.469 HG11 HG13 ' A' ' 33' ' ' VAL . 53.5 t -66.32 -33.37 63.07 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.779 0.832 . . . . 0.0 110.623 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.25 -51.62 68.77 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.5 0.72 . . . . 0.0 111.147 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.74 79.93 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.85 0.719 . . . . 0.0 111.301 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.17 -53.71 18.64 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 123.819 0.699 . . . . 0.0 111.462 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.575 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 65.8 mtp -69.79 -34.34 73.61 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.442 0.297 . . . . 0.0 111.498 -175.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.2 m -68.41 -36.09 78.6 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.523 0.329 . . . . 0.0 110.762 175.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.67 -47.31 84.23 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.204 0.526 . . . . 0.0 110.219 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.7 mt -75.79 -8.14 56.14 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.442 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.0 t70 61.42 54.62 3.08 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.145 1.378 . . . . 0.0 110.384 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.7 m -114.06 30.18 7.47 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.801 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -93.54 -16.7 24.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.946 0.499 . . . . 0.0 111.18 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -74.12 176.2 6.78 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.764 0.826 . . . . 0.0 111.465 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.99 -112.68 2.06 Favored Glycine 0 C--N 1.355 1.593 0 O-C-N 123.911 0.757 . . . . 0.0 113.957 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.464 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 88.0 m-70 -147.53 104.62 3.64 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.415 1.486 . . . . 0.0 107.51 169.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -134.51 134.59 41.62 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.024 0.53 . . . . 0.0 109.989 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.43 -175.26 2.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.762 1.225 . . . . 0.0 108.991 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.575 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.1 p -144.96 156.08 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.163 0.585 . . . . 0.0 110.132 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -132.28 102.16 5.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.954 0.901 . . . . 0.0 109.011 176.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.8 tp -86.66 114.99 23.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 56.52 36.29 27.34 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.078 0.951 . . . . 0.0 110.863 -170.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 74.02 -2.03 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.97 1.708 . . . . 0.0 113.106 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -95.87 122.11 38.31 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 59.0 t -70.3 132.75 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.559 0.744 . . . . 0.0 111.799 -170.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.57 124.44 40.77 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -64.61 154.89 69.82 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.71 2.273 . . . . 0.0 111.703 170.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -64.41 -44.14 92.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.694 0.798 . . . . 0.0 112.202 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.61 -3.99 29.84 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.252 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -113.34 -9.45 13.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.147 0.979 . . . . 0.0 113.033 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -52.04 -39.78 60.08 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 119.011 0.823 . . . . 0.0 111.157 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -71.28 -41.9 69.42 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.956 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.95 -12.31 60.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.403 1.081 . . . . 0.0 112.683 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -105.1 115.15 62.78 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -176.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.51 159.14 32.42 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.602 2.201 . . . . 0.0 112.957 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.47 HG11 HD11 ' A' ' 56' ' ' ILE . 84.9 t -119.06 139.19 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.54 1.136 . . . . 0.0 108.004 174.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.8 p -126.26 165.61 18.65 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.256 1.022 . . . . 0.0 109.206 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 1' ' ' MET . . . -61.7 129.97 43.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.965 0.906 . . . . 0.0 112.244 -176.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.52 2.05 68.09 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.218 -0.768 . . . . 0.0 114.164 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.31 147.14 44.76 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 117.897 0.848 . . . . 0.0 111.755 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -94.28 92.39 7.19 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.47 HD11 HG11 ' A' ' 50' ' ' VAL . 3.1 mp -84.93 95.02 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 172.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 36.0 tt0 -96.47 100.39 11.99 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.4 mt -73.95 103.55 2.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.95 131.4 45.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.528 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.3 p -109.41 86.12 4.1 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HD2' ' O ' ' A' ' 30' ' ' HIS . 28.5 Cg_exo -61.94 117.75 4.6 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.573 2.182 . . . . 0.0 111.57 -177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -65.91 99.96 0.53 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.174 0.99 . . . . 0.0 109.887 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 59.8 77.83 0.3 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.307 1.043 . . . . 0.0 109.654 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.96 92.57 0.2 Allowed Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.605 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.89 -92.76 0.04 OUTLIER Glycine 0 C--N 1.347 1.157 0 O-C-N 123.922 0.424 . . . . 0.0 112.324 -174.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.7 tp -68.24 99.69 0.94 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.896 0.878 . . . . 0.0 110.224 176.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -58.78 143.42 47.23 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.655 1.182 . . . . 0.0 108.833 169.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -143.06 91.88 2.33 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -172.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -75.2 129.02 36.79 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -61.99 107.5 0.87 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.29 1.036 . . . . 0.0 110.647 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -174.38 131.98 0.37 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.618 1.567 . . . . 0.0 108.798 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -134.07 -176.07 4.06 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.214 1.005 . . . . 0.0 110.129 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.8 m80 . . . . . 0 C--O 1.253 1.274 0 C-N-CA 123.534 0.734 . . . . 0.0 110.299 -177.428 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptp . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.584 0.231 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 52.4 tp -82.18 114.53 20.76 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.31 -180.0 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.276 1.03 . . . . 0.0 110.57 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.6 m -117.74 100.3 7.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.138 0.575 . . . . 0.0 109.655 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.522 HD13 HD11 ' A' ' 24' ' ' LEU . 69.5 mt -102.41 122.27 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.62 0.768 . . . . 0.0 108.98 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 58.92 30.39 20.13 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.274 1.03 . . . . 0.0 111.927 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.06 -2.74 87.08 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 120.028 -0.318 . . . . 0.0 113.64 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.3 136.0 46.8 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.099 0.96 . . . . 0.0 109.929 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -77.92 113.14 15.54 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -132.1 136.61 47.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.545 1.138 . . . . 0.0 109.512 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.95 131.85 35.36 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.81 155.26 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.632 0.773 . . . . 0.0 110.449 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -93.63 -43.34 8.72 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.041 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 m -58.83 120.99 10.02 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.857 0.863 . . . . 0.0 112.353 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.54 -0.37 57.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.985 0.914 . . . . 0.0 111.261 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.5 t -116.17 141.39 48.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.384 1.073 . . . . 0.0 108.891 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.64 -33.62 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.497 0.719 . . . . 0.0 110.993 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.73 -53.01 61.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.525 0.33 . . . . 0.0 110.308 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.465 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -60.19 -39.45 86.56 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.065 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.2 tp -66.0 -48.1 72.32 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.842 0.457 . . . . 0.0 111.255 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.483 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 83.0 mtp -67.94 -25.68 65.58 Favored 'General case' 0 C--O 1.211 -0.955 0 O-C-N 123.372 0.42 . . . . 0.0 110.238 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.1 m -69.45 -40.95 76.85 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 118.16 0.436 . . . . 0.0 110.343 172.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 18.2 mm-40 -65.93 -37.5 86.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.943 0.497 . . . . 0.0 111.105 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.522 HD11 HD13 ' A' ' 5' ' ' ILE . 95.5 mt -82.0 -12.86 58.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.02 0.928 . . . . 0.0 111.314 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 63.62 51.13 2.57 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.105 1.362 . . . . 0.0 110.553 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.93 35.71 4.78 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.339 1.456 . . . . 0.0 110.443 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.9 p -110.73 -6.46 14.79 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -115.89 -68.03 0.95 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -167.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.58 64.41 4.25 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-O 119.733 -0.481 . . . . 0.0 114.17 -167.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 56.18 72.56 0.49 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.617 1.167 . . . . 0.0 111.568 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -129.82 144.3 51.24 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.097 0.559 . . . . 0.0 109.925 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.0 147.8 52.27 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.207 1.003 . . . . 0.0 109.115 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 5.6 p -106.82 135.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -116.46 100.98 8.24 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.0 tp -88.71 113.72 24.57 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 56.9 42.85 25.78 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.74 1.275 . . . . 0.0 110.072 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 68.04 21.15 8.89 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.385 1.474 . . . . 0.0 112.328 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -124.59 115.44 20.82 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.804 0.842 . . . . 0.0 108.868 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 58.8 t -63.82 127.96 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.55 0.74 . . . . 0.0 111.144 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.433 ' HB ' HG12 ' A' ' 33' ' ' VAL . 98.4 t -96.02 126.64 43.77 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.401 1.081 . . . . 0.0 109.612 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.38 146.22 68.01 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.44 2.093 . . . . 0.0 112.47 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -48.02 -48.55 32.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.892 1.677 . . . . 0.0 113.315 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.1 -15.65 60.99 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 123.749 0.655 . . . . 0.0 114.561 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -106.68 -10.04 16.28 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 117.922 -1.037 . . . . 0.0 112.34 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -46.8 -40.55 13.92 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 123.646 0.778 . . . . 0.0 112.554 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -70.08 -41.01 74.67 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.955 0.902 . . . . 0.0 110.64 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -76.72 -11.91 59.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.595 1.158 . . . . 0.0 111.418 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.0 m -92.78 118.12 67.82 Favored Pre-proline 0 C--O 1.243 0.722 0 C-N-CA 123.515 0.726 . . . . 0.0 109.55 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -82.14 156.73 17.42 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.207 1.938 . . . . 0.0 113.021 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.3 t -96.99 138.64 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.748 1.219 . . . . 0.0 107.867 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.9 m -130.02 139.37 51.03 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.228 1.011 . . . . 0.0 109.461 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.66 114.6 2.82 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.96 0.346 . . . . 0.0 111.392 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.74 20.68 42.82 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-O 119.371 -0.683 . . . . 0.0 114.253 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -84.73 165.69 17.64 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.004 0.902 . . . . 0.0 110.229 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.74 85.5 2.24 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.861 0.464 . . . . 0.0 110.117 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 82.8 mt -88.01 97.32 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 36.6 tt0 -103.99 102.52 12.29 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.211 0.605 . . . . 0.0 109.974 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 64.3 mt -97.88 105.77 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.9 178.14 4.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.52 1.128 . . . . 0.0 110.508 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.0 p -103.53 102.3 29.02 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.271 0.629 . . . . 0.0 109.52 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.08 133.01 29.53 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.651 2.234 . . . . 0.0 111.183 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -76.87 -29.64 55.9 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.081 0.552 . . . . 0.0 110.51 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 81.25 -62.33 0.19 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.747 1.619 . . . . 0.0 110.628 165.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.47 73.0 2.72 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 169.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.09 92.56 0.01 OUTLIER Glycine 0 C--N 1.36 1.886 0 C-N-CA 123.783 0.706 . . . . 0.0 114.792 -175.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.1 tp -149.08 2.12 0.57 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.86 0.864 . . . . 0.0 110.363 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.49 -43.91 93.19 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.081 0.952 . . . . 0.0 110.533 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -133.86 171.95 13.46 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.428 1.091 . . . . 0.0 109.354 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -81.16 176.48 9.74 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.093 0.557 . . . . 0.0 109.7 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -71.99 89.46 1.11 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.298 0.639 . . . . 0.0 109.914 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -90.3 85.63 6.27 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.388 0.675 . . . . 0.0 109.971 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 69.59 171.51 0.3 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.27 1.428 . . . . 0.0 111.991 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 74.0 t60 . . . . . 0 C--O 1.249 1.032 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.507 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.5 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 120.718 0.294 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 9' ' ' GLN . 59.2 tp -79.65 119.08 22.1 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.954 0.902 . . . . 0.0 110.324 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.47 162.97 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.344 1.058 . . . . 0.0 109.069 176.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 m -105.02 99.99 9.6 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.611 HD13 HD13 ' A' ' 24' ' ' LEU . 32.9 mt -101.5 108.96 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.732 0.813 . . . . 0.0 109.321 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.4 m120 63.48 22.73 13.36 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.249 1.02 . . . . 0.0 112.999 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.94 8.75 72.1 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.358 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -103.91 131.27 51.3 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.729 0.811 . . . . 0.0 108.834 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.47 ' HB3' HD12 ' A' ' 2' ' ' LEU . 24.9 mt-30 -80.05 113.84 18.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 172.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -137.3 130.56 30.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.146 0.578 . . . . 0.0 110.225 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -82.52 129.52 34.93 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.751 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.99 159.56 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.764 0.826 . . . . 0.0 110.136 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -112.32 -12.69 13.53 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.877 0.871 . . . . 0.0 110.371 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 p -66.16 105.47 1.4 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.128 0.971 . . . . 0.0 110.973 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.95 -17.56 62.07 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.813 0.845 . . . . 0.0 111.748 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.7 t -105.03 143.24 33.49 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.01 0.924 . . . . 0.0 110.097 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.16 -33.63 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.62 95.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.843 0.457 . . . . 0.0 110.511 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.08 79.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.084 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.1 tp -69.42 -43.13 74.02 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.659 0.599 . . . . 0.0 110.695 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.411 ' HE2' HG22 ' A' ' 58' ' ' ILE . 91.8 mmm -67.44 -29.12 68.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.915 0.486 . . . . 0.0 109.988 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 m -79.99 -29.25 39.46 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.682 0.393 . . . . 0.0 110.663 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -68.48 -37.52 80.2 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.759 0.824 . . . . 0.0 109.931 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.611 HD13 HD13 ' A' ' 5' ' ' ILE . 57.4 mt -98.26 8.62 44.56 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.349 1.06 . . . . 0.0 110.851 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 p30 51.03 23.78 1.63 Allowed 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 125.814 1.646 . . . . 0.0 113.389 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.8 m -87.84 20.5 3.03 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.749 1.219 . . . . 0.0 110.655 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 p -95.07 -47.86 6.2 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.562 0.745 . . . . 0.0 109.535 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.22 111.71 13.15 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.602 0.761 . . . . 0.0 110.209 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.98 -172.75 14.37 Favored Glycine 0 C--O 1.242 0.643 0 O-C-N 123.641 0.588 . . . . 0.0 113.119 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -75.78 86.01 2.78 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -138.3 155.69 48.35 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.556 0.693 . . . . 0.0 111.202 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.59 168.32 22.3 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.764 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG12 ' HB ' ' A' ' 40' ' ' VAL . 12.8 p -130.91 147.98 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -126.56 104.96 8.4 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.477 1.111 . . . . 0.0 108.447 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 tp -88.35 109.82 20.29 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 57.06 52.22 9.42 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 124.662 1.226 . . . . 0.0 111.191 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 71.18 -2.1 2.49 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.507 1.523 . . . . 0.0 112.988 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -103.7 110.26 22.28 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.78 0.832 . . . . 0.0 108.943 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 78.0 t -69.92 115.76 9.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 122.896 0.479 . . . . 0.0 110.404 -175.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.457 ' HB ' HG12 ' A' ' 33' ' ' VAL . 58.4 t -87.23 122.39 70.94 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.23 1.012 . . . . 0.0 108.637 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.9 159.17 53.42 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 122.767 2.311 . . . . 0.0 111.145 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -61.56 -34.05 74.91 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.621 0.576 . . . . 0.0 111.985 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.87 -5.85 21.13 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.792 -0.64 . . . . 0.0 114.066 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -119.46 -6.86 10.24 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 117.655 -1.164 . . . . 0.0 112.827 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -55.86 -46.47 78.21 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 120.132 1.333 . . . . 0.0 111.454 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.51 -39.45 67.61 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.782 0.433 . . . . 0.0 110.108 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.77 -22.37 65.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.713 0.805 . . . . 0.0 112.617 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.5 m -99.56 127.88 32.99 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 123.554 0.742 . . . . 0.0 109.596 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -83.34 167.25 13.79 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.558 2.172 . . . . 0.0 113.429 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.406 HG11 HD12 ' A' ' 56' ' ' ILE . 67.7 t -115.45 125.59 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.278 1.031 . . . . 0.0 108.37 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.5 p -123.8 160.65 26.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.098 0.559 . . . . 0.0 110.207 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' A' ' 1' ' ' MET . . . -64.29 142.02 58.57 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.824 1.249 . . . . 0.0 112.588 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.28 -13.2 60.53 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-O 119.71 -0.495 . . . . 0.0 114.01 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.82 145.16 40.86 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.73 0.765 . . . . 0.0 112.049 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -93.14 99.67 12.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.207 1.003 . . . . 0.0 110.127 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 61.6 mt -97.89 97.51 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.901 0.881 . . . . 0.0 108.924 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -96.83 107.11 19.54 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.707 0.803 . . . . 0.0 109.536 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.411 HG22 ' HE2' ' A' ' 21' ' ' MET . 58.9 mt -94.96 114.84 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.414 HD12 ' H ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -123.38 155.36 37.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.455 0.702 . . . . 0.0 110.414 -176.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.8 p -85.08 146.77 46.19 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.16 132.94 50.4 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.199 1.933 . . . . 0.0 110.589 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.46 78.11 0.19 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.95 1.3 . . . . 0.0 108.201 -168.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -148.22 159.5 43.9 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.889 0.875 . . . . 0.0 109.429 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.09 -126.84 1.94 Allowed Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.34 169.6 22.95 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 117.028 0.414 . . . . 0.0 112.668 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -110.97 10.03 22.21 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.948 0.899 . . . . 0.0 111.0 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.16 109.12 2.93 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 123.931 0.892 . . . . 0.0 110.242 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 58.42 34.67 24.17 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.324 1.05 . . . . 0.0 110.997 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -69.29 91.01 0.52 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.585 0.354 . . . . 0.0 110.55 -175.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -87.11 122.32 30.76 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.142 0.977 . . . . 0.0 109.533 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -72.51 150.42 43.24 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.261 0.624 . . . . 0.0 110.008 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -84.22 131.71 34.72 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 174.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 124.375 1.07 . . . . 0.0 108.78 175.906 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.52 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 24.3 ptp . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.653 0.264 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 36.2 tp -81.49 112.32 18.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.39 165.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.955 0.902 . . . . 0.0 110.087 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.7 m -111.64 100.73 9.21 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.972 0.509 . . . . 0.0 109.871 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.426 HD12 HD11 ' A' ' 20' ' ' LEU . 70.7 mt -108.35 117.8 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 124.109 0.964 . . . . 0.0 109.203 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 65.41 24.49 11.99 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.517 1.127 . . . . 0.0 112.644 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.18 -3.08 84.18 Favored Glycine 0 N--CA 1.47 0.908 0 CA-C-N 116.445 -0.343 . . . . 0.0 113.156 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -105.78 154.97 19.76 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.613 1.165 . . . . 0.0 108.42 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -105.27 136.12 45.38 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.074 0.397 . . . . 0.0 110.07 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -141.3 130.97 24.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.293 1.037 . . . . 0.0 109.503 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.15 124.96 29.68 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.3 m -135.99 161.92 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.212 1.005 . . . . 0.0 110.724 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.82 24.08 5.0 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.781 1.232 . . . . 0.0 108.884 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.3 m -55.98 -48.11 76.44 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.932 1.293 . . . . 0.0 113.705 -171.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 77.02 -50.33 0.55 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.953 1.701 . . . . 0.0 111.701 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -108.19 151.55 25.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.033 0.933 . . . . 0.0 109.301 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 21' ' ' MET . 87.6 t -66.43 -24.97 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 O-C-N 124.056 0.848 . . . . 0.0 110.754 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.63 -56.73 15.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.73 0.812 . . . . 0.0 110.512 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.12 -30.32 68.03 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.465 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.426 HD11 HD12 ' A' ' 5' ' ' ILE . 48.3 tp -64.49 -54.74 27.68 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.752 0.821 . . . . 0.0 110.703 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.508 ' HE2' HG22 ' A' ' 58' ' ' ILE . 97.6 mmm -64.78 -26.43 68.35 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.005 0.522 . . . . 0.0 111.527 -177.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.8 m -75.02 -38.49 61.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.66 0.784 . . . . 0.0 110.936 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.91 -45.13 93.93 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.695 HD11 HD12 ' A' ' 58' ' ' ILE . 48.1 mt -72.65 -12.27 60.97 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.569 1.147 . . . . 0.0 111.828 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 63.62 14.36 8.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.936 1.294 . . . . 0.0 111.626 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.2 m -96.92 37.71 1.28 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.886 1.274 . . . . 0.0 109.098 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.9 t -113.47 -28.51 7.51 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.337 0.655 . . . . 0.0 110.512 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -81.09 84.79 6.43 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.106 0.562 . . . . 0.0 110.26 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 134.27 -162.5 24.56 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.481 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -84.42 80.87 9.07 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.787 0.835 . . . . 0.0 109.381 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -118.86 157.66 27.19 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.516 0.674 . . . . 0.0 110.965 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.54 154.3 50.11 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.422 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 8.8 p -123.1 150.33 27.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.86 99.32 5.7 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.511 HD11 HG12 ' A' ' 56' ' ' ILE . 18.3 tp -90.08 121.12 31.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.73 23.04 8.73 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.635 1.174 . . . . 0.0 108.734 -170.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.464 ' CE2' ' HB3' ' A' ' 55' ' ' GLU . 59.3 m-85 68.96 3.96 4.28 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.848 1.659 . . . . 0.0 113.059 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -92.63 127.17 38.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.282 0.633 . . . . 0.0 109.39 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.9 t -66.27 114.27 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.748 0.819 . . . . 0.0 111.024 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.402 ' HB ' HG12 ' A' ' 33' ' ' VAL . 80.2 t -87.61 120.41 71.03 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.1 143.36 99.55 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.096 2.531 . . . . 0.0 110.739 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -57.8 -40.07 79.07 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.96 -24.19 62.47 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 123.803 0.689 . . . . 0.0 114.173 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -103.13 2.39 34.53 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -50.79 -41.93 57.5 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 118.13 0.423 . . . . 0.0 111.031 175.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.25 -49.42 60.76 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.578 0.751 . . . . 0.0 110.884 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.15 -26.02 67.24 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.826 0.85 . . . . 0.0 111.694 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.2 m -95.52 119.56 65.04 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.73 167.88 23.28 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.856 2.371 . . . . 0.0 113.504 176.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.6 t -104.29 145.76 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.609 1.163 . . . . 0.0 109.305 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.1 m -108.58 148.57 30.12 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.579 0.752 . . . . 0.0 109.683 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.52 ' HA ' ' HB2' ' A' ' 1' ' ' MET . . . -65.67 115.34 5.74 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.735 0.814 . . . . 0.0 110.741 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.86 41.1 73.99 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 123.365 0.415 . . . . 0.0 112.551 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.95 149.03 28.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.084 0.554 . . . . 0.0 110.364 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.464 ' HB3' ' CE2' ' A' ' 37' ' ' TYR . 2.9 mp0 -84.63 81.71 8.74 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 121.854 0.835 . . . . 0.0 109.586 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.511 HG12 HD11 ' A' ' 35' ' ' LEU . 32.4 mt -99.04 153.65 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.729 1.212 . . . . 0.0 109.637 -177.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -151.17 125.01 9.12 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.469 0.708 . . . . 0.0 109.14 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.695 HD12 HD11 ' A' ' 24' ' ' LEU . 66.8 mt -80.37 105.36 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.4 mt -83.39 117.94 23.38 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.2 p -93.56 99.2 3.14 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 170.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.83 117.82 4.63 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.848 2.365 . . . . 0.0 111.972 -171.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -83.92 -50.65 7.85 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.291 -172.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 82.86 -56.61 0.18 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.648 1.579 . . . . 0.0 112.008 171.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.8 75.55 1.26 Allowed Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 175.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.35 121.43 4.4 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -165.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 tt -138.48 109.58 6.82 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -91.73 150.3 21.18 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 170.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -88.32 -12.8 42.44 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.065 0.546 . . . . 0.0 111.712 -175.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 72.42 117.4 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.348 1.459 . . . . 0.0 109.682 -168.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -62.13 137.59 58.28 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.718 0.807 . . . . 0.0 109.989 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -67.57 89.32 0.24 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.984 0.421 . . . . 0.0 110.14 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -74.57 142.01 44.72 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.74 0.816 . . . . 0.0 109.1 173.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.5 p80 . . . . . 0 C--O 1.25 1.125 0 C-N-CA 123.839 0.856 . . . . 0.0 109.23 -179.241 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtm . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.62 103.52 9.59 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.64 152.13 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.363 1.065 . . . . 0.0 109.118 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 38.9 m -86.37 106.44 17.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.156 0.582 . . . . 0.0 109.577 176.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 70.2 mt -100.22 106.2 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.986 0.515 . . . . 0.0 110.733 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 t30 66.5 23.61 10.44 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.709 1.204 . . . . 0.0 110.708 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.4 -15.58 62.58 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.354 -174.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -98.18 110.31 22.91 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.38 0.672 . . . . 0.0 109.314 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 18.5 mt-30 -71.94 114.5 10.11 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 120.786 0.326 . . . . 0.0 110.15 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.466 ' NH1' HG12 ' A' ' 12' ' ' VAL . 61.1 ttt-85 -131.23 143.87 50.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.419 1.088 . . . . 0.0 109.265 -176.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.3 137.98 35.74 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.466 HG12 ' NH1' ' A' ' 10' ' ' ARG . 33.1 m -114.81 152.94 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 122.841 0.456 . . . . 0.0 111.261 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.92 -38.43 11.7 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 168.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -66.44 120.05 12.69 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.938 0.895 . . . . 0.0 111.849 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.35 -0.88 52.24 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.787 0.835 . . . . 0.0 111.529 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.7 p -122.14 148.11 45.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.059 0.944 . . . . 0.0 109.093 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.6 t -68.61 -31.43 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 123.478 0.711 . . . . 0.0 111.486 -176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.34 -52.8 63.13 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.896 0.478 . . . . 0.0 110.88 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.63 -30.65 71.67 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.137 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.4 tp -71.16 -44.92 64.55 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 124.0 0.812 . . . . 0.0 111.483 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.504 ' HE3' HG22 ' A' ' 58' ' ' ILE . 98.8 mmm -70.03 -24.38 63.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.719 0.408 . . . . 0.0 110.681 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -74.38 -43.01 58.27 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.764 0.426 . . . . 0.0 110.413 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.12 -37.87 86.76 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.719 1.208 . . . . 0.0 110.895 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.548 HD11 HD12 ' A' ' 58' ' ' ILE . 71.3 mt -88.65 -7.73 55.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.306 1.042 . . . . 0.0 111.367 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.5 t70 59.78 42.68 16.33 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.027 1.331 . . . . 0.0 110.933 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.0 m -121.56 35.91 4.76 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.386 1.074 . . . . 0.0 110.769 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.403 ' HG1' ' HZ3' ' A' ' 45' ' ' TRP . 15.2 t -120.69 1.91 10.58 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.193 0.597 . . . . 0.0 110.478 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.09 -61.59 2.37 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.833 0.853 . . . . 0.0 112.228 -169.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.3 -131.68 4.82 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-O 120.046 -0.308 . . . . 0.0 112.607 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -78.26 87.25 4.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.726 0.811 . . . . 0.0 109.305 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -135.92 152.62 51.18 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.743 0.817 . . . . 0.0 110.925 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.416 ' HA ' ' HZ2' ' A' ' 45' ' ' TRP . . . -136.02 -177.84 4.88 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.412 1.485 . . . . 0.0 108.226 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.405 HG13 ' NE1' ' A' ' 45' ' ' TRP . 7.9 p -149.8 159.61 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.543 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . . . -133.15 109.86 9.76 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.013 0.525 . . . . 0.0 109.737 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.3 tp -88.59 113.02 23.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 59.48 36.44 23.03 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.154 0.982 . . . . 0.0 110.614 -172.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 72.0 13.18 5.97 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.061 1.344 . . . . 0.0 112.217 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -102.02 112.07 24.58 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.922 0.889 . . . . 0.0 109.247 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.4 t -62.93 111.03 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.557 0 O-C-N 123.921 0.763 . . . . 0.0 110.73 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -90.41 121.36 68.54 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.41 151.84 75.71 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.538 2.159 . . . . 0.0 111.053 173.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -58.24 -38.09 76.18 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.916 0.886 . . . . 0.0 113.053 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.67 3.55 25.83 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 114.567 0.587 . . . . 0.0 114.567 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -121.73 -9.96 8.8 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.882 0.873 . . . . 0.0 112.026 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.416 ' HZ2' ' HA ' ' A' ' 32' ' ' ALA . 40.9 m0 -49.66 -39.69 37.12 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.124 0.57 . . . . 0.0 112.23 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -70.06 -43.07 71.96 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.772 0.829 . . . . 0.0 110.819 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -73.08 -14.59 61.43 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 112.303 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.6 m -100.45 120.37 56.38 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.478 0.711 . . . . 0.0 109.324 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -83.99 166.81 12.88 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.897 2.398 . . . . 0.0 113.278 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.6 129.22 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.019 1.328 . . . . 0.0 107.855 175.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.9 p -125.22 149.53 47.89 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.99 126.88 29.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.842 0.857 . . . . 0.0 111.4 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.56 -4.05 39.89 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 119.564 -0.576 . . . . 0.0 113.358 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -78.11 154.64 31.11 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 117.443 0.622 . . . . 0.0 111.366 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -110.09 90.91 3.45 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.778 0.831 . . . . 0.0 109.387 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 4.0 mp -88.13 97.45 6.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HG3' ' HB2' ' A' ' 34' ' ' ALA . 8.2 pt-20 -99.1 125.44 44.63 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.69 0.757 . . . . 0.0 109.231 175.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.548 HD12 HD11 ' A' ' 24' ' ' LEU . 70.2 mt -84.74 126.22 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.453 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.0 mt -103.35 130.0 50.53 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.687 0.795 . . . . 0.0 109.724 -177.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 52.4 m -102.48 93.87 4.47 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 163.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.18 115.08 3.99 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 122.518 2.145 . . . . 0.0 111.378 -169.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 60' ' ' THR . 40.7 mtt85 -111.97 -78.99 0.58 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -116.2 84.48 2.13 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.99 -58.86 0.33 Allowed Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.659 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.41 -31.46 59.01 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mp -122.86 88.91 3.01 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 173.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -140.52 -172.57 3.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.22 0.608 . . . . 0.0 110.098 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -134.97 14.31 3.59 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 167.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 57.78 -83.19 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.131 1.372 . . . . 0.0 111.655 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 49.1 m80 63.06 -153.71 0.34 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -169.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -72.41 88.55 1.2 Allowed 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 166.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -163.17 135.98 5.51 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.879 1.272 . . . . 0.0 108.261 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 . . . . . 0 C--O 1.248 0.974 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.663 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 47.3 tp -79.11 96.88 5.95 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.92 139.03 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.41 1.084 . . . . 0.0 109.642 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 8.7 m -84.5 99.66 10.86 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -176.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 65.9 mt -98.6 108.31 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.626 0.77 . . . . 0.0 109.707 -177.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.485 HD21 ' N ' ' A' ' 6' ' ' ASN . 0.7 OUTLIER 67.66 34.09 4.66 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.9 1.28 . . . . 0.0 110.899 176.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.53 10.16 84.64 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.441 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -125.68 110.99 14.43 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.502 1.121 . . . . 0.0 108.244 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 79.6 mt-30 -66.44 143.89 56.84 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -151.43 128.34 11.0 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.815 1.246 . . . . 0.0 108.595 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.83 116.32 22.1 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.67 155.78 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.286 1.035 . . . . 0.0 109.607 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -109.44 -12.6 14.7 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.846 0.859 . . . . 0.0 109.506 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.2 m -57.46 100.07 0.05 OUTLIER 'General case' 0 C--N 1.353 0.731 0 C-N-CA 124.651 1.18 . . . . 0.0 110.672 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.69 -13.98 60.0 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.631 0.773 . . . . 0.0 111.967 -177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 t -114.42 142.01 46.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 109.46 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.479 HG11 HG11 ' A' ' 33' ' ' VAL . 94.9 t -69.65 -27.07 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.437 0.695 . . . . 0.0 110.435 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.32 -54.32 42.25 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.79 -31.7 71.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.186 0.594 . . . . 0.0 111.474 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.2 -51.97 46.89 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.491 0.716 . . . . 0.0 111.195 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.545 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 76.4 mtp -75.02 -18.8 60.29 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.782 0.433 . . . . 0.0 111.425 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -67.1 -45.23 77.87 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 166.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -67.1 -41.05 86.92 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.277 1.031 . . . . 0.0 111.613 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 5' ' ' ILE . 80.9 mt -80.4 -11.55 59.68 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.835 0.854 . . . . 0.0 110.609 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.3 t70 62.81 35.14 13.94 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.138 1.375 . . . . 0.0 110.817 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.606 ' SG ' HD13 ' A' ' 58' ' ' ILE . 59.8 m -96.36 40.68 1.12 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.394 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.9 p -111.75 6.14 19.57 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.199 0.6 . . . . 0.0 111.781 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.52 109.02 0.62 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.996 0.918 . . . . 0.0 112.42 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.62 -90.72 0.39 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-O 120.047 -0.307 . . . . 0.0 112.553 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -147.7 77.98 1.44 Allowed 'General case' 0 C--N 1.354 0.794 0 CA-C-O 121.552 0.692 . . . . 0.0 109.742 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -93.77 173.68 7.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.842 1.257 . . . . 0.0 111.196 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -153.29 168.97 24.23 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.272 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.545 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 6.6 p -128.76 139.03 52.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 C-N-CA 124.057 0.943 . . . . 0.0 108.855 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.427 ' HB1' ' HB2' ' A' ' 57' ' ' GLU . . . -108.08 104.19 13.57 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.0 tp -90.11 107.02 18.87 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 173.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.16 37.8 14.16 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.65 1.18 . . . . 0.0 110.42 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 71.98 11.85 6.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.084 1.754 . . . . 0.0 112.86 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.84 109.32 21.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 84.7 t -71.2 122.91 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.127 0.571 . . . . 0.0 109.937 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.47 126.97 48.2 Favored Pre-proline 0 C--O 1.246 0.917 0 C-N-CA 124.293 1.037 . . . . 0.0 109.322 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.81 145.69 59.92 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.087 2.525 . . . . 0.0 112.389 170.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -60.33 -42.19 95.13 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.843 0.857 . . . . 0.0 112.277 -173.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.15 11.7 11.33 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-N 116.317 -0.401 . . . . 0.0 113.14 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -126.32 -6.93 6.44 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.243 1.017 . . . . 0.0 110.611 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 52.5 m0 -54.24 -33.74 59.11 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.19 0.596 . . . . 0.0 111.358 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -71.39 -39.58 71.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.983 0.913 . . . . 0.0 110.471 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.29 -17.9 63.1 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.083 0.953 . . . . 0.0 111.773 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 m -96.41 114.5 64.48 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.981 0.512 . . . . 0.0 109.84 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.74 155.85 53.66 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.214 1.943 . . . . 0.0 112.471 168.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.9 t -101.02 129.33 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -127.17 135.75 51.11 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.116 0.566 . . . . 0.0 109.831 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.49 133.69 56.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.657 1.183 . . . . 0.0 112.598 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.41 -6.1 71.18 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.351 -0.694 . . . . 0.0 114.372 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.29 164.23 15.02 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 117.872 0.836 . . . . 0.0 112.108 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -97.05 108.57 21.33 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.666 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 73.8 mt -111.38 96.96 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.94 0.896 . . . . 0.0 109.535 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.427 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -91.33 145.37 24.7 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.427 0.691 . . . . 0.0 109.242 177.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.606 HD13 ' SG ' ' A' ' 26' ' ' CYS . 99.6 mt -120.81 114.51 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.403 HD23 ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -135.96 155.13 50.73 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.498 1.119 . . . . 0.0 108.641 -174.362 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.7 t -125.22 92.65 46.85 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 123.132 0.573 . . . . 0.0 110.067 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.54 116.83 4.72 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.177 1.918 . . . . 0.0 111.364 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -66.56 -43.04 86.12 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.272 0.629 . . . . 0.0 111.65 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -72.13 -26.56 62.16 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.192 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.59 35.91 3.53 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 116.255 -0.429 . . . . 0.0 113.057 -174.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.18 -115.1 0.29 Allowed Glycine 0 C--N 1.355 1.623 0 C-N-CA 123.048 0.356 . . . . 0.0 113.013 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.4 tp -156.36 80.33 0.97 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.835 0.854 . . . . 0.0 108.751 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -168.04 143.77 3.82 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.609 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -122.88 2.99 9.44 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.159 0.984 . . . . 0.0 109.852 171.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -84.07 45.07 1.06 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.599 0.714 . . . . 0.0 111.017 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -155.93 116.13 3.7 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.014 1.725 . . . . 0.0 106.893 172.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -139.03 128.3 24.11 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.02 0.928 . . . . 0.0 109.102 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -83.71 -34.44 24.9 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.064 0.545 . . . . 0.0 110.168 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 . . . . . 0 C--O 1.245 0.82 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 168.693 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 120.932 0.396 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 9' ' ' GLN . 8.5 tt -85.55 114.57 22.66 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.4 HG21 HG13 ' A' ' 5' ' ' ILE . 9.7 m -132.8 139.46 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.246 1.018 . . . . 0.0 110.568 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.9 m -67.79 100.43 0.93 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 55.7 mt -104.19 104.57 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.44 0.696 . . . . 0.0 109.328 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 62.45 31.43 17.13 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 122.375 1.083 . . . . 0.0 110.28 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.44 -6.52 83.25 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 121.649 -0.657 . . . . 0.0 113.402 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -106.31 105.59 15.7 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.502 ' HB3' HD22 ' A' ' 2' ' ' LEU . 27.0 mt-30 -61.21 107.23 0.72 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB3' HD13 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -118.72 121.53 40.33 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -169.177 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -81.42 112.78 19.0 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.921 0.888 . . . . 0.0 109.031 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.77 169.65 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.59 1.156 . . . . 0.0 109.85 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -129.59 17.77 5.82 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.383 0.673 . . . . 0.0 110.847 175.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.0 p -94.96 108.65 20.71 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.336 0.654 . . . . 0.0 109.311 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.79 -0.38 47.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.813 0.845 . . . . 0.0 112.035 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.0 t -110.34 135.62 50.78 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.153 0.981 . . . . 0.0 108.916 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.8 t -68.66 -26.69 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.153 0.581 . . . . 0.0 110.451 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.67 -55.2 18.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.086 0.554 . . . . 0.0 109.999 172.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.2 -30.1 69.15 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.65 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -69.11 -54.66 13.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.786 0.834 . . . . 0.0 110.867 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.588 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 78.8 mtp -70.04 -21.5 63.18 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.3 m -75.18 -37.89 61.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.638 0.375 . . . . 0.0 110.021 171.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.6 -40.92 98.45 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.854 0.861 . . . . 0.0 110.389 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.472 HD13 HD12 ' A' ' 5' ' ' ILE . 64.4 mt -86.89 -3.68 59.1 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.387 -176.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.49 19.67 10.52 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.245 1.418 . . . . 0.0 112.682 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.506 ' SG ' HG21 ' A' ' 58' ' ' ILE . 56.2 m -87.22 21.0 2.53 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.018 1.327 . . . . 0.0 111.237 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.42 HG22 ' HZ3' ' A' ' 45' ' ' TRP . 10.2 p -100.08 -19.48 16.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.552 1.141 . . . . 0.0 109.706 174.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -89.85 126.85 35.85 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.95 0.9 . . . . 0.0 109.679 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.77 -174.16 51.34 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 112.247 -0.341 . . . . 0.0 112.247 -174.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -84.23 89.1 7.27 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.538 0.685 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -129.07 146.94 50.91 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.445 0.698 . . . . 0.0 110.17 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.71 159.67 40.92 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.46 1.104 . . . . 0.0 109.333 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.588 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 11.1 p -118.49 148.01 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.523 0.729 . . . . 0.0 110.103 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.507 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . . . -129.55 102.53 6.42 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.625 0.77 . . . . 0.0 110.221 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.472 HD12 HG12 ' A' ' 56' ' ' ILE . 64.3 tp -89.67 123.07 33.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.0 m120 64.38 39.13 7.3 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.555 1.142 . . . . 0.0 111.079 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 66.48 21.31 10.82 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.456 1.502 . . . . 0.0 112.0 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -131.89 123.53 27.67 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.946 0.899 . . . . 0.0 108.66 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 59.4 t -66.12 126.27 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.302 0.641 . . . . 0.0 111.07 -176.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.422 ' HB ' HG12 ' A' ' 33' ' ' VAL . 61.2 t -88.7 125.93 61.41 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.057 0.943 . . . . 0.0 109.085 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.06 146.56 91.11 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.605 2.203 . . . . 0.0 112.031 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -59.78 -39.17 84.01 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.37 -14.64 57.56 Favored Glycine 0 CA--C 1.532 1.095 0 O-C-N 123.752 0.657 . . . . 0.0 113.051 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -104.74 -16.67 14.88 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 117.73 -1.129 . . . . 0.0 112.676 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.42 ' HZ3' HG22 ' A' ' 27' ' ' THR . 38.3 m0 -46.61 -42.82 16.75 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 118.994 0.815 . . . . 0.0 111.908 -176.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -67.43 -42.72 82.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.566 1.146 . . . . 0.0 112.052 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -90.05 -2.98 58.2 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.917 0.487 . . . . 0.0 112.302 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.3 m -89.53 115.61 64.23 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.82 153.99 33.76 Favored 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 122.364 2.043 . . . . 0.0 112.785 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.3 t -105.22 119.27 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.561 1.144 . . . . 0.0 108.754 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 p -120.63 148.2 44.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.85 0.86 . . . . 0.0 109.88 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.72 131.81 49.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.139 0.976 . . . . 0.0 112.478 -171.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.62 -0.54 82.97 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-O 119.287 -0.729 . . . . 0.0 114.92 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.46 155.37 24.65 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 117.657 0.728 . . . . 0.0 111.561 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -87.77 92.41 9.1 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.594 1.158 . . . . 0.0 109.177 -173.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 62.1 mt -97.83 97.49 6.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 45.0 mt-10 -93.08 116.77 29.35 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.506 HG21 ' SG ' ' A' ' 26' ' ' CYS . 45.8 mm -98.16 118.1 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.44 165.49 24.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.169 0.588 . . . . 0.0 109.977 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 t -113.09 99.58 49.17 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 123.919 0.887 . . . . 0.0 109.02 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.61 132.7 31.73 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.568 2.179 . . . . 0.0 112.417 -178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 60.08 77.17 0.33 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.743 1.217 . . . . 0.0 109.982 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -145.11 -49.35 0.24 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.096 0.959 . . . . 0.0 108.908 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.31 -55.69 4.37 Favored Glycine 0 C--N 1.349 1.267 0 O-C-N 123.997 0.81 . . . . 0.0 114.41 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.94 -28.67 0.18 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.9 mt -83.24 112.35 19.78 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.532 0.733 . . . . 0.0 109.601 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -54.62 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.281 1.032 . . . . 0.0 110.308 171.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -68.74 -33.54 74.09 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.312 0.645 . . . . 0.0 112.004 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -164.35 104.57 0.85 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.5 0.72 . . . . 0.0 109.585 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -141.99 159.24 42.63 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.078 0.951 . . . . 0.0 110.187 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -81.01 84.31 6.5 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.733 0.813 . . . . 0.0 109.963 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -74.95 -50.81 15.46 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.028 173.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 62.3 t60 . . . . . 0 CA--C 1.557 1.226 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.984 175.617 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 21.3 ptp . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 57.9 tp -79.2 107.11 11.71 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -110.74 179.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.043 0.937 . . . . 0.0 108.879 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 25.2 m -116.43 110.52 18.75 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -106.76 114.14 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.247 0.619 . . . . 0.0 109.603 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 65.35 26.97 12.04 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.054 1.342 . . . . 0.0 111.645 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.37 3.74 74.86 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.121 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -122.9 114.85 21.01 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.21 1.004 . . . . 0.0 109.232 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 13.9 pt20 -67.73 130.03 41.73 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.058 0.456 . . . . 0.0 111.193 -178.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 42.6 ttm105 -150.59 141.94 23.32 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.2 1.0 . . . . 0.0 109.045 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -80.82 137.78 36.22 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -124.11 144.71 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.114 0.483 . . . . 0.0 110.187 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -93.28 -23.17 18.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.348 1.059 . . . . 0.0 108.984 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.1 p -76.73 110.15 11.09 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.786 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.49 26.14 2.39 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.752 0.821 . . . . 0.0 110.938 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 57.7 m -146.48 149.41 33.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.917 0.887 . . . . 0.0 109.703 173.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.03 -36.51 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.138 0.975 . . . . 0.0 111.998 -174.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.05 -54.33 39.83 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 120.759 0.314 . . . . 0.0 110.495 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.82 -31.68 69.95 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.442 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.42 HD21 HG21 ' A' ' 56' ' ' ILE . 60.4 tp -67.25 -53.31 31.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.843 0.857 . . . . 0.0 111.135 177.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.526 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 71.5 mtp -69.71 -23.37 63.41 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.155 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.4 m -76.0 -35.22 59.64 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.74 -32.31 70.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.288 0.635 . . . . 0.0 110.762 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.35 2.93 56.04 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.477 0.711 . . . . 0.0 111.963 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 65.14 21.69 12.19 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.646 1.178 . . . . 0.0 111.859 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.598 ' SG ' HG21 ' A' ' 58' ' ' ILE . 60.6 m -92.78 36.92 1.01 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.596 1.158 . . . . 0.0 110.628 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.0 t -139.94 -9.49 1.18 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.91 0.484 . . . . 0.0 111.585 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -64.39 -37.44 87.53 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.052 0.541 . . . . 0.0 111.648 -175.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -113.98 -128.95 4.78 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -117.47 102.06 8.9 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.613 1.165 . . . . 0.0 109.078 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -130.4 156.67 44.34 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.233 1.013 . . . . 0.0 109.411 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . . . -124.9 171.92 9.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.981 0.912 . . . . 0.0 108.65 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.526 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.2 p -135.38 140.33 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -110.73 105.71 14.67 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 170.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.3 tp -92.68 115.37 28.05 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 57.83 37.78 27.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.947 1.299 . . . . 0.0 111.734 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 72.49 30.68 1.89 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.93 1.292 . . . . 0.0 112.193 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -137.38 128.77 28.14 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.718 0.807 . . . . 0.0 109.489 169.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.0 t -72.27 116.76 14.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 123.096 0.559 . . . . 0.0 110.842 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.422 ' HB ' HG12 ' A' ' 33' ' ' VAL . 33.7 t -86.79 120.65 71.86 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.82 155.63 68.03 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.656 2.237 . . . . 0.0 111.302 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -60.14 -32.29 70.88 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.951 0.901 . . . . 0.0 112.808 -173.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.27 -5.22 26.94 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 123.857 0.723 . . . . 0.0 114.502 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -109.06 -25.96 10.41 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.694 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -48.39 -45.69 36.15 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -167.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.49 -47.78 77.63 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.05 0.54 . . . . 0.0 110.371 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.55 -11.34 60.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.298 1.039 . . . . 0.0 112.345 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.6 m -101.6 112.4 65.13 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 98.0 Cg_endo -77.59 171.44 17.51 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.025 1.816 . . . . 0.0 113.081 175.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.3 t -119.32 130.64 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.112 1.365 . . . . 0.0 107.825 172.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.4 p -120.13 156.44 31.05 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.82 0.848 . . . . 0.0 108.932 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' A' ' 1' ' ' MET . . . -56.21 135.57 53.27 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.593 0.757 . . . . 0.0 111.69 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.15 -16.59 58.06 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.689 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -60.37 127.8 33.56 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.681 0.741 . . . . 0.0 111.991 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -79.82 86.57 5.36 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.42 HG21 HD21 ' A' ' 20' ' ' LEU . 55.6 mt -89.52 149.73 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.721 1.208 . . . . 0.0 108.878 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 35.2 tt0 -147.33 137.15 22.98 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.598 HG21 ' SG ' ' A' ' 26' ' ' CYS . 36.9 mm -103.31 111.0 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 57.6 mt -79.45 137.28 37.18 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.747 0.819 . . . . 0.0 110.404 172.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.8 m -112.43 87.33 9.31 Favored Pre-proline 0 C--O 1.243 0.718 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 169.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.47 114.43 2.88 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.404 2.069 . . . . 0.0 111.213 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.8 tpp85 -155.38 -0.72 0.15 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.235 0.614 . . . . 0.0 110.663 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -135.8 8.02 3.26 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.481 1.112 . . . . 0.0 110.198 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.41 154.29 21.71 Favored Glycine 0 C--N 1.348 1.223 0 C-N-CA 123.225 0.441 . . . . 0.0 112.109 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.619 ' HA3' ' HB3' ' A' ' 68' ' ' HIS . . . -70.0 123.94 13.52 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt -66.63 -54.49 22.77 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.38 0.672 . . . . 0.0 110.57 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -86.14 -39.37 16.77 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.821 173.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.619 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 26.4 t60 -65.04 91.3 0.09 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.316 1.046 . . . . 0.0 109.899 176.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -93.8 160.37 14.78 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.213 0.605 . . . . 0.0 109.917 176.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -70.53 125.14 25.97 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.078 0.551 . . . . 0.0 109.701 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -66.44 -19.84 65.9 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.922 0.489 . . . . 0.0 112.21 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -96.98 -69.08 0.77 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.829 0.851 . . . . 0.0 109.131 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.2 t60 . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.421 178.673 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 111.23 0.085 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 9' ' ' GLN . 7.7 tt -82.06 113.46 19.95 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -109.07 -179.68 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.098 1.359 . . . . 0.0 110.539 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.0 m -129.23 101.97 6.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.202 0.601 . . . . 0.0 109.719 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.9 mt -103.4 120.38 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.609 0.764 . . . . 0.0 109.177 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.62 30.42 18.59 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.917 1.287 . . . . 0.0 112.141 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.07 -1.66 88.68 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.595 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -113.5 132.29 55.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.436 1.094 . . . . 0.0 108.293 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.526 ' HB3' HD22 ' A' ' 2' ' ' LEU . 1.5 mp0 -80.11 121.98 26.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.209 0.604 . . . . 0.0 111.038 -175.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -128.2 145.96 50.87 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.418 1.087 . . . . 0.0 108.138 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 39.9 tt0 -93.12 117.5 30.14 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 173.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -113.61 174.19 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.742 0.817 . . . . 0.0 109.999 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -149.89 18.16 0.89 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.003 0.921 . . . . 0.0 109.642 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.8 m -64.17 -31.54 72.77 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.086 0.954 . . . . 0.0 112.644 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 75.79 -46.69 0.56 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.605 1.562 . . . . 0.0 112.427 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.6 t -103.52 146.92 27.82 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.124 0.97 . . . . 0.0 109.914 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.03 -30.67 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 123.618 0.767 . . . . 0.0 110.723 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.3 -55.81 21.69 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.931 0.492 . . . . 0.0 110.098 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.45 65.28 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 124.341 1.026 . . . . 0.0 111.506 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.73 -59.86 3.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.786 0.834 . . . . 0.0 111.34 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.472 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 81.2 mtp -70.7 -21.35 62.58 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.816 0.446 . . . . 0.0 111.651 -174.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 m -70.01 -43.9 70.43 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.152 0.581 . . . . 0.0 110.122 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -73.63 -31.82 63.72 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.002 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.76 -10.89 59.84 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.532 0.733 . . . . 0.0 110.882 175.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 62.83 33.18 15.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.544 1.138 . . . . 0.0 111.404 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.1 m -106.15 37.44 2.28 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.276 1.43 . . . . 0.0 110.001 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.2 t -130.85 23.31 4.98 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 122.125 -0.359 . . . . 0.0 111.412 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.404 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . 3.0 m-20 -57.57 -63.94 1.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.406 1.082 . . . . 0.0 111.339 -176.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.81 -104.96 0.57 Allowed Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.421 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -85.15 81.14 8.97 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.532 0.733 . . . . 0.0 110.051 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 28' ' ' ASP . 76.8 m-85 -136.52 123.27 21.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.536 1.134 . . . . 0.0 108.339 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.77 -179.38 3.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.466 0.706 . . . . 0.0 109.525 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.472 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.1 p -140.54 146.14 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.053 0.541 . . . . 0.0 109.666 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -117.51 98.99 6.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.3 tp -90.97 118.86 30.69 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 56.62 33.25 22.43 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.904 0.882 . . . . 0.0 111.465 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 68.97 15.3 8.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.036 1.334 . . . . 0.0 112.185 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -109.24 115.81 30.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 40.7 t -77.17 121.0 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.139 0.576 . . . . 0.0 109.988 -175.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.42 129.54 25.87 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.514 0.725 . . . . 0.0 109.599 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.72 160.07 28.0 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.942 2.428 . . . . 0.0 112.009 174.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -52.87 -43.47 66.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.689 0.795 . . . . 0.0 112.179 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.37 -21.58 48.58 Favored Glycine 0 C--N 1.345 1.065 0 O-C-N 123.81 0.694 . . . . 0.0 114.237 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -103.75 -22.27 13.57 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.357 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -46.64 -42.21 15.93 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 123.623 0.769 . . . . 0.0 112.641 -174.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -61.13 -49.53 76.9 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.971 0.908 . . . . 0.0 111.335 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -77.82 -15.22 59.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.809 0.844 . . . . 0.0 111.923 -176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.5 m -91.18 117.63 67.99 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -83.84 158.3 13.85 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.784 2.323 . . . . 0.0 112.948 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.59 135.93 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.192 0.997 . . . . 0.0 108.311 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.4 m -121.05 147.62 45.27 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.725 0.81 . . . . 0.0 111.232 -168.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.54 114.01 3.66 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.219 0.608 . . . . 0.0 111.334 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.2 32.75 34.39 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 113.137 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.9 p30 -81.24 175.37 10.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.838 0.455 . . . . 0.0 110.891 174.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.06 82.91 1.78 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.629 0.372 . . . . 0.0 110.447 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 75.2 mt -84.82 141.31 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.629 0.772 . . . . 0.0 109.166 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 42.0 tt0 -141.53 112.2 7.12 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.5 mm -77.22 105.44 6.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -79.06 137.99 37.78 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.206 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.5 p -117.52 84.3 18.61 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 167.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.49 116.39 3.38 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.281 1.987 . . . . 0.0 112.229 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -166.15 -79.55 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.404 1.082 . . . . 0.0 108.347 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 71.14 -75.45 0.08 Allowed 'General case' 0 C--N 1.368 1.372 0 C-N-CA 125.576 1.55 . . . . 0.0 110.441 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.79 -164.05 35.81 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 115.869 -0.605 . . . . 0.0 114.077 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.94 77.64 0.79 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.1 mt 62.11 81.23 0.2 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.775 1.23 . . . . 0.0 110.688 -172.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.78 133.69 25.92 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.566 1.146 . . . . 0.0 111.403 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -79.5 91.89 5.2 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.293 0.637 . . . . 0.0 110.716 -171.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -116.51 -0.93 12.33 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.285 1.034 . . . . 0.0 109.372 170.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 65.56 99.29 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.833 1.253 . . . . 0.0 111.033 -177.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -63.2 128.02 33.94 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.307 0.643 . . . . 0.0 110.711 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -80.14 80.85 6.5 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.148 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 . . . . . 0 CA--C 1.548 0.897 0 CA-C-N 114.86 -1.063 . . . . 0.0 108.869 -174.889 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' HG11 ' A' ' 50' ' ' VAL . 17.7 ptp . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 120.973 0.416 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.6 tp -80.05 97.35 6.78 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.01 0.924 . . . . 0.0 108.557 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.7 m -110.84 145.66 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.944 0.897 . . . . 0.0 109.821 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 6.8 m -83.77 99.44 10.28 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 58.6 mt -95.76 108.53 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 60.73 36.07 19.47 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.739 1.215 . . . . 0.0 111.238 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.54 -3.89 86.65 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.519 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -118.04 110.95 18.28 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.055 0.942 . . . . 0.0 108.743 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 94.5 mt-30 -66.03 118.74 10.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.267 0.627 . . . . 0.0 110.845 -178.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -121.91 139.98 52.98 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.472 1.509 . . . . 0.0 108.768 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -81.87 125.18 30.41 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.81 155.25 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.816 0.847 . . . . 0.0 110.55 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -91.52 -25.64 19.16 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.182 0.593 . . . . 0.0 110.957 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.0 m -70.98 114.99 9.59 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.181 0.592 . . . . 0.0 111.918 -175.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.89 13.04 26.1 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.328 1.051 . . . . 0.0 111.439 173.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.8 t -128.44 138.1 52.15 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.983 1.313 . . . . 0.0 108.403 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.499 HG12 HG11 ' A' ' 33' ' ' VAL . 76.1 t -68.06 -34.16 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 123.722 0.639 . . . . 0.0 110.839 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.48 -56.68 18.95 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.01 0.524 . . . . 0.0 110.394 174.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.36 75.32 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 124.211 0.944 . . . . 0.0 111.491 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.9 tp -64.32 -55.64 19.9 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 123.732 0.645 . . . . 0.0 110.074 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.545 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 72.0 mtp -69.52 -25.84 64.23 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 122.679 0.392 . . . . 0.0 111.098 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -67.35 -39.57 85.78 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 117.938 0.336 . . . . 0.0 110.549 172.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -69.02 -39.14 79.44 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.081 0.953 . . . . 0.0 110.599 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 81.8 mt -86.93 5.89 34.81 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.067 0.947 . . . . 0.0 111.987 -175.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.3 t70 58.29 44.41 18.68 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.757 1.265 . . . . 0.0 110.868 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m -123.59 18.6 9.6 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.473 1.509 . . . . 0.0 110.473 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.8 t -99.89 25.53 7.23 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.562 0.696 . . . . 0.0 110.077 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.92 -25.18 68.03 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.148 0.979 . . . . 0.0 111.415 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.55 -43.26 1.69 Allowed Glycine 0 C--N 1.347 1.176 0 O-C-N 123.549 0.531 . . . . 0.0 112.082 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -86.4 1.62 50.6 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.991 0.516 . . . . 0.0 111.065 -176.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -89.05 156.4 18.87 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.738 0.815 . . . . 0.0 109.617 174.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.71 170.85 15.2 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.456 1.103 . . . . 0.0 108.485 173.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.545 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 9.1 p -130.08 151.71 36.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' ' 57' ' ' GLU . . . -125.25 100.42 6.52 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 174.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.2 tp -88.86 108.8 19.73 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 55' ' ' GLU . 50.2 m-20 54.71 47.43 22.51 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.607 1.163 . . . . 0.0 110.034 -173.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 73.44 -9.88 1.12 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.48 1.512 . . . . 0.0 113.252 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -84.22 116.59 23.03 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.9 t -73.76 117.55 17.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 122.925 0.49 . . . . 0.0 110.1 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.4 t -102.04 119.77 55.74 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.079 0.952 . . . . 0.0 108.627 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.53 165.83 29.76 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.105 2.537 . . . . 0.0 112.345 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -53.07 -41.53 64.96 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.818 1.247 . . . . 0.0 113.38 -173.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.67 -21.05 60.15 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 123.853 0.721 . . . . 0.0 113.934 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -109.42 -7.6 15.17 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.01 -0.995 . . . . 0.0 112.088 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -52.27 -40.88 62.32 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.073 0.851 . . . . 0.0 110.616 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.69 -41.39 98.14 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.755 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -84.18 -11.06 57.18 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.375 1.07 . . . . 0.0 112.529 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.8 m -102.36 112.45 65.52 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -76.33 173.86 13.78 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.409 2.072 . . . . 0.0 112.615 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.546 HG11 ' SD ' ' A' ' 1' ' ' MET . 86.4 t -124.69 143.73 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.918 1.287 . . . . 0.0 108.643 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.5 m -142.62 149.39 38.9 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.866 0.866 . . . . 0.0 109.804 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.14 126.58 26.68 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.576 0.75 . . . . 0.0 111.135 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.54 -22.07 17.95 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 119.011 -0.883 . . . . 0.0 114.259 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -69.13 141.92 54.53 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.024 0.912 . . . . 0.0 112.518 -173.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 36' ' ' ASN . 9.9 mp0 -80.52 80.53 6.96 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.751 1.22 . . . . 0.0 109.353 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 63.1 mt -91.03 96.36 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' HB3' ' HB1' ' A' ' 34' ' ' ALA . 39.5 tt0 -98.65 106.43 18.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.038 0.935 . . . . 0.0 108.669 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.447 HG22 ' HE1' ' A' ' 21' ' ' MET . 70.0 mt -76.56 105.06 5.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.6 mt -80.58 143.83 32.88 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.217 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.4 p -111.83 92.18 16.94 Favored Pre-proline 0 C--O 1.246 0.913 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 160.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.33 127.78 23.36 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.339 2.693 . . . . 0.0 112.475 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -59.47 -48.36 81.96 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 124.349 1.031 . . . . 0.0 109.988 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -92.6 87.47 5.94 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 167.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.03 0.22 17.09 Favored Glycine 0 N--CA 1.467 0.729 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.181 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.32 116.64 2.86 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.8 tp -71.8 90.29 1.09 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.253 1.021 . . . . 0.0 110.85 -171.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.63 -53.8 53.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.892 0.877 . . . . 0.0 112.525 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -65.72 100.68 0.56 Allowed 'General case' 0 CA--C 1.558 1.259 0 CA-C-O 122.09 0.948 . . . . 0.0 110.439 177.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -148.72 96.59 2.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.803 1.241 . . . . 0.0 108.594 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -174.78 30.92 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.551 1.14 . . . . 0.0 110.547 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -123.45 35.12 4.93 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.892 0.477 . . . . 0.0 111.22 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.7 m80 66.64 38.08 4.14 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.38 1.072 . . . . 0.0 111.838 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 . . . . . 0 CA--C 1.554 1.129 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.2 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 pmm? . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.669 -0.123 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.624 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 5.0 tt -83.0 122.64 28.57 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.01 145.25 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.098 0.959 . . . . 0.0 110.42 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 18.4 m -78.69 102.1 7.86 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.033 0.533 . . . . 0.0 110.088 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 24.1 mt -101.35 105.61 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.061 0.544 . . . . 0.0 109.947 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 60.41 41.82 15.51 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.514 1.126 . . . . 0.0 110.708 173.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.39 -18.35 57.15 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 114.595 -1.184 . . . . 0.0 114.027 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -108.79 116.39 31.89 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.626 0.77 . . . . 0.0 110.093 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 48.1 mt-30 -70.89 131.49 43.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.857 0.463 . . . . 0.0 109.782 174.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.52 ' NH2' HD21 ' A' ' 24' ' ' LEU . 65.1 ttp85 -152.87 142.9 22.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.34 0.656 . . . . 0.0 109.727 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.624 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 38.5 tt0 -83.66 127.05 33.48 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.4 m -120.14 164.15 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.046 0.938 . . . . 0.0 111.069 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -102.89 -1.72 29.09 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.668 1.187 . . . . 0.0 109.744 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.1 m -67.07 99.37 0.65 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 124.304 1.042 . . . . 0.0 111.003 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.69 -14.51 58.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.115 0.566 . . . . 0.0 110.822 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.2 t -127.57 154.35 45.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.102 0.961 . . . . 0.0 109.753 177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.431 ' O ' ' HG2' ' A' ' 21' ' ' MET . 95.2 t -65.7 -38.56 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.661 0.785 . . . . 0.0 110.774 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.51 95.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.473 0.309 . . . . 0.0 110.882 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.04 80.21 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.708 0.803 . . . . 0.0 111.318 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 5' ' ' ILE . 28.1 tp -64.98 -45.94 83.55 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.84 0.713 . . . . 0.0 111.358 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 83.0 mmm -68.17 -24.86 65.02 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.726 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.0 m -74.95 -45.37 42.76 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.935 0.494 . . . . 0.0 110.721 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -57.69 -47.48 82.22 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.805 0.842 . . . . 0.0 110.675 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.52 HD21 ' NH2' ' A' ' 10' ' ' ARG . 80.8 mt -84.47 1.47 45.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.246 -175.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 61.73 20.44 11.37 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.574 1.15 . . . . 0.0 111.119 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.441 ' SG ' HG21 ' A' ' 58' ' ' ILE . 36.1 t -94.08 10.59 33.06 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.833 1.253 . . . . 0.0 111.321 -170.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -100.05 -27.03 13.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.985 0.514 . . . . 0.0 110.395 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.75 -61.59 2.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.008 0.923 . . . . 0.0 112.53 -174.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.65 -167.14 31.56 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.989 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -86.57 63.63 8.09 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.361 0.664 . . . . 0.0 110.357 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -106.53 170.52 7.88 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.125 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.83 173.26 12.01 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.464 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -139.86 140.48 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.05 0.54 . . . . 0.0 109.834 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.99 100.33 7.48 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.151 0.98 . . . . 0.0 108.52 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 tp -92.56 113.81 26.19 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 64.29 37.14 8.77 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.365 1.041 . . . . 0.0 110.374 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 79.26 -17.04 0.62 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 126.584 1.954 . . . . 0.0 112.741 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -96.52 119.83 35.72 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -171.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 p -67.36 126.54 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.316 0.579 . . . . 0.0 110.756 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.44 119.35 65.48 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.43 156.25 42.39 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.394 2.063 . . . . 0.0 112.485 174.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -60.87 -39.27 88.54 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.089 0.555 . . . . 0.0 111.702 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.89 -19.97 59.38 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 123.72 0.638 . . . . 0.0 113.035 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -99.53 -20.16 16.54 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 117.83 -1.081 . . . . 0.0 111.593 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -49.73 -47.3 50.78 Favored 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 119.399 0.999 . . . . 0.0 110.999 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.98 -45.26 78.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.889 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -72.09 -15.16 62.0 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.488 1.115 . . . . 0.0 112.577 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 m -104.52 129.33 25.2 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.369 0.668 . . . . 0.0 110.28 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -84.58 174.77 7.51 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.698 2.266 . . . . 0.0 113.267 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.439 HG11 HD12 ' A' ' 56' ' ' ILE . 67.3 t -117.89 126.65 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.603 1.161 . . . . 0.0 108.766 173.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -108.91 145.11 35.91 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.384 1.074 . . . . 0.0 109.027 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.14 118.29 5.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.304 0.642 . . . . 0.0 111.388 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.87 -2.0 31.83 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.53 -0.595 . . . . 0.0 114.055 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.38 131.27 44.54 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.534 0.667 . . . . 0.0 112.156 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -84.77 92.56 8.25 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 39.4 mt -100.33 95.86 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.417 1.087 . . . . 0.0 108.676 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.75 120.3 37.89 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.71 -0.619 . . . . 0.0 110.086 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.441 HG21 ' SG ' ' A' ' 26' ' ' CYS . 76.6 mt -76.32 121.98 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.4 mt -112.63 142.51 45.14 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.604 0.762 . . . . 0.0 109.753 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 m -116.16 87.64 20.13 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.74 166.13 30.43 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.6 2.2 . . . . 0.0 112.642 -165.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.8 mtt-85 -62.84 86.92 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.812 0.845 . . . . 0.0 111.709 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 173.44 -61.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 -170.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.65 -14.44 50.06 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.208 170.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.5 15.71 44.41 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 123.001 0.334 . . . . 0.0 113.026 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.2 mt -90.57 100.05 12.96 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.268 1.027 . . . . 0.0 108.413 174.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.6 81.29 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.702 0.801 . . . . 0.0 111.321 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -150.78 145.51 25.79 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -62.15 87.8 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -168.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -87.68 -25.29 23.56 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.944 1.298 . . . . 0.0 109.386 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -139.01 146.27 40.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.359 1.064 . . . . 0.0 110.825 -175.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -179.64 -46.82 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.188 1.395 . . . . 0.0 109.286 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 76.2 t60 . . . . . 0 CA--C 1.552 1.03 0 C-N-CA 124.851 1.26 . . . . 0.0 109.267 -174.11 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.503 ' SD ' HG12 ' A' ' 50' ' ' VAL . 49.5 ttm . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.2 tp -79.62 105.14 10.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.52 0.728 . . . . 0.0 109.51 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.0 m -125.32 139.39 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.294 1.038 . . . . 0.0 109.664 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.5 m -77.03 99.58 5.36 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.512 HD11 ' HD3' ' A' ' 10' ' ' ARG . 50.5 mt -97.55 114.27 34.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 123.148 0.579 . . . . 0.0 109.643 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 55.3 t30 59.87 35.57 21.85 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.671 1.588 . . . . 0.0 111.434 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.39 -3.36 83.85 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.978 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -109.37 130.98 55.48 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 117.464 0.632 . . . . 0.0 110.469 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -69.98 103.02 2.14 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 174.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' HD3' HD11 ' A' ' 5' ' ' ILE . 53.1 ttt180 -122.17 122.54 39.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.703 0.801 . . . . 0.0 110.113 -173.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -88.43 104.62 16.96 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.48 160.59 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.72 0.808 . . . . 0.0 109.94 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -105.44 -1.35 25.06 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.311 0.644 . . . . 0.0 111.011 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.2 p -77.18 117.28 18.56 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.829 0.852 . . . . 0.0 110.744 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.61 1.73 56.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.954 0.901 . . . . 0.0 111.73 174.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -125.65 142.98 51.23 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.366 1.066 . . . . 0.0 109.58 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.56 -28.23 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.236 0.614 . . . . 0.0 110.39 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.67 -54.41 39.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.759 0.424 . . . . 0.0 110.303 172.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.54 64.77 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.911 0.757 . . . . 0.0 111.679 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.02 -58.93 6.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 172.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.54 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 95.7 mmm -63.43 -32.62 74.12 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.106 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.2 m -66.62 -44.84 80.96 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.057 0.543 . . . . 0.0 110.059 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.95 -31.09 68.64 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.966 0.906 . . . . 0.0 110.382 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.6 mt -91.89 -0.69 57.51 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.754 0.822 . . . . 0.0 111.127 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 63.97 38.81 8.47 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.098 1.359 . . . . 0.0 112.942 171.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.5 m -118.82 27.24 9.01 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.118 1.367 . . . . 0.0 110.832 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 p -96.51 20.49 10.58 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.665 0.786 . . . . 0.0 110.865 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.37 -36.61 80.72 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.468 0.707 . . . . 0.0 110.892 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.31 -55.92 0.68 Allowed Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.165 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -78.48 14.08 1.38 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.538 0.735 . . . . 0.0 112.501 -177.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -108.04 150.41 27.19 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.546 0.738 . . . . 0.0 109.808 174.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 59' ' ' LEU . . . -127.01 167.31 16.08 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.225 1.01 . . . . 0.0 109.111 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.54 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 8.5 p -133.06 148.21 31.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.41 109.37 11.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.988 0.423 . . . . 0.0 109.916 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.9 tp -88.11 109.28 19.76 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 60.57 51.25 5.2 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 124.755 1.284 . . . . 0.0 110.62 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 72.02 6.74 5.66 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 125.374 1.47 . . . . 0.0 113.671 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -124.5 127.28 47.22 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.129 0.572 . . . . 0.0 109.926 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 p -64.49 135.15 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 124.191 0.932 . . . . 0.0 111.687 -175.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.13 122.48 57.94 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.92 152.61 63.1 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.393 2.062 . . . . 0.0 112.607 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -54.16 -52.53 60.86 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.423 1.089 . . . . 0.0 113.056 -170.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.59 -9.5 61.97 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 116.412 -0.358 . . . . 0.0 113.266 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' HD2' ' HB2' ' A' ' 47' ' ' GLU . 54.8 tptt -96.54 -15.44 21.63 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.23 1.012 . . . . 0.0 110.057 -177.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -52.91 -44.41 66.94 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.176 0.591 . . . . 0.0 111.191 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.46 -38.18 80.86 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.002 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 44' ' ' LYS . 32.8 mt-10 -75.41 -21.41 58.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.796 0.838 . . . . 0.0 112.09 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.401 ' HG1' ' HG3' ' A' ' 44' ' ' LYS . 58.0 m -100.3 117.89 62.25 Favored Pre-proline 0 N--CA 1.47 0.544 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.93 165.98 27.56 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.079 1.853 . . . . 0.0 112.604 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.503 HG12 ' SD ' ' A' ' 1' ' ' MET . 61.7 t -99.79 141.21 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 167.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.9 m -134.44 139.72 45.73 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.09 144.24 56.82 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.692 0.797 . . . . 0.0 111.088 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 -10.98 71.3 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.554 -0.581 . . . . 0.0 112.893 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -87.13 162.45 17.52 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.364 0.602 . . . . 0.0 110.788 174.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -121.06 99.36 6.45 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.835 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 55.8 mt -103.24 153.51 5.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 C-N-CA 124.711 1.204 . . . . 0.0 109.154 -176.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -146.62 139.28 25.18 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 119.26 0.936 . . . . 0.0 109.441 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.1 mt -85.07 121.04 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.412 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 84.7 mt -91.32 125.91 36.24 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.906 0.883 . . . . 0.0 109.448 176.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 63' ' ' GLN . 65.7 p -108.95 87.46 4.62 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 173.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.37 121.68 9.77 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.115 2.543 . . . . 0.0 112.363 -169.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 72.4 -3.04 2.41 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.358 1.463 . . . . 0.0 112.842 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.444 ' HB2' ' HB ' ' A' ' 60' ' ' THR . 79.5 mm-40 -100.77 158.05 16.25 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.032 0.933 . . . . 0.0 110.645 -174.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.52 -79.53 1.9 Allowed Glycine 0 C--N 1.341 0.832 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -174.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.8 122.11 2.24 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-O 119.05 -0.861 . . . . 0.0 111.002 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -56.47 -72.5 0.08 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.722 0.809 . . . . 0.0 111.716 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 46.89 58.14 5.01 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.571 1.169 . . . . 0.0 111.452 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -40.28 99.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 124.514 1.134 . . . . 0.0 112.76 -172.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -57.71 110.51 0.91 Allowed 'General case' 0 C--N 1.358 0.968 0 CA-C-N 114.722 -1.127 . . . . 0.0 110.14 -172.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -74.19 107.7 6.53 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -68.58 -40.81 80.39 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.334 0.654 . . . . 0.0 111.009 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 74.75 -60.33 0.52 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.985 1.714 . . . . 0.0 111.902 -177.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 79.3 t60 . . . . . 0 CA--C 1.558 1.276 0 C-N-CA 124.649 1.18 . . . . 0.0 109.317 -173.525 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptp . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.5 tp -80.54 100.7 8.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.626 0.77 . . . . 0.0 108.972 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.412 HG11 HG12 ' A' ' 50' ' ' VAL . 17.3 m -123.02 137.33 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.565 0.746 . . . . 0.0 110.515 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 26.5 m -73.44 97.26 2.51 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.455 0.702 . . . . 0.0 109.623 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 62.8 mt -95.17 108.21 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.112 0.565 . . . . 0.0 109.629 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 62.85 28.73 16.51 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.244 1.018 . . . . 0.0 111.277 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.56 -6.53 65.31 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 113.84 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -105.47 113.02 26.35 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.712 0.805 . . . . 0.0 109.626 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 47.7 mt-30 -64.78 103.11 0.66 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 173.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -118.7 127.75 53.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.356 1.062 . . . . 0.0 109.795 -170.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -86.08 102.63 14.01 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.876 1.27 . . . . 0.0 109.415 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -105.36 168.9 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.899 0.88 . . . . 0.0 111.064 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -110.57 -4.52 15.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.577 0.751 . . . . 0.0 111.776 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -91.71 129.99 37.58 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.581 0.753 . . . . 0.0 111.88 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.46 -6.25 37.7 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.334 1.053 . . . . 0.0 112.557 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 42.5 t -123.52 147.29 47.38 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.108 0.963 . . . . 0.0 109.173 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.3 -34.67 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.145 0.978 . . . . 0.0 111.269 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.73 -52.04 67.1 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 -29.16 69.19 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.9 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.42 -52.89 22.59 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.84 0.856 . . . . 0.0 110.32 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 91.2 mmm -62.94 -34.44 77.47 Favored 'General case' 0 CA--C 1.554 1.1 0 O-C-N 123.72 0.637 . . . . 0.0 109.979 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -70.9 -36.08 72.58 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.238 0.615 . . . . 0.0 110.895 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.73 -35.11 76.71 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.073 0.949 . . . . 0.0 110.433 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.532 HD11 HD13 ' A' ' 5' ' ' ILE . 76.9 mt -93.32 -0.81 56.53 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.885 0.874 . . . . 0.0 112.006 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.3 t70 69.74 15.03 8.09 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.079 0.952 . . . . 0.0 112.189 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.418 ' SG ' HD13 ' A' ' 58' ' ' ILE . 27.6 m . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 124.331 1.052 . . . . 0.0 111.902 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.17 160.86 40.79 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.024 1.33 . . . . 0.0 108.491 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.579 HG23 HG23 ' A' ' 56' ' ' ILE . 7.7 p -115.56 136.69 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.291 0.637 . . . . 0.0 109.493 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -118.24 99.89 7.15 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.1 tp -88.98 107.64 19.14 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 m120 62.3 38.74 13.01 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.114 0.966 . . . . 0.0 110.11 -172.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 72.89 -5.86 1.81 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 125.407 1.483 . . . . 0.0 112.463 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -92.02 111.37 22.88 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -67.65 122.85 19.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 O-C-N 123.516 0.51 . . . . 0.0 111.033 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.445 ' HB ' HG13 ' A' ' 33' ' ' VAL . 60.9 t -90.66 119.23 69.05 Favored Pre-proline 0 C--O 1.247 0.939 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.85 144.93 64.35 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.576 2.184 . . . . 0.0 111.178 171.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -31.33 65.39 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.943 0.777 . . . . 0.0 112.7 -175.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.39 -2.36 41.48 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-O 119.384 -0.675 . . . . 0.0 114.11 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -119.16 -3.64 10.58 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.102 0.961 . . . . 0.0 112.228 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -55.0 -41.03 70.77 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.227 0.611 . . . . 0.0 112.239 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.01 -35.16 66.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.356 0.662 . . . . 0.0 110.817 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.55 -26.64 64.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.732 0.813 . . . . 0.0 111.488 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.3 m -97.0 117.58 65.67 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 84.7 Cg_endo -81.58 161.87 19.3 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.388 2.059 . . . . 0.0 111.783 168.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.412 HG12 HG11 ' A' ' 3' ' ' VAL . 13.7 t -90.29 147.15 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 p -124.09 133.74 53.54 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.736 0.814 . . . . 0.0 109.593 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.15 127.49 32.41 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.703 0.801 . . . . 0.0 111.985 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.83 7.64 74.29 Favored Glycine 0 N--CA 1.472 1.073 0 O-C-N 123.798 0.686 . . . . 0.0 113.637 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.21 167.32 16.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.429 0.691 . . . . 0.0 109.559 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -114.98 101.55 9.12 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.184 0.593 . . . . 0.0 109.939 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.579 HG23 HG23 ' A' ' 33' ' ' VAL . 2.7 mp -97.88 97.83 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 124.37 1.068 . . . . 0.0 108.919 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 41.9 tt0 -91.43 108.92 20.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.328 0.651 . . . . 0.0 109.467 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.418 HD13 ' SG ' ' A' ' 26' ' ' CYS . 68.9 mt -78.13 109.72 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 123.198 0.599 . . . . 0.0 110.969 178.26 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 120.842 0.353 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 47.1 tp -79.02 113.44 17.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.606 0.763 . . . . 0.0 109.345 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.04 179.64 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.206 1.002 . . . . 0.0 109.236 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 25.2 m -120.64 101.66 7.89 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 118.775 0.716 . . . . 0.0 110.092 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.56 HD13 HD11 ' A' ' 24' ' ' LEU . 71.5 mt -95.71 117.2 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 123.624 0.769 . . . . 0.0 109.887 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 61.74 22.07 12.69 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.894 1.278 . . . . 0.0 112.567 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.84 1.49 65.5 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-O 120.072 -0.293 . . . . 0.0 113.713 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.78 126.71 50.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.696 0.798 . . . . 0.0 109.8 172.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 42.9 mt-30 -69.84 135.79 50.0 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.971 0.415 . . . . 0.0 111.354 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -146.95 136.4 22.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.402 1.081 . . . . 0.0 108.519 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 45.4 tt0 -81.5 123.0 28.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.468 0.707 . . . . 0.0 109.442 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.92 160.01 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.931 0.892 . . . . 0.0 109.324 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.55 -2.3 9.98 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.713 0.405 . . . . 0.0 111.006 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.5 p -66.21 107.97 2.13 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.604 0.762 . . . . 0.0 110.252 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.26 60.2 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.676 0.79 . . . . 0.0 112.874 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.6 p -112.03 150.03 31.21 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 33' ' ' VAL . 72.7 t -67.61 -33.4 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.247 0.619 . . . . 0.0 110.368 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.42 -46.18 90.95 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.973 0.509 . . . . 0.0 110.84 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -59.14 -44.31 92.07 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 124.167 0.917 . . . . 0.0 110.525 177.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.8 tp -63.94 -44.45 92.82 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.935 0.772 . . . . 0.0 111.674 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 95.0 mmm -63.31 -28.04 69.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.851 0.46 . . . . 0.0 110.598 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -74.56 -39.07 62.52 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.188 0.595 . . . . 0.0 111.496 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 10.6 mm-40 -63.84 -38.86 92.68 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.503 0.668 . . . . 0.0 110.36 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 5' ' ' ILE . 79.4 mt -91.32 -1.87 57.53 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.598 -176.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.19 28.86 14.05 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.829 1.252 . . . . 0.0 113.179 171.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.6 m . . . . . 0 CA--C 1.545 0.753 0 C-N-CA 124.47 1.108 . . . . 0.0 110.726 178.29 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.468 0.434 0 CA-C-O 121.756 0.789 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -133.45 -176.39 4.13 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.937 168.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 17' ' ' VAL . 8.5 p -146.56 158.25 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.52 110.3 10.39 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.193 0.597 . . . . 0.0 110.529 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.9 tp -89.31 109.27 20.18 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.1 m120 52.28 65.86 1.38 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.958 1.303 . . . . 0.0 111.866 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 68.43 1.16 2.82 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 124.941 1.296 . . . . 0.0 112.696 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -119.35 116.64 26.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.002 0.921 . . . . 0.0 109.532 -171.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.62 119.87 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 123.764 0.665 . . . . 0.0 111.06 -174.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 48' ' ' THR . 91.8 t -92.52 124.16 59.93 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.064 0.946 . . . . 0.0 108.813 176.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.95 154.7 66.72 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.364 2.043 . . . . 0.0 111.412 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -56.11 -41.38 75.17 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.298 1.039 . . . . 0.0 112.473 -171.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.63 14.17 5.89 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 114.361 0.504 . . . . 0.0 114.361 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -17.48 6.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.092 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.431 ' NE1' HG12 ' A' ' 33' ' ' VAL . 50.3 m0 -46.34 -41.86 14.0 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 123.902 0.751 . . . . 0.0 112.492 -175.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.54 -48.5 77.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.547 1.139 . . . . 0.0 111.327 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.52 -0.48 57.27 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.849 0.86 . . . . 0.0 112.253 -175.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.403 HG21 HG21 ' A' ' 40' ' ' VAL . 91.7 m -96.89 120.85 60.84 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.66 146.74 9.48 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.298 1.999 . . . . 0.0 113.636 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.9 t -86.87 130.49 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 109.071 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 54' ' ' ASP . 10.6 m -103.99 146.99 27.89 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.767 0.827 . . . . 0.0 110.043 -173.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.97 116.73 8.95 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.321 0.648 . . . . 0.0 110.973 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.91 33.73 49.85 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.612 0.57 . . . . 0.0 112.659 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.538 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 27.8 p30 -83.87 -165.27 1.08 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.686 0.394 . . . . 0.0 110.779 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -134.85 94.66 3.2 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 37.5 mt -95.04 100.63 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.519 0.727 . . . . 0.0 109.977 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.26 114.1 25.85 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.701 0.801 . . . . 0.0 109.316 177.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.1 mt -77.65 129.85 36.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 90.4 mt . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.116 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.479 0.181 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 9' ' ' GLN . 40.6 tp -86.59 127.42 34.91 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.52 0.728 . . . . 0.0 109.464 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.73 138.02 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.528 1.131 . . . . 0.0 109.267 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 28.4 m -78.33 97.71 5.69 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.174 0.443 . . . . 0.0 109.861 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.403 HG12 ' HB ' ' A' ' 56' ' ' ILE . 55.8 mt -94.22 104.25 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 67.0 t30 62.04 36.2 15.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.63 1.172 . . . . 0.0 111.145 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.94 10.83 82.4 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.517 -0.765 . . . . 0.0 113.496 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -130.19 108.88 10.38 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.869 0.867 . . . . 0.0 108.98 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.549 ' HB3' HD11 ' A' ' 2' ' ' LEU . 98.3 mt-30 -64.92 119.77 11.33 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.539 0.736 . . . . 0.0 110.457 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -126.59 158.11 37.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.844 0.858 . . . . 0.0 110.327 -177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -97.59 113.79 25.58 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.172 0.989 . . . . 0.0 109.741 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.6 m -120.16 147.25 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.832 0.853 . . . . 0.0 110.85 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -119.01 22.2 12.02 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.74 0.781 . . . . 0.0 109.389 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 p -75.97 -49.84 16.56 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.91 1.284 . . . . 0.0 112.418 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 67.21 0.4 2.05 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.676 1.19 . . . . 0.0 113.669 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 39.7 m -154.33 153.6 31.93 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.132 1.373 . . . . 0.0 109.106 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.45 ' CG1' HG11 ' A' ' 33' ' ' VAL . 58.3 t -69.95 -34.36 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 O-C-N 124.297 0.998 . . . . 0.0 112.506 -172.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.23 -53.24 39.48 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 -33.15 70.37 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.137 0.898 . . . . 0.0 111.238 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.653 HD21 HG21 ' A' ' 56' ' ' ILE . 42.0 tp -61.54 -59.88 4.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.194 1.398 . . . . 0.0 111.817 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.522 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 60.6 mtp -73.63 -19.92 60.72 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.477 0.485 . . . . 0.0 111.256 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.1 m -70.97 -41.72 70.67 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 121.159 0.504 . . . . 0.0 110.061 168.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.84 -35.96 70.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.508 1.123 . . . . 0.0 111.312 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.3 mt -80.22 -5.93 56.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.531 0.732 . . . . 0.0 110.707 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.2 t70 65.55 24.62 11.77 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.352 1.461 . . . . 0.0 110.819 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 58' ' ' ILE . 35.0 t . . . . . 0 CA--C 1.554 1.108 0 C-N-CA 124.609 1.163 . . . . 0.0 111.467 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 121.146 0.498 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.81 175.45 9.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.537 1.135 . . . . 0.0 108.467 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.522 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 6.4 p -134.71 144.2 35.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 123.983 0.913 . . . . 0.0 109.649 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -117.77 100.14 7.4 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.4 tp -97.37 112.01 24.02 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 54.47 55.94 7.45 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.588 1.155 . . . . 0.0 111.49 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 62.86 34.85 14.01 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.434 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -152.06 126.39 9.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.039 0.536 . . . . 0.0 109.898 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 t -73.72 126.03 33.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 O-C-N 123.674 0.609 . . . . 0.0 110.38 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.08 117.39 66.8 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.91 152.69 79.67 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.579 2.186 . . . . 0.0 111.059 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -61.37 -38.64 87.76 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -167.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.9 -1.71 33.9 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 123.481 0.488 . . . . 0.0 114.118 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -114.44 -9.35 12.74 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.73 0.812 . . . . 0.0 112.156 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -51.47 -41.03 60.62 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 123.396 0.678 . . . . 0.0 111.399 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -70.96 -38.32 72.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.468 1.107 . . . . 0.0 111.802 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -77.39 -14.84 59.62 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.1 m -106.27 119.58 51.51 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 88.2 Cg_endo -81.77 167.76 16.37 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.396 2.064 . . . . 0.0 112.316 172.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.464 HG11 HD11 ' A' ' 56' ' ' ILE . 63.0 t -118.73 140.85 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.429 1.092 . . . . 0.0 108.271 171.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.1 m -123.24 154.35 38.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.415 1.086 . . . . 0.0 108.815 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.78 126.93 29.55 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.468 0.707 . . . . 0.0 110.662 175.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 -2.96 52.42 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.959 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -76.42 138.72 40.54 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.447 0.624 . . . . 0.0 111.205 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -92.39 110.48 21.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.655 0.782 . . . . 0.0 109.11 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.653 HG21 HD21 ' A' ' 20' ' ' LEU . 56.4 mt -107.26 98.28 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.054 0.942 . . . . 0.0 109.829 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 41.3 tt0 -96.67 117.06 30.19 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.448 HG21 ' SG ' ' A' ' 26' ' ' CYS . 75.2 mt -76.3 141.45 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 N--CA 1.47 0.549 0 C-N-CA 123.457 0.703 . . . . 0.0 110.522 -177.611 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mtp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 9' ' ' GLN . 4.4 tt -79.18 105.22 10.35 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.54 178.02 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.365 1.066 . . . . 0.0 109.021 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.6 m -122.63 100.52 6.96 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.6 mt -95.14 110.04 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.72 0.808 . . . . 0.0 108.982 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.462 HD22 ' HB ' ' A' ' 58' ' ' ILE . 2.3 m120 65.23 34.01 8.8 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.166 1.386 . . . . 0.0 110.86 175.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.32 2.52 85.33 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.524 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -115.76 120.2 38.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.163 0.585 . . . . 0.0 110.51 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.468 ' HB3' HD21 ' A' ' 2' ' ' LEU . 47.9 mt-30 -64.11 113.65 3.67 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.406 0.683 . . . . 0.0 110.351 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -125.08 133.56 52.84 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.285 1.034 . . . . 0.0 109.965 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -85.18 114.99 22.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.414 1.086 . . . . 0.0 108.993 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.9 m -125.12 168.55 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.445 1.098 . . . . 0.0 109.089 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -124.83 5.53 8.08 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.453 0.701 . . . . 0.0 109.5 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.4 m -78.58 105.21 9.7 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 123.296 0.638 . . . . 0.0 110.576 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.88 2.47 34.21 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.172 0.589 . . . . 0.0 111.106 171.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.7 t -124.52 133.89 53.18 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.431 1.093 . . . . 0.0 109.261 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 33' ' ' VAL . 66.8 t -63.41 -43.05 98.31 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 O-C-N 123.743 0.652 . . . . 0.0 110.046 174.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -50.39 68.49 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 0.0 111.415 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.06 92.11 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 124.047 0.842 . . . . 0.0 111.207 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.0 tp -60.78 -45.94 92.4 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.968 0.792 . . . . 0.0 111.685 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.0 mmm -71.77 -24.31 61.73 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.214 0.606 . . . . 0.0 111.25 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -69.58 -41.07 76.32 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.901 0.481 . . . . 0.0 110.119 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.44 -37.58 77.45 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.085 0.954 . . . . 0.0 111.51 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -82.81 -4.7 58.34 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.563 0.745 . . . . 0.0 111.145 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.2 t70 69.08 12.25 8.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.491 1.116 . . . . 0.0 111.506 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 124.19 0.996 . . . . 0.0 110.423 -175.058 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 121.076 0.465 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -119.69 167.85 11.63 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.698 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 17' ' ' VAL . 9.8 p -122.82 156.41 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -131.14 100.86 5.35 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -89.84 108.84 19.94 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 59.71 39.75 20.65 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.763 1.225 . . . . 0.0 109.889 -169.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 73.91 -9.28 1.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.99 1.716 . . . . 0.0 113.297 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -77.97 108.94 11.6 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.8 t -67.57 121.72 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 123.6 0.562 . . . . 0.0 109.904 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.482 HG21 HG21 ' A' ' 48' ' ' THR . 67.9 t -105.69 132.56 20.78 Favored Pre-proline 0 C--O 1.245 0.818 0 C-N-CA 124.124 0.97 . . . . 0.0 108.827 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.11 149.83 59.01 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.465 2.11 . . . . 0.0 111.256 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -63.48 -34.2 77.24 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -165.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.96 -29.06 67.12 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 123.384 0.427 . . . . 0.0 112.773 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -95.09 -4.21 46.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.718 0.807 . . . . 0.0 112.718 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -57.9 -29.99 65.52 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 118.495 0.589 . . . . 0.0 110.625 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.24 -39.6 82.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.395 1.078 . . . . 0.0 110.888 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -79.47 -24.84 42.1 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.122 0.969 . . . . 0.0 112.131 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.482 HG21 HG21 ' A' ' 40' ' ' VAL . 56.6 m -92.9 110.98 49.24 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.835 0.854 . . . . 0.0 109.464 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -81.03 171.59 13.93 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.8 2.333 . . . . 0.0 112.439 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.405 HG13 HD11 ' A' ' 56' ' ' ILE . 58.0 t -121.85 138.82 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.209 1.004 . . . . 0.0 108.388 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.2 p -128.69 150.85 50.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.567 1.147 . . . . 0.0 108.294 173.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.63 122.39 15.17 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.522 0.729 . . . . 0.0 110.705 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.01 -13.94 19.43 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.191 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -67.18 139.49 57.44 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 117.198 0.499 . . . . 0.0 111.986 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.68 99.45 12.35 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 50' ' ' VAL . 62.4 mt -98.3 96.28 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.714 0.805 . . . . 0.0 109.289 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 34.5 tt0 -93.67 119.96 33.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.808 0.843 . . . . 0.0 109.726 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.462 ' HB ' HD22 ' A' ' 6' ' ' ASN . 88.5 mt -87.73 136.42 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 80.0 mt . . . . . 0 N--CA 1.467 0.385 0 C-N-CA 124.245 1.018 . . . . 0.0 109.763 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.523 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 1.3 pmm? . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.91 0.386 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 tt -79.93 118.56 21.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 m -131.0 142.56 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.524 1.129 . . . . 0.0 110.415 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 55' ' ' GLU . 8.3 m -79.75 98.92 7.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.793 0.837 . . . . 0.0 109.437 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.645 HD13 HD11 ' A' ' 24' ' ' LEU . 74.1 mt -104.38 110.77 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.437 HD21 ' HB ' ' A' ' 58' ' ' ILE . 88.9 m-20 64.13 22.42 12.88 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.605 1.162 . . . . 0.0 111.494 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.66 -15.1 64.06 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-O 119.72 -0.489 . . . . 0.0 113.535 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -86.09 133.08 33.91 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 117.401 0.601 . . . . 0.0 109.72 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -75.08 100.16 4.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -105.17 146.2 29.55 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.059 0.944 . . . . 0.0 109.973 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -109.61 104.29 13.29 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 m -113.33 165.14 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.569 0.748 . . . . 0.0 110.156 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -128.1 9.12 6.21 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.661 0.784 . . . . 0.0 109.627 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -57.0 -49.1 76.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.803 1.241 . . . . 0.0 112.799 -170.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 61.78 9.36 2.85 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.179 0.992 . . . . 0.0 112.802 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.2 t -162.05 141.48 9.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.152 1.381 . . . . 0.0 108.109 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.462 HG11 HG11 ' A' ' 33' ' ' VAL . 94.6 t -72.05 -33.39 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.335 0.654 . . . . 0.0 111.461 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.88 -53.6 51.7 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.641 0.376 . . . . 0.0 110.275 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.65 -44.83 73.59 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.66 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.7 tp -58.81 -56.02 27.59 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.273 1.029 . . . . 0.0 111.886 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.2 mtp -68.95 -19.27 64.17 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.027 0.531 . . . . 0.0 111.2 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.7 m -73.27 -46.28 50.8 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.795 0.438 . . . . 0.0 110.663 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -70.1 -34.57 73.3 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.282 1.033 . . . . 0.0 111.604 -175.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.645 HD11 HD13 ' A' ' 5' ' ' ILE . 89.5 mt -79.09 -12.23 60.0 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.522 0.729 . . . . 0.0 111.25 175.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 63.54 24.57 14.08 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.576 1.15 . . . . 0.0 111.027 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.448 ' HB3' HG21 ' A' ' 58' ' ' ILE . 88.3 m . . . . . 0 N--CA 1.47 0.57 0 C-N-CA 125.473 1.509 . . . . 0.0 110.566 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 120.801 0.334 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -138.54 177.96 7.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.088 1.355 . . . . 0.0 108.466 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 HG11 ' A' ' 17' ' ' VAL . 11.1 p -138.17 148.41 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.227 0.537 . . . . 0.0 110.824 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -129.9 105.53 8.05 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.129 1.372 . . . . 0.0 108.037 172.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.0 tp -86.83 105.79 17.27 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 54.74 52.88 11.36 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.266 1.427 . . . . 0.0 110.725 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 74.89 -16.8 0.53 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 125.765 1.626 . . . . 0.0 113.761 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.03 107.71 19.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 75.4 t -69.96 117.49 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.371 0.669 . . . . 0.0 110.874 -176.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.23 119.45 65.59 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 123.853 0.861 . . . . 0.0 109.157 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.33 154.47 74.11 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.421 2.081 . . . . 0.0 112.159 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -59.39 -33.94 71.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.087 0.955 . . . . 0.0 112.115 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.44 1.31 7.21 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.994 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -127.88 -9.82 5.48 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 117.976 -1.011 . . . . 0.0 112.334 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -49.46 -42.33 42.77 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 119.072 0.851 . . . . 0.0 111.685 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -68.09 -41.72 81.42 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.379 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.44 -19.03 60.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.772 0.829 . . . . 0.0 111.812 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.0 m -96.06 115.35 65.51 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.45 169.91 20.98 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.475 2.117 . . . . 0.0 112.832 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.26 104.72 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.802 1.241 . . . . 0.0 108.499 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 p -97.97 166.64 11.35 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.158 0.983 . . . . 0.0 110.678 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 1' ' ' MET . . . -64.22 116.52 6.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.783 0.833 . . . . 0.0 112.003 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.66 26.78 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 119.315 -0.714 . . . . 0.0 114.479 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -74.09 140.52 45.36 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.023 0.912 . . . . 0.0 111.841 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.404 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 42.9 tt0 -89.89 92.56 9.07 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 64.3 mt -96.19 100.91 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.79 0.836 . . . . 0.0 109.861 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -88.92 104.47 16.99 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 26' ' ' CYS . 50.6 mm -78.56 106.69 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 61.1 mt . . . . . 0 C--N 1.323 -0.552 0 C-N-CA 123.298 0.639 . . . . 0.0 110.538 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.466 ' HG2' HG13 ' A' ' 3' ' ' VAL . 1.5 pmm? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.371 0.129 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 44.9 tp -77.86 116.71 18.57 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 173.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.466 HG13 ' HG2' ' A' ' 1' ' ' MET . 32.7 m -120.33 -176.46 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.762 1.225 . . . . 0.0 109.273 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.7 m -126.67 101.65 6.73 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.4 mt -96.29 115.6 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.757 0.823 . . . . 0.0 110.006 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 t30 50.42 52.74 14.21 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.851 1.26 . . . . 0.0 111.243 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.07 -0.8 61.74 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 114.62 -1.173 . . . . 0.0 114.429 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -107.56 109.67 21.38 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.817 0.847 . . . . 0.0 110.155 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -66.32 102.03 0.81 Allowed 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.746 0.784 . . . . 0.0 109.774 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -137.34 136.97 38.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.506 0.722 . . . . 0.0 109.392 -171.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 36.7 tt0 -84.67 130.83 34.66 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.239 0.616 . . . . 0.0 109.595 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.41 177.04 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.713 1.205 . . . . 0.0 108.933 171.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -119.67 7.38 11.05 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.8 m -68.33 112.2 5.07 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 123.441 0.697 . . . . 0.0 110.618 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.97 -16.49 43.91 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.374 0.669 . . . . 0.0 110.728 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.3 t -121.28 141.34 50.99 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.319 1.048 . . . . 0.0 109.432 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.3 t -69.77 -30.19 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 123.535 0.522 . . . . 0.0 110.371 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.74 64.21 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.456 0.702 . . . . 0.0 110.368 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.39 90.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.544 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 53.6 tp -61.77 -54.58 40.43 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.626 0.578 . . . . 0.0 110.888 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.3 mmm -61.57 -32.31 72.39 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.044 0.84 . . . . 0.0 110.905 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -70.03 -40.94 74.87 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.212 0.605 . . . . 0.0 110.887 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.52 -20.77 59.85 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.097 0.559 . . . . 0.0 111.376 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 92.8 mt -87.29 -6.43 58.53 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.056 0.543 . . . . 0.0 110.081 172.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.5 t70 62.03 31.47 17.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.147 1.379 . . . . 0.0 110.564 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.5 t . . . . . 0 CA--C 1.553 1.063 0 C-N-CA 125.223 1.409 . . . . 0.0 109.286 -177.852 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 121.111 0.482 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.1 179.54 9.05 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.82 1.248 . . . . 0.0 108.784 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.459 HG12 ' NE1' ' A' ' 45' ' ' TRP . 7.3 p -147.06 119.09 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.246 0.546 . . . . 0.0 110.299 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -80.32 97.48 7.03 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 171.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.427 HD13 HG12 ' A' ' 56' ' ' ILE . 46.5 tp -92.11 120.49 32.77 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 63.45 25.72 14.62 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.69 1.196 . . . . 0.0 110.071 -173.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 74.47 8.31 4.46 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 126.256 1.822 . . . . 0.0 112.644 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -106.04 126.91 52.77 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.49 124.16 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.564 0.746 . . . . 0.0 111.094 -171.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.5 116.69 57.38 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.536 1.135 . . . . 0.0 109.063 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.537 ' HD2' ' HD3' ' A' ' 44' ' ' LYS . 57.4 Cg_endo -70.23 164.26 35.65 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.858 2.372 . . . . 0.0 112.135 173.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -56.53 -43.42 79.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.081 0.952 . . . . 0.0 112.66 -172.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.8 -30.18 74.32 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 123.804 0.69 . . . . 0.0 113.301 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.537 ' HD3' ' HD2' ' A' ' 41' ' ' PRO . 28.2 mtpp -82.01 -25.92 34.28 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.328 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.459 ' NE1' HG12 ' A' ' 33' ' ' VAL . 51.9 m0 -49.19 -36.34 19.43 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 123.76 0.824 . . . . 0.0 111.65 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.73 -54.23 38.62 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.012 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -86.03 2.78 45.12 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.092 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.7 m -108.37 114.67 59.05 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.1 166.12 12.9 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.579 2.186 . . . . 0.0 113.29 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 56' ' ' ILE . 49.1 t -95.17 147.75 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.884 0.873 . . . . 0.0 108.839 172.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 m -123.51 149.16 45.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.848 0.859 . . . . 0.0 110.119 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.29 113.76 3.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.462 0.305 . . . . 0.0 111.243 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.83 39.3 24.95 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.448 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -94.39 164.84 12.84 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.823 0.449 . . . . 0.0 111.386 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -101.15 86.99 3.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.566 0.698 . . . . 0.0 110.204 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.457 HD11 HG13 ' A' ' 50' ' ' VAL . 82.5 mt -86.19 144.2 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.026 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 33.8 tt0 -147.48 136.25 22.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mm -83.29 134.73 26.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.1 mt . . . . . 0 C--N 1.323 -0.546 0 C-N-CA 124.013 0.925 . . . . 0.0 109.543 178.038 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' HG12 ' A' ' 50' ' ' VAL . 23.8 ptp . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 121.064 0.459 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.9 tt -85.43 107.27 17.32 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.484 HG23 HG13 ' A' ' 5' ' ' ILE . 28.6 m -118.69 162.04 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.396 1.079 . . . . 0.0 109.449 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.3 m -94.12 101.52 13.53 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.121 0.569 . . . . 0.0 109.711 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.657 HD13 HD11 ' A' ' 24' ' ' LEU . 69.1 mt -100.02 107.85 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.2 m120 68.26 22.21 8.19 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.917 1.287 . . . . 0.0 112.399 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.17 4.91 66.22 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.455 -0.339 . . . . 0.0 112.66 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -119.99 111.57 18.07 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.143 0.977 . . . . 0.0 108.488 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -60.2 111.28 1.47 Allowed 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.953 0.406 . . . . 0.0 110.287 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -119.94 131.34 55.17 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.626 1.17 . . . . 0.0 108.872 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -80.65 124.42 28.99 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 170.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.43 163.3 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.311 1.044 . . . . 0.0 108.973 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -114.73 -2.22 13.07 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.862 0.465 . . . . 0.0 111.539 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -70.77 117.3 12.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.718 0.407 . . . . 0.0 110.851 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.55 14.27 19.34 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.196 0.998 . . . . 0.0 110.931 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 p -142.38 141.57 32.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.501 1.12 . . . . 0.0 108.702 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.508 HG11 HG11 ' A' ' 33' ' ' VAL . 98.7 t -67.74 -31.73 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 124.027 0.829 . . . . 0.0 112.033 -172.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.5 -45.87 78.14 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.46 0.304 . . . . 0.0 110.521 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -61.29 -38.12 85.63 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.076 0.86 . . . . 0.0 111.092 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.1 tp -62.63 -50.57 70.7 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.902 0.881 . . . . 0.0 111.438 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.5 mtp -72.84 -16.8 61.59 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.65 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.2 m -69.54 -45.84 67.84 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 166.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 22.2 mm-40 -65.89 -30.6 71.23 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.243 0.617 . . . . 0.0 112.217 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.657 HD11 HD13 ' A' ' 5' ' ' ILE . 60.7 mt -99.6 -0.82 39.62 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.634 0.774 . . . . 0.0 111.675 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t70 62.4 25.45 15.18 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.076 1.35 . . . . 0.0 111.503 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.9 m . . . . . 0 CA--C 1.547 0.851 0 C-N-CA 124.434 1.094 . . . . 0.0 110.622 178.232 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 . . . . . 0 C--O 1.237 0.429 0 CA-C-O 121.093 0.473 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.67 134.64 54.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.508 HG11 HG11 ' A' ' 17' ' ' VAL . 11.0 p -106.05 137.92 33.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.43 100.56 8.86 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.419 HD12 HG12 ' A' ' 56' ' ' ILE . 28.5 tp -87.01 108.64 18.94 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 60.39 39.45 18.57 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.232 0.957 . . . . 0.0 110.182 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 68.21 13.87 9.14 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.28 1.432 . . . . 0.0 113.184 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -111.7 116.99 31.67 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.8 t -67.15 126.97 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.247 0.619 . . . . 0.0 111.181 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.7 t -103.8 127.86 28.53 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.544 1.137 . . . . 0.0 108.333 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.68 161.39 33.85 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.947 2.431 . . . . 0.0 111.836 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -59.18 -41.72 89.12 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.476 0.71 . . . . 0.0 112.864 -169.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.45 -29.13 70.81 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 123.373 0.421 . . . . 0.0 112.899 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -88.74 -14.89 36.11 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-O 117.936 -1.031 . . . . 0.0 112.177 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -53.88 -43.37 69.55 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.96 0.8 . . . . 0.0 111.701 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.1 -42.14 85.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.669 0.788 . . . . 0.0 110.432 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -75.77 -21.18 57.65 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.46 1.104 . . . . 0.0 112.445 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 83.8 m -95.0 116.81 66.73 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.27 169.81 16.05 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.409 2.073 . . . . 0.0 112.744 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' SD ' ' A' ' 1' ' ' MET . 98.2 t -121.91 134.62 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 169.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.8 p -128.0 155.69 43.89 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.118 0.967 . . . . 0.0 108.753 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.9 134.08 55.66 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.613 0.571 . . . . 0.0 111.67 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.1 -13.04 57.44 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-O 118.979 -0.901 . . . . 0.0 114.393 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -60.25 137.8 58.05 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -82.43 82.04 8.04 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 62.2 mt -88.58 95.41 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.87 106.13 16.64 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -174.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.8 mt -93.04 100.93 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.539 0.685 . . . . 0.0 109.44 -174.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.1 mt . . . . . 0 C--N 1.325 -0.478 0 C-N-CA 124.286 1.035 . . . . 0.0 110.746 176.834 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.414 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 1.7 pmm? . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.594 0.235 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 9' ' ' GLN . 48.1 tp -89.24 128.15 35.82 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.404 HG23 HG13 ' A' ' 5' ' ' ILE . 6.9 m -140.25 158.33 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.591 1.156 . . . . 0.0 109.325 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -92.29 98.78 11.72 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 62.1 mt -106.61 120.33 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.9 m120 64.01 21.27 12.54 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.692 1.197 . . . . 0.0 111.945 -176.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.75 0.51 78.47 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 119.721 -0.488 . . . . 0.0 114.12 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -115.21 161.11 18.89 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.778 0.789 . . . . 0.0 110.0 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 2' ' ' LEU . 26.3 mp0 -81.6 118.75 23.03 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -127.64 125.75 40.73 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.685 1.194 . . . . 0.0 109.605 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -95.1 113.51 25.21 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.26 157.38 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.697 0.799 . . . . 0.0 110.775 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.15 -2.29 15.0 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.744 0.818 . . . . 0.0 110.607 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 m -60.55 -44.66 95.89 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.76 1.224 . . . . 0.0 112.972 -168.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 75.45 -43.17 0.49 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.245 1.418 . . . . 0.0 113.227 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -97.18 146.51 25.0 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 33' ' ' VAL . 54.9 t -67.91 -31.67 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 123.687 0.617 . . . . 0.0 110.457 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.26 -50.25 72.46 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.668 0.387 . . . . 0.0 110.539 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.84 72.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.602 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.2 tp -68.42 -49.24 61.38 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.794 0.838 . . . . 0.0 111.384 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 92.6 mmm -68.49 -22.49 64.55 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.368 0.667 . . . . 0.0 110.325 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -81.67 -39.39 24.43 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.552 0.341 . . . . 0.0 111.493 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.65 -42.62 98.09 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.696 0.798 . . . . 0.0 110.26 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -88.18 -0.09 56.68 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.983 0.913 . . . . 0.0 111.436 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.0 t70 64.31 20.84 12.33 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.04 1.336 . . . . 0.0 112.437 173.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.4 ' SG ' HG21 ' A' ' 58' ' ' ILE . 56.0 m . . . . . 0 CA--C 1.553 1.09 0 C-N-CA 124.318 1.047 . . . . 0.0 111.884 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.401 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -109.92 153.26 24.76 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 17' ' ' VAL . 9.3 p -105.13 146.01 12.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -126.87 101.83 6.76 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.13 116.92 24.63 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 65.02 28.44 12.46 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 124.604 1.19 . . . . 0.0 110.276 -172.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 68.92 22.2 7.21 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.473 1.509 . . . . 0.0 112.751 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -114.58 115.79 27.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.932 0.893 . . . . 0.0 108.91 172.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.401 HG13 ' HB1' ' A' ' 32' ' ' ALA . 77.1 t -66.65 120.77 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.906 0.882 . . . . 0.0 112.109 -170.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.436 ' HB ' HG13 ' A' ' 33' ' ' VAL . 91.7 t -95.52 126.6 45.03 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.981 1.312 . . . . 0.0 109.248 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.45 157.19 59.44 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 123.111 2.54 . . . . 0.0 112.475 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.452 ' HA ' ' CE2' ' A' ' 45' ' ' TRP . 74.7 ttt180 -59.05 -40.59 85.59 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.921 0.889 . . . . 0.0 112.695 -171.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.41 -17.97 54.48 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.885 0.741 . . . . 0.0 114.349 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -102.89 -8.28 20.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.452 ' CE2' ' HA ' ' A' ' 42' ' ' ARG . 50.7 m0 -55.35 -37.19 67.15 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 120.991 0.424 . . . . 0.0 111.866 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.21 -50.03 71.88 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.343 1.057 . . . . 0.0 111.445 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.1 2.28 40.14 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.594 0.758 . . . . 0.0 112.515 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.3 m -104.53 122.52 43.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.412 0.685 . . . . 0.0 109.517 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.96 161.36 18.38 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.711 2.274 . . . . 0.0 114.584 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.2 94.59 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.7 p -104.36 142.74 34.03 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -60.03 127.42 31.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.4 1.08 . . . . 0.0 113.319 -167.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.03 12.92 75.78 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-O 119.397 -0.668 . . . . 0.0 114.455 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.96 147.06 25.91 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.869 0.835 . . . . 0.0 111.119 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -84.86 81.75 8.75 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.918 1.287 . . . . 0.0 109.842 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 72.7 mt -88.37 96.43 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.911 0.884 . . . . 0.0 109.158 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 10.4 tp10 -93.65 111.14 22.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.4 HG21 ' SG ' ' A' ' 26' ' ' CYS . 55.7 mt -100.55 104.02 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.728 0 C-N-CA 124.304 1.042 . . . . 0.0 110.389 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.461 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.722 0.296 . . . . 0.0 111.213 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 40.8 tp -90.82 116.51 28.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.178 0.991 . . . . 0.0 110.012 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -129.66 140.6 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.406 0.682 . . . . 0.0 110.495 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 59.9 m -71.33 104.58 3.21 Favored 'General case' 0 C--O 1.216 -0.674 0 C-N-CA 123.915 0.886 . . . . 0.0 110.295 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 46.6 mt -102.32 105.45 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 122.825 0.45 . . . . 0.0 109.955 175.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.8 m120 65.62 31.78 9.64 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.09 1.356 . . . . 0.0 112.308 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.13 1.5 81.77 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.944 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -122.4 115.13 21.74 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.745 0.818 . . . . 0.0 109.112 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 1.2 mp0 -68.9 146.01 53.17 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.101 0.56 . . . . 0.0 110.143 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -150.92 139.57 20.66 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.564 0.346 . . . . 0.0 111.267 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.49 99.91 9.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.572 1.149 . . . . 0.0 109.098 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.3 m -121.61 158.73 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.188 0.995 . . . . 0.0 110.259 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -112.14 9.85 20.21 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.635 0.774 . . . . 0.0 110.075 172.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.0 m -73.37 94.04 2.01 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.576 0.75 . . . . 0.0 110.489 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.77 -3.25 37.24 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.432 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.0 t -129.49 148.69 51.42 Favored 'General case' 0 C--O 1.247 0.958 0 C-N-CA 124.616 1.166 . . . . 0.0 109.62 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.514 HG11 HG11 ' A' ' 33' ' ' VAL . 53.5 t -66.32 -33.37 63.07 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.779 0.832 . . . . 0.0 110.623 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.25 -51.62 68.77 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.5 0.72 . . . . 0.0 111.147 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.74 79.93 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.85 0.719 . . . . 0.0 111.301 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.17 -53.71 18.64 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 123.819 0.699 . . . . 0.0 111.462 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.564 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 65.8 mtp -69.79 -34.34 73.61 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.442 0.297 . . . . 0.0 111.498 -175.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.2 m -68.41 -36.09 78.6 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.523 0.329 . . . . 0.0 110.762 175.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.67 -47.31 84.23 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.204 0.526 . . . . 0.0 110.219 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.7 mt -75.79 -8.14 56.14 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.442 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.0 t70 61.42 54.62 3.08 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.145 1.378 . . . . 0.0 110.384 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.7 m . . . . . 0 CA--C 1.544 0.735 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.801 179.038 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.931 0.396 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.43 -175.26 2.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.762 1.225 . . . . 0.0 108.991 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.564 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.1 p -144.96 156.08 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.163 0.585 . . . . 0.0 110.132 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -132.28 102.16 5.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.954 0.901 . . . . 0.0 109.011 176.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.8 tp -86.66 114.99 23.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 56.52 36.29 27.34 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.078 0.951 . . . . 0.0 110.863 -170.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 74.02 -2.03 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.97 1.708 . . . . 0.0 113.106 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -95.87 122.11 38.31 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 59.0 t -70.3 132.75 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.559 0.744 . . . . 0.0 111.799 -170.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.57 124.44 40.77 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -64.61 154.89 69.82 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.71 2.273 . . . . 0.0 111.703 170.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -64.41 -44.14 92.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.694 0.798 . . . . 0.0 112.202 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.61 -3.99 29.84 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.252 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -113.34 -9.45 13.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.147 0.979 . . . . 0.0 113.033 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -52.04 -39.78 60.08 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 119.011 0.823 . . . . 0.0 111.157 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -71.28 -41.9 69.42 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.956 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.95 -12.31 60.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.403 1.081 . . . . 0.0 112.683 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -105.1 115.15 62.78 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -176.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.51 159.14 32.42 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.602 2.201 . . . . 0.0 112.957 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.484 HG13 HD11 ' A' ' 56' ' ' ILE . 84.9 t -119.06 139.19 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.54 1.136 . . . . 0.0 108.004 174.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.8 p -126.26 165.61 18.65 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.256 1.022 . . . . 0.0 109.206 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.461 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -61.7 129.97 43.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.965 0.906 . . . . 0.0 112.244 -176.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.52 2.05 68.09 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.218 -0.768 . . . . 0.0 114.164 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.31 147.14 44.76 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 117.897 0.848 . . . . 0.0 111.755 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.444 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 4.0 mp0 -94.28 92.39 7.19 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.484 HD11 HG13 ' A' ' 50' ' ' VAL . 3.1 mp -84.93 95.02 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 172.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 36.0 tt0 -96.47 100.39 11.99 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.4 mt -73.95 103.55 2.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.2 mt . . . . . 0 N--CA 1.448 -0.539 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.528 178.562 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptp . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.584 0.231 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 52.4 tp -82.18 114.53 20.76 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.472 ' HA ' ' H ' ' A' ' 53' ' ' GLY . 33.8 m -119.31 -180.0 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.276 1.03 . . . . 0.0 110.57 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.6 m -117.74 100.3 7.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.138 0.575 . . . . 0.0 109.655 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 HD11 ' A' ' 24' ' ' LEU . 69.5 mt -102.41 122.27 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.62 0.768 . . . . 0.0 108.98 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 58.92 30.39 20.13 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.274 1.03 . . . . 0.0 111.927 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.06 -2.74 87.08 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 120.028 -0.318 . . . . 0.0 113.64 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.3 136.0 46.8 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.099 0.96 . . . . 0.0 109.929 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -77.92 113.14 15.54 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -132.1 136.61 47.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.545 1.138 . . . . 0.0 109.512 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.95 131.85 35.36 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 5' ' ' ILE . 27.7 m -133.81 155.26 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.632 0.773 . . . . 0.0 110.449 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -93.63 -43.34 8.72 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.041 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 m -58.83 120.99 10.02 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.857 0.863 . . . . 0.0 112.353 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.54 -0.37 57.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.985 0.914 . . . . 0.0 111.261 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.5 t -116.17 141.39 48.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.384 1.073 . . . . 0.0 108.891 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.64 -33.62 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.497 0.719 . . . . 0.0 110.993 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.73 -53.01 61.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.525 0.33 . . . . 0.0 110.308 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -60.19 -39.45 86.56 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.065 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.2 tp -66.0 -48.1 72.32 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.842 0.457 . . . . 0.0 111.255 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.479 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 83.0 mtp -67.94 -25.68 65.58 Favored 'General case' 0 C--O 1.211 -0.955 0 O-C-N 123.372 0.42 . . . . 0.0 110.238 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.1 m -69.45 -40.95 76.85 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 118.16 0.436 . . . . 0.0 110.343 172.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 18.2 mm-40 -65.93 -37.5 86.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.943 0.497 . . . . 0.0 111.105 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 5' ' ' ILE . 95.5 mt -82.0 -12.86 58.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.02 0.928 . . . . 0.0 111.314 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 63.62 51.13 2.57 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.105 1.362 . . . . 0.0 110.553 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.3 m . . . . . 0 CA--C 1.55 0.947 0 C-N-CA 125.339 1.456 . . . . 0.0 110.443 -178.271 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.0 147.8 52.27 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.207 1.003 . . . . 0.0 109.115 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.479 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 5.6 p -106.82 135.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -116.46 100.98 8.24 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.0 tp -88.71 113.72 24.57 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 56.9 42.85 25.78 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.74 1.275 . . . . 0.0 110.072 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 68.04 21.15 8.89 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.385 1.474 . . . . 0.0 112.328 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -124.59 115.44 20.82 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.804 0.842 . . . . 0.0 108.868 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 58.8 t -63.82 127.96 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.55 0.74 . . . . 0.0 111.144 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.43 ' HB ' HG13 ' A' ' 33' ' ' VAL . 98.4 t -96.02 126.64 43.77 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.401 1.081 . . . . 0.0 109.612 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.38 146.22 68.01 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.44 2.093 . . . . 0.0 112.47 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -48.02 -48.55 32.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.892 1.677 . . . . 0.0 113.315 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.1 -15.65 60.99 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 123.749 0.655 . . . . 0.0 114.561 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -106.68 -10.04 16.28 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 117.922 -1.037 . . . . 0.0 112.34 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -46.8 -40.55 13.92 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 123.646 0.778 . . . . 0.0 112.554 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -70.08 -41.01 74.67 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.955 0.902 . . . . 0.0 110.64 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -76.72 -11.91 59.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.595 1.158 . . . . 0.0 111.418 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.0 m -92.78 118.12 67.82 Favored Pre-proline 0 C--O 1.243 0.722 0 C-N-CA 123.515 0.726 . . . . 0.0 109.55 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -82.14 156.73 17.42 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.207 1.938 . . . . 0.0 113.021 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.3 t -96.99 138.64 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.748 1.219 . . . . 0.0 107.867 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.9 m -130.02 139.37 51.03 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.228 1.011 . . . . 0.0 109.461 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.66 114.6 2.82 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.96 0.346 . . . . 0.0 111.392 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 3' ' ' VAL . . . 89.74 20.68 42.82 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-O 119.371 -0.683 . . . . 0.0 114.253 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -84.73 165.69 17.64 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.004 0.902 . . . . 0.0 110.229 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.74 85.5 2.24 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.861 0.464 . . . . 0.0 110.117 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 82.8 mt -88.01 97.32 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 36.6 tt0 -103.99 102.52 12.29 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.211 0.605 . . . . 0.0 109.974 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 64.3 mt -97.88 105.77 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.474 0.739 0 C-N-CA 124.52 1.128 . . . . 0.0 110.508 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 120.718 0.294 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 9' ' ' GLN . 59.2 tp -79.65 119.08 22.1 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.954 0.902 . . . . 0.0 110.324 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.47 162.97 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.344 1.058 . . . . 0.0 109.069 176.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 m -105.02 99.99 9.6 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.64 HD13 HD11 ' A' ' 24' ' ' LEU . 32.9 mt -101.5 108.96 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.732 0.813 . . . . 0.0 109.321 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.4 m120 63.48 22.73 13.36 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.249 1.02 . . . . 0.0 112.999 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.94 8.75 72.1 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.358 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -103.91 131.27 51.3 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.729 0.811 . . . . 0.0 108.834 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.489 ' HB3' HD11 ' A' ' 2' ' ' LEU . 74.4 mt-30 -80.05 113.84 18.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 172.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -137.3 130.56 30.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.146 0.578 . . . . 0.0 110.225 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -82.52 129.52 34.93 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.751 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.99 159.56 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.764 0.826 . . . . 0.0 110.136 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -112.32 -12.69 13.53 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.877 0.871 . . . . 0.0 110.371 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 p -66.16 105.47 1.4 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.128 0.971 . . . . 0.0 110.973 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.95 -17.56 62.07 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.813 0.845 . . . . 0.0 111.748 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.7 t -105.03 143.24 33.49 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.01 0.924 . . . . 0.0 110.097 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 21' ' ' MET . 88.0 t -68.16 -33.63 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 173.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.62 95.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.843 0.457 . . . . 0.0 110.511 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.08 79.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.084 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.1 tp -69.42 -43.13 74.02 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.659 0.599 . . . . 0.0 110.695 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 91.8 mmm -67.44 -29.12 68.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.915 0.486 . . . . 0.0 109.988 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 m -79.99 -29.25 39.46 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.682 0.393 . . . . 0.0 110.663 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -68.48 -37.52 80.2 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.759 0.824 . . . . 0.0 109.931 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.64 HD11 HD13 ' A' ' 5' ' ' ILE . 57.4 mt -98.26 8.62 44.56 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.349 1.06 . . . . 0.0 110.851 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 p30 51.03 23.78 1.63 Allowed 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 125.814 1.646 . . . . 0.0 113.389 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.8 m . . . . . 0 CA--C 1.555 1.14 0 C-N-CA 124.749 1.219 . . . . 0.0 110.655 177.899 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.556 0.693 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.59 168.32 22.3 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.764 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.451 HG13 ' HB ' ' A' ' 40' ' ' VAL . 12.8 p -130.91 147.98 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -126.56 104.96 8.4 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.477 1.111 . . . . 0.0 108.447 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 tp -88.35 109.82 20.29 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 57.06 52.22 9.42 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 124.662 1.226 . . . . 0.0 111.191 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 71.18 -2.1 2.49 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.507 1.523 . . . . 0.0 112.988 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -103.7 110.26 22.28 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.78 0.832 . . . . 0.0 108.943 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 78.0 t -69.92 115.76 9.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 122.896 0.479 . . . . 0.0 110.404 -175.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HB ' HG13 ' A' ' 33' ' ' VAL . 58.4 t -87.23 122.39 70.94 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.23 1.012 . . . . 0.0 108.637 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.9 159.17 53.42 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 122.767 2.311 . . . . 0.0 111.145 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -61.56 -34.05 74.91 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.621 0.576 . . . . 0.0 111.985 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.87 -5.85 21.13 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.792 -0.64 . . . . 0.0 114.066 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -119.46 -6.86 10.24 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 117.655 -1.164 . . . . 0.0 112.827 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -55.86 -46.47 78.21 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 120.132 1.333 . . . . 0.0 111.454 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.51 -39.45 67.61 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.782 0.433 . . . . 0.0 110.108 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.77 -22.37 65.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.713 0.805 . . . . 0.0 112.617 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.5 m -99.56 127.88 32.99 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 123.554 0.742 . . . . 0.0 109.596 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -83.34 167.25 13.79 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.558 2.172 . . . . 0.0 113.429 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 56' ' ' ILE . 67.7 t -115.45 125.59 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.278 1.031 . . . . 0.0 108.37 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.5 p -123.8 160.65 26.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.098 0.559 . . . . 0.0 110.207 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -64.29 142.02 58.57 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.824 1.249 . . . . 0.0 112.588 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.28 -13.2 60.53 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-O 119.71 -0.495 . . . . 0.0 114.01 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.82 145.16 40.86 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.73 0.765 . . . . 0.0 112.049 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -93.14 99.67 12.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.207 1.003 . . . . 0.0 110.127 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 61.6 mt -97.89 97.51 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.901 0.881 . . . . 0.0 108.924 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -96.83 107.11 19.54 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.707 0.803 . . . . 0.0 109.536 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.96 114.84 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.525 HD13 ' H ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.634 0 C-N-CA 123.455 0.702 . . . . 0.0 110.414 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.514 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 24.3 ptp . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.653 0.264 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 36.2 tp -81.49 112.32 18.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.39 165.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.955 0.902 . . . . 0.0 110.087 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.7 m -111.64 100.73 9.21 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.972 0.509 . . . . 0.0 109.871 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.45 HD11 HD11 ' A' ' 20' ' ' LEU . 70.7 mt -108.35 117.8 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 124.109 0.964 . . . . 0.0 109.203 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 65.41 24.49 11.99 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.517 1.127 . . . . 0.0 112.644 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.18 -3.08 84.18 Favored Glycine 0 N--CA 1.47 0.908 0 CA-C-N 116.445 -0.343 . . . . 0.0 113.156 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -105.78 154.97 19.76 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.613 1.165 . . . . 0.0 108.42 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -105.27 136.12 45.38 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.074 0.397 . . . . 0.0 110.07 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -141.3 130.97 24.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.293 1.037 . . . . 0.0 109.503 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.15 124.96 29.68 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.3 m -135.99 161.92 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.212 1.005 . . . . 0.0 110.724 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -130.82 24.08 5.0 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.781 1.232 . . . . 0.0 108.884 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.3 m -55.98 -48.11 76.44 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.932 1.293 . . . . 0.0 113.705 -171.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 77.02 -50.33 0.55 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.953 1.701 . . . . 0.0 111.701 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -108.19 151.55 25.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.033 0.933 . . . . 0.0 109.301 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.442 ' CG1' HG11 ' A' ' 33' ' ' VAL . 87.6 t -66.43 -24.97 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 O-C-N 124.056 0.848 . . . . 0.0 110.754 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.63 -56.73 15.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.73 0.812 . . . . 0.0 110.512 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.12 -30.32 68.03 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.465 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.45 HD11 HD11 ' A' ' 5' ' ' ILE . 48.3 tp -64.49 -54.74 27.68 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.752 0.821 . . . . 0.0 110.703 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.438 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 97.6 mmm -64.78 -26.43 68.35 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.005 0.522 . . . . 0.0 111.527 -177.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.8 m -75.02 -38.49 61.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.66 0.784 . . . . 0.0 110.936 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.91 -45.13 93.93 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.752 HD13 HD11 ' A' ' 58' ' ' ILE . 48.1 mt -72.65 -12.27 60.97 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.569 1.147 . . . . 0.0 111.828 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 63.62 14.36 8.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.936 1.294 . . . . 0.0 111.626 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.2 m . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 124.886 1.274 . . . . 0.0 109.098 179.23 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 121.516 0.674 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.54 154.3 50.11 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.442 HG11 ' CG1' ' A' ' 17' ' ' VAL . 8.8 p -123.1 150.33 27.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.86 99.32 5.7 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.523 HD12 HG12 ' A' ' 56' ' ' ILE . 18.3 tp -90.08 121.12 31.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 67.73 23.04 8.73 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.635 1.174 . . . . 0.0 108.734 -170.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.474 ' CE2' ' HB3' ' A' ' 55' ' ' GLU . 59.3 m-85 68.96 3.96 4.28 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.848 1.659 . . . . 0.0 113.059 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -92.63 127.17 38.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.282 0.633 . . . . 0.0 109.39 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.9 t -66.27 114.27 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.748 0.819 . . . . 0.0 111.024 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.417 ' HB ' HG13 ' A' ' 33' ' ' VAL . 80.2 t -87.61 120.41 71.03 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.1 143.36 99.55 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.096 2.531 . . . . 0.0 110.739 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -57.8 -40.07 79.07 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.96 -24.19 62.47 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 123.803 0.689 . . . . 0.0 114.173 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -103.13 2.39 34.53 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.427 ' NE1' HG12 ' A' ' 33' ' ' VAL . 40.9 m0 -50.79 -41.93 57.5 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 118.13 0.423 . . . . 0.0 111.031 175.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.25 -49.42 60.76 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.578 0.751 . . . . 0.0 110.884 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.15 -26.02 67.24 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.826 0.85 . . . . 0.0 111.694 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.2 m -95.52 119.56 65.04 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.73 167.88 23.28 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.856 2.371 . . . . 0.0 113.504 176.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.6 t -104.29 145.76 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.609 1.163 . . . . 0.0 109.305 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.1 m -108.58 148.57 30.12 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.579 0.752 . . . . 0.0 109.683 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 1' ' ' MET . . . -65.67 115.34 5.74 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.735 0.814 . . . . 0.0 110.741 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.86 41.1 73.99 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 123.365 0.415 . . . . 0.0 112.551 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.95 149.03 28.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.084 0.554 . . . . 0.0 110.364 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 37' ' ' TYR . 2.9 mp0 -84.63 81.71 8.74 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 121.854 0.835 . . . . 0.0 109.586 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.523 HG12 HD12 ' A' ' 35' ' ' LEU . 32.4 mt -99.04 153.65 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.729 1.212 . . . . 0.0 109.637 -177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -151.17 125.01 9.12 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.469 0.708 . . . . 0.0 109.14 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.752 HD11 HD13 ' A' ' 24' ' ' LEU . 66.8 mt -80.37 105.36 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.4 mt . . . . . 0 C--O 1.221 -0.44 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.282 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtm . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.62 103.52 9.59 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.64 152.13 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.363 1.065 . . . . 0.0 109.118 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 38.9 m -86.37 106.44 17.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.156 0.582 . . . . 0.0 109.577 176.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 70.2 mt -100.22 106.2 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.986 0.515 . . . . 0.0 110.733 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 t30 66.5 23.61 10.44 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.709 1.204 . . . . 0.0 110.708 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.4 -15.58 62.58 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.354 -174.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -98.18 110.31 22.91 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.38 0.672 . . . . 0.0 109.314 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 18.5 mt-30 -71.94 114.5 10.11 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 120.786 0.326 . . . . 0.0 110.15 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.47 ' NH1' HG12 ' A' ' 12' ' ' VAL . 61.1 ttt-85 -131.23 143.87 50.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.419 1.088 . . . . 0.0 109.265 -176.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.3 137.98 35.74 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.47 HG12 ' NH1' ' A' ' 10' ' ' ARG . 33.1 m -114.81 152.94 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 122.841 0.456 . . . . 0.0 111.261 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.92 -38.43 11.7 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 168.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -66.44 120.05 12.69 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.938 0.895 . . . . 0.0 111.849 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.35 -0.88 52.24 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.787 0.835 . . . . 0.0 111.529 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.7 p -122.14 148.11 45.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.059 0.944 . . . . 0.0 109.093 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.6 t -68.61 -31.43 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 123.478 0.711 . . . . 0.0 111.486 -176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.34 -52.8 63.13 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.896 0.478 . . . . 0.0 110.88 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.63 -30.65 71.67 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.137 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.426 HD22 HG21 ' A' ' 50' ' ' VAL . 36.4 tp -71.16 -44.92 64.55 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 124.0 0.812 . . . . 0.0 111.483 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.8 mmm -70.03 -24.38 63.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.719 0.408 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -74.38 -43.01 58.27 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.764 0.426 . . . . 0.0 110.413 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.12 -37.87 86.76 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.719 1.208 . . . . 0.0 110.895 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.524 HD13 HD11 ' A' ' 58' ' ' ILE . 71.3 mt -88.65 -7.73 55.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.306 1.042 . . . . 0.0 111.367 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.5 t70 59.78 42.68 16.33 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.027 1.331 . . . . 0.0 110.933 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.471 0.615 0 C-N-CA 124.386 1.074 . . . . 0.0 110.769 176.505 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 121.425 0.631 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.02 -177.84 4.88 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.412 1.485 . . . . 0.0 108.226 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.449 HG12 ' NE1' ' A' ' 45' ' ' TRP . 7.9 p -149.8 159.61 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.567 ' HB3' ' HG3' ' A' ' 57' ' ' GLU . . . -133.15 109.86 9.76 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.013 0.525 . . . . 0.0 109.737 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.3 tp -88.59 113.02 23.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 59.48 36.44 23.03 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.154 0.982 . . . . 0.0 110.614 -172.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 72.0 13.18 5.97 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.061 1.344 . . . . 0.0 112.217 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -102.02 112.07 24.58 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.922 0.889 . . . . 0.0 109.247 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.4 t -62.93 111.03 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.557 0 O-C-N 123.921 0.763 . . . . 0.0 110.73 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -90.41 121.36 68.54 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.41 151.84 75.71 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.538 2.159 . . . . 0.0 111.053 173.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -58.24 -38.09 76.18 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.916 0.886 . . . . 0.0 113.053 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.67 3.55 25.83 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 114.567 0.587 . . . . 0.0 114.567 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -121.73 -9.96 8.8 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.882 0.873 . . . . 0.0 112.026 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.449 ' NE1' HG12 ' A' ' 33' ' ' VAL . 40.9 m0 -49.66 -39.69 37.12 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.124 0.57 . . . . 0.0 112.23 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -70.06 -43.07 71.96 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.772 0.829 . . . . 0.0 110.819 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -73.08 -14.59 61.43 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 112.303 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.6 m -100.45 120.37 56.38 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.478 0.711 . . . . 0.0 109.324 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -83.99 166.81 12.88 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.897 2.398 . . . . 0.0 113.278 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.426 HG21 HD22 ' A' ' 20' ' ' LEU . 58.6 t -123.6 129.22 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.019 1.328 . . . . 0.0 107.855 175.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.9 p -125.22 149.53 47.89 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.99 126.88 29.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.842 0.857 . . . . 0.0 111.4 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.56 -4.05 39.89 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 119.564 -0.576 . . . . 0.0 113.358 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -78.11 154.64 31.11 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 117.443 0.622 . . . . 0.0 111.366 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -110.09 90.91 3.45 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.778 0.831 . . . . 0.0 109.387 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 4.0 mp -88.13 97.45 6.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.567 ' HG3' ' HB3' ' A' ' 34' ' ' ALA . 8.2 pt-20 -99.1 125.44 44.63 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.69 0.757 . . . . 0.0 109.231 175.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.524 HD11 HD13 ' A' ' 24' ' ' LEU . 70.2 mt -84.74 126.22 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.453 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 C--N 1.328 -0.366 0 C-N-CA 123.687 0.795 . . . . 0.0 109.724 -177.859 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 47.3 tp -79.11 96.88 5.95 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 52' ' ' ALA . 26.8 m -109.92 139.03 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.41 1.084 . . . . 0.0 109.642 -175.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 8.7 m -84.5 99.66 10.86 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -176.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.47 HD13 HD11 ' A' ' 24' ' ' LEU . 65.9 mt -98.6 108.31 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.626 0.77 . . . . 0.0 109.707 -177.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.433 HD22 ' HB ' ' A' ' 58' ' ' ILE . 2.2 m-20 67.66 34.09 4.66 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.9 1.28 . . . . 0.0 110.899 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.53 10.16 84.64 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.441 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -125.68 110.99 14.43 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.502 1.121 . . . . 0.0 108.244 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 79.6 mt-30 -66.44 143.89 56.84 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -151.43 128.34 11.0 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.815 1.246 . . . . 0.0 108.595 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.83 116.32 22.1 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.67 155.78 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.286 1.035 . . . . 0.0 109.607 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -109.44 -12.6 14.7 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.846 0.859 . . . . 0.0 109.506 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.2 m -57.46 100.07 0.05 OUTLIER 'General case' 0 C--N 1.353 0.731 0 C-N-CA 124.651 1.18 . . . . 0.0 110.672 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.69 -13.98 60.0 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.631 0.773 . . . . 0.0 111.967 -177.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 t -114.42 142.01 46.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 109.46 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.499 HG11 HG11 ' A' ' 33' ' ' VAL . 94.9 t -69.65 -27.07 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.437 0.695 . . . . 0.0 110.435 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.32 -54.32 42.25 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.79 -31.7 71.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.186 0.594 . . . . 0.0 111.474 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.2 -51.97 46.89 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.491 0.716 . . . . 0.0 111.195 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.54 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 76.4 mtp -75.02 -18.8 60.29 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.782 0.433 . . . . 0.0 111.425 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -67.1 -45.23 77.87 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 166.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -67.1 -41.05 86.92 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.277 1.031 . . . . 0.0 111.613 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.47 HD11 HD13 ' A' ' 5' ' ' ILE . 80.9 mt -80.4 -11.55 59.68 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.835 0.854 . . . . 0.0 110.609 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.3 t70 62.81 35.14 13.94 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.138 1.375 . . . . 0.0 110.817 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.618 ' SG ' HD13 ' A' ' 58' ' ' ILE . 59.8 m . . . . . 0 CA--C 1.545 0.753 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.394 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 121.401 0.619 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HA ' ' HZ2' ' A' ' 45' ' ' TRP . . . -153.29 168.97 24.23 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.272 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.54 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 6.6 p -128.76 139.03 52.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 C-N-CA 124.057 0.943 . . . . 0.0 108.855 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 57' ' ' GLU . . . -108.08 104.19 13.57 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.0 tp -90.11 107.02 18.87 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 173.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.16 37.8 14.16 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.65 1.18 . . . . 0.0 110.42 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 71.98 11.85 6.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.084 1.754 . . . . 0.0 112.86 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.84 109.32 21.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 84.7 t -71.2 122.91 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.127 0.571 . . . . 0.0 109.937 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.47 126.97 48.2 Favored Pre-proline 0 C--O 1.246 0.917 0 C-N-CA 124.293 1.037 . . . . 0.0 109.322 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.81 145.69 59.92 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.087 2.525 . . . . 0.0 112.389 170.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -60.33 -42.19 95.13 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.843 0.857 . . . . 0.0 112.277 -173.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.15 11.7 11.33 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-N 116.317 -0.401 . . . . 0.0 113.14 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -126.32 -6.93 6.44 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.243 1.017 . . . . 0.0 110.611 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.403 ' HZ2' ' HA ' ' A' ' 32' ' ' ALA . 52.5 m0 -54.24 -33.74 59.11 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.19 0.596 . . . . 0.0 111.358 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -71.39 -39.58 71.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.983 0.913 . . . . 0.0 110.471 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.29 -17.9 63.1 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.083 0.953 . . . . 0.0 111.773 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 m -96.41 114.5 64.48 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.981 0.512 . . . . 0.0 109.84 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.74 155.85 53.66 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.214 1.943 . . . . 0.0 112.471 168.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.9 t -101.02 129.33 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -127.17 135.75 51.11 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.116 0.566 . . . . 0.0 109.831 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.417 ' HA ' HG12 ' A' ' 3' ' ' VAL . . . -58.49 133.69 56.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.657 1.183 . . . . 0.0 112.598 -176.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.41 -6.1 71.18 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.351 -0.694 . . . . 0.0 114.372 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.29 164.23 15.02 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 117.872 0.836 . . . . 0.0 112.108 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -97.05 108.57 21.33 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.666 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 73.8 mt -111.38 96.96 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.94 0.896 . . . . 0.0 109.535 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -91.33 145.37 24.7 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.427 0.691 . . . . 0.0 109.242 177.647 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.618 HD13 ' SG ' ' A' ' 26' ' ' CYS . 99.6 mt -120.81 114.51 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.312 0 C-N-CA 124.498 1.119 . . . . 0.0 108.641 -174.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 120.932 0.396 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' A' ' 9' ' ' GLN . 8.5 tt -85.55 114.57 22.66 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.408 HG23 HG13 ' A' ' 5' ' ' ILE . 9.7 m -132.8 139.46 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.246 1.018 . . . . 0.0 110.568 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.9 m -67.79 100.43 0.93 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 55.7 mt -104.19 104.57 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.44 0.696 . . . . 0.0 109.328 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 62.45 31.43 17.13 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 122.375 1.083 . . . . 0.0 110.28 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.44 -6.52 83.25 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 121.649 -0.657 . . . . 0.0 113.402 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -106.31 105.59 15.7 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.516 ' HB3' HD21 ' A' ' 2' ' ' LEU . 27.0 mt-30 -61.21 107.23 0.72 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.522 ' HB3' HD12 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -118.72 121.53 40.33 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -169.177 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -81.42 112.78 19.0 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.921 0.888 . . . . 0.0 109.031 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.77 169.65 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.59 1.156 . . . . 0.0 109.85 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -129.59 17.77 5.82 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.383 0.673 . . . . 0.0 110.847 175.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.0 p -94.96 108.65 20.71 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.336 0.654 . . . . 0.0 109.311 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 49' ' ' PRO . . . -82.79 -0.38 47.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.813 0.845 . . . . 0.0 112.035 178.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.0 t -110.34 135.62 50.78 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.153 0.981 . . . . 0.0 108.916 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.8 t -68.66 -26.69 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.153 0.581 . . . . 0.0 110.451 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.67 -55.2 18.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.086 0.554 . . . . 0.0 109.999 172.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.2 -30.1 69.15 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.65 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -69.11 -54.66 13.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.786 0.834 . . . . 0.0 110.867 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.58 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 78.8 mtp -70.04 -21.5 63.18 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.3 m -75.18 -37.89 61.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.638 0.375 . . . . 0.0 110.021 171.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.6 -40.92 98.45 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.854 0.861 . . . . 0.0 110.389 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.51 HD11 HD13 ' A' ' 5' ' ' ILE . 64.4 mt -86.89 -3.68 59.1 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.387 -176.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.49 19.67 10.52 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.245 1.418 . . . . 0.0 112.682 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.513 ' SG ' HG21 ' A' ' 58' ' ' ILE . 56.2 m . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 125.018 1.327 . . . . 0.0 111.237 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.995 0.426 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.71 159.67 40.92 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.46 1.104 . . . . 0.0 109.333 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.58 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 11.1 p -118.49 148.01 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.523 0.729 . . . . 0.0 110.103 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' A' ' 57' ' ' GLU . . . -129.55 102.53 6.42 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.625 0.77 . . . . 0.0 110.221 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.49 HD13 HG12 ' A' ' 56' ' ' ILE . 64.3 tp -89.67 123.07 33.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.0 m120 64.38 39.13 7.3 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.555 1.142 . . . . 0.0 111.079 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 66.48 21.31 10.82 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.456 1.502 . . . . 0.0 112.0 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -131.89 123.53 27.67 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.946 0.899 . . . . 0.0 108.66 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 59.4 t -66.12 126.27 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.302 0.641 . . . . 0.0 111.07 -176.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.413 ' HB ' HG13 ' A' ' 33' ' ' VAL . 61.2 t -88.7 125.93 61.41 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.057 0.943 . . . . 0.0 109.085 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.06 146.56 91.11 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.605 2.203 . . . . 0.0 112.031 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -59.78 -39.17 84.01 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.37 -14.64 57.56 Favored Glycine 0 CA--C 1.532 1.095 0 O-C-N 123.752 0.657 . . . . 0.0 113.051 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -104.74 -16.67 14.88 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 117.73 -1.129 . . . . 0.0 112.676 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -46.61 -42.82 16.75 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 118.994 0.815 . . . . 0.0 111.908 -176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -67.43 -42.72 82.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.566 1.146 . . . . 0.0 112.052 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -90.05 -2.98 58.2 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.917 0.487 . . . . 0.0 112.302 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.3 m -89.53 115.61 64.23 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 96.1 Cg_endo -76.82 153.99 33.76 Favored 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 122.364 2.043 . . . . 0.0 112.785 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.3 t -105.22 119.27 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.561 1.144 . . . . 0.0 108.754 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 p -120.63 148.2 44.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.85 0.86 . . . . 0.0 109.88 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.72 131.81 49.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.139 0.976 . . . . 0.0 112.478 -171.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.62 -0.54 82.97 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-O 119.287 -0.729 . . . . 0.0 114.92 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.46 155.37 24.65 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 117.657 0.728 . . . . 0.0 111.561 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -87.77 92.41 9.1 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.594 1.158 . . . . 0.0 109.177 -173.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 62.1 mt -97.83 97.49 6.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 45.0 mt-10 -93.08 116.77 29.35 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.513 HG21 ' SG ' ' A' ' 26' ' ' CYS . 45.8 mm -98.16 118.1 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 123.169 0.588 . . . . 0.0 109.977 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.431 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 21.3 ptp . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 57.9 tp -79.2 107.11 11.71 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.413 HG21 HD12 ' A' ' 56' ' ' ILE . 27.4 m -110.74 179.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.043 0.937 . . . . 0.0 108.879 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 25.2 m -116.43 110.52 18.75 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -106.76 114.14 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.247 0.619 . . . . 0.0 109.603 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 65.35 26.97 12.04 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.054 1.342 . . . . 0.0 111.645 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.37 3.74 74.86 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.121 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -122.9 114.85 21.01 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.21 1.004 . . . . 0.0 109.232 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.621 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 13.9 pt20 -67.73 130.03 41.73 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.058 0.456 . . . . 0.0 111.193 -178.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 42.6 ttm105 -150.59 141.94 23.32 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.2 1.0 . . . . 0.0 109.045 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -80.82 137.78 36.22 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -124.11 144.71 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.114 0.483 . . . . 0.0 110.187 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -93.28 -23.17 18.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.348 1.059 . . . . 0.0 108.984 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.1 p -76.73 110.15 11.09 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.786 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.49 26.14 2.39 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.752 0.821 . . . . 0.0 110.938 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 57.7 m -146.48 149.41 33.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.917 0.887 . . . . 0.0 109.703 173.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.03 -36.51 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.138 0.975 . . . . 0.0 111.998 -174.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.05 -54.33 39.83 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 120.759 0.314 . . . . 0.0 110.495 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.82 -31.68 69.95 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.442 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.408 HD21 HG21 ' A' ' 56' ' ' ILE . 60.4 tp -67.25 -53.31 31.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.843 0.857 . . . . 0.0 111.135 177.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.518 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 71.5 mtp -69.71 -23.37 63.41 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.155 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.4 m -76.0 -35.22 59.64 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.74 -32.31 70.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.288 0.635 . . . . 0.0 110.762 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.35 2.93 56.04 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.477 0.711 . . . . 0.0 111.963 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 65.14 21.69 12.19 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.646 1.178 . . . . 0.0 111.859 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.62 ' SG ' HG21 ' A' ' 58' ' ' ILE . 60.6 m . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 124.596 1.158 . . . . 0.0 110.628 -177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -124.9 171.92 9.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.981 0.912 . . . . 0.0 108.65 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.518 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.2 p -135.38 140.33 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -110.73 105.71 14.67 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 170.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.3 tp -92.68 115.37 28.05 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 57.83 37.78 27.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.947 1.299 . . . . 0.0 111.734 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 72.49 30.68 1.89 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.93 1.292 . . . . 0.0 112.193 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -137.38 128.77 28.14 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.718 0.807 . . . . 0.0 109.489 169.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.0 t -72.27 116.76 14.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 123.096 0.559 . . . . 0.0 110.842 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.404 ' HB ' HG13 ' A' ' 33' ' ' VAL . 33.7 t -86.79 120.65 71.86 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.82 155.63 68.03 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.656 2.237 . . . . 0.0 111.302 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -60.14 -32.29 70.88 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.951 0.901 . . . . 0.0 112.808 -173.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.27 -5.22 26.94 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 123.857 0.723 . . . . 0.0 114.502 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -109.06 -25.96 10.41 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.694 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -48.39 -45.69 36.15 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -167.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.49 -47.78 77.63 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.05 0.54 . . . . 0.0 110.371 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.55 -11.34 60.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.298 1.039 . . . . 0.0 112.345 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.6 m -101.6 112.4 65.13 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 98.0 Cg_endo -77.59 171.44 17.51 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.025 1.816 . . . . 0.0 113.081 175.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.3 t -119.32 130.64 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.112 1.365 . . . . 0.0 107.825 172.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.4 p -120.13 156.44 31.05 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.82 0.848 . . . . 0.0 108.932 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -56.21 135.57 53.27 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.593 0.757 . . . . 0.0 111.69 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.15 -16.59 58.06 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.689 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -60.37 127.8 33.56 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.681 0.741 . . . . 0.0 111.991 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -79.82 86.57 5.36 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 3' ' ' VAL . 55.6 mt -89.52 149.73 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.721 1.208 . . . . 0.0 108.878 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 35.2 tt0 -147.33 137.15 22.98 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.62 HG21 ' SG ' ' A' ' 26' ' ' CYS . 36.9 mm -103.31 111.0 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 57.6 mt . . . . . 0 C--O 1.238 0.451 0 C-N-CA 123.747 0.819 . . . . 0.0 110.404 172.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.408 ' HG2' HG13 ' A' ' 3' ' ' VAL . 1.5 pmm? . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 111.23 0.085 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 9' ' ' GLN . 7.7 tt -82.06 113.46 19.95 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.408 HG13 ' HG2' ' A' ' 1' ' ' MET . 27.5 m -109.07 -179.68 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.098 1.359 . . . . 0.0 110.539 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.0 m -129.23 101.97 6.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.202 0.601 . . . . 0.0 109.719 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.9 mt -103.4 120.38 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.609 0.764 . . . . 0.0 109.177 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.62 30.42 18.59 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.917 1.287 . . . . 0.0 112.141 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.07 -1.66 88.68 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.595 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -113.5 132.29 55.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.436 1.094 . . . . 0.0 108.293 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.591 ' HB3' HD21 ' A' ' 2' ' ' LEU . 1.5 mp0 -80.11 121.98 26.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.209 0.604 . . . . 0.0 111.038 -175.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -128.2 145.96 50.87 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.418 1.087 . . . . 0.0 108.138 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 39.9 tt0 -93.12 117.5 30.14 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 173.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -113.61 174.19 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.742 0.817 . . . . 0.0 109.999 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -149.89 18.16 0.89 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.003 0.921 . . . . 0.0 109.642 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.8 m -64.17 -31.54 72.77 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.086 0.954 . . . . 0.0 112.644 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 75.79 -46.69 0.56 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.605 1.562 . . . . 0.0 112.427 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.6 t -103.52 146.92 27.82 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.124 0.97 . . . . 0.0 109.914 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 33' ' ' VAL . 89.6 t -69.03 -30.67 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 123.618 0.767 . . . . 0.0 110.723 175.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.3 -55.81 21.69 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.931 0.492 . . . . 0.0 110.098 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.45 65.28 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 124.341 1.026 . . . . 0.0 111.506 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.73 -59.86 3.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.786 0.834 . . . . 0.0 111.34 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.467 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 81.2 mtp -70.7 -21.35 62.58 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.816 0.446 . . . . 0.0 111.651 -174.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 m -70.01 -43.9 70.43 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.152 0.581 . . . . 0.0 110.122 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -73.63 -31.82 63.72 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.002 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.76 -10.89 59.84 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.532 0.733 . . . . 0.0 110.882 175.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 62.83 33.18 15.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.544 1.138 . . . . 0.0 111.404 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.1 m . . . . . 0 N--CA 1.477 0.878 0 C-N-CA 125.276 1.43 . . . . 0.0 110.001 179.968 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.77 -179.38 3.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.466 0.706 . . . . 0.0 109.525 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.467 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.1 p -140.54 146.14 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.053 0.541 . . . . 0.0 109.666 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -117.51 98.99 6.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.3 tp -90.97 118.86 30.69 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 56.62 33.25 22.43 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.904 0.882 . . . . 0.0 111.465 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 68.97 15.3 8.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.036 1.334 . . . . 0.0 112.185 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -109.24 115.81 30.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 40.7 t -77.17 121.0 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.139 0.576 . . . . 0.0 109.988 -175.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.42 129.54 25.87 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.514 0.725 . . . . 0.0 109.599 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.72 160.07 28.0 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.942 2.428 . . . . 0.0 112.009 174.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -52.87 -43.47 66.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.689 0.795 . . . . 0.0 112.179 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.37 -21.58 48.58 Favored Glycine 0 C--N 1.345 1.065 0 O-C-N 123.81 0.694 . . . . 0.0 114.237 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -103.75 -22.27 13.57 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.357 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -46.64 -42.21 15.93 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 123.623 0.769 . . . . 0.0 112.641 -174.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -61.13 -49.53 76.9 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.971 0.908 . . . . 0.0 111.335 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -77.82 -15.22 59.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.809 0.844 . . . . 0.0 111.923 -176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.5 m -91.18 117.63 67.99 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -83.84 158.3 13.85 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.784 2.323 . . . . 0.0 112.948 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.59 135.93 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.192 0.997 . . . . 0.0 108.311 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.4 m -121.05 147.62 45.27 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.725 0.81 . . . . 0.0 111.232 -168.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.54 114.01 3.66 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.219 0.608 . . . . 0.0 111.334 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.2 32.75 34.39 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 113.137 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.9 p30 -81.24 175.37 10.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.838 0.455 . . . . 0.0 110.891 174.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.06 82.91 1.78 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.629 0.372 . . . . 0.0 110.447 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 75.2 mt -84.82 141.31 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.629 0.772 . . . . 0.0 109.166 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 42.0 tt0 -141.53 112.2 7.12 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.5 mm -77.22 105.44 6.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 CA--C 1.533 0.303 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.206 178.114 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' HG12 ' A' ' 50' ' ' VAL . 17.7 ptp . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 120.973 0.416 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.6 tp -80.05 97.35 6.78 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.01 0.924 . . . . 0.0 108.557 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.7 m -110.84 145.66 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.944 0.897 . . . . 0.0 109.821 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 6.8 m -83.77 99.44 10.28 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 58.6 mt -95.76 108.53 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 60.73 36.07 19.47 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.739 1.215 . . . . 0.0 111.238 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.54 -3.89 86.65 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.519 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -118.04 110.95 18.28 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.055 0.942 . . . . 0.0 108.743 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.544 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 94.5 mt-30 -66.03 118.74 10.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.267 0.627 . . . . 0.0 110.845 -178.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -121.91 139.98 52.98 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.472 1.509 . . . . 0.0 108.768 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -81.87 125.18 30.41 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.81 155.25 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.816 0.847 . . . . 0.0 110.55 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -91.52 -25.64 19.16 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.182 0.593 . . . . 0.0 110.957 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.0 m -70.98 114.99 9.59 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.181 0.592 . . . . 0.0 111.918 -175.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.89 13.04 26.1 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.328 1.051 . . . . 0.0 111.439 173.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.8 t -128.44 138.1 52.15 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.983 1.313 . . . . 0.0 108.403 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 33' ' ' VAL . 76.1 t -68.06 -34.16 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 123.722 0.639 . . . . 0.0 110.839 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.48 -56.68 18.95 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.01 0.524 . . . . 0.0 110.394 174.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.36 75.32 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 124.211 0.944 . . . . 0.0 111.491 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.9 tp -64.32 -55.64 19.9 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 123.732 0.645 . . . . 0.0 110.074 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.541 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 72.0 mtp -69.52 -25.84 64.23 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 122.679 0.392 . . . . 0.0 111.098 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -67.35 -39.57 85.78 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 117.938 0.336 . . . . 0.0 110.549 172.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -69.02 -39.14 79.44 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.081 0.953 . . . . 0.0 110.599 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 81.8 mt -86.93 5.89 34.81 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.067 0.947 . . . . 0.0 111.987 -175.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.3 t70 58.29 44.41 18.68 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.757 1.265 . . . . 0.0 110.868 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 CA--C 1.548 0.873 0 C-N-CA 125.473 1.509 . . . . 0.0 110.473 179.22 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 121.246 0.546 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.71 170.85 15.2 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.456 1.103 . . . . 0.0 108.485 173.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.541 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 9.1 p -130.08 151.71 36.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -125.25 100.42 6.52 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 174.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.2 tp -88.86 108.8 19.73 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 55' ' ' GLU . 50.2 m-20 54.71 47.43 22.51 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.607 1.163 . . . . 0.0 110.034 -173.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 73.44 -9.88 1.12 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.48 1.512 . . . . 0.0 113.252 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -84.22 116.59 23.03 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.9 t -73.76 117.55 17.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 122.925 0.49 . . . . 0.0 110.1 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.4 t -102.04 119.77 55.74 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.079 0.952 . . . . 0.0 108.627 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.53 165.83 29.76 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.105 2.537 . . . . 0.0 112.345 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -53.07 -41.53 64.96 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.818 1.247 . . . . 0.0 113.38 -173.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.67 -21.05 60.15 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 123.853 0.721 . . . . 0.0 113.934 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -109.42 -7.6 15.17 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.01 -0.995 . . . . 0.0 112.088 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -52.27 -40.88 62.32 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.073 0.851 . . . . 0.0 110.616 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.69 -41.39 98.14 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.755 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -84.18 -11.06 57.18 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.375 1.07 . . . . 0.0 112.529 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.8 m -102.36 112.45 65.52 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -76.33 173.86 13.78 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.409 2.072 . . . . 0.0 112.615 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.565 HG12 ' SD ' ' A' ' 1' ' ' MET . 86.4 t -124.69 143.73 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.918 1.287 . . . . 0.0 108.643 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.5 m -142.62 149.39 38.9 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.866 0.866 . . . . 0.0 109.804 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.14 126.58 26.68 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.576 0.75 . . . . 0.0 111.135 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.54 -22.07 17.95 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 119.011 -0.883 . . . . 0.0 114.259 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -69.13 141.92 54.53 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.024 0.912 . . . . 0.0 112.518 -173.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 36' ' ' ASN . 9.9 mp0 -80.52 80.53 6.96 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.751 1.22 . . . . 0.0 109.353 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 63.1 mt -91.03 96.36 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 39.5 tt0 -98.65 106.43 18.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.038 0.935 . . . . 0.0 108.669 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.56 105.06 5.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.235 0.328 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.217 179.92 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.669 -0.123 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 5.0 tt -83.0 122.64 28.57 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.01 145.25 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.098 0.959 . . . . 0.0 110.42 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 18.4 m -78.69 102.1 7.86 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.033 0.533 . . . . 0.0 110.088 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 24.1 mt -101.35 105.61 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.061 0.544 . . . . 0.0 109.947 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 60.41 41.82 15.51 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.514 1.126 . . . . 0.0 110.708 173.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.39 -18.35 57.15 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 114.595 -1.184 . . . . 0.0 114.027 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -108.79 116.39 31.89 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.626 0.77 . . . . 0.0 110.093 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 48.1 mt-30 -70.89 131.49 43.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.857 0.463 . . . . 0.0 109.782 174.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.527 ' NH2' HD21 ' A' ' 24' ' ' LEU . 65.1 ttp85 -152.87 142.9 22.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.34 0.656 . . . . 0.0 109.727 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 38.5 tt0 -83.66 127.05 33.48 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.4 m -120.14 164.15 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.046 0.938 . . . . 0.0 111.069 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -102.89 -1.72 29.09 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.668 1.187 . . . . 0.0 109.744 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.1 m -67.07 99.37 0.65 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 124.304 1.042 . . . . 0.0 111.003 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.69 -14.51 58.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.115 0.566 . . . . 0.0 110.822 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 44.2 t -127.57 154.35 45.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.102 0.961 . . . . 0.0 109.753 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.446 ' O ' ' HG2' ' A' ' 21' ' ' MET . 95.2 t -65.7 -38.56 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.661 0.785 . . . . 0.0 110.774 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.51 95.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.473 0.309 . . . . 0.0 110.882 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.04 80.21 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.708 0.803 . . . . 0.0 111.318 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.476 HD11 HD13 ' A' ' 5' ' ' ILE . 28.1 tp -64.98 -45.94 83.55 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.84 0.713 . . . . 0.0 111.358 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 83.0 mmm -68.17 -24.86 65.02 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.726 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.0 m -74.95 -45.37 42.76 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.935 0.494 . . . . 0.0 110.721 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -57.69 -47.48 82.22 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.805 0.842 . . . . 0.0 110.675 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.527 HD21 ' NH2' ' A' ' 10' ' ' ARG . 80.8 mt -84.47 1.47 45.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.246 -175.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 61.73 20.44 11.37 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.574 1.15 . . . . 0.0 111.119 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.481 ' SG ' HG21 ' A' ' 58' ' ' ILE . 36.1 t . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 124.833 1.253 . . . . 0.0 111.321 -170.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 121.53 0.681 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.83 173.26 12.01 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.464 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG12 ' NE1' ' A' ' 45' ' ' TRP . 14.8 p -139.86 140.48 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.05 0.54 . . . . 0.0 109.834 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.99 100.33 7.48 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.151 0.98 . . . . 0.0 108.52 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 tp -92.56 113.81 26.19 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 64.29 37.14 8.77 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.365 1.041 . . . . 0.0 110.374 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 79.26 -17.04 0.62 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 126.584 1.954 . . . . 0.0 112.741 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -96.52 119.83 35.72 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -171.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 p -67.36 126.54 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.316 0.579 . . . . 0.0 110.756 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.44 119.35 65.48 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.43 156.25 42.39 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.394 2.063 . . . . 0.0 112.485 174.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -60.87 -39.27 88.54 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.089 0.555 . . . . 0.0 111.702 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.89 -19.97 59.38 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 123.72 0.638 . . . . 0.0 113.035 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -99.53 -20.16 16.54 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 117.83 -1.081 . . . . 0.0 111.593 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.425 ' NE1' HG12 ' A' ' 33' ' ' VAL . 39.4 m0 -49.73 -47.3 50.78 Favored 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 119.399 0.999 . . . . 0.0 110.999 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.98 -45.26 78.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.889 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -72.09 -15.16 62.0 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.488 1.115 . . . . 0.0 112.577 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 m -104.52 129.33 25.2 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.369 0.668 . . . . 0.0 110.28 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 54.0 Cg_endo -84.58 174.77 7.51 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.698 2.266 . . . . 0.0 113.267 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.451 HG13 HD11 ' A' ' 56' ' ' ILE . 67.3 t -117.89 126.65 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.603 1.161 . . . . 0.0 108.766 173.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -108.91 145.11 35.91 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.384 1.074 . . . . 0.0 109.027 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.14 118.29 5.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.304 0.642 . . . . 0.0 111.388 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.87 -2.0 31.83 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.53 -0.595 . . . . 0.0 114.055 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.38 131.27 44.54 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.534 0.667 . . . . 0.0 112.156 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -84.77 92.56 8.25 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 39.4 mt -100.33 95.86 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.417 1.087 . . . . 0.0 108.676 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.75 120.3 37.89 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.71 -0.619 . . . . 0.0 110.086 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.481 HG21 ' SG ' ' A' ' 26' ' ' CYS . 76.6 mt -76.32 121.98 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.4 mt . . . . . 0 C--O 1.219 -0.532 0 C-N-CA 123.604 0.762 . . . . 0.0 109.753 177.633 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' HG12 ' A' ' 50' ' ' VAL . 49.5 ttm . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.2 tp -79.62 105.14 10.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.52 0.728 . . . . 0.0 109.51 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.0 m -125.32 139.39 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.294 1.038 . . . . 0.0 109.664 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.5 m -77.03 99.58 5.36 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.524 HD12 ' HD3' ' A' ' 10' ' ' ARG . 50.5 mt -97.55 114.27 34.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 123.148 0.579 . . . . 0.0 109.643 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 55.3 t30 59.87 35.57 21.85 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.671 1.588 . . . . 0.0 111.434 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.39 -3.36 83.85 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.978 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -109.37 130.98 55.48 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 117.464 0.632 . . . . 0.0 110.469 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -69.98 103.02 2.14 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 174.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.524 ' HD3' HD12 ' A' ' 5' ' ' ILE . 53.1 ttt180 -122.17 122.54 39.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.703 0.801 . . . . 0.0 110.113 -173.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -88.43 104.62 16.96 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.48 160.59 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.72 0.808 . . . . 0.0 109.94 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -105.44 -1.35 25.06 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.311 0.644 . . . . 0.0 111.011 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.2 p -77.18 117.28 18.56 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.829 0.852 . . . . 0.0 110.744 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.61 1.73 56.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.954 0.901 . . . . 0.0 111.73 174.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -125.65 142.98 51.23 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.366 1.066 . . . . 0.0 109.58 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.56 -28.23 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.236 0.614 . . . . 0.0 110.39 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.67 -54.41 39.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.759 0.424 . . . . 0.0 110.303 172.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.54 64.77 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.911 0.757 . . . . 0.0 111.679 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.02 -58.93 6.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 172.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.546 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 95.7 mmm -63.43 -32.62 74.12 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.106 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.2 m -66.62 -44.84 80.96 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.057 0.543 . . . . 0.0 110.059 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.95 -31.09 68.64 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.966 0.906 . . . . 0.0 110.382 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.6 mt -91.89 -0.69 57.51 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.754 0.822 . . . . 0.0 111.127 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 63.97 38.81 8.47 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.098 1.359 . . . . 0.0 112.942 171.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 CA--C 1.553 1.091 0 C-N-CA 125.118 1.367 . . . . 0.0 110.832 178.174 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 121.162 0.506 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -127.01 167.31 16.08 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.225 1.01 . . . . 0.0 109.111 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.546 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 8.5 p -133.06 148.21 31.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.41 109.37 11.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.988 0.423 . . . . 0.0 109.916 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.9 tp -88.11 109.28 19.76 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 60.57 51.25 5.2 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 124.755 1.284 . . . . 0.0 110.62 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 72.02 6.74 5.66 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 125.374 1.47 . . . . 0.0 113.671 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -124.5 127.28 47.22 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.129 0.572 . . . . 0.0 109.926 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 p -64.49 135.15 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 124.191 0.932 . . . . 0.0 111.687 -175.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.13 122.48 57.94 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.92 152.61 63.1 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.393 2.062 . . . . 0.0 112.607 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -54.16 -52.53 60.86 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.423 1.089 . . . . 0.0 113.056 -170.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.59 -9.5 61.97 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 116.412 -0.358 . . . . 0.0 113.266 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HD2' ' HB2' ' A' ' 47' ' ' GLU . 54.8 tptt -96.54 -15.44 21.63 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.23 1.012 . . . . 0.0 110.057 -177.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -52.91 -44.41 66.94 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.176 0.591 . . . . 0.0 111.191 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.46 -38.18 80.86 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.002 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HB2' ' HD2' ' A' ' 44' ' ' LYS . 32.8 mt-10 -75.41 -21.41 58.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.796 0.838 . . . . 0.0 112.09 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.0 m -100.3 117.89 62.25 Favored Pre-proline 0 N--CA 1.47 0.544 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.93 165.98 27.56 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.079 1.853 . . . . 0.0 112.604 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' SD ' ' A' ' 1' ' ' MET . 61.7 t -99.79 141.21 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 167.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.9 m -134.44 139.72 45.73 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.09 144.24 56.82 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.692 0.797 . . . . 0.0 111.088 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 -10.98 71.3 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.554 -0.581 . . . . 0.0 112.893 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -87.13 162.45 17.52 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.364 0.602 . . . . 0.0 110.788 174.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -121.06 99.36 6.45 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.835 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 55.8 mt -103.24 153.51 5.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 C-N-CA 124.711 1.204 . . . . 0.0 109.154 -176.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -146.62 139.28 25.18 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 119.26 0.936 . . . . 0.0 109.441 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.1 mt -85.07 121.04 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 84.7 mt . . . . . 0 C--N 1.328 -0.353 0 C-N-CA 123.906 0.883 . . . . 0.0 109.448 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptp . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.5 tp -80.54 100.7 8.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.626 0.77 . . . . 0.0 108.972 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.412 HG11 HG12 ' A' ' 50' ' ' VAL . 17.3 m -123.02 137.33 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.565 0.746 . . . . 0.0 110.515 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 26.5 m -73.44 97.26 2.51 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.455 0.702 . . . . 0.0 109.623 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 62.8 mt -95.17 108.21 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.112 0.565 . . . . 0.0 109.629 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 62.85 28.73 16.51 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.244 1.018 . . . . 0.0 111.277 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.56 -6.53 65.31 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 113.84 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -105.47 113.02 26.35 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.712 0.805 . . . . 0.0 109.626 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 47.7 mt-30 -64.78 103.11 0.66 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 173.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -118.7 127.75 53.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.356 1.062 . . . . 0.0 109.795 -170.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -86.08 102.63 14.01 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.876 1.27 . . . . 0.0 109.415 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -105.36 168.9 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.899 0.88 . . . . 0.0 111.064 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -110.57 -4.52 15.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.577 0.751 . . . . 0.0 111.776 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -91.71 129.99 37.58 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.581 0.753 . . . . 0.0 111.88 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.46 -6.25 37.7 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.334 1.053 . . . . 0.0 112.557 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 42.5 t -123.52 147.29 47.38 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.108 0.963 . . . . 0.0 109.173 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.3 -34.67 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.145 0.978 . . . . 0.0 111.269 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.73 -52.04 67.1 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 -29.16 69.19 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.9 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.42 -52.89 22.59 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.84 0.856 . . . . 0.0 110.32 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 91.2 mmm -62.94 -34.44 77.47 Favored 'General case' 0 CA--C 1.554 1.1 0 O-C-N 123.72 0.637 . . . . 0.0 109.979 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -70.9 -36.08 72.58 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.238 0.615 . . . . 0.0 110.895 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.73 -35.11 76.71 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.073 0.949 . . . . 0.0 110.433 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.532 HD11 HD13 ' A' ' 5' ' ' ILE . 76.9 mt -93.32 -0.81 56.53 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.885 0.874 . . . . 0.0 112.006 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.3 t70 69.74 15.03 8.09 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.079 0.952 . . . . 0.0 112.189 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.418 ' SG ' HD13 ' A' ' 58' ' ' ILE . 27.6 m -92.48 38.17 1.01 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.331 1.052 . . . . 0.0 111.902 -176.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.1 p -108.38 -8.27 15.66 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -113.22 -173.81 2.33 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.078 0.551 . . . . 0.0 110.72 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.83 -103.67 0.35 Allowed Glycine 0 C--N 1.355 1.615 0 O-C-N 123.507 0.504 . . . . 0.0 112.467 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -154.78 86.1 1.12 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.729 0.775 . . . . 0.0 109.596 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -118.3 158.67 24.77 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 171.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.17 160.86 40.79 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.024 1.33 . . . . 0.0 108.491 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.579 HG23 HG23 ' A' ' 56' ' ' ILE . 7.7 p -115.56 136.69 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.291 0.637 . . . . 0.0 109.493 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -118.24 99.89 7.15 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.1 tp -88.98 107.64 19.14 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 m120 62.3 38.74 13.01 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.114 0.966 . . . . 0.0 110.11 -172.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 72.89 -5.86 1.81 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 125.407 1.483 . . . . 0.0 112.463 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -92.02 111.37 22.88 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -67.65 122.85 19.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 O-C-N 123.516 0.51 . . . . 0.0 111.033 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.445 ' HB ' HG13 ' A' ' 33' ' ' VAL . 60.9 t -90.66 119.23 69.05 Favored Pre-proline 0 C--O 1.247 0.939 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.85 144.93 64.35 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.576 2.184 . . . . 0.0 111.178 171.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -31.33 65.39 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.943 0.777 . . . . 0.0 112.7 -175.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.39 -2.36 41.48 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-O 119.384 -0.675 . . . . 0.0 114.11 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -119.16 -3.64 10.58 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.102 0.961 . . . . 0.0 112.228 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -55.0 -41.03 70.77 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.227 0.611 . . . . 0.0 112.239 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.01 -35.16 66.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.356 0.662 . . . . 0.0 110.817 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.55 -26.64 64.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.732 0.813 . . . . 0.0 111.488 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.3 m -97.0 117.58 65.67 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 84.7 Cg_endo -81.58 161.87 19.3 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.388 2.059 . . . . 0.0 111.783 168.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.412 HG12 HG11 ' A' ' 3' ' ' VAL . 13.7 t -90.29 147.15 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 p -124.09 133.74 53.54 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.736 0.814 . . . . 0.0 109.593 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.15 127.49 32.41 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.703 0.801 . . . . 0.0 111.985 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.83 7.64 74.29 Favored Glycine 0 N--CA 1.472 1.073 0 O-C-N 123.798 0.686 . . . . 0.0 113.637 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.21 167.32 16.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.429 0.691 . . . . 0.0 109.559 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -114.98 101.55 9.12 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.184 0.593 . . . . 0.0 109.939 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.579 HG23 HG23 ' A' ' 33' ' ' VAL . 2.7 mp -97.88 97.83 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 124.37 1.068 . . . . 0.0 108.919 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 41.9 tt0 -91.43 108.92 20.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.328 0.651 . . . . 0.0 109.467 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.418 HD13 ' SG ' ' A' ' 26' ' ' CYS . 68.9 mt -78.13 109.72 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.1 mt -89.93 142.99 27.17 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.198 0.599 . . . . 0.0 110.969 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.7 p -107.65 85.44 2.36 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.39 132.25 42.67 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.988 2.459 . . . . 0.0 113.039 -169.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -74.43 98.12 3.22 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.396 1.078 . . . . 0.0 109.163 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.81 21.13 5.47 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.244 1.018 . . . . 0.0 110.973 -176.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.86 -61.6 5.14 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.64 43.08 3.08 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 112.294 -0.323 . . . . 0.0 112.294 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 tt -113.18 119.66 38.55 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -52.06 -33.13 37.7 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.565 1.146 . . . . 0.0 113.739 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -71.57 -14.5 62.11 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.627 0.771 . . . . 0.0 111.428 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -49.27 -30.52 7.38 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 124.296 1.039 . . . . 0.0 112.014 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -160.74 118.13 2.42 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -134.83 118.38 16.93 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -59.61 131.6 51.41 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.043 0.537 . . . . 0.0 109.681 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 . . . . . 0 CA--C 1.57 1.725 0 O-C-N 124.539 1.149 . . . . 0.0 110.218 -175.118 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 120.842 0.353 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 47.1 tp -79.02 113.44 17.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.606 0.763 . . . . 0.0 109.345 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.04 179.64 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.206 1.002 . . . . 0.0 109.236 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 25.2 m -120.64 101.66 7.89 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 118.775 0.716 . . . . 0.0 110.092 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.56 HD13 HD11 ' A' ' 24' ' ' LEU . 71.5 mt -95.71 117.2 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 123.624 0.769 . . . . 0.0 109.887 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 61.74 22.07 12.69 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.894 1.278 . . . . 0.0 112.567 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.84 1.49 65.5 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-O 120.072 -0.293 . . . . 0.0 113.713 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.78 126.71 50.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.696 0.798 . . . . 0.0 109.8 172.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 42.9 mt-30 -69.84 135.79 50.0 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.971 0.415 . . . . 0.0 111.354 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -146.95 136.4 22.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.402 1.081 . . . . 0.0 108.519 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 45.4 tt0 -81.5 123.0 28.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.468 0.707 . . . . 0.0 109.442 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.92 160.01 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.931 0.892 . . . . 0.0 109.324 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.55 -2.3 9.98 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.713 0.405 . . . . 0.0 111.006 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.5 p -66.21 107.97 2.13 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.604 0.762 . . . . 0.0 110.252 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.26 60.2 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.676 0.79 . . . . 0.0 112.874 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.6 p -112.03 150.03 31.21 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 33' ' ' VAL . 72.7 t -67.61 -33.4 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.247 0.619 . . . . 0.0 110.368 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.42 -46.18 90.95 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.973 0.509 . . . . 0.0 110.84 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -59.14 -44.31 92.07 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 124.167 0.917 . . . . 0.0 110.525 177.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.8 tp -63.94 -44.45 92.82 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.935 0.772 . . . . 0.0 111.674 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 95.0 mmm -63.31 -28.04 69.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.851 0.46 . . . . 0.0 110.598 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -74.56 -39.07 62.52 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.188 0.595 . . . . 0.0 111.496 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 10.6 mm-40 -63.84 -38.86 92.68 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.503 0.668 . . . . 0.0 110.36 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 5' ' ' ILE . 79.4 mt -91.32 -1.87 57.53 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.598 -176.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.19 28.86 14.05 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.829 1.252 . . . . 0.0 113.179 171.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.6 m -115.27 21.25 14.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.47 1.108 . . . . 0.0 110.726 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 t -84.67 62.62 7.46 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 122.531 1.157 . . . . 0.0 110.493 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HB3' ' HD1' ' A' ' 31' ' ' TYR . 19.4 t70 -139.91 158.43 44.1 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.715 -174.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.12 -24.06 76.8 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 114.428 0.531 . . . . 0.0 114.428 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -71.13 -25.37 62.55 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.602 0.361 . . . . 0.0 110.027 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.521 ' HD1' ' HB3' ' A' ' 28' ' ' ASP . 90.2 m-85 -92.09 158.72 16.05 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.756 0.789 . . . . 0.0 110.392 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -133.45 -176.39 4.13 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.937 168.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 17' ' ' VAL . 8.5 p -146.56 158.25 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.52 110.3 10.39 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.193 0.597 . . . . 0.0 110.529 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.9 tp -89.31 109.27 20.18 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.1 m120 52.28 65.86 1.38 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.958 1.303 . . . . 0.0 111.866 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 68.43 1.16 2.82 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 124.941 1.296 . . . . 0.0 112.696 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -119.35 116.64 26.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.002 0.921 . . . . 0.0 109.532 -171.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.62 119.87 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 123.764 0.665 . . . . 0.0 111.06 -174.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 48' ' ' THR . 91.8 t -92.52 124.16 59.93 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.064 0.946 . . . . 0.0 108.813 176.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.95 154.7 66.72 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.364 2.043 . . . . 0.0 111.412 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -56.11 -41.38 75.17 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.298 1.039 . . . . 0.0 112.473 -171.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.63 14.17 5.89 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 114.361 0.504 . . . . 0.0 114.361 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -17.48 6.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.092 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.431 ' NE1' HG12 ' A' ' 33' ' ' VAL . 50.3 m0 -46.34 -41.86 14.0 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 123.902 0.751 . . . . 0.0 112.492 -175.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.54 -48.5 77.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.547 1.139 . . . . 0.0 111.327 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.52 -0.48 57.27 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.849 0.86 . . . . 0.0 112.253 -175.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.403 HG21 HG21 ' A' ' 40' ' ' VAL . 91.7 m -96.89 120.85 60.84 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.66 146.74 9.48 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.298 1.999 . . . . 0.0 113.636 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.9 t -86.87 130.49 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 109.071 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 54' ' ' ASP . 10.6 m -103.99 146.99 27.89 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.767 0.827 . . . . 0.0 110.043 -173.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.97 116.73 8.95 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.321 0.648 . . . . 0.0 110.973 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.91 33.73 49.85 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.612 0.57 . . . . 0.0 112.659 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.538 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 27.8 p30 -83.87 -165.27 1.08 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.686 0.394 . . . . 0.0 110.779 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -134.85 94.66 3.2 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 37.5 mt -95.04 100.63 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.519 0.727 . . . . 0.0 109.977 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.26 114.1 25.85 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.701 0.801 . . . . 0.0 109.316 177.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.1 mt -77.65 129.85 36.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 90.4 mt -104.93 147.43 27.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.116 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.7 t -141.75 75.72 21.18 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.55 117.75 4.88 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.272 1.981 . . . . 0.0 111.168 -172.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 -57.28 -41.91 80.66 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.222 0.609 . . . . 0.0 109.999 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -71.38 86.49 0.83 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.176 171.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.93 63.63 0.28 Allowed Glycine 0 N--CA 1.474 1.217 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.79 -168.82 40.92 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.2 mt 51.39 54.88 10.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.483 1.113 . . . . 0.0 110.843 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -87.5 63.85 7.84 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.336 -172.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -73.61 -44.77 56.23 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.14 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -108.82 80.38 1.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 168.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -70.67 96.31 1.2 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.416 0.627 . . . . 0.0 109.864 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -77.15 106.11 8.66 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.218 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -94.65 142.05 27.9 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 174.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 174.344 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.479 0.181 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 9' ' ' GLN . 40.6 tp -86.59 127.42 34.91 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.52 0.728 . . . . 0.0 109.464 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.73 138.02 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.528 1.131 . . . . 0.0 109.267 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 28.4 m -78.33 97.71 5.69 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.174 0.443 . . . . 0.0 109.861 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.403 HG12 ' HB ' ' A' ' 56' ' ' ILE . 55.8 mt -94.22 104.25 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 67.0 t30 62.04 36.2 15.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.63 1.172 . . . . 0.0 111.145 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.94 10.83 82.4 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.517 -0.765 . . . . 0.0 113.496 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -130.19 108.88 10.38 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.869 0.867 . . . . 0.0 108.98 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.549 ' HB3' HD11 ' A' ' 2' ' ' LEU . 98.3 mt-30 -64.92 119.77 11.33 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.539 0.736 . . . . 0.0 110.457 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -126.59 158.11 37.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.844 0.858 . . . . 0.0 110.327 -177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -97.59 113.79 25.58 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.172 0.989 . . . . 0.0 109.741 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.6 m -120.16 147.25 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.832 0.853 . . . . 0.0 110.85 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -119.01 22.2 12.02 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.74 0.781 . . . . 0.0 109.389 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 p -75.97 -49.84 16.56 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.91 1.284 . . . . 0.0 112.418 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 67.21 0.4 2.05 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.676 1.19 . . . . 0.0 113.669 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 39.7 m -154.33 153.6 31.93 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.132 1.373 . . . . 0.0 109.106 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.45 ' CG1' HG11 ' A' ' 33' ' ' VAL . 58.3 t -69.95 -34.36 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 O-C-N 124.297 0.998 . . . . 0.0 112.506 -172.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.23 -53.24 39.48 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 -33.15 70.37 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.137 0.898 . . . . 0.0 111.238 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.653 HD21 HG21 ' A' ' 56' ' ' ILE . 42.0 tp -61.54 -59.88 4.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.194 1.398 . . . . 0.0 111.817 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.522 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 60.6 mtp -73.63 -19.92 60.72 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.477 0.485 . . . . 0.0 111.256 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.1 m -70.97 -41.72 70.67 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 121.159 0.504 . . . . 0.0 110.061 168.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.84 -35.96 70.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.508 1.123 . . . . 0.0 111.312 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.3 mt -80.22 -5.93 56.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.531 0.732 . . . . 0.0 110.707 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.2 t70 65.55 24.62 11.77 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.352 1.461 . . . . 0.0 110.819 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 58' ' ' ILE . 35.0 t -92.75 34.56 1.07 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.609 1.163 . . . . 0.0 111.467 -175.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.1 p -118.76 15.39 13.53 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.787 0.835 . . . . 0.0 110.45 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -80.77 0.28 35.47 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.736 0.814 . . . . 0.0 112.702 -175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.68 -151.52 6.6 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -90.54 61.55 4.94 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.426 0.69 . . . . 0.0 109.509 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -91.38 156.13 17.98 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.356 0.662 . . . . 0.0 110.935 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.81 175.45 9.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.537 1.135 . . . . 0.0 108.467 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.522 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 6.4 p -134.71 144.2 35.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 123.983 0.913 . . . . 0.0 109.649 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -117.77 100.14 7.4 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.4 tp -97.37 112.01 24.02 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 54.47 55.94 7.45 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.588 1.155 . . . . 0.0 111.49 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 62.86 34.85 14.01 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.434 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -152.06 126.39 9.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.039 0.536 . . . . 0.0 109.898 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 t -73.72 126.03 33.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 O-C-N 123.674 0.609 . . . . 0.0 110.38 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.08 117.39 66.8 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.91 152.69 79.67 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.579 2.186 . . . . 0.0 111.059 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -61.37 -38.64 87.76 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -167.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.9 -1.71 33.9 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 123.481 0.488 . . . . 0.0 114.118 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -114.44 -9.35 12.74 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.73 0.812 . . . . 0.0 112.156 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -51.47 -41.03 60.62 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 123.396 0.678 . . . . 0.0 111.399 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -70.96 -38.32 72.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.468 1.107 . . . . 0.0 111.802 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -77.39 -14.84 59.62 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.1 m -106.27 119.58 51.51 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 88.2 Cg_endo -81.77 167.76 16.37 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.396 2.064 . . . . 0.0 112.316 172.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.464 HG11 HD11 ' A' ' 56' ' ' ILE . 63.0 t -118.73 140.85 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.429 1.092 . . . . 0.0 108.271 171.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.1 m -123.24 154.35 38.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.415 1.086 . . . . 0.0 108.815 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.78 126.93 29.55 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.468 0.707 . . . . 0.0 110.662 175.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 -2.96 52.42 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.959 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -76.42 138.72 40.54 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.447 0.624 . . . . 0.0 111.205 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -92.39 110.48 21.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.655 0.782 . . . . 0.0 109.11 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.653 HG21 HD21 ' A' ' 20' ' ' LEU . 56.4 mt -107.26 98.28 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.054 0.942 . . . . 0.0 109.829 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 41.3 tt0 -96.67 117.06 30.19 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.448 HG21 ' SG ' ' A' ' 26' ' ' CYS . 75.2 mt -76.3 141.45 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.2 mt -125.23 151.69 45.57 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.457 0.703 . . . . 0.0 110.522 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 64.1 p -122.9 84.6 50.23 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 168.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -65.12 114.97 3.04 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.174 1.916 . . . . 0.0 111.384 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -156.76 111.32 2.77 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 65.78 8.2 5.09 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.431 1.492 . . . . 0.0 113.052 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.513 ' HA3' ' NE2' ' A' ' 70' ' ' HIS . . . 104.47 10.77 32.76 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.46 -117.92 9.44 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 119.68 -0.511 . . . . 0.0 114.259 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 tt -74.38 -52.44 12.12 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.405 0.682 . . . . 0.0 109.975 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.98 140.53 45.58 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.188 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -114.02 -9.66 12.96 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.824 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -114.24 84.17 2.0 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.946 0.899 . . . . 0.0 108.647 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.513 ' NE2' ' HA3' ' A' ' 64' ' ' GLY . 96.7 m-70 -93.64 144.91 24.95 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.25 0.62 . . . . 0.0 110.547 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -122.18 -62.05 1.42 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 172.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -139.47 84.04 1.97 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 169.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 50.3 m80 . . . . . 0 C--O 1.252 1.215 0 C-N-CA 124.902 1.281 . . . . 0.0 109.855 -170.962 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mtp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 9' ' ' GLN . 4.4 tt -79.18 105.22 10.35 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.54 178.02 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.365 1.066 . . . . 0.0 109.021 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.6 m -122.63 100.52 6.96 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.6 mt -95.14 110.04 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.72 0.808 . . . . 0.0 108.982 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.462 HD22 ' HB ' ' A' ' 58' ' ' ILE . 2.3 m120 65.23 34.01 8.8 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.166 1.386 . . . . 0.0 110.86 175.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.32 2.52 85.33 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.524 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -115.76 120.2 38.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.163 0.585 . . . . 0.0 110.51 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.468 ' HB3' HD21 ' A' ' 2' ' ' LEU . 47.9 mt-30 -64.11 113.65 3.67 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.406 0.683 . . . . 0.0 110.351 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -125.08 133.56 52.84 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.285 1.034 . . . . 0.0 109.965 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -85.18 114.99 22.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.414 1.086 . . . . 0.0 108.993 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.9 m -125.12 168.55 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.445 1.098 . . . . 0.0 109.089 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -124.83 5.53 8.08 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.453 0.701 . . . . 0.0 109.5 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.4 m -78.58 105.21 9.7 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 123.296 0.638 . . . . 0.0 110.576 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.88 2.47 34.21 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.172 0.589 . . . . 0.0 111.106 171.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.7 t -124.52 133.89 53.18 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.431 1.093 . . . . 0.0 109.261 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 33' ' ' VAL . 66.8 t -63.41 -43.05 98.31 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 O-C-N 123.743 0.652 . . . . 0.0 110.046 174.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -50.39 68.49 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 0.0 111.415 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.06 92.11 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 124.047 0.842 . . . . 0.0 111.207 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.0 tp -60.78 -45.94 92.4 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.968 0.792 . . . . 0.0 111.685 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.0 mmm -71.77 -24.31 61.73 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.214 0.606 . . . . 0.0 111.25 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -69.58 -41.07 76.32 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.901 0.481 . . . . 0.0 110.119 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.44 -37.58 77.45 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.085 0.954 . . . . 0.0 111.51 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -82.81 -4.7 58.34 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.563 0.745 . . . . 0.0 111.145 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.2 t70 69.08 12.25 8.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.491 1.116 . . . . 0.0 111.506 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.8 m -95.5 33.52 1.59 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.19 0.996 . . . . 0.0 110.423 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.1 t -125.6 -13.77 6.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.735 0.814 . . . . 0.0 110.304 173.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.76 -68.39 0.34 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.734 0.814 . . . . 0.0 110.694 -175.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.04 -164.92 40.69 Favored Glycine 0 C--N 1.34 0.782 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.936 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -74.5 84.99 2.03 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 122.278 1.037 . . . . 0.0 110.154 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -123.69 150.09 44.7 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.415 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -119.69 167.85 11.63 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.698 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 17' ' ' VAL . 9.8 p -122.82 156.41 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -131.14 100.86 5.35 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -89.84 108.84 19.94 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 59.71 39.75 20.65 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.763 1.225 . . . . 0.0 109.889 -169.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 73.91 -9.28 1.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.99 1.716 . . . . 0.0 113.297 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -77.97 108.94 11.6 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.8 t -67.57 121.72 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 123.6 0.562 . . . . 0.0 109.904 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.482 HG21 HG21 ' A' ' 48' ' ' THR . 67.9 t -105.69 132.56 20.78 Favored Pre-proline 0 C--O 1.245 0.818 0 C-N-CA 124.124 0.97 . . . . 0.0 108.827 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.11 149.83 59.01 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.465 2.11 . . . . 0.0 111.256 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -63.48 -34.2 77.24 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -165.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.96 -29.06 67.12 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 123.384 0.427 . . . . 0.0 112.773 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -95.09 -4.21 46.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.718 0.807 . . . . 0.0 112.718 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -57.9 -29.99 65.52 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 118.495 0.589 . . . . 0.0 110.625 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.24 -39.6 82.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.395 1.078 . . . . 0.0 110.888 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -79.47 -24.84 42.1 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.122 0.969 . . . . 0.0 112.131 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.482 HG21 HG21 ' A' ' 40' ' ' VAL . 56.6 m -92.9 110.98 49.24 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.835 0.854 . . . . 0.0 109.464 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -81.03 171.59 13.93 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.8 2.333 . . . . 0.0 112.439 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.405 HG13 HD11 ' A' ' 56' ' ' ILE . 58.0 t -121.85 138.82 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.209 1.004 . . . . 0.0 108.388 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.2 p -128.69 150.85 50.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.567 1.147 . . . . 0.0 108.294 173.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.63 122.39 15.17 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.522 0.729 . . . . 0.0 110.705 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.01 -13.94 19.43 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.191 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -67.18 139.49 57.44 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 117.198 0.499 . . . . 0.0 111.986 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.68 99.45 12.35 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 50' ' ' VAL . 62.4 mt -98.3 96.28 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.714 0.805 . . . . 0.0 109.289 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 34.5 tt0 -93.67 119.96 33.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.808 0.843 . . . . 0.0 109.726 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.462 ' HB ' HD22 ' A' ' 6' ' ' ASN . 88.5 mt -87.73 136.42 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 80.0 mt -120.07 152.45 37.53 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.245 1.018 . . . . 0.0 109.763 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 m -126.28 82.7 65.28 Favored Pre-proline 0 C--O 1.243 0.716 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 167.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -61.35 116.4 3.38 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.522 2.148 . . . . 0.0 112.152 -170.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 59.5 72.9 0.5 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.701 1.2 . . . . 0.0 110.603 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -84.08 -40.54 18.17 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.931 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.8 106.86 1.77 Allowed Glycine 0 C--N 1.354 1.53 0 O-C-N 124.079 0.862 . . . . 0.0 112.394 -177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.06 65.33 0.17 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.9 tp -51.46 -41.91 61.22 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.305 1.042 . . . . 0.0 111.258 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -106.06 -40.04 5.79 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.045 0.538 . . . . 0.0 110.309 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -72.89 9.41 1.16 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -53.94 -39.17 65.67 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 123.301 0.64 . . . . 0.0 110.67 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -87.54 95.79 10.16 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 169.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -83.31 -2.76 56.47 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.714 -170.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 85.4 t60 59.03 84.83 0.1 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.302 1.041 . . . . 0.0 110.469 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.8 p80 . . . . . 0 CA--C 1.56 1.331 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -177.562 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.523 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 1.3 pmm? . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.91 0.386 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 tt -79.93 118.56 21.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 m -131.0 142.56 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.524 1.129 . . . . 0.0 110.415 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 55' ' ' GLU . 8.3 m -79.75 98.92 7.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.793 0.837 . . . . 0.0 109.437 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.645 HD13 HD11 ' A' ' 24' ' ' LEU . 74.1 mt -104.38 110.77 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.437 HD21 ' HB ' ' A' ' 58' ' ' ILE . 88.9 m-20 64.13 22.42 12.88 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.605 1.162 . . . . 0.0 111.494 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.66 -15.1 64.06 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-O 119.72 -0.489 . . . . 0.0 113.535 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -86.09 133.08 33.91 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 117.401 0.601 . . . . 0.0 109.72 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -75.08 100.16 4.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -105.17 146.2 29.55 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.059 0.944 . . . . 0.0 109.973 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -109.61 104.29 13.29 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 m -113.33 165.14 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.569 0.748 . . . . 0.0 110.156 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -128.1 9.12 6.21 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.661 0.784 . . . . 0.0 109.627 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -57.0 -49.1 76.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.803 1.241 . . . . 0.0 112.799 -170.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 61.78 9.36 2.85 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.179 0.992 . . . . 0.0 112.802 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.2 t -162.05 141.48 9.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.152 1.381 . . . . 0.0 108.109 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.462 HG11 HG11 ' A' ' 33' ' ' VAL . 94.6 t -72.05 -33.39 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.335 0.654 . . . . 0.0 111.461 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.88 -53.6 51.7 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.641 0.376 . . . . 0.0 110.275 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.65 -44.83 73.59 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.66 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.7 tp -58.81 -56.02 27.59 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.273 1.029 . . . . 0.0 111.886 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.2 mtp -68.95 -19.27 64.17 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.027 0.531 . . . . 0.0 111.2 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.7 m -73.27 -46.28 50.8 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.795 0.438 . . . . 0.0 110.663 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -70.1 -34.57 73.3 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.282 1.033 . . . . 0.0 111.604 -175.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.645 HD11 HD13 ' A' ' 5' ' ' ILE . 89.5 mt -79.09 -12.23 60.0 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.522 0.729 . . . . 0.0 111.25 175.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 63.54 24.57 14.08 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.576 1.15 . . . . 0.0 111.027 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.448 ' HB3' HG21 ' A' ' 58' ' ' ILE . 88.3 m -88.98 40.95 1.0 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.473 1.509 . . . . 0.0 110.566 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -138.46 25.48 2.64 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.369 1.067 . . . . 0.0 109.46 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -89.54 85.64 6.55 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.865 0.866 . . . . 0.0 110.112 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.67 -102.11 0.66 Allowed Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.59 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -75.85 77.81 2.77 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.94 0.896 . . . . 0.0 111.076 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.443 ' CE1' HG22 ' A' ' 60' ' ' THR . 27.3 m-85 -141.22 140.08 33.89 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.391 0.676 . . . . 0.0 110.196 174.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -138.54 177.96 7.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.088 1.355 . . . . 0.0 108.466 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 HG11 ' A' ' 17' ' ' VAL . 11.1 p -138.17 148.41 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.227 0.537 . . . . 0.0 110.824 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -129.9 105.53 8.05 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.129 1.372 . . . . 0.0 108.037 172.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.0 tp -86.83 105.79 17.27 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 54.74 52.88 11.36 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.266 1.427 . . . . 0.0 110.725 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 74.89 -16.8 0.53 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 125.765 1.626 . . . . 0.0 113.761 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.03 107.71 19.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 75.4 t -69.96 117.49 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.371 0.669 . . . . 0.0 110.874 -176.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.23 119.45 65.59 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 123.853 0.861 . . . . 0.0 109.157 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.33 154.47 74.11 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.421 2.081 . . . . 0.0 112.159 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -59.39 -33.94 71.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.087 0.955 . . . . 0.0 112.115 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.44 1.31 7.21 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.994 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -127.88 -9.82 5.48 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 117.976 -1.011 . . . . 0.0 112.334 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -49.46 -42.33 42.77 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 119.072 0.851 . . . . 0.0 111.685 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -68.09 -41.72 81.42 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.379 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.44 -19.03 60.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.772 0.829 . . . . 0.0 111.812 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.0 m -96.06 115.35 65.51 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.45 169.91 20.98 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.475 2.117 . . . . 0.0 112.832 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.26 104.72 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.802 1.241 . . . . 0.0 108.499 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 p -97.97 166.64 11.35 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.158 0.983 . . . . 0.0 110.678 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 1' ' ' MET . . . -64.22 116.52 6.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.783 0.833 . . . . 0.0 112.003 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.66 26.78 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 119.315 -0.714 . . . . 0.0 114.479 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -74.09 140.52 45.36 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.023 0.912 . . . . 0.0 111.841 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.404 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 42.9 tt0 -89.89 92.56 9.07 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 64.3 mt -96.19 100.91 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.79 0.836 . . . . 0.0 109.861 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -88.92 104.47 16.99 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 26' ' ' CYS . 50.6 mm -78.56 106.69 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 61.1 mt -73.75 141.83 46.29 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.298 0.639 . . . . 0.0 110.538 176.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.443 HG22 ' CE1' ' A' ' 31' ' ' TYR . 81.4 p -119.0 67.84 8.52 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.617 0.767 . . . . 0.0 109.248 171.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.25 115.31 3.78 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 121.636 1.557 . . . . 0.0 110.203 -172.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -57.12 -44.8 83.63 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.184 0.994 . . . . 0.0 110.804 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -137.09 153.58 50.52 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.129 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.15 -163.89 35.09 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 112.338 -0.305 . . . . 0.0 112.338 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.8 108.77 0.46 Allowed Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -46.25 -36.31 6.04 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.666 1.186 . . . . 0.0 112.4 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -147.1 167.7 23.45 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 169.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -109.66 85.73 2.16 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.362 0.665 . . . . 0.0 109.308 174.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -75.35 128.06 34.54 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 165.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.5 p80 47.87 106.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.583 1.553 . . . . 0.0 111.425 -167.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -36.16 -58.26 0.68 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 125.541 1.536 . . . . 0.0 113.562 -167.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 54.34 93.53 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 O-C-N 124.688 1.243 . . . . 0.0 111.44 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 . . . . . 0 CA--C 1.553 1.063 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.996 -175.632 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.466 ' HG2' HG13 ' A' ' 3' ' ' VAL . 1.5 pmm? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.371 0.129 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 44.9 tp -77.86 116.71 18.57 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 173.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.466 HG13 ' HG2' ' A' ' 1' ' ' MET . 32.7 m -120.33 -176.46 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.762 1.225 . . . . 0.0 109.273 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.7 m -126.67 101.65 6.73 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.4 mt -96.29 115.6 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.757 0.823 . . . . 0.0 110.006 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 t30 50.42 52.74 14.21 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.851 1.26 . . . . 0.0 111.243 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.07 -0.8 61.74 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 114.62 -1.173 . . . . 0.0 114.429 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -107.56 109.67 21.38 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.817 0.847 . . . . 0.0 110.155 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -66.32 102.03 0.81 Allowed 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.746 0.784 . . . . 0.0 109.774 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -137.34 136.97 38.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.506 0.722 . . . . 0.0 109.392 -171.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 36.7 tt0 -84.67 130.83 34.66 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.239 0.616 . . . . 0.0 109.595 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.41 177.04 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.713 1.205 . . . . 0.0 108.933 171.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -119.67 7.38 11.05 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.8 m -68.33 112.2 5.07 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 123.441 0.697 . . . . 0.0 110.618 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.97 -16.49 43.91 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.374 0.669 . . . . 0.0 110.728 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.3 t -121.28 141.34 50.99 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.319 1.048 . . . . 0.0 109.432 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.3 t -69.77 -30.19 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 123.535 0.522 . . . . 0.0 110.371 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.74 64.21 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.456 0.702 . . . . 0.0 110.368 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.39 90.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.544 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 53.6 tp -61.77 -54.58 40.43 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.626 0.578 . . . . 0.0 110.888 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.3 mmm -61.57 -32.31 72.39 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.044 0.84 . . . . 0.0 110.905 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -70.03 -40.94 74.87 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.212 0.605 . . . . 0.0 110.887 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.52 -20.77 59.85 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.097 0.559 . . . . 0.0 111.376 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 92.8 mt -87.29 -6.43 58.53 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.056 0.543 . . . . 0.0 110.081 172.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.5 t70 62.03 31.47 17.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.147 1.379 . . . . 0.0 110.564 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.5 t -107.38 38.52 2.11 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.223 1.409 . . . . 0.0 109.286 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.445 HG22 ' HZ3' ' A' ' 45' ' ' TRP . 21.5 p -124.06 0.32 8.48 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.713 0.805 . . . . 0.0 112.551 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -81.33 -5.65 58.05 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -170.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.74 -146.64 5.17 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.706 -0.497 . . . . 0.0 112.726 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -77.14 94.6 4.09 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.992 0.901 . . . . 0.0 110.603 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -130.96 171.56 13.06 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.895 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.1 179.54 9.05 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.82 1.248 . . . . 0.0 108.784 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.459 HG12 ' NE1' ' A' ' 45' ' ' TRP . 7.3 p -147.06 119.09 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.246 0.546 . . . . 0.0 110.299 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -80.32 97.48 7.03 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 171.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.427 HD13 HG12 ' A' ' 56' ' ' ILE . 46.5 tp -92.11 120.49 32.77 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 63.45 25.72 14.62 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.69 1.196 . . . . 0.0 110.071 -173.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 74.47 8.31 4.46 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 126.256 1.822 . . . . 0.0 112.644 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -106.04 126.91 52.77 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.49 124.16 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.564 0.746 . . . . 0.0 111.094 -171.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.5 116.69 57.38 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.536 1.135 . . . . 0.0 109.063 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.537 ' HD2' ' HD3' ' A' ' 44' ' ' LYS . 57.4 Cg_endo -70.23 164.26 35.65 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.858 2.372 . . . . 0.0 112.135 173.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -56.53 -43.42 79.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.081 0.952 . . . . 0.0 112.66 -172.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.8 -30.18 74.32 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 123.804 0.69 . . . . 0.0 113.301 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.537 ' HD3' ' HD2' ' A' ' 41' ' ' PRO . 28.2 mtpp -82.01 -25.92 34.28 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.328 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.459 ' NE1' HG12 ' A' ' 33' ' ' VAL . 51.9 m0 -49.19 -36.34 19.43 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 123.76 0.824 . . . . 0.0 111.65 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.73 -54.23 38.62 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.012 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -86.03 2.78 45.12 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.092 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.7 m -108.37 114.67 59.05 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.1 166.12 12.9 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.579 2.186 . . . . 0.0 113.29 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 56' ' ' ILE . 49.1 t -95.17 147.75 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.884 0.873 . . . . 0.0 108.839 172.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 m -123.51 149.16 45.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.848 0.859 . . . . 0.0 110.119 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.29 113.76 3.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.462 0.305 . . . . 0.0 111.243 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.83 39.3 24.95 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.448 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -94.39 164.84 12.84 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.823 0.449 . . . . 0.0 111.386 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -101.15 86.99 3.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.566 0.698 . . . . 0.0 110.204 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.457 HD11 HG13 ' A' ' 50' ' ' VAL . 82.5 mt -86.19 144.2 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.026 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 33.8 tt0 -147.48 136.25 22.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mm -83.29 134.73 26.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.1 mt -125.46 149.61 48.08 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.013 0.925 . . . . 0.0 109.543 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.5 p -126.02 89.77 51.64 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 171.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.23 143.9 32.52 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.379 2.052 . . . . 0.0 110.408 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 66.86 23.07 10.06 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.012 0.925 . . . . 0.0 111.305 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -73.29 135.88 44.47 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.971 0.908 . . . . 0.0 111.134 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.2 -18.0 46.59 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-O 119.071 -0.85 . . . . 0.0 112.894 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.72 123.34 12.96 Favored Glycine 0 C--N 1.357 1.721 0 C-N-CA 123.278 0.466 . . . . 0.0 113.713 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.0 mt -99.73 20.92 13.23 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.798 0.839 . . . . 0.0 111.536 -172.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.73 93.33 0.52 Allowed 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 122.285 1.04 . . . . 0.0 110.669 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 74.74 -77.19 0.05 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 125.836 1.654 . . . . 0.0 111.457 170.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -141.13 159.62 41.84 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.997 0.519 . . . . 0.0 110.923 -175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -109.21 106.31 16.12 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -79.85 76.04 6.54 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.266 0.555 . . . . 0.0 109.919 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -148.32 173.98 12.49 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.847 1.259 . . . . 0.0 109.402 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.8 p80 . . . . . 0 CA--C 1.561 1.37 0 C-N-CA 123.775 0.83 . . . . 0.0 109.393 -175.623 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' HG12 ' A' ' 50' ' ' VAL . 23.8 ptp . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 121.064 0.459 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.9 tt -85.43 107.27 17.32 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.484 HG23 HG13 ' A' ' 5' ' ' ILE . 28.6 m -118.69 162.04 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.396 1.079 . . . . 0.0 109.449 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.3 m -94.12 101.52 13.53 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.121 0.569 . . . . 0.0 109.711 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.657 HD13 HD11 ' A' ' 24' ' ' LEU . 69.1 mt -100.02 107.85 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.2 m120 68.26 22.21 8.19 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.917 1.287 . . . . 0.0 112.399 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.17 4.91 66.22 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.455 -0.339 . . . . 0.0 112.66 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -119.99 111.57 18.07 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.143 0.977 . . . . 0.0 108.488 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -60.2 111.28 1.47 Allowed 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.953 0.406 . . . . 0.0 110.287 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -119.94 131.34 55.17 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.626 1.17 . . . . 0.0 108.872 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -80.65 124.42 28.99 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 170.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.43 163.3 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.311 1.044 . . . . 0.0 108.973 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -114.73 -2.22 13.07 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.862 0.465 . . . . 0.0 111.539 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -70.77 117.3 12.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.718 0.407 . . . . 0.0 110.851 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.55 14.27 19.34 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.196 0.998 . . . . 0.0 110.931 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 p -142.38 141.57 32.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.501 1.12 . . . . 0.0 108.702 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.508 HG11 HG11 ' A' ' 33' ' ' VAL . 98.7 t -67.74 -31.73 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 124.027 0.829 . . . . 0.0 112.033 -172.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.5 -45.87 78.14 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.46 0.304 . . . . 0.0 110.521 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -61.29 -38.12 85.63 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.076 0.86 . . . . 0.0 111.092 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.1 tp -62.63 -50.57 70.7 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.902 0.881 . . . . 0.0 111.438 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.5 mtp -72.84 -16.8 61.59 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.65 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.2 m -69.54 -45.84 67.84 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 166.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 22.2 mm-40 -65.89 -30.6 71.23 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.243 0.617 . . . . 0.0 112.217 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.657 HD11 HD13 ' A' ' 5' ' ' ILE . 60.7 mt -99.6 -0.82 39.62 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.634 0.774 . . . . 0.0 111.675 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t70 62.4 25.45 15.18 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.076 1.35 . . . . 0.0 111.503 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.9 m -90.8 14.31 13.94 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.434 1.094 . . . . 0.0 110.622 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.4 t -110.19 -9.57 14.68 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.268 1.027 . . . . 0.0 109.643 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -67.73 -64.96 0.75 Allowed 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.026 0.93 . . . . 0.0 110.499 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.64 -158.43 33.87 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.819 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -90.69 98.29 11.69 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.936 0.495 . . . . 0.0 109.767 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -122.79 148.65 45.12 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.379 0.672 . . . . 0.0 110.177 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.67 134.64 54.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.508 HG11 HG11 ' A' ' 17' ' ' VAL . 11.0 p -106.05 137.92 33.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.43 100.56 8.86 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.419 HD12 HG12 ' A' ' 56' ' ' ILE . 28.5 tp -87.01 108.64 18.94 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 60.39 39.45 18.57 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.232 0.957 . . . . 0.0 110.182 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 68.21 13.87 9.14 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.28 1.432 . . . . 0.0 113.184 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -111.7 116.99 31.67 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.8 t -67.15 126.97 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.247 0.619 . . . . 0.0 111.181 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.7 t -103.8 127.86 28.53 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.544 1.137 . . . . 0.0 108.333 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.68 161.39 33.85 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.947 2.431 . . . . 0.0 111.836 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -59.18 -41.72 89.12 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.476 0.71 . . . . 0.0 112.864 -169.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.45 -29.13 70.81 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 123.373 0.421 . . . . 0.0 112.899 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -88.74 -14.89 36.11 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-O 117.936 -1.031 . . . . 0.0 112.177 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -53.88 -43.37 69.55 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.96 0.8 . . . . 0.0 111.701 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.1 -42.14 85.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.669 0.788 . . . . 0.0 110.432 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -75.77 -21.18 57.65 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.46 1.104 . . . . 0.0 112.445 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 83.8 m -95.0 116.81 66.73 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.27 169.81 16.05 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.409 2.073 . . . . 0.0 112.744 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' SD ' ' A' ' 1' ' ' MET . 98.2 t -121.91 134.62 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 169.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.8 p -128.0 155.69 43.89 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.118 0.967 . . . . 0.0 108.753 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.9 134.08 55.66 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.613 0.571 . . . . 0.0 111.67 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.1 -13.04 57.44 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-O 118.979 -0.901 . . . . 0.0 114.393 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -60.25 137.8 58.05 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -82.43 82.04 8.04 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 62.2 mt -88.58 95.41 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.87 106.13 16.64 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -174.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.8 mt -93.04 100.93 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.539 0.685 . . . . 0.0 109.44 -174.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.1 mt -80.1 153.58 28.63 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.286 1.035 . . . . 0.0 110.746 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.1 m -110.23 91.33 11.29 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 167.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.26 136.81 38.42 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.923 2.416 . . . . 0.0 111.797 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -73.44 121.24 20.2 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -67.36 103.34 1.26 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.571 0.748 . . . . 0.0 109.281 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.5 121.37 0.59 Allowed Glycine 0 C--N 1.348 1.25 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.06 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.53 -66.6 3.87 Favored Glycine 0 C--N 1.35 1.351 0 C-N-CA 123.088 0.375 . . . . 0.0 112.347 173.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.98 -60.96 2.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.579 0.752 . . . . 0.0 109.296 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -88.01 32.1 0.76 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.269 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -73.84 94.07 2.24 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -94.58 110.43 22.25 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -54.29 -38.27 65.72 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.966 0.906 . . . . 0.0 109.737 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -102.12 80.28 1.97 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.482 168.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -82.21 86.49 6.64 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.936 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 . . . . . 0 CA--C 1.551 1.008 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.237 179.81 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 1.7 pmm? . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.594 0.235 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 9' ' ' GLN . 48.1 tp -89.24 128.15 35.82 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG23 HG13 ' A' ' 5' ' ' ILE . 6.9 m -140.25 158.33 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.591 1.156 . . . . 0.0 109.325 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -92.29 98.78 11.72 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 62.1 mt -106.61 120.33 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.9 m120 64.01 21.27 12.54 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.692 1.197 . . . . 0.0 111.945 -176.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.75 0.51 78.47 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 119.721 -0.488 . . . . 0.0 114.12 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -115.21 161.11 18.89 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.778 0.789 . . . . 0.0 110.0 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 2' ' ' LEU . 26.3 mp0 -81.6 118.75 23.03 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -127.64 125.75 40.73 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.685 1.194 . . . . 0.0 109.605 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -95.1 113.51 25.21 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.26 157.38 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.697 0.799 . . . . 0.0 110.775 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.15 -2.29 15.0 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.744 0.818 . . . . 0.0 110.607 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 m -60.55 -44.66 95.89 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.76 1.224 . . . . 0.0 112.972 -168.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 75.45 -43.17 0.49 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.245 1.418 . . . . 0.0 113.227 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -97.18 146.51 25.0 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 33' ' ' VAL . 54.9 t -67.91 -31.67 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 123.687 0.617 . . . . 0.0 110.457 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.26 -50.25 72.46 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.668 0.387 . . . . 0.0 110.539 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.84 72.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.602 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.2 tp -68.42 -49.24 61.38 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.794 0.838 . . . . 0.0 111.384 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 92.6 mmm -68.49 -22.49 64.55 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.368 0.667 . . . . 0.0 110.325 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -81.67 -39.39 24.43 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.552 0.341 . . . . 0.0 111.493 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.65 -42.62 98.09 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.696 0.798 . . . . 0.0 110.26 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -88.18 -0.09 56.68 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.983 0.913 . . . . 0.0 111.436 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.0 t70 64.31 20.84 12.33 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.04 1.336 . . . . 0.0 112.437 173.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.4 ' SG ' HG21 ' A' ' 58' ' ' ILE . 56.0 m -83.08 21.39 1.08 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.318 1.047 . . . . 0.0 111.884 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.473 HG22 ' HZ3' ' A' ' 45' ' ' TRP . 51.4 p -96.85 -31.32 12.66 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.449 0.7 . . . . 0.0 109.875 173.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.09 -60.24 4.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.36 1.064 . . . . 0.0 112.182 -172.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.44 24.27 10.34 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-O 119.588 -0.562 . . . . 0.0 113.759 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 55.5 m80 52.23 64.0 2.02 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.336 1.055 . . . . 0.0 111.376 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -89.75 153.66 20.52 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.401 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -109.92 153.26 24.76 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 17' ' ' VAL . 9.3 p -105.13 146.01 12.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -126.87 101.83 6.76 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.13 116.92 24.63 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 65.02 28.44 12.46 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 124.604 1.19 . . . . 0.0 110.276 -172.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 68.92 22.2 7.21 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.473 1.509 . . . . 0.0 112.751 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -114.58 115.79 27.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.932 0.893 . . . . 0.0 108.91 172.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.401 HG13 ' HB1' ' A' ' 32' ' ' ALA . 77.1 t -66.65 120.77 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.906 0.882 . . . . 0.0 112.109 -170.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.436 ' HB ' HG13 ' A' ' 33' ' ' VAL . 91.7 t -95.52 126.6 45.03 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.981 1.312 . . . . 0.0 109.248 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.45 157.19 59.44 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 123.111 2.54 . . . . 0.0 112.475 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.452 ' HA ' ' CE2' ' A' ' 45' ' ' TRP . 74.7 ttt180 -59.05 -40.59 85.59 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.921 0.889 . . . . 0.0 112.695 -171.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.41 -17.97 54.48 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.885 0.741 . . . . 0.0 114.349 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -102.89 -8.28 20.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.473 ' HZ3' HG22 ' A' ' 27' ' ' THR . 50.7 m0 -55.35 -37.19 67.15 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 120.991 0.424 . . . . 0.0 111.866 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.21 -50.03 71.88 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.343 1.057 . . . . 0.0 111.445 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.1 2.28 40.14 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.594 0.758 . . . . 0.0 112.515 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.3 m -104.53 122.52 43.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.412 0.685 . . . . 0.0 109.517 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.96 161.36 18.38 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.711 2.274 . . . . 0.0 114.584 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.2 94.59 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.7 p -104.36 142.74 34.03 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -60.03 127.42 31.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.4 1.08 . . . . 0.0 113.319 -167.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.03 12.92 75.78 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-O 119.397 -0.668 . . . . 0.0 114.455 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.96 147.06 25.91 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.869 0.835 . . . . 0.0 111.119 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -84.86 81.75 8.75 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.918 1.287 . . . . 0.0 109.842 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 72.7 mt -88.37 96.43 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.911 0.884 . . . . 0.0 109.158 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 10.4 tp10 -93.65 111.14 22.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.4 HG21 ' SG ' ' A' ' 26' ' ' CYS . 55.7 mt -100.55 104.02 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.25 177.71 5.25 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.304 1.042 . . . . 0.0 110.389 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.554 ' HB ' ' HA3' ' A' ' 64' ' ' GLY . 21.2 m -106.97 113.95 62.03 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.09 117.58 4.9 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.133 1.888 . . . . 0.0 111.631 -175.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 70.66 115.99 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.59 1.556 . . . . 0.0 111.468 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 67.51 38.13 3.22 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.381 1.072 . . . . 0.0 111.303 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.554 ' HA3' ' HB ' ' A' ' 60' ' ' THR . . . -106.95 -7.15 33.75 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.609 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.26 -40.73 92.25 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 116.874 0.337 . . . . 0.0 112.954 172.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.58 42.4 1.71 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.127 0.971 . . . . 0.0 108.878 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.5 130.06 30.66 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.271 1.028 . . . . 0.0 109.842 175.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -87.75 80.6 7.85 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -56.62 102.52 0.08 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.618 1.167 . . . . 0.0 111.48 -174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -102.65 26.58 7.8 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.29 1.036 . . . . 0.0 109.533 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -63.11 131.96 50.26 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.313 1.045 . . . . 0.0 109.218 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -53.64 -44.38 69.52 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.268 0.627 . . . . 0.0 111.881 -174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 . . . . . 0 C--O 1.245 0.837 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.128 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.461 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.722 0.296 . . . . 0.0 111.213 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 40.8 tp -90.82 116.51 28.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.178 0.991 . . . . 0.0 110.012 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -129.66 140.6 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.406 0.682 . . . . 0.0 110.495 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 59.9 m -71.33 104.58 3.21 Favored 'General case' 0 C--O 1.216 -0.674 0 C-N-CA 123.915 0.886 . . . . 0.0 110.295 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 46.6 mt -102.32 105.45 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 122.825 0.45 . . . . 0.0 109.955 175.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.8 m120 65.62 31.78 9.64 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.09 1.356 . . . . 0.0 112.308 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.13 1.5 81.77 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.944 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -122.4 115.13 21.74 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.745 0.818 . . . . 0.0 109.112 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 1.2 mp0 -68.9 146.01 53.17 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.101 0.56 . . . . 0.0 110.143 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -150.92 139.57 20.66 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.564 0.346 . . . . 0.0 111.267 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.49 99.91 9.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.572 1.149 . . . . 0.0 109.098 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.3 m -121.61 158.73 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.188 0.995 . . . . 0.0 110.259 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -112.14 9.85 20.21 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.635 0.774 . . . . 0.0 110.075 172.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.0 m -73.37 94.04 2.01 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.576 0.75 . . . . 0.0 110.489 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.77 -3.25 37.24 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.432 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.0 t -129.49 148.69 51.42 Favored 'General case' 0 C--O 1.247 0.958 0 C-N-CA 124.616 1.166 . . . . 0.0 109.62 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.514 HG11 HG11 ' A' ' 33' ' ' VAL . 53.5 t -66.32 -33.37 63.07 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.779 0.832 . . . . 0.0 110.623 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.25 -51.62 68.77 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.5 0.72 . . . . 0.0 111.147 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.74 79.93 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.85 0.719 . . . . 0.0 111.301 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.17 -53.71 18.64 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 123.819 0.699 . . . . 0.0 111.462 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.564 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 65.8 mtp -69.79 -34.34 73.61 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.442 0.297 . . . . 0.0 111.498 -175.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.2 m -68.41 -36.09 78.6 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.523 0.329 . . . . 0.0 110.762 175.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.67 -47.31 84.23 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.204 0.526 . . . . 0.0 110.219 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.7 mt -75.79 -8.14 56.14 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.442 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.0 t70 61.42 54.62 3.08 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.145 1.378 . . . . 0.0 110.384 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.7 m -114.06 30.18 7.47 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.801 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -93.54 -16.7 24.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.946 0.499 . . . . 0.0 111.18 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -74.12 176.2 6.78 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.764 0.826 . . . . 0.0 111.465 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.99 -112.68 2.06 Favored Glycine 0 C--N 1.355 1.593 0 O-C-N 123.911 0.757 . . . . 0.0 113.957 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.472 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 88.0 m-70 -147.53 104.62 3.64 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.415 1.486 . . . . 0.0 107.51 169.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -134.51 134.59 41.62 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.024 0.53 . . . . 0.0 109.989 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.43 -175.26 2.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.762 1.225 . . . . 0.0 108.991 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.564 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.1 p -144.96 156.08 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.163 0.585 . . . . 0.0 110.132 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -132.28 102.16 5.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.954 0.901 . . . . 0.0 109.011 176.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.8 tp -86.66 114.99 23.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 56.52 36.29 27.34 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.078 0.951 . . . . 0.0 110.863 -170.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 74.02 -2.03 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.97 1.708 . . . . 0.0 113.106 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -95.87 122.11 38.31 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 59.0 t -70.3 132.75 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.559 0.744 . . . . 0.0 111.799 -170.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.57 124.44 40.77 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -64.61 154.89 69.82 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.71 2.273 . . . . 0.0 111.703 170.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -64.41 -44.14 92.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.694 0.798 . . . . 0.0 112.202 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.61 -3.99 29.84 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.252 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -113.34 -9.45 13.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.147 0.979 . . . . 0.0 113.033 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -52.04 -39.78 60.08 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 119.011 0.823 . . . . 0.0 111.157 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -71.28 -41.9 69.42 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.956 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.95 -12.31 60.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.403 1.081 . . . . 0.0 112.683 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -105.1 115.15 62.78 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -176.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.51 159.14 32.42 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.602 2.201 . . . . 0.0 112.957 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.484 HG13 HD11 ' A' ' 56' ' ' ILE . 84.9 t -119.06 139.19 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.54 1.136 . . . . 0.0 108.004 174.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.8 p -126.26 165.61 18.65 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.256 1.022 . . . . 0.0 109.206 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.461 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -61.7 129.97 43.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.965 0.906 . . . . 0.0 112.244 -176.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.52 2.05 68.09 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.218 -0.768 . . . . 0.0 114.164 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.31 147.14 44.76 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 117.897 0.848 . . . . 0.0 111.755 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.444 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 4.0 mp0 -94.28 92.39 7.19 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.484 HD11 HG13 ' A' ' 50' ' ' VAL . 3.1 mp -84.93 95.02 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 172.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 36.0 tt0 -96.47 100.39 11.99 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.4 mt -73.95 103.55 2.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.95 131.4 45.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.528 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.3 p -109.41 86.12 4.1 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 30' ' ' HIS . 28.5 Cg_exo -61.94 117.75 4.6 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.573 2.182 . . . . 0.0 111.57 -177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -65.91 99.96 0.53 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.174 0.99 . . . . 0.0 109.887 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 59.8 77.83 0.3 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.307 1.043 . . . . 0.0 109.654 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.96 92.57 0.2 Allowed Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.605 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.89 -92.76 0.04 OUTLIER Glycine 0 C--N 1.347 1.157 0 O-C-N 123.922 0.424 . . . . 0.0 112.324 -174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.7 tp -68.24 99.69 0.94 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.896 0.878 . . . . 0.0 110.224 176.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -58.78 143.42 47.23 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.655 1.182 . . . . 0.0 108.833 169.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -143.06 91.88 2.33 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -172.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -75.2 129.02 36.79 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -61.99 107.5 0.87 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.29 1.036 . . . . 0.0 110.647 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -174.38 131.98 0.37 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.618 1.567 . . . . 0.0 108.798 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -134.07 -176.07 4.06 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.214 1.005 . . . . 0.0 110.129 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.8 m80 . . . . . 0 C--O 1.253 1.274 0 C-N-CA 123.534 0.734 . . . . 0.0 110.299 -177.428 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptp . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.584 0.231 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 52.4 tp -82.18 114.53 20.76 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.472 ' HA ' ' H ' ' A' ' 53' ' ' GLY . 33.8 m -119.31 -180.0 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.276 1.03 . . . . 0.0 110.57 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.6 m -117.74 100.3 7.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.138 0.575 . . . . 0.0 109.655 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 HD11 ' A' ' 24' ' ' LEU . 69.5 mt -102.41 122.27 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.62 0.768 . . . . 0.0 108.98 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 58.92 30.39 20.13 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.274 1.03 . . . . 0.0 111.927 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.06 -2.74 87.08 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 120.028 -0.318 . . . . 0.0 113.64 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.3 136.0 46.8 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.099 0.96 . . . . 0.0 109.929 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -77.92 113.14 15.54 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -132.1 136.61 47.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.545 1.138 . . . . 0.0 109.512 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.95 131.85 35.36 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 5' ' ' ILE . 27.7 m -133.81 155.26 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.632 0.773 . . . . 0.0 110.449 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -93.63 -43.34 8.72 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.041 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 m -58.83 120.99 10.02 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.857 0.863 . . . . 0.0 112.353 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.54 -0.37 57.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.985 0.914 . . . . 0.0 111.261 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.5 t -116.17 141.39 48.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.384 1.073 . . . . 0.0 108.891 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.64 -33.62 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.497 0.719 . . . . 0.0 110.993 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.73 -53.01 61.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.525 0.33 . . . . 0.0 110.308 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -60.19 -39.45 86.56 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.065 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.2 tp -66.0 -48.1 72.32 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.842 0.457 . . . . 0.0 111.255 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.479 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 83.0 mtp -67.94 -25.68 65.58 Favored 'General case' 0 C--O 1.211 -0.955 0 O-C-N 123.372 0.42 . . . . 0.0 110.238 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.1 m -69.45 -40.95 76.85 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 118.16 0.436 . . . . 0.0 110.343 172.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 18.2 mm-40 -65.93 -37.5 86.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.943 0.497 . . . . 0.0 111.105 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 5' ' ' ILE . 95.5 mt -82.0 -12.86 58.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.02 0.928 . . . . 0.0 111.314 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 63.62 51.13 2.57 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.105 1.362 . . . . 0.0 110.553 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.93 35.71 4.78 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.339 1.456 . . . . 0.0 110.443 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.407 HG22 ' HZ3' ' A' ' 45' ' ' TRP . 39.9 p -110.73 -6.46 14.79 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -176.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -115.89 -68.03 0.95 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -167.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.58 64.41 4.25 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-O 119.733 -0.481 . . . . 0.0 114.17 -167.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 56.18 72.56 0.49 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.617 1.167 . . . . 0.0 111.568 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -129.82 144.3 51.24 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.097 0.559 . . . . 0.0 109.925 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.0 147.8 52.27 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.207 1.003 . . . . 0.0 109.115 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.479 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 5.6 p -106.82 135.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -116.46 100.98 8.24 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.0 tp -88.71 113.72 24.57 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 56.9 42.85 25.78 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.74 1.275 . . . . 0.0 110.072 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 68.04 21.15 8.89 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.385 1.474 . . . . 0.0 112.328 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -124.59 115.44 20.82 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.804 0.842 . . . . 0.0 108.868 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 58.8 t -63.82 127.96 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.55 0.74 . . . . 0.0 111.144 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.43 ' HB ' HG13 ' A' ' 33' ' ' VAL . 98.4 t -96.02 126.64 43.77 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.401 1.081 . . . . 0.0 109.612 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.38 146.22 68.01 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.44 2.093 . . . . 0.0 112.47 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -48.02 -48.55 32.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.892 1.677 . . . . 0.0 113.315 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.1 -15.65 60.99 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 123.749 0.655 . . . . 0.0 114.561 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -106.68 -10.04 16.28 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 117.922 -1.037 . . . . 0.0 112.34 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.407 ' HZ3' HG22 ' A' ' 27' ' ' THR . 39.0 m0 -46.8 -40.55 13.92 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 123.646 0.778 . . . . 0.0 112.554 -177.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -70.08 -41.01 74.67 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.955 0.902 . . . . 0.0 110.64 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -76.72 -11.91 59.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.595 1.158 . . . . 0.0 111.418 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.0 m -92.78 118.12 67.82 Favored Pre-proline 0 C--O 1.243 0.722 0 C-N-CA 123.515 0.726 . . . . 0.0 109.55 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -82.14 156.73 17.42 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.207 1.938 . . . . 0.0 113.021 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.3 t -96.99 138.64 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.748 1.219 . . . . 0.0 107.867 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.9 m -130.02 139.37 51.03 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.228 1.011 . . . . 0.0 109.461 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.66 114.6 2.82 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.96 0.346 . . . . 0.0 111.392 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 3' ' ' VAL . . . 89.74 20.68 42.82 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-O 119.371 -0.683 . . . . 0.0 114.253 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -84.73 165.69 17.64 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.004 0.902 . . . . 0.0 110.229 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.74 85.5 2.24 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.861 0.464 . . . . 0.0 110.117 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 82.8 mt -88.01 97.32 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 36.6 tt0 -103.99 102.52 12.29 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.211 0.605 . . . . 0.0 109.974 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 64.3 mt -97.88 105.77 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.9 178.14 4.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.52 1.128 . . . . 0.0 110.508 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.0 p -103.53 102.3 29.02 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.271 0.629 . . . . 0.0 109.52 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.08 133.01 29.53 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.651 2.234 . . . . 0.0 111.183 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -76.87 -29.64 55.9 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.081 0.552 . . . . 0.0 110.51 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 81.25 -62.33 0.19 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.747 1.619 . . . . 0.0 110.628 165.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.47 73.0 2.72 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 169.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.09 92.56 0.01 OUTLIER Glycine 0 C--N 1.36 1.886 0 C-N-CA 123.783 0.706 . . . . 0.0 114.792 -175.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.1 tp -149.08 2.12 0.57 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.86 0.864 . . . . 0.0 110.363 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.49 -43.91 93.19 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.081 0.952 . . . . 0.0 110.533 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -133.86 171.95 13.46 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.428 1.091 . . . . 0.0 109.354 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -81.16 176.48 9.74 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.093 0.557 . . . . 0.0 109.7 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -71.99 89.46 1.11 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.298 0.639 . . . . 0.0 109.914 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -90.3 85.63 6.27 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.388 0.675 . . . . 0.0 109.971 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 69.59 171.51 0.3 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.27 1.428 . . . . 0.0 111.991 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 74.0 t60 . . . . . 0 C--O 1.249 1.032 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.507 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 120.718 0.294 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 9' ' ' GLN . 59.2 tp -79.65 119.08 22.1 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.954 0.902 . . . . 0.0 110.324 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.47 162.97 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.344 1.058 . . . . 0.0 109.069 176.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 m -105.02 99.99 9.6 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.64 HD13 HD11 ' A' ' 24' ' ' LEU . 32.9 mt -101.5 108.96 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.732 0.813 . . . . 0.0 109.321 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.4 m120 63.48 22.73 13.36 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.249 1.02 . . . . 0.0 112.999 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.94 8.75 72.1 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.358 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -103.91 131.27 51.3 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.729 0.811 . . . . 0.0 108.834 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.489 ' HB3' HD11 ' A' ' 2' ' ' LEU . 74.4 mt-30 -80.05 113.84 18.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 172.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -137.3 130.56 30.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.146 0.578 . . . . 0.0 110.225 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -82.52 129.52 34.93 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.751 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.99 159.56 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.764 0.826 . . . . 0.0 110.136 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -112.32 -12.69 13.53 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.877 0.871 . . . . 0.0 110.371 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 p -66.16 105.47 1.4 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.128 0.971 . . . . 0.0 110.973 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.95 -17.56 62.07 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.813 0.845 . . . . 0.0 111.748 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.7 t -105.03 143.24 33.49 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.01 0.924 . . . . 0.0 110.097 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 21' ' ' MET . 88.0 t -68.16 -33.63 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 173.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.62 95.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.843 0.457 . . . . 0.0 110.511 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.08 79.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.084 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.1 tp -69.42 -43.13 74.02 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.659 0.599 . . . . 0.0 110.695 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 91.8 mmm -67.44 -29.12 68.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.915 0.486 . . . . 0.0 109.988 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 m -79.99 -29.25 39.46 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.682 0.393 . . . . 0.0 110.663 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -68.48 -37.52 80.2 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.759 0.824 . . . . 0.0 109.931 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.64 HD11 HD13 ' A' ' 5' ' ' ILE . 57.4 mt -98.26 8.62 44.56 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.349 1.06 . . . . 0.0 110.851 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 p30 51.03 23.78 1.63 Allowed 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 125.814 1.646 . . . . 0.0 113.389 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.8 m -87.84 20.5 3.03 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.749 1.219 . . . . 0.0 110.655 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 p -95.07 -47.86 6.2 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.562 0.745 . . . . 0.0 109.535 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.22 111.71 13.15 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.602 0.761 . . . . 0.0 110.209 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.98 -172.75 14.37 Favored Glycine 0 C--O 1.242 0.643 0 O-C-N 123.641 0.588 . . . . 0.0 113.119 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -75.78 86.01 2.78 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -138.3 155.69 48.35 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.556 0.693 . . . . 0.0 111.202 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.59 168.32 22.3 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.764 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.451 HG13 ' HB ' ' A' ' 40' ' ' VAL . 12.8 p -130.91 147.98 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -126.56 104.96 8.4 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.477 1.111 . . . . 0.0 108.447 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 tp -88.35 109.82 20.29 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 57.06 52.22 9.42 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 124.662 1.226 . . . . 0.0 111.191 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 71.18 -2.1 2.49 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.507 1.523 . . . . 0.0 112.988 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -103.7 110.26 22.28 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.78 0.832 . . . . 0.0 108.943 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 78.0 t -69.92 115.76 9.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 122.896 0.479 . . . . 0.0 110.404 -175.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HB ' HG13 ' A' ' 33' ' ' VAL . 58.4 t -87.23 122.39 70.94 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.23 1.012 . . . . 0.0 108.637 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.9 159.17 53.42 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 122.767 2.311 . . . . 0.0 111.145 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -61.56 -34.05 74.91 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.621 0.576 . . . . 0.0 111.985 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.87 -5.85 21.13 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.792 -0.64 . . . . 0.0 114.066 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -119.46 -6.86 10.24 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 117.655 -1.164 . . . . 0.0 112.827 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -55.86 -46.47 78.21 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 120.132 1.333 . . . . 0.0 111.454 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.51 -39.45 67.61 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.782 0.433 . . . . 0.0 110.108 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.77 -22.37 65.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.713 0.805 . . . . 0.0 112.617 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.5 m -99.56 127.88 32.99 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 123.554 0.742 . . . . 0.0 109.596 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -83.34 167.25 13.79 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.558 2.172 . . . . 0.0 113.429 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 56' ' ' ILE . 67.7 t -115.45 125.59 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.278 1.031 . . . . 0.0 108.37 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.5 p -123.8 160.65 26.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.098 0.559 . . . . 0.0 110.207 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -64.29 142.02 58.57 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.824 1.249 . . . . 0.0 112.588 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.28 -13.2 60.53 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-O 119.71 -0.495 . . . . 0.0 114.01 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.82 145.16 40.86 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.73 0.765 . . . . 0.0 112.049 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -93.14 99.67 12.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.207 1.003 . . . . 0.0 110.127 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 61.6 mt -97.89 97.51 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.901 0.881 . . . . 0.0 108.924 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -96.83 107.11 19.54 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.707 0.803 . . . . 0.0 109.536 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.96 114.84 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.525 HD13 ' H ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -123.38 155.36 37.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.455 0.702 . . . . 0.0 110.414 -176.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.8 p -85.08 146.77 46.19 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.16 132.94 50.4 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.199 1.933 . . . . 0.0 110.589 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.46 78.11 0.19 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.95 1.3 . . . . 0.0 108.201 -168.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -148.22 159.5 43.9 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.889 0.875 . . . . 0.0 109.429 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.09 -126.84 1.94 Allowed Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.34 169.6 22.95 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 117.028 0.414 . . . . 0.0 112.668 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -110.97 10.03 22.21 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.948 0.899 . . . . 0.0 111.0 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.16 109.12 2.93 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 123.931 0.892 . . . . 0.0 110.242 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 58.42 34.67 24.17 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.324 1.05 . . . . 0.0 110.997 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -69.29 91.01 0.52 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.585 0.354 . . . . 0.0 110.55 -175.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -87.11 122.32 30.76 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.142 0.977 . . . . 0.0 109.533 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -72.51 150.42 43.24 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.261 0.624 . . . . 0.0 110.008 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -84.22 131.71 34.72 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 174.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 124.375 1.07 . . . . 0.0 108.78 175.906 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.514 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 24.3 ptp . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.653 0.264 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 36.2 tp -81.49 112.32 18.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.39 165.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.955 0.902 . . . . 0.0 110.087 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.7 m -111.64 100.73 9.21 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.972 0.509 . . . . 0.0 109.871 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.45 HD11 HD11 ' A' ' 20' ' ' LEU . 70.7 mt -108.35 117.8 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 124.109 0.964 . . . . 0.0 109.203 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 65.41 24.49 11.99 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.517 1.127 . . . . 0.0 112.644 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.18 -3.08 84.18 Favored Glycine 0 N--CA 1.47 0.908 0 CA-C-N 116.445 -0.343 . . . . 0.0 113.156 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -105.78 154.97 19.76 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.613 1.165 . . . . 0.0 108.42 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -105.27 136.12 45.38 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.074 0.397 . . . . 0.0 110.07 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -141.3 130.97 24.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.293 1.037 . . . . 0.0 109.503 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.15 124.96 29.68 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.3 m -135.99 161.92 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.212 1.005 . . . . 0.0 110.724 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -130.82 24.08 5.0 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.781 1.232 . . . . 0.0 108.884 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.3 m -55.98 -48.11 76.44 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.932 1.293 . . . . 0.0 113.705 -171.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 77.02 -50.33 0.55 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.953 1.701 . . . . 0.0 111.701 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -108.19 151.55 25.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.033 0.933 . . . . 0.0 109.301 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.442 ' CG1' HG11 ' A' ' 33' ' ' VAL . 87.6 t -66.43 -24.97 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 O-C-N 124.056 0.848 . . . . 0.0 110.754 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.63 -56.73 15.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.73 0.812 . . . . 0.0 110.512 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.12 -30.32 68.03 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.465 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.45 HD11 HD11 ' A' ' 5' ' ' ILE . 48.3 tp -64.49 -54.74 27.68 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.752 0.821 . . . . 0.0 110.703 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.438 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 97.6 mmm -64.78 -26.43 68.35 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.005 0.522 . . . . 0.0 111.527 -177.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.8 m -75.02 -38.49 61.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.66 0.784 . . . . 0.0 110.936 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.91 -45.13 93.93 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.752 HD13 HD11 ' A' ' 58' ' ' ILE . 48.1 mt -72.65 -12.27 60.97 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.569 1.147 . . . . 0.0 111.828 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 63.62 14.36 8.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.936 1.294 . . . . 0.0 111.626 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.2 m -96.92 37.71 1.28 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.886 1.274 . . . . 0.0 109.098 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.9 t -113.47 -28.51 7.51 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.337 0.655 . . . . 0.0 110.512 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -81.09 84.79 6.43 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.106 0.562 . . . . 0.0 110.26 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 134.27 -162.5 24.56 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.481 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -84.42 80.87 9.07 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.787 0.835 . . . . 0.0 109.381 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -118.86 157.66 27.19 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.516 0.674 . . . . 0.0 110.965 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.54 154.3 50.11 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.442 HG11 ' CG1' ' A' ' 17' ' ' VAL . 8.8 p -123.1 150.33 27.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.86 99.32 5.7 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.523 HD12 HG12 ' A' ' 56' ' ' ILE . 18.3 tp -90.08 121.12 31.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 67.73 23.04 8.73 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.635 1.174 . . . . 0.0 108.734 -170.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.474 ' CE2' ' HB3' ' A' ' 55' ' ' GLU . 59.3 m-85 68.96 3.96 4.28 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.848 1.659 . . . . 0.0 113.059 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -92.63 127.17 38.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.282 0.633 . . . . 0.0 109.39 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.9 t -66.27 114.27 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.748 0.819 . . . . 0.0 111.024 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.417 ' HB ' HG13 ' A' ' 33' ' ' VAL . 80.2 t -87.61 120.41 71.03 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.1 143.36 99.55 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.096 2.531 . . . . 0.0 110.739 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -57.8 -40.07 79.07 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.96 -24.19 62.47 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 123.803 0.689 . . . . 0.0 114.173 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -103.13 2.39 34.53 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.427 ' NE1' HG12 ' A' ' 33' ' ' VAL . 40.9 m0 -50.79 -41.93 57.5 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 118.13 0.423 . . . . 0.0 111.031 175.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.25 -49.42 60.76 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.578 0.751 . . . . 0.0 110.884 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.15 -26.02 67.24 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.826 0.85 . . . . 0.0 111.694 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.2 m -95.52 119.56 65.04 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.73 167.88 23.28 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.856 2.371 . . . . 0.0 113.504 176.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.6 t -104.29 145.76 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.609 1.163 . . . . 0.0 109.305 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.1 m -108.58 148.57 30.12 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.579 0.752 . . . . 0.0 109.683 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 1' ' ' MET . . . -65.67 115.34 5.74 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.735 0.814 . . . . 0.0 110.741 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.86 41.1 73.99 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 123.365 0.415 . . . . 0.0 112.551 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.95 149.03 28.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.084 0.554 . . . . 0.0 110.364 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 37' ' ' TYR . 2.9 mp0 -84.63 81.71 8.74 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 121.854 0.835 . . . . 0.0 109.586 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.523 HG12 HD12 ' A' ' 35' ' ' LEU . 32.4 mt -99.04 153.65 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.729 1.212 . . . . 0.0 109.637 -177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -151.17 125.01 9.12 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.469 0.708 . . . . 0.0 109.14 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.752 HD11 HD13 ' A' ' 24' ' ' LEU . 66.8 mt -80.37 105.36 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.4 mt -83.39 117.94 23.38 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.2 p -93.56 99.2 3.14 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 170.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.83 117.82 4.63 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.848 2.365 . . . . 0.0 111.972 -171.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -83.92 -50.65 7.85 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.291 -172.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 82.86 -56.61 0.18 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.648 1.579 . . . . 0.0 112.008 171.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.8 75.55 1.26 Allowed Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 175.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.35 121.43 4.4 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -165.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 tt -138.48 109.58 6.82 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -91.73 150.3 21.18 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 170.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -88.32 -12.8 42.44 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.065 0.546 . . . . 0.0 111.712 -175.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 72.42 117.4 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.348 1.459 . . . . 0.0 109.682 -168.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -62.13 137.59 58.28 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.718 0.807 . . . . 0.0 109.989 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -67.57 89.32 0.24 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.984 0.421 . . . . 0.0 110.14 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -74.57 142.01 44.72 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.74 0.816 . . . . 0.0 109.1 173.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.5 p80 . . . . . 0 C--O 1.25 1.125 0 C-N-CA 123.839 0.856 . . . . 0.0 109.23 -179.241 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtm . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.62 103.52 9.59 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.64 152.13 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.363 1.065 . . . . 0.0 109.118 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 38.9 m -86.37 106.44 17.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.156 0.582 . . . . 0.0 109.577 176.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 70.2 mt -100.22 106.2 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.986 0.515 . . . . 0.0 110.733 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 t30 66.5 23.61 10.44 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.709 1.204 . . . . 0.0 110.708 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.4 -15.58 62.58 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.354 -174.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -98.18 110.31 22.91 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.38 0.672 . . . . 0.0 109.314 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 18.5 mt-30 -71.94 114.5 10.11 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 120.786 0.326 . . . . 0.0 110.15 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.47 ' NH1' HG12 ' A' ' 12' ' ' VAL . 61.1 ttt-85 -131.23 143.87 50.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.419 1.088 . . . . 0.0 109.265 -176.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.3 137.98 35.74 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.47 HG12 ' NH1' ' A' ' 10' ' ' ARG . 33.1 m -114.81 152.94 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 122.841 0.456 . . . . 0.0 111.261 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.92 -38.43 11.7 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 168.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -66.44 120.05 12.69 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.938 0.895 . . . . 0.0 111.849 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.35 -0.88 52.24 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.787 0.835 . . . . 0.0 111.529 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.7 p -122.14 148.11 45.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.059 0.944 . . . . 0.0 109.093 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.6 t -68.61 -31.43 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 123.478 0.711 . . . . 0.0 111.486 -176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.34 -52.8 63.13 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.896 0.478 . . . . 0.0 110.88 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.63 -30.65 71.67 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.137 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.426 HD22 HG21 ' A' ' 50' ' ' VAL . 36.4 tp -71.16 -44.92 64.55 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 124.0 0.812 . . . . 0.0 111.483 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.8 mmm -70.03 -24.38 63.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.719 0.408 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -74.38 -43.01 58.27 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.764 0.426 . . . . 0.0 110.413 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.12 -37.87 86.76 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.719 1.208 . . . . 0.0 110.895 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.524 HD13 HD11 ' A' ' 58' ' ' ILE . 71.3 mt -88.65 -7.73 55.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.306 1.042 . . . . 0.0 111.367 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.5 t70 59.78 42.68 16.33 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.027 1.331 . . . . 0.0 110.933 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.0 m -121.56 35.91 4.76 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.386 1.074 . . . . 0.0 110.769 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.2 t -120.69 1.91 10.58 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.193 0.597 . . . . 0.0 110.478 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.09 -61.59 2.37 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.833 0.853 . . . . 0.0 112.228 -169.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.3 -131.68 4.82 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-O 120.046 -0.308 . . . . 0.0 112.607 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -78.26 87.25 4.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.726 0.811 . . . . 0.0 109.305 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -135.92 152.62 51.18 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.743 0.817 . . . . 0.0 110.925 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.02 -177.84 4.88 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.412 1.485 . . . . 0.0 108.226 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.449 HG12 ' NE1' ' A' ' 45' ' ' TRP . 7.9 p -149.8 159.61 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.567 ' HB3' ' HG3' ' A' ' 57' ' ' GLU . . . -133.15 109.86 9.76 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.013 0.525 . . . . 0.0 109.737 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.3 tp -88.59 113.02 23.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 59.48 36.44 23.03 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.154 0.982 . . . . 0.0 110.614 -172.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 72.0 13.18 5.97 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.061 1.344 . . . . 0.0 112.217 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -102.02 112.07 24.58 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.922 0.889 . . . . 0.0 109.247 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.4 t -62.93 111.03 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.557 0 O-C-N 123.921 0.763 . . . . 0.0 110.73 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -90.41 121.36 68.54 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.41 151.84 75.71 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.538 2.159 . . . . 0.0 111.053 173.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -58.24 -38.09 76.18 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.916 0.886 . . . . 0.0 113.053 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.67 3.55 25.83 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 114.567 0.587 . . . . 0.0 114.567 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -121.73 -9.96 8.8 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.882 0.873 . . . . 0.0 112.026 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.449 ' NE1' HG12 ' A' ' 33' ' ' VAL . 40.9 m0 -49.66 -39.69 37.12 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.124 0.57 . . . . 0.0 112.23 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -70.06 -43.07 71.96 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.772 0.829 . . . . 0.0 110.819 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -73.08 -14.59 61.43 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 112.303 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.6 m -100.45 120.37 56.38 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.478 0.711 . . . . 0.0 109.324 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -83.99 166.81 12.88 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.897 2.398 . . . . 0.0 113.278 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.426 HG21 HD22 ' A' ' 20' ' ' LEU . 58.6 t -123.6 129.22 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.019 1.328 . . . . 0.0 107.855 175.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.9 p -125.22 149.53 47.89 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.99 126.88 29.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.842 0.857 . . . . 0.0 111.4 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.56 -4.05 39.89 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 119.564 -0.576 . . . . 0.0 113.358 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -78.11 154.64 31.11 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 117.443 0.622 . . . . 0.0 111.366 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -110.09 90.91 3.45 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.778 0.831 . . . . 0.0 109.387 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 4.0 mp -88.13 97.45 6.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.567 ' HG3' ' HB3' ' A' ' 34' ' ' ALA . 8.2 pt-20 -99.1 125.44 44.63 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.69 0.757 . . . . 0.0 109.231 175.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.524 HD11 HD13 ' A' ' 24' ' ' LEU . 70.2 mt -84.74 126.22 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.453 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.0 mt -103.35 130.0 50.53 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.687 0.795 . . . . 0.0 109.724 -177.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.408 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 52.4 m -102.48 93.87 4.47 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 163.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.18 115.08 3.99 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 122.518 2.145 . . . . 0.0 111.378 -169.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 60' ' ' THR . 40.7 mtt85 -111.97 -78.99 0.58 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -116.2 84.48 2.13 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.99 -58.86 0.33 Allowed Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.659 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.41 -31.46 59.01 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mp -122.86 88.91 3.01 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 173.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -140.52 -172.57 3.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.22 0.608 . . . . 0.0 110.098 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -134.97 14.31 3.59 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 167.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 57.78 -83.19 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.131 1.372 . . . . 0.0 111.655 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 49.1 m80 63.06 -153.71 0.34 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -169.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -72.41 88.55 1.2 Allowed 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 166.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -163.17 135.98 5.51 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.879 1.272 . . . . 0.0 108.261 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 . . . . . 0 C--O 1.248 0.974 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.663 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 47.3 tp -79.11 96.88 5.95 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 52' ' ' ALA . 26.8 m -109.92 139.03 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.41 1.084 . . . . 0.0 109.642 -175.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 8.7 m -84.5 99.66 10.86 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -176.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.47 HD13 HD11 ' A' ' 24' ' ' LEU . 65.9 mt -98.6 108.31 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.626 0.77 . . . . 0.0 109.707 -177.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.433 HD22 ' HB ' ' A' ' 58' ' ' ILE . 2.2 m-20 67.66 34.09 4.66 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.9 1.28 . . . . 0.0 110.899 176.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.53 10.16 84.64 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.441 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -125.68 110.99 14.43 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.502 1.121 . . . . 0.0 108.244 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 79.6 mt-30 -66.44 143.89 56.84 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -151.43 128.34 11.0 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.815 1.246 . . . . 0.0 108.595 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.83 116.32 22.1 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.67 155.78 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.286 1.035 . . . . 0.0 109.607 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -109.44 -12.6 14.7 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.846 0.859 . . . . 0.0 109.506 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.2 m -57.46 100.07 0.05 OUTLIER 'General case' 0 C--N 1.353 0.731 0 C-N-CA 124.651 1.18 . . . . 0.0 110.672 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.69 -13.98 60.0 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.631 0.773 . . . . 0.0 111.967 -177.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 t -114.42 142.01 46.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 109.46 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.499 HG11 HG11 ' A' ' 33' ' ' VAL . 94.9 t -69.65 -27.07 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.437 0.695 . . . . 0.0 110.435 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.32 -54.32 42.25 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.79 -31.7 71.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.186 0.594 . . . . 0.0 111.474 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.2 -51.97 46.89 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.491 0.716 . . . . 0.0 111.195 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.54 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 76.4 mtp -75.02 -18.8 60.29 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.782 0.433 . . . . 0.0 111.425 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -67.1 -45.23 77.87 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 166.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -67.1 -41.05 86.92 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.277 1.031 . . . . 0.0 111.613 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.47 HD11 HD13 ' A' ' 5' ' ' ILE . 80.9 mt -80.4 -11.55 59.68 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.835 0.854 . . . . 0.0 110.609 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.3 t70 62.81 35.14 13.94 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.138 1.375 . . . . 0.0 110.817 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.618 ' SG ' HD13 ' A' ' 58' ' ' ILE . 59.8 m -96.36 40.68 1.12 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.394 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.402 HG22 ' HZ3' ' A' ' 45' ' ' TRP . 76.9 p -111.75 6.14 19.57 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.199 0.6 . . . . 0.0 111.781 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.52 109.02 0.62 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.996 0.918 . . . . 0.0 112.42 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.62 -90.72 0.39 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-O 120.047 -0.307 . . . . 0.0 112.553 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -147.7 77.98 1.44 Allowed 'General case' 0 C--N 1.354 0.794 0 CA-C-O 121.552 0.692 . . . . 0.0 109.742 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -93.77 173.68 7.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.842 1.257 . . . . 0.0 111.196 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HA ' ' HZ2' ' A' ' 45' ' ' TRP . . . -153.29 168.97 24.23 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.272 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.54 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 6.6 p -128.76 139.03 52.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 C-N-CA 124.057 0.943 . . . . 0.0 108.855 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 57' ' ' GLU . . . -108.08 104.19 13.57 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.0 tp -90.11 107.02 18.87 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 173.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.16 37.8 14.16 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.65 1.18 . . . . 0.0 110.42 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 71.98 11.85 6.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.084 1.754 . . . . 0.0 112.86 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.84 109.32 21.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 84.7 t -71.2 122.91 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.127 0.571 . . . . 0.0 109.937 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.47 126.97 48.2 Favored Pre-proline 0 C--O 1.246 0.917 0 C-N-CA 124.293 1.037 . . . . 0.0 109.322 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.81 145.69 59.92 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.087 2.525 . . . . 0.0 112.389 170.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -60.33 -42.19 95.13 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.843 0.857 . . . . 0.0 112.277 -173.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.15 11.7 11.33 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-N 116.317 -0.401 . . . . 0.0 113.14 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -126.32 -6.93 6.44 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.243 1.017 . . . . 0.0 110.611 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.403 ' HZ2' ' HA ' ' A' ' 32' ' ' ALA . 52.5 m0 -54.24 -33.74 59.11 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.19 0.596 . . . . 0.0 111.358 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -71.39 -39.58 71.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.983 0.913 . . . . 0.0 110.471 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.29 -17.9 63.1 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.083 0.953 . . . . 0.0 111.773 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 m -96.41 114.5 64.48 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.981 0.512 . . . . 0.0 109.84 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.74 155.85 53.66 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.214 1.943 . . . . 0.0 112.471 168.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.9 t -101.02 129.33 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -127.17 135.75 51.11 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.116 0.566 . . . . 0.0 109.831 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.417 ' HA ' HG12 ' A' ' 3' ' ' VAL . . . -58.49 133.69 56.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.657 1.183 . . . . 0.0 112.598 -176.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.41 -6.1 71.18 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.351 -0.694 . . . . 0.0 114.372 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.29 164.23 15.02 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 117.872 0.836 . . . . 0.0 112.108 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -97.05 108.57 21.33 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.666 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 73.8 mt -111.38 96.96 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.94 0.896 . . . . 0.0 109.535 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -91.33 145.37 24.7 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.427 0.691 . . . . 0.0 109.242 177.647 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.618 HD13 ' SG ' ' A' ' 26' ' ' CYS . 99.6 mt -120.81 114.51 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.96 155.13 50.73 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.498 1.119 . . . . 0.0 108.641 -174.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.7 t -125.22 92.65 46.85 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 123.132 0.573 . . . . 0.0 110.067 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.54 116.83 4.72 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.177 1.918 . . . . 0.0 111.364 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -66.56 -43.04 86.12 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.272 0.629 . . . . 0.0 111.65 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -72.13 -26.56 62.16 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.192 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.59 35.91 3.53 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 116.255 -0.429 . . . . 0.0 113.057 -174.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.18 -115.1 0.29 Allowed Glycine 0 C--N 1.355 1.623 0 C-N-CA 123.048 0.356 . . . . 0.0 113.013 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.4 tp -156.36 80.33 0.97 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.835 0.854 . . . . 0.0 108.751 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -168.04 143.77 3.82 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.609 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -122.88 2.99 9.44 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.159 0.984 . . . . 0.0 109.852 171.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -84.07 45.07 1.06 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.599 0.714 . . . . 0.0 111.017 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -155.93 116.13 3.7 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.014 1.725 . . . . 0.0 106.893 172.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -139.03 128.3 24.11 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.02 0.928 . . . . 0.0 109.102 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -83.71 -34.44 24.9 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.064 0.545 . . . . 0.0 110.168 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 . . . . . 0 C--O 1.245 0.82 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 168.693 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 120.932 0.396 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' A' ' 9' ' ' GLN . 8.5 tt -85.55 114.57 22.66 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.408 HG23 HG13 ' A' ' 5' ' ' ILE . 9.7 m -132.8 139.46 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.246 1.018 . . . . 0.0 110.568 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.9 m -67.79 100.43 0.93 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 55.7 mt -104.19 104.57 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.44 0.696 . . . . 0.0 109.328 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 62.45 31.43 17.13 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 122.375 1.083 . . . . 0.0 110.28 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.44 -6.52 83.25 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 121.649 -0.657 . . . . 0.0 113.402 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -106.31 105.59 15.7 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.516 ' HB3' HD21 ' A' ' 2' ' ' LEU . 27.0 mt-30 -61.21 107.23 0.72 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.522 ' HB3' HD12 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -118.72 121.53 40.33 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -169.177 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -81.42 112.78 19.0 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.921 0.888 . . . . 0.0 109.031 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.77 169.65 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.59 1.156 . . . . 0.0 109.85 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -129.59 17.77 5.82 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.383 0.673 . . . . 0.0 110.847 175.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.0 p -94.96 108.65 20.71 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.336 0.654 . . . . 0.0 109.311 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 49' ' ' PRO . . . -82.79 -0.38 47.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.813 0.845 . . . . 0.0 112.035 178.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.0 t -110.34 135.62 50.78 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.153 0.981 . . . . 0.0 108.916 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.8 t -68.66 -26.69 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.153 0.581 . . . . 0.0 110.451 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.67 -55.2 18.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.086 0.554 . . . . 0.0 109.999 172.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.2 -30.1 69.15 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.65 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -69.11 -54.66 13.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.786 0.834 . . . . 0.0 110.867 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.58 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 78.8 mtp -70.04 -21.5 63.18 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.3 m -75.18 -37.89 61.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.638 0.375 . . . . 0.0 110.021 171.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.6 -40.92 98.45 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.854 0.861 . . . . 0.0 110.389 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.51 HD11 HD13 ' A' ' 5' ' ' ILE . 64.4 mt -86.89 -3.68 59.1 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.387 -176.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.49 19.67 10.52 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.245 1.418 . . . . 0.0 112.682 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.513 ' SG ' HG21 ' A' ' 58' ' ' ILE . 56.2 m -87.22 21.0 2.53 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.018 1.327 . . . . 0.0 111.237 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.442 HG22 ' HZ3' ' A' ' 45' ' ' TRP . 10.2 p -100.08 -19.48 16.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.552 1.141 . . . . 0.0 109.706 174.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -89.85 126.85 35.85 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.95 0.9 . . . . 0.0 109.679 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.77 -174.16 51.34 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 112.247 -0.341 . . . . 0.0 112.247 -174.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -84.23 89.1 7.27 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.538 0.685 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -129.07 146.94 50.91 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.445 0.698 . . . . 0.0 110.17 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.71 159.67 40.92 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.46 1.104 . . . . 0.0 109.333 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.58 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 11.1 p -118.49 148.01 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.523 0.729 . . . . 0.0 110.103 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' A' ' 57' ' ' GLU . . . -129.55 102.53 6.42 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.625 0.77 . . . . 0.0 110.221 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.49 HD13 HG12 ' A' ' 56' ' ' ILE . 64.3 tp -89.67 123.07 33.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.0 m120 64.38 39.13 7.3 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.555 1.142 . . . . 0.0 111.079 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 66.48 21.31 10.82 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.456 1.502 . . . . 0.0 112.0 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -131.89 123.53 27.67 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.946 0.899 . . . . 0.0 108.66 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 59.4 t -66.12 126.27 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.302 0.641 . . . . 0.0 111.07 -176.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.413 ' HB ' HG13 ' A' ' 33' ' ' VAL . 61.2 t -88.7 125.93 61.41 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.057 0.943 . . . . 0.0 109.085 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.06 146.56 91.11 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.605 2.203 . . . . 0.0 112.031 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -59.78 -39.17 84.01 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.37 -14.64 57.56 Favored Glycine 0 CA--C 1.532 1.095 0 O-C-N 123.752 0.657 . . . . 0.0 113.051 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -104.74 -16.67 14.88 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 117.73 -1.129 . . . . 0.0 112.676 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.442 ' HZ3' HG22 ' A' ' 27' ' ' THR . 38.3 m0 -46.61 -42.82 16.75 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 118.994 0.815 . . . . 0.0 111.908 -176.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -67.43 -42.72 82.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.566 1.146 . . . . 0.0 112.052 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -90.05 -2.98 58.2 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.917 0.487 . . . . 0.0 112.302 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.3 m -89.53 115.61 64.23 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 96.1 Cg_endo -76.82 153.99 33.76 Favored 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 122.364 2.043 . . . . 0.0 112.785 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.3 t -105.22 119.27 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.561 1.144 . . . . 0.0 108.754 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 p -120.63 148.2 44.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.85 0.86 . . . . 0.0 109.88 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.72 131.81 49.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.139 0.976 . . . . 0.0 112.478 -171.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.62 -0.54 82.97 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-O 119.287 -0.729 . . . . 0.0 114.92 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.46 155.37 24.65 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 117.657 0.728 . . . . 0.0 111.561 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -87.77 92.41 9.1 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.594 1.158 . . . . 0.0 109.177 -173.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 62.1 mt -97.83 97.49 6.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 45.0 mt-10 -93.08 116.77 29.35 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.513 HG21 ' SG ' ' A' ' 26' ' ' CYS . 45.8 mm -98.16 118.1 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.44 165.49 24.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.169 0.588 . . . . 0.0 109.977 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 t -113.09 99.58 49.17 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 123.919 0.887 . . . . 0.0 109.02 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.61 132.7 31.73 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.568 2.179 . . . . 0.0 112.417 -178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 60.08 77.17 0.33 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.743 1.217 . . . . 0.0 109.982 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -145.11 -49.35 0.24 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.096 0.959 . . . . 0.0 108.908 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.31 -55.69 4.37 Favored Glycine 0 C--N 1.349 1.267 0 O-C-N 123.997 0.81 . . . . 0.0 114.41 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.94 -28.67 0.18 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.9 mt -83.24 112.35 19.78 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.532 0.733 . . . . 0.0 109.601 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -54.62 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.281 1.032 . . . . 0.0 110.308 171.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -68.74 -33.54 74.09 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.312 0.645 . . . . 0.0 112.004 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -164.35 104.57 0.85 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.5 0.72 . . . . 0.0 109.585 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -141.99 159.24 42.63 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.078 0.951 . . . . 0.0 110.187 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -81.01 84.31 6.5 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.733 0.813 . . . . 0.0 109.963 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -74.95 -50.81 15.46 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.028 173.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 62.3 t60 . . . . . 0 CA--C 1.557 1.226 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.984 175.617 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 21.3 ptp . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 57.9 tp -79.2 107.11 11.71 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.413 HG21 HD12 ' A' ' 56' ' ' ILE . 27.4 m -110.74 179.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.043 0.937 . . . . 0.0 108.879 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 25.2 m -116.43 110.52 18.75 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -106.76 114.14 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.247 0.619 . . . . 0.0 109.603 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 65.35 26.97 12.04 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.054 1.342 . . . . 0.0 111.645 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.37 3.74 74.86 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.121 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -122.9 114.85 21.01 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.21 1.004 . . . . 0.0 109.232 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.621 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 13.9 pt20 -67.73 130.03 41.73 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.058 0.456 . . . . 0.0 111.193 -178.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 42.6 ttm105 -150.59 141.94 23.32 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.2 1.0 . . . . 0.0 109.045 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -80.82 137.78 36.22 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -124.11 144.71 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.114 0.483 . . . . 0.0 110.187 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -93.28 -23.17 18.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.348 1.059 . . . . 0.0 108.984 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.1 p -76.73 110.15 11.09 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.786 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.49 26.14 2.39 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.752 0.821 . . . . 0.0 110.938 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 57.7 m -146.48 149.41 33.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.917 0.887 . . . . 0.0 109.703 173.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.03 -36.51 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.138 0.975 . . . . 0.0 111.998 -174.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.05 -54.33 39.83 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 120.759 0.314 . . . . 0.0 110.495 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.82 -31.68 69.95 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.442 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.408 HD21 HG21 ' A' ' 56' ' ' ILE . 60.4 tp -67.25 -53.31 31.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.843 0.857 . . . . 0.0 111.135 177.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.518 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 71.5 mtp -69.71 -23.37 63.41 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.155 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.4 m -76.0 -35.22 59.64 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.74 -32.31 70.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.288 0.635 . . . . 0.0 110.762 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.35 2.93 56.04 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.477 0.711 . . . . 0.0 111.963 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 65.14 21.69 12.19 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.646 1.178 . . . . 0.0 111.859 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.62 ' SG ' HG21 ' A' ' 58' ' ' ILE . 60.6 m -92.78 36.92 1.01 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.596 1.158 . . . . 0.0 110.628 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.0 t -139.94 -9.49 1.18 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.91 0.484 . . . . 0.0 111.585 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -64.39 -37.44 87.53 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.052 0.541 . . . . 0.0 111.648 -175.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -113.98 -128.95 4.78 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -117.47 102.06 8.9 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.613 1.165 . . . . 0.0 109.078 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -130.4 156.67 44.34 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.233 1.013 . . . . 0.0 109.411 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -124.9 171.92 9.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.981 0.912 . . . . 0.0 108.65 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.518 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.2 p -135.38 140.33 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -110.73 105.71 14.67 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 170.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.3 tp -92.68 115.37 28.05 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 57.83 37.78 27.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.947 1.299 . . . . 0.0 111.734 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 72.49 30.68 1.89 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.93 1.292 . . . . 0.0 112.193 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -137.38 128.77 28.14 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.718 0.807 . . . . 0.0 109.489 169.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.0 t -72.27 116.76 14.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 123.096 0.559 . . . . 0.0 110.842 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.404 ' HB ' HG13 ' A' ' 33' ' ' VAL . 33.7 t -86.79 120.65 71.86 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.82 155.63 68.03 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.656 2.237 . . . . 0.0 111.302 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -60.14 -32.29 70.88 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.951 0.901 . . . . 0.0 112.808 -173.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.27 -5.22 26.94 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 123.857 0.723 . . . . 0.0 114.502 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -109.06 -25.96 10.41 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.694 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -48.39 -45.69 36.15 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -167.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.49 -47.78 77.63 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.05 0.54 . . . . 0.0 110.371 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.55 -11.34 60.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.298 1.039 . . . . 0.0 112.345 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.6 m -101.6 112.4 65.13 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 98.0 Cg_endo -77.59 171.44 17.51 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.025 1.816 . . . . 0.0 113.081 175.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.3 t -119.32 130.64 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.112 1.365 . . . . 0.0 107.825 172.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.4 p -120.13 156.44 31.05 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.82 0.848 . . . . 0.0 108.932 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -56.21 135.57 53.27 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.593 0.757 . . . . 0.0 111.69 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.15 -16.59 58.06 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.689 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -60.37 127.8 33.56 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.681 0.741 . . . . 0.0 111.991 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -79.82 86.57 5.36 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 3' ' ' VAL . 55.6 mt -89.52 149.73 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.721 1.208 . . . . 0.0 108.878 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 35.2 tt0 -147.33 137.15 22.98 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.62 HG21 ' SG ' ' A' ' 26' ' ' CYS . 36.9 mm -103.31 111.0 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 57.6 mt -79.45 137.28 37.18 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.747 0.819 . . . . 0.0 110.404 172.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.8 m -112.43 87.33 9.31 Favored Pre-proline 0 C--O 1.243 0.718 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 169.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.47 114.43 2.88 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.404 2.069 . . . . 0.0 111.213 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.8 tpp85 -155.38 -0.72 0.15 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.235 0.614 . . . . 0.0 110.663 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -135.8 8.02 3.26 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.481 1.112 . . . . 0.0 110.198 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.41 154.29 21.71 Favored Glycine 0 C--N 1.348 1.223 0 C-N-CA 123.225 0.441 . . . . 0.0 112.109 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.647 ' HA3' ' HB3' ' A' ' 68' ' ' HIS . . . -70.0 123.94 13.52 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt -66.63 -54.49 22.77 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.38 0.672 . . . . 0.0 110.57 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -86.14 -39.37 16.77 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.821 173.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.647 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 26.4 t60 -65.04 91.3 0.09 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.316 1.046 . . . . 0.0 109.899 176.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -93.8 160.37 14.78 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.213 0.605 . . . . 0.0 109.917 176.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -70.53 125.14 25.97 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.078 0.551 . . . . 0.0 109.701 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -66.44 -19.84 65.9 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.922 0.489 . . . . 0.0 112.21 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -96.98 -69.08 0.77 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.829 0.851 . . . . 0.0 109.131 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.2 t60 . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.421 178.673 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' HG2' HG13 ' A' ' 3' ' ' VAL . 1.5 pmm? . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 111.23 0.085 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 9' ' ' GLN . 7.7 tt -82.06 113.46 19.95 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.408 HG13 ' HG2' ' A' ' 1' ' ' MET . 27.5 m -109.07 -179.68 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.098 1.359 . . . . 0.0 110.539 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.0 m -129.23 101.97 6.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.202 0.601 . . . . 0.0 109.719 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.9 mt -103.4 120.38 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.609 0.764 . . . . 0.0 109.177 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.62 30.42 18.59 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.917 1.287 . . . . 0.0 112.141 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.07 -1.66 88.68 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.595 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -113.5 132.29 55.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.436 1.094 . . . . 0.0 108.293 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.591 ' HB3' HD21 ' A' ' 2' ' ' LEU . 1.5 mp0 -80.11 121.98 26.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.209 0.604 . . . . 0.0 111.038 -175.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -128.2 145.96 50.87 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.418 1.087 . . . . 0.0 108.138 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 39.9 tt0 -93.12 117.5 30.14 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 173.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -113.61 174.19 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.742 0.817 . . . . 0.0 109.999 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -149.89 18.16 0.89 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.003 0.921 . . . . 0.0 109.642 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.8 m -64.17 -31.54 72.77 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.086 0.954 . . . . 0.0 112.644 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 75.79 -46.69 0.56 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.605 1.562 . . . . 0.0 112.427 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.6 t -103.52 146.92 27.82 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.124 0.97 . . . . 0.0 109.914 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 33' ' ' VAL . 89.6 t -69.03 -30.67 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 123.618 0.767 . . . . 0.0 110.723 175.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.3 -55.81 21.69 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.931 0.492 . . . . 0.0 110.098 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.45 65.28 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 124.341 1.026 . . . . 0.0 111.506 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.73 -59.86 3.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.786 0.834 . . . . 0.0 111.34 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.467 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 81.2 mtp -70.7 -21.35 62.58 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.816 0.446 . . . . 0.0 111.651 -174.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 m -70.01 -43.9 70.43 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.152 0.581 . . . . 0.0 110.122 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -73.63 -31.82 63.72 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.002 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.76 -10.89 59.84 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.532 0.733 . . . . 0.0 110.882 175.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 62.83 33.18 15.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.544 1.138 . . . . 0.0 111.404 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.1 m -106.15 37.44 2.28 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.276 1.43 . . . . 0.0 110.001 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.2 t -130.85 23.31 4.98 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 122.125 -0.359 . . . . 0.0 111.412 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.404 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . 3.0 m-20 -57.57 -63.94 1.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.406 1.082 . . . . 0.0 111.339 -176.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.81 -104.96 0.57 Allowed Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.421 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -85.15 81.14 8.97 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.532 0.733 . . . . 0.0 110.051 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 28' ' ' ASP . 76.8 m-85 -136.52 123.27 21.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.536 1.134 . . . . 0.0 108.339 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.77 -179.38 3.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.466 0.706 . . . . 0.0 109.525 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.467 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.1 p -140.54 146.14 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.053 0.541 . . . . 0.0 109.666 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -117.51 98.99 6.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.3 tp -90.97 118.86 30.69 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 56.62 33.25 22.43 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.904 0.882 . . . . 0.0 111.465 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 68.97 15.3 8.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.036 1.334 . . . . 0.0 112.185 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -109.24 115.81 30.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 40.7 t -77.17 121.0 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.139 0.576 . . . . 0.0 109.988 -175.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.42 129.54 25.87 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.514 0.725 . . . . 0.0 109.599 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.72 160.07 28.0 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.942 2.428 . . . . 0.0 112.009 174.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -52.87 -43.47 66.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.689 0.795 . . . . 0.0 112.179 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.37 -21.58 48.58 Favored Glycine 0 C--N 1.345 1.065 0 O-C-N 123.81 0.694 . . . . 0.0 114.237 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -103.75 -22.27 13.57 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.357 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -46.64 -42.21 15.93 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 123.623 0.769 . . . . 0.0 112.641 -174.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -61.13 -49.53 76.9 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.971 0.908 . . . . 0.0 111.335 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -77.82 -15.22 59.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.809 0.844 . . . . 0.0 111.923 -176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.5 m -91.18 117.63 67.99 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -83.84 158.3 13.85 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.784 2.323 . . . . 0.0 112.948 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.59 135.93 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.192 0.997 . . . . 0.0 108.311 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.4 m -121.05 147.62 45.27 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.725 0.81 . . . . 0.0 111.232 -168.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.54 114.01 3.66 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.219 0.608 . . . . 0.0 111.334 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.2 32.75 34.39 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 113.137 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.9 p30 -81.24 175.37 10.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.838 0.455 . . . . 0.0 110.891 174.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.06 82.91 1.78 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.629 0.372 . . . . 0.0 110.447 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 75.2 mt -84.82 141.31 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.629 0.772 . . . . 0.0 109.166 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 42.0 tt0 -141.53 112.2 7.12 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.5 mm -77.22 105.44 6.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -79.06 137.99 37.78 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.206 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.5 p -117.52 84.3 18.61 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 167.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.49 116.39 3.38 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.281 1.987 . . . . 0.0 112.229 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -166.15 -79.55 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.404 1.082 . . . . 0.0 108.347 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 71.14 -75.45 0.08 Allowed 'General case' 0 C--N 1.368 1.372 0 C-N-CA 125.576 1.55 . . . . 0.0 110.441 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.79 -164.05 35.81 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 115.869 -0.605 . . . . 0.0 114.077 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.94 77.64 0.79 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.1 mt 62.11 81.23 0.2 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.775 1.23 . . . . 0.0 110.688 -172.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.78 133.69 25.92 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.566 1.146 . . . . 0.0 111.403 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -79.5 91.89 5.2 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.293 0.637 . . . . 0.0 110.716 -171.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -116.51 -0.93 12.33 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.285 1.034 . . . . 0.0 109.372 170.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 65.56 99.29 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.833 1.253 . . . . 0.0 111.033 -177.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -63.2 128.02 33.94 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.307 0.643 . . . . 0.0 110.711 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -80.14 80.85 6.5 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.148 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 . . . . . 0 CA--C 1.548 0.897 0 CA-C-N 114.86 -1.063 . . . . 0.0 108.869 -174.889 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' HG12 ' A' ' 50' ' ' VAL . 17.7 ptp . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 120.973 0.416 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.6 tp -80.05 97.35 6.78 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.01 0.924 . . . . 0.0 108.557 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.7 m -110.84 145.66 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.944 0.897 . . . . 0.0 109.821 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 6.8 m -83.77 99.44 10.28 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 58.6 mt -95.76 108.53 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 60.73 36.07 19.47 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.739 1.215 . . . . 0.0 111.238 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.54 -3.89 86.65 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.519 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -118.04 110.95 18.28 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.055 0.942 . . . . 0.0 108.743 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.544 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 94.5 mt-30 -66.03 118.74 10.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.267 0.627 . . . . 0.0 110.845 -178.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -121.91 139.98 52.98 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.472 1.509 . . . . 0.0 108.768 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -81.87 125.18 30.41 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.81 155.25 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.816 0.847 . . . . 0.0 110.55 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -91.52 -25.64 19.16 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.182 0.593 . . . . 0.0 110.957 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.0 m -70.98 114.99 9.59 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.181 0.592 . . . . 0.0 111.918 -175.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.89 13.04 26.1 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.328 1.051 . . . . 0.0 111.439 173.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.8 t -128.44 138.1 52.15 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.983 1.313 . . . . 0.0 108.403 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 33' ' ' VAL . 76.1 t -68.06 -34.16 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 123.722 0.639 . . . . 0.0 110.839 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.48 -56.68 18.95 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.01 0.524 . . . . 0.0 110.394 174.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.36 75.32 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 124.211 0.944 . . . . 0.0 111.491 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.9 tp -64.32 -55.64 19.9 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 123.732 0.645 . . . . 0.0 110.074 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.541 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 72.0 mtp -69.52 -25.84 64.23 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 122.679 0.392 . . . . 0.0 111.098 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -67.35 -39.57 85.78 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 117.938 0.336 . . . . 0.0 110.549 172.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -69.02 -39.14 79.44 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.081 0.953 . . . . 0.0 110.599 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 81.8 mt -86.93 5.89 34.81 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.067 0.947 . . . . 0.0 111.987 -175.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.3 t70 58.29 44.41 18.68 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.757 1.265 . . . . 0.0 110.868 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m -123.59 18.6 9.6 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.473 1.509 . . . . 0.0 110.473 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.8 t -99.89 25.53 7.23 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.562 0.696 . . . . 0.0 110.077 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.92 -25.18 68.03 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.148 0.979 . . . . 0.0 111.415 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.55 -43.26 1.69 Allowed Glycine 0 C--N 1.347 1.176 0 O-C-N 123.549 0.531 . . . . 0.0 112.082 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -86.4 1.62 50.6 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.991 0.516 . . . . 0.0 111.065 -176.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -89.05 156.4 18.87 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.738 0.815 . . . . 0.0 109.617 174.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.71 170.85 15.2 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.456 1.103 . . . . 0.0 108.485 173.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.541 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 9.1 p -130.08 151.71 36.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -125.25 100.42 6.52 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 174.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.2 tp -88.86 108.8 19.73 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 55' ' ' GLU . 50.2 m-20 54.71 47.43 22.51 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.607 1.163 . . . . 0.0 110.034 -173.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 73.44 -9.88 1.12 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.48 1.512 . . . . 0.0 113.252 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -84.22 116.59 23.03 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.9 t -73.76 117.55 17.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 122.925 0.49 . . . . 0.0 110.1 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.4 t -102.04 119.77 55.74 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.079 0.952 . . . . 0.0 108.627 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.53 165.83 29.76 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.105 2.537 . . . . 0.0 112.345 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -53.07 -41.53 64.96 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.818 1.247 . . . . 0.0 113.38 -173.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.67 -21.05 60.15 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 123.853 0.721 . . . . 0.0 113.934 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -109.42 -7.6 15.17 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.01 -0.995 . . . . 0.0 112.088 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -52.27 -40.88 62.32 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.073 0.851 . . . . 0.0 110.616 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.69 -41.39 98.14 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.755 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -84.18 -11.06 57.18 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.375 1.07 . . . . 0.0 112.529 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.8 m -102.36 112.45 65.52 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -76.33 173.86 13.78 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.409 2.072 . . . . 0.0 112.615 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.565 HG12 ' SD ' ' A' ' 1' ' ' MET . 86.4 t -124.69 143.73 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.918 1.287 . . . . 0.0 108.643 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.5 m -142.62 149.39 38.9 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.866 0.866 . . . . 0.0 109.804 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.14 126.58 26.68 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.576 0.75 . . . . 0.0 111.135 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.54 -22.07 17.95 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 119.011 -0.883 . . . . 0.0 114.259 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -69.13 141.92 54.53 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.024 0.912 . . . . 0.0 112.518 -173.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 36' ' ' ASN . 9.9 mp0 -80.52 80.53 6.96 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.751 1.22 . . . . 0.0 109.353 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 63.1 mt -91.03 96.36 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 39.5 tt0 -98.65 106.43 18.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.038 0.935 . . . . 0.0 108.669 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.56 105.06 5.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.6 mt -80.58 143.83 32.88 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.217 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.4 p -111.83 92.18 16.94 Favored Pre-proline 0 C--O 1.246 0.913 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 160.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.33 127.78 23.36 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.339 2.693 . . . . 0.0 112.475 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -59.47 -48.36 81.96 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 124.349 1.031 . . . . 0.0 109.988 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -92.6 87.47 5.94 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 167.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.03 0.22 17.09 Favored Glycine 0 N--CA 1.467 0.729 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.181 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.32 116.64 2.86 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.8 tp -71.8 90.29 1.09 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.253 1.021 . . . . 0.0 110.85 -171.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.63 -53.8 53.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.892 0.877 . . . . 0.0 112.525 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -65.72 100.68 0.56 Allowed 'General case' 0 CA--C 1.558 1.259 0 CA-C-O 122.09 0.948 . . . . 0.0 110.439 177.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -148.72 96.59 2.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.803 1.241 . . . . 0.0 108.594 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -174.78 30.92 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.551 1.14 . . . . 0.0 110.547 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -123.45 35.12 4.93 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.892 0.477 . . . . 0.0 111.22 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.7 m80 66.64 38.08 4.14 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.38 1.072 . . . . 0.0 111.838 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 . . . . . 0 CA--C 1.554 1.129 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.2 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.669 -0.123 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 5.0 tt -83.0 122.64 28.57 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.01 145.25 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.098 0.959 . . . . 0.0 110.42 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 18.4 m -78.69 102.1 7.86 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.033 0.533 . . . . 0.0 110.088 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 24.1 mt -101.35 105.61 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.061 0.544 . . . . 0.0 109.947 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 60.41 41.82 15.51 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.514 1.126 . . . . 0.0 110.708 173.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.39 -18.35 57.15 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 114.595 -1.184 . . . . 0.0 114.027 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -108.79 116.39 31.89 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.626 0.77 . . . . 0.0 110.093 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 48.1 mt-30 -70.89 131.49 43.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.857 0.463 . . . . 0.0 109.782 174.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.527 ' NH2' HD21 ' A' ' 24' ' ' LEU . 65.1 ttp85 -152.87 142.9 22.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.34 0.656 . . . . 0.0 109.727 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 38.5 tt0 -83.66 127.05 33.48 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.4 m -120.14 164.15 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.046 0.938 . . . . 0.0 111.069 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -102.89 -1.72 29.09 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.668 1.187 . . . . 0.0 109.744 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.1 m -67.07 99.37 0.65 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 124.304 1.042 . . . . 0.0 111.003 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.69 -14.51 58.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.115 0.566 . . . . 0.0 110.822 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 44.2 t -127.57 154.35 45.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.102 0.961 . . . . 0.0 109.753 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.446 ' O ' ' HG2' ' A' ' 21' ' ' MET . 95.2 t -65.7 -38.56 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.661 0.785 . . . . 0.0 110.774 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.51 95.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.473 0.309 . . . . 0.0 110.882 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.04 80.21 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.708 0.803 . . . . 0.0 111.318 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.476 HD11 HD13 ' A' ' 5' ' ' ILE . 28.1 tp -64.98 -45.94 83.55 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.84 0.713 . . . . 0.0 111.358 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 83.0 mmm -68.17 -24.86 65.02 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.726 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.0 m -74.95 -45.37 42.76 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.935 0.494 . . . . 0.0 110.721 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -57.69 -47.48 82.22 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.805 0.842 . . . . 0.0 110.675 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.527 HD21 ' NH2' ' A' ' 10' ' ' ARG . 80.8 mt -84.47 1.47 45.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.246 -175.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 61.73 20.44 11.37 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.574 1.15 . . . . 0.0 111.119 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.481 ' SG ' HG21 ' A' ' 58' ' ' ILE . 36.1 t -94.08 10.59 33.06 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.833 1.253 . . . . 0.0 111.321 -170.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -100.05 -27.03 13.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.985 0.514 . . . . 0.0 110.395 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.75 -61.59 2.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.008 0.923 . . . . 0.0 112.53 -174.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.65 -167.14 31.56 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.989 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -86.57 63.63 8.09 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.361 0.664 . . . . 0.0 110.357 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -106.53 170.52 7.88 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.125 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.83 173.26 12.01 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.464 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG12 ' NE1' ' A' ' 45' ' ' TRP . 14.8 p -139.86 140.48 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.05 0.54 . . . . 0.0 109.834 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.99 100.33 7.48 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.151 0.98 . . . . 0.0 108.52 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 tp -92.56 113.81 26.19 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 64.29 37.14 8.77 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.365 1.041 . . . . 0.0 110.374 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 79.26 -17.04 0.62 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 126.584 1.954 . . . . 0.0 112.741 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -96.52 119.83 35.72 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -171.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 p -67.36 126.54 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.316 0.579 . . . . 0.0 110.756 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.44 119.35 65.48 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.43 156.25 42.39 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.394 2.063 . . . . 0.0 112.485 174.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -60.87 -39.27 88.54 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.089 0.555 . . . . 0.0 111.702 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.89 -19.97 59.38 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 123.72 0.638 . . . . 0.0 113.035 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -99.53 -20.16 16.54 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 117.83 -1.081 . . . . 0.0 111.593 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.425 ' NE1' HG12 ' A' ' 33' ' ' VAL . 39.4 m0 -49.73 -47.3 50.78 Favored 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 119.399 0.999 . . . . 0.0 110.999 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.98 -45.26 78.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.889 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -72.09 -15.16 62.0 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.488 1.115 . . . . 0.0 112.577 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 m -104.52 129.33 25.2 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.369 0.668 . . . . 0.0 110.28 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 54.0 Cg_endo -84.58 174.77 7.51 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.698 2.266 . . . . 0.0 113.267 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.451 HG13 HD11 ' A' ' 56' ' ' ILE . 67.3 t -117.89 126.65 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.603 1.161 . . . . 0.0 108.766 173.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -108.91 145.11 35.91 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.384 1.074 . . . . 0.0 109.027 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.14 118.29 5.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.304 0.642 . . . . 0.0 111.388 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.87 -2.0 31.83 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.53 -0.595 . . . . 0.0 114.055 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.38 131.27 44.54 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.534 0.667 . . . . 0.0 112.156 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -84.77 92.56 8.25 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 39.4 mt -100.33 95.86 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.417 1.087 . . . . 0.0 108.676 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.75 120.3 37.89 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.71 -0.619 . . . . 0.0 110.086 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.481 HG21 ' SG ' ' A' ' 26' ' ' CYS . 76.6 mt -76.32 121.98 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.4 mt -112.63 142.51 45.14 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.604 0.762 . . . . 0.0 109.753 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 m -116.16 87.64 20.13 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.74 166.13 30.43 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.6 2.2 . . . . 0.0 112.642 -165.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.8 mtt-85 -62.84 86.92 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.812 0.845 . . . . 0.0 111.709 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 173.44 -61.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 -170.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.65 -14.44 50.06 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.208 170.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.5 15.71 44.41 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 123.001 0.334 . . . . 0.0 113.026 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.2 mt -90.57 100.05 12.96 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.268 1.027 . . . . 0.0 108.413 174.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.6 81.29 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.702 0.801 . . . . 0.0 111.321 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -150.78 145.51 25.79 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -62.15 87.8 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -168.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -87.68 -25.29 23.56 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.944 1.298 . . . . 0.0 109.386 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -139.01 146.27 40.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.359 1.064 . . . . 0.0 110.825 -175.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -179.64 -46.82 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.188 1.395 . . . . 0.0 109.286 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 76.2 t60 . . . . . 0 CA--C 1.552 1.03 0 C-N-CA 124.851 1.26 . . . . 0.0 109.267 -174.11 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' HG12 ' A' ' 50' ' ' VAL . 49.5 ttm . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.2 tp -79.62 105.14 10.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.52 0.728 . . . . 0.0 109.51 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.0 m -125.32 139.39 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.294 1.038 . . . . 0.0 109.664 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.5 m -77.03 99.58 5.36 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.524 HD12 ' HD3' ' A' ' 10' ' ' ARG . 50.5 mt -97.55 114.27 34.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 123.148 0.579 . . . . 0.0 109.643 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 55.3 t30 59.87 35.57 21.85 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.671 1.588 . . . . 0.0 111.434 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.39 -3.36 83.85 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.978 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -109.37 130.98 55.48 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 117.464 0.632 . . . . 0.0 110.469 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -69.98 103.02 2.14 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 174.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.524 ' HD3' HD12 ' A' ' 5' ' ' ILE . 53.1 ttt180 -122.17 122.54 39.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.703 0.801 . . . . 0.0 110.113 -173.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -88.43 104.62 16.96 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.48 160.59 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.72 0.808 . . . . 0.0 109.94 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -105.44 -1.35 25.06 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.311 0.644 . . . . 0.0 111.011 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.2 p -77.18 117.28 18.56 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.829 0.852 . . . . 0.0 110.744 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.61 1.73 56.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.954 0.901 . . . . 0.0 111.73 174.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -125.65 142.98 51.23 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.366 1.066 . . . . 0.0 109.58 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.56 -28.23 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.236 0.614 . . . . 0.0 110.39 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.67 -54.41 39.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.759 0.424 . . . . 0.0 110.303 172.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.54 64.77 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.911 0.757 . . . . 0.0 111.679 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.02 -58.93 6.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 172.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.546 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 95.7 mmm -63.43 -32.62 74.12 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.106 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.2 m -66.62 -44.84 80.96 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.057 0.543 . . . . 0.0 110.059 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.95 -31.09 68.64 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.966 0.906 . . . . 0.0 110.382 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.6 mt -91.89 -0.69 57.51 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.754 0.822 . . . . 0.0 111.127 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 63.97 38.81 8.47 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.098 1.359 . . . . 0.0 112.942 171.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.5 m -118.82 27.24 9.01 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.118 1.367 . . . . 0.0 110.832 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 p -96.51 20.49 10.58 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.665 0.786 . . . . 0.0 110.865 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.37 -36.61 80.72 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.468 0.707 . . . . 0.0 110.892 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.31 -55.92 0.68 Allowed Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.165 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -78.48 14.08 1.38 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.538 0.735 . . . . 0.0 112.501 -177.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -108.04 150.41 27.19 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.546 0.738 . . . . 0.0 109.808 174.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -127.01 167.31 16.08 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.225 1.01 . . . . 0.0 109.111 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.546 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 8.5 p -133.06 148.21 31.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.41 109.37 11.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.988 0.423 . . . . 0.0 109.916 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.9 tp -88.11 109.28 19.76 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 60.57 51.25 5.2 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 124.755 1.284 . . . . 0.0 110.62 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 72.02 6.74 5.66 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 125.374 1.47 . . . . 0.0 113.671 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -124.5 127.28 47.22 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.129 0.572 . . . . 0.0 109.926 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 p -64.49 135.15 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 124.191 0.932 . . . . 0.0 111.687 -175.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.13 122.48 57.94 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.92 152.61 63.1 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.393 2.062 . . . . 0.0 112.607 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -54.16 -52.53 60.86 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.423 1.089 . . . . 0.0 113.056 -170.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.59 -9.5 61.97 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 116.412 -0.358 . . . . 0.0 113.266 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HD2' ' HB2' ' A' ' 47' ' ' GLU . 54.8 tptt -96.54 -15.44 21.63 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.23 1.012 . . . . 0.0 110.057 -177.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -52.91 -44.41 66.94 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.176 0.591 . . . . 0.0 111.191 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.46 -38.18 80.86 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.002 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HB2' ' HD2' ' A' ' 44' ' ' LYS . 32.8 mt-10 -75.41 -21.41 58.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.796 0.838 . . . . 0.0 112.09 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.0 m -100.3 117.89 62.25 Favored Pre-proline 0 N--CA 1.47 0.544 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.93 165.98 27.56 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.079 1.853 . . . . 0.0 112.604 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' SD ' ' A' ' 1' ' ' MET . 61.7 t -99.79 141.21 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 167.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.9 m -134.44 139.72 45.73 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.09 144.24 56.82 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.692 0.797 . . . . 0.0 111.088 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 -10.98 71.3 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.554 -0.581 . . . . 0.0 112.893 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -87.13 162.45 17.52 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.364 0.602 . . . . 0.0 110.788 174.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -121.06 99.36 6.45 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.835 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 55.8 mt -103.24 153.51 5.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 C-N-CA 124.711 1.204 . . . . 0.0 109.154 -176.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -146.62 139.28 25.18 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 119.26 0.936 . . . . 0.0 109.441 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.1 mt -85.07 121.04 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 84.7 mt -91.32 125.91 36.24 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.906 0.883 . . . . 0.0 109.448 176.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 63' ' ' GLN . 65.7 p -108.95 87.46 4.62 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 173.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.37 121.68 9.77 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.115 2.543 . . . . 0.0 112.363 -169.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 72.4 -3.04 2.41 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.358 1.463 . . . . 0.0 112.842 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.453 ' HB2' ' HB ' ' A' ' 60' ' ' THR . 79.5 mm-40 -100.77 158.05 16.25 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.032 0.933 . . . . 0.0 110.645 -174.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.52 -79.53 1.9 Allowed Glycine 0 C--N 1.341 0.832 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -174.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.8 122.11 2.24 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-O 119.05 -0.861 . . . . 0.0 111.002 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -56.47 -72.5 0.08 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.722 0.809 . . . . 0.0 111.716 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 46.89 58.14 5.01 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.571 1.169 . . . . 0.0 111.452 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -40.28 99.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 124.514 1.134 . . . . 0.0 112.76 -172.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -57.71 110.51 0.91 Allowed 'General case' 0 C--N 1.358 0.968 0 CA-C-N 114.722 -1.127 . . . . 0.0 110.14 -172.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -74.19 107.7 6.53 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -68.58 -40.81 80.39 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.334 0.654 . . . . 0.0 111.009 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 74.75 -60.33 0.52 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.985 1.714 . . . . 0.0 111.902 -177.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 79.3 t60 . . . . . 0 CA--C 1.558 1.276 0 C-N-CA 124.649 1.18 . . . . 0.0 109.317 -173.525 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptp . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.5 tp -80.54 100.7 8.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.626 0.77 . . . . 0.0 108.972 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.412 HG11 HG12 ' A' ' 50' ' ' VAL . 17.3 m -123.02 137.33 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.565 0.746 . . . . 0.0 110.515 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 26.5 m -73.44 97.26 2.51 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.455 0.702 . . . . 0.0 109.623 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 62.8 mt -95.17 108.21 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.112 0.565 . . . . 0.0 109.629 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 62.85 28.73 16.51 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.244 1.018 . . . . 0.0 111.277 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.56 -6.53 65.31 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 113.84 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -105.47 113.02 26.35 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.712 0.805 . . . . 0.0 109.626 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 47.7 mt-30 -64.78 103.11 0.66 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 173.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -118.7 127.75 53.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.356 1.062 . . . . 0.0 109.795 -170.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -86.08 102.63 14.01 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.876 1.27 . . . . 0.0 109.415 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -105.36 168.9 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.899 0.88 . . . . 0.0 111.064 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -110.57 -4.52 15.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.577 0.751 . . . . 0.0 111.776 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -91.71 129.99 37.58 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.581 0.753 . . . . 0.0 111.88 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.46 -6.25 37.7 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.334 1.053 . . . . 0.0 112.557 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 42.5 t -123.52 147.29 47.38 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.108 0.963 . . . . 0.0 109.173 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.3 -34.67 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.145 0.978 . . . . 0.0 111.269 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.73 -52.04 67.1 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 -29.16 69.19 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.9 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.42 -52.89 22.59 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.84 0.856 . . . . 0.0 110.32 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 91.2 mmm -62.94 -34.44 77.47 Favored 'General case' 0 CA--C 1.554 1.1 0 O-C-N 123.72 0.637 . . . . 0.0 109.979 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -70.9 -36.08 72.58 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.238 0.615 . . . . 0.0 110.895 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.73 -35.11 76.71 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.073 0.949 . . . . 0.0 110.433 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.532 HD11 HD13 ' A' ' 5' ' ' ILE . 76.9 mt -93.32 -0.81 56.53 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.885 0.874 . . . . 0.0 112.006 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.3 t70 69.74 15.03 8.09 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.079 0.952 . . . . 0.0 112.189 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.418 ' SG ' HD13 ' A' ' 58' ' ' ILE . 27.6 m . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 124.331 1.052 . . . . 0.0 111.902 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.17 160.86 40.79 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.024 1.33 . . . . 0.0 108.491 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.579 HG23 HG23 ' A' ' 56' ' ' ILE . 7.7 p -115.56 136.69 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.291 0.637 . . . . 0.0 109.493 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -118.24 99.89 7.15 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.1 tp -88.98 107.64 19.14 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 62.3 38.74 13.01 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.114 0.966 . . . . 0.0 110.11 -172.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 72.89 -5.86 1.81 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 125.407 1.483 . . . . 0.0 112.463 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -92.02 111.37 22.88 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -67.65 122.85 19.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 O-C-N 123.516 0.51 . . . . 0.0 111.033 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.445 ' HB ' HG13 ' A' ' 33' ' ' VAL . 60.9 t -90.66 119.23 69.05 Favored Pre-proline 0 C--O 1.247 0.939 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.85 144.93 64.35 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.576 2.184 . . . . 0.0 111.178 171.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -31.33 65.39 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.943 0.777 . . . . 0.0 112.7 -175.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.39 -2.36 41.48 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-O 119.384 -0.675 . . . . 0.0 114.11 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -119.16 -3.64 10.58 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.102 0.961 . . . . 0.0 112.228 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -55.0 -41.03 70.77 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.227 0.611 . . . . 0.0 112.239 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.01 -35.16 66.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.356 0.662 . . . . 0.0 110.817 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.55 -26.64 64.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.732 0.813 . . . . 0.0 111.488 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.3 m -97.0 117.58 65.67 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 84.7 Cg_endo -81.58 161.87 19.3 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.388 2.059 . . . . 0.0 111.783 168.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.412 HG12 HG11 ' A' ' 3' ' ' VAL . 13.7 t -90.29 147.15 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 p -124.09 133.74 53.54 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.736 0.814 . . . . 0.0 109.593 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.15 127.49 32.41 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.703 0.801 . . . . 0.0 111.985 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.83 7.64 74.29 Favored Glycine 0 N--CA 1.472 1.073 0 O-C-N 123.798 0.686 . . . . 0.0 113.637 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.21 167.32 16.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.429 0.691 . . . . 0.0 109.559 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -114.98 101.55 9.12 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.184 0.593 . . . . 0.0 109.939 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.579 HG23 HG23 ' A' ' 33' ' ' VAL . 2.7 mp -97.88 97.83 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 124.37 1.068 . . . . 0.0 108.919 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 41.9 tt0 -91.43 108.92 20.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.328 0.651 . . . . 0.0 109.467 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.418 HD13 ' SG ' ' A' ' 26' ' ' CYS . 68.9 mt -78.13 109.72 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 123.198 0.599 . . . . 0.0 110.969 178.26 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 120.842 0.353 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 47.1 tp -79.02 113.44 17.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.606 0.763 . . . . 0.0 109.345 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.04 179.64 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.206 1.002 . . . . 0.0 109.236 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 25.2 m -120.64 101.66 7.89 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 118.775 0.716 . . . . 0.0 110.092 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.56 HD13 HD11 ' A' ' 24' ' ' LEU . 71.5 mt -95.71 117.2 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 123.624 0.769 . . . . 0.0 109.887 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 61.74 22.07 12.69 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.894 1.278 . . . . 0.0 112.567 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.84 1.49 65.5 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-O 120.072 -0.293 . . . . 0.0 113.713 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.78 126.71 50.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.696 0.798 . . . . 0.0 109.8 172.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 42.9 mt-30 -69.84 135.79 50.0 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.971 0.415 . . . . 0.0 111.354 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -146.95 136.4 22.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.402 1.081 . . . . 0.0 108.519 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 45.4 tt0 -81.5 123.0 28.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.468 0.707 . . . . 0.0 109.442 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.92 160.01 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.931 0.892 . . . . 0.0 109.324 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.55 -2.3 9.98 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.713 0.405 . . . . 0.0 111.006 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.5 p -66.21 107.97 2.13 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.604 0.762 . . . . 0.0 110.252 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.26 60.2 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.676 0.79 . . . . 0.0 112.874 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.6 p -112.03 150.03 31.21 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 33' ' ' VAL . 72.7 t -67.61 -33.4 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.247 0.619 . . . . 0.0 110.368 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.42 -46.18 90.95 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.973 0.509 . . . . 0.0 110.84 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -59.14 -44.31 92.07 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 124.167 0.917 . . . . 0.0 110.525 177.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.8 tp -63.94 -44.45 92.82 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.935 0.772 . . . . 0.0 111.674 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 95.0 mmm -63.31 -28.04 69.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.851 0.46 . . . . 0.0 110.598 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -74.56 -39.07 62.52 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.188 0.595 . . . . 0.0 111.496 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 10.6 mm-40 -63.84 -38.86 92.68 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.503 0.668 . . . . 0.0 110.36 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 5' ' ' ILE . 79.4 mt -91.32 -1.87 57.53 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.598 -176.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.19 28.86 14.05 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.829 1.252 . . . . 0.0 113.179 171.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.6 m . . . . . 0 CA--C 1.545 0.753 0 C-N-CA 124.47 1.108 . . . . 0.0 110.726 178.29 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.468 0.434 0 CA-C-O 121.756 0.789 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -133.45 -176.39 4.13 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.937 168.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 17' ' ' VAL . 8.5 p -146.56 158.25 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.52 110.3 10.39 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.193 0.597 . . . . 0.0 110.529 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.405 ' HG ' HD22 ' A' ' 36' ' ' ASN . 56.9 tp -89.31 109.27 20.18 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.405 HD22 ' HG ' ' A' ' 35' ' ' LEU . 50.0 m-80 52.28 65.86 1.38 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.958 1.303 . . . . 0.0 111.866 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 68.43 1.16 2.82 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 124.941 1.296 . . . . 0.0 112.696 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -119.35 116.64 26.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.002 0.921 . . . . 0.0 109.532 -171.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.62 119.87 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 123.764 0.665 . . . . 0.0 111.06 -174.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 48' ' ' THR . 91.8 t -92.52 124.16 59.93 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.064 0.946 . . . . 0.0 108.813 176.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.95 154.7 66.72 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.364 2.043 . . . . 0.0 111.412 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -56.11 -41.38 75.17 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.298 1.039 . . . . 0.0 112.473 -171.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.63 14.17 5.89 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 114.361 0.504 . . . . 0.0 114.361 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -17.48 6.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.092 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.431 ' NE1' HG12 ' A' ' 33' ' ' VAL . 50.3 m0 -46.34 -41.86 14.0 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 123.902 0.751 . . . . 0.0 112.492 -175.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.54 -48.5 77.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.547 1.139 . . . . 0.0 111.327 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.52 -0.48 57.27 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.849 0.86 . . . . 0.0 112.253 -175.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.403 HG21 HG21 ' A' ' 40' ' ' VAL . 91.7 m -96.89 120.85 60.84 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.66 146.74 9.48 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.298 1.999 . . . . 0.0 113.636 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.9 t -86.87 130.49 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 109.071 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 54' ' ' ASP . 10.6 m -103.99 146.99 27.89 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.767 0.827 . . . . 0.0 110.043 -173.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.97 116.73 8.95 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.321 0.648 . . . . 0.0 110.973 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.91 33.73 49.85 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.612 0.57 . . . . 0.0 112.659 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.538 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 27.8 p30 -83.87 -165.27 1.08 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.686 0.394 . . . . 0.0 110.779 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -134.85 94.66 3.2 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 37.5 mt -95.04 100.63 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.519 0.727 . . . . 0.0 109.977 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.26 114.1 25.85 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.701 0.801 . . . . 0.0 109.316 177.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.1 mt -77.65 129.85 36.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 90.4 mt . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.116 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.479 0.181 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 9' ' ' GLN . 40.6 tp -86.59 127.42 34.91 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.52 0.728 . . . . 0.0 109.464 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.73 138.02 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.528 1.131 . . . . 0.0 109.267 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 28.4 m -78.33 97.71 5.69 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.174 0.443 . . . . 0.0 109.861 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.403 HG12 ' HB ' ' A' ' 56' ' ' ILE . 55.8 mt -94.22 104.25 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 67.0 t30 62.04 36.2 15.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.63 1.172 . . . . 0.0 111.145 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.94 10.83 82.4 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.517 -0.765 . . . . 0.0 113.496 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -130.19 108.88 10.38 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.869 0.867 . . . . 0.0 108.98 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.549 ' HB3' HD11 ' A' ' 2' ' ' LEU . 98.3 mt-30 -64.92 119.77 11.33 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.539 0.736 . . . . 0.0 110.457 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -126.59 158.11 37.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.844 0.858 . . . . 0.0 110.327 -177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -97.59 113.79 25.58 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.172 0.989 . . . . 0.0 109.741 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.6 m -120.16 147.25 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.832 0.853 . . . . 0.0 110.85 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -119.01 22.2 12.02 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.74 0.781 . . . . 0.0 109.389 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 p -75.97 -49.84 16.56 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.91 1.284 . . . . 0.0 112.418 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 67.21 0.4 2.05 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.676 1.19 . . . . 0.0 113.669 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 39.7 m -154.33 153.6 31.93 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.132 1.373 . . . . 0.0 109.106 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.45 ' CG1' HG11 ' A' ' 33' ' ' VAL . 58.3 t -69.95 -34.36 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 O-C-N 124.297 0.998 . . . . 0.0 112.506 -172.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.23 -53.24 39.48 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 -33.15 70.37 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.137 0.898 . . . . 0.0 111.238 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.653 HD21 HG21 ' A' ' 56' ' ' ILE . 42.0 tp -61.54 -59.88 4.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.194 1.398 . . . . 0.0 111.817 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.522 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 60.6 mtp -73.63 -19.92 60.72 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.477 0.485 . . . . 0.0 111.256 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.1 m -70.97 -41.72 70.67 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 121.159 0.504 . . . . 0.0 110.061 168.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.84 -35.96 70.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.508 1.123 . . . . 0.0 111.312 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.3 mt -80.22 -5.93 56.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.531 0.732 . . . . 0.0 110.707 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.2 t70 65.55 24.62 11.77 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.352 1.461 . . . . 0.0 110.819 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 58' ' ' ILE . 35.0 t . . . . . 0 CA--C 1.554 1.108 0 C-N-CA 124.609 1.163 . . . . 0.0 111.467 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 . . . . . 0 N--CA 1.476 0.859 0 CA-C-O 121.146 0.498 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.81 175.45 9.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.537 1.135 . . . . 0.0 108.467 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.522 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 6.4 p -134.71 144.2 35.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 123.983 0.913 . . . . 0.0 109.649 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -117.77 100.14 7.4 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.4 tp -97.37 112.01 24.02 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 54.47 55.94 7.45 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.588 1.155 . . . . 0.0 111.49 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 62.86 34.85 14.01 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.434 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -152.06 126.39 9.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.039 0.536 . . . . 0.0 109.898 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 t -73.72 126.03 33.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 O-C-N 123.674 0.609 . . . . 0.0 110.38 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.08 117.39 66.8 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.91 152.69 79.67 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.579 2.186 . . . . 0.0 111.059 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -61.37 -38.64 87.76 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -167.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.9 -1.71 33.9 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 123.481 0.488 . . . . 0.0 114.118 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -114.44 -9.35 12.74 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.73 0.812 . . . . 0.0 112.156 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -51.47 -41.03 60.62 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 123.396 0.678 . . . . 0.0 111.399 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -70.96 -38.32 72.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.468 1.107 . . . . 0.0 111.802 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -77.39 -14.84 59.62 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.1 m -106.27 119.58 51.51 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 88.2 Cg_endo -81.77 167.76 16.37 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.396 2.064 . . . . 0.0 112.316 172.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.464 HG11 HD11 ' A' ' 56' ' ' ILE . 63.0 t -118.73 140.85 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.429 1.092 . . . . 0.0 108.271 171.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.1 m -123.24 154.35 38.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.415 1.086 . . . . 0.0 108.815 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.78 126.93 29.55 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.468 0.707 . . . . 0.0 110.662 175.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 -2.96 52.42 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.959 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -76.42 138.72 40.54 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.447 0.624 . . . . 0.0 111.205 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -92.39 110.48 21.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.655 0.782 . . . . 0.0 109.11 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.653 HG21 HD21 ' A' ' 20' ' ' LEU . 56.4 mt -107.26 98.28 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.054 0.942 . . . . 0.0 109.829 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 41.3 tt0 -96.67 117.06 30.19 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.448 HG21 ' SG ' ' A' ' 26' ' ' CYS . 75.2 mt -76.3 141.45 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 N--CA 1.47 0.549 0 C-N-CA 123.457 0.703 . . . . 0.0 110.522 -177.611 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mtp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 9' ' ' GLN . 4.4 tt -79.18 105.22 10.35 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.54 178.02 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.365 1.066 . . . . 0.0 109.021 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.6 m -122.63 100.52 6.96 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.6 mt -95.14 110.04 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.72 0.808 . . . . 0.0 108.982 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.53 HD21 HG13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER 65.23 34.01 8.8 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.166 1.386 . . . . 0.0 110.86 175.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.32 2.52 85.33 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.524 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -115.76 120.2 38.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.163 0.585 . . . . 0.0 110.51 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.468 ' HB3' HD21 ' A' ' 2' ' ' LEU . 47.9 mt-30 -64.11 113.65 3.67 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.406 0.683 . . . . 0.0 110.351 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -125.08 133.56 52.84 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.285 1.034 . . . . 0.0 109.965 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -85.18 114.99 22.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.414 1.086 . . . . 0.0 108.993 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.9 m -125.12 168.55 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.445 1.098 . . . . 0.0 109.089 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -124.83 5.53 8.08 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.453 0.701 . . . . 0.0 109.5 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.4 m -78.58 105.21 9.7 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 123.296 0.638 . . . . 0.0 110.576 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.88 2.47 34.21 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.172 0.589 . . . . 0.0 111.106 171.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.7 t -124.52 133.89 53.18 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.431 1.093 . . . . 0.0 109.261 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 33' ' ' VAL . 66.8 t -63.41 -43.05 98.31 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 O-C-N 123.743 0.652 . . . . 0.0 110.046 174.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -50.39 68.49 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 0.0 111.415 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.06 92.11 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 124.047 0.842 . . . . 0.0 111.207 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.0 tp -60.78 -45.94 92.4 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.968 0.792 . . . . 0.0 111.685 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.0 mmm -71.77 -24.31 61.73 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.214 0.606 . . . . 0.0 111.25 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -69.58 -41.07 76.32 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.901 0.481 . . . . 0.0 110.119 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.44 -37.58 77.45 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.085 0.954 . . . . 0.0 111.51 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -82.81 -4.7 58.34 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.563 0.745 . . . . 0.0 111.145 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.2 t70 69.08 12.25 8.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.491 1.116 . . . . 0.0 111.506 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 124.19 0.996 . . . . 0.0 110.423 -175.058 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 121.076 0.465 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -119.69 167.85 11.63 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.698 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 17' ' ' VAL . 9.8 p -122.82 156.41 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -131.14 100.86 5.35 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -89.84 108.84 19.94 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 59.71 39.75 20.65 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.763 1.225 . . . . 0.0 109.889 -169.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 73.91 -9.28 1.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.99 1.716 . . . . 0.0 113.297 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -77.97 108.94 11.6 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.8 t -67.57 121.72 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 123.6 0.562 . . . . 0.0 109.904 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.482 HG21 HG21 ' A' ' 48' ' ' THR . 67.9 t -105.69 132.56 20.78 Favored Pre-proline 0 C--O 1.245 0.818 0 C-N-CA 124.124 0.97 . . . . 0.0 108.827 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.11 149.83 59.01 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.465 2.11 . . . . 0.0 111.256 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -63.48 -34.2 77.24 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -165.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.96 -29.06 67.12 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 123.384 0.427 . . . . 0.0 112.773 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -95.09 -4.21 46.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.718 0.807 . . . . 0.0 112.718 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -57.9 -29.99 65.52 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 118.495 0.589 . . . . 0.0 110.625 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.24 -39.6 82.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.395 1.078 . . . . 0.0 110.888 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -79.47 -24.84 42.1 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.122 0.969 . . . . 0.0 112.131 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.482 HG21 HG21 ' A' ' 40' ' ' VAL . 56.6 m -92.9 110.98 49.24 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.835 0.854 . . . . 0.0 109.464 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -81.03 171.59 13.93 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.8 2.333 . . . . 0.0 112.439 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.405 HG13 HD11 ' A' ' 56' ' ' ILE . 58.0 t -121.85 138.82 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.209 1.004 . . . . 0.0 108.388 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.2 p -128.69 150.85 50.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.567 1.147 . . . . 0.0 108.294 173.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.63 122.39 15.17 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.522 0.729 . . . . 0.0 110.705 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.01 -13.94 19.43 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.191 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -67.18 139.49 57.44 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 117.198 0.499 . . . . 0.0 111.986 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.68 99.45 12.35 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 50' ' ' VAL . 62.4 mt -98.3 96.28 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.714 0.805 . . . . 0.0 109.289 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 34.5 tt0 -93.67 119.96 33.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.808 0.843 . . . . 0.0 109.726 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.53 HG13 HD21 ' A' ' 6' ' ' ASN . 88.5 mt -87.73 136.42 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 80.0 mt . . . . . 0 N--CA 1.467 0.385 0 C-N-CA 124.245 1.018 . . . . 0.0 109.763 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.523 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 1.3 pmm? . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.91 0.386 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 tt -79.93 118.56 21.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 m -131.0 142.56 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.524 1.129 . . . . 0.0 110.415 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 55' ' ' GLU . 8.3 m -79.75 98.92 7.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.793 0.837 . . . . 0.0 109.437 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.645 HD13 HD11 ' A' ' 24' ' ' LEU . 74.1 mt -104.38 110.77 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.437 HD21 ' HB ' ' A' ' 58' ' ' ILE . 88.9 m-20 64.13 22.42 12.88 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.605 1.162 . . . . 0.0 111.494 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.66 -15.1 64.06 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-O 119.72 -0.489 . . . . 0.0 113.535 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -86.09 133.08 33.91 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 117.401 0.601 . . . . 0.0 109.72 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -75.08 100.16 4.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -105.17 146.2 29.55 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.059 0.944 . . . . 0.0 109.973 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -109.61 104.29 13.29 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 m -113.33 165.14 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.569 0.748 . . . . 0.0 110.156 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -128.1 9.12 6.21 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.661 0.784 . . . . 0.0 109.627 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -57.0 -49.1 76.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.803 1.241 . . . . 0.0 112.799 -170.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 61.78 9.36 2.85 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.179 0.992 . . . . 0.0 112.802 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.2 t -162.05 141.48 9.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.152 1.381 . . . . 0.0 108.109 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.462 HG11 HG11 ' A' ' 33' ' ' VAL . 94.6 t -72.05 -33.39 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.335 0.654 . . . . 0.0 111.461 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.88 -53.6 51.7 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.641 0.376 . . . . 0.0 110.275 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.65 -44.83 73.59 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.66 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.7 tp -58.81 -56.02 27.59 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.273 1.029 . . . . 0.0 111.886 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.2 mtp -68.95 -19.27 64.17 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.027 0.531 . . . . 0.0 111.2 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.7 m -73.27 -46.28 50.8 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.795 0.438 . . . . 0.0 110.663 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -70.1 -34.57 73.3 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.282 1.033 . . . . 0.0 111.604 -175.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.645 HD11 HD13 ' A' ' 5' ' ' ILE . 89.5 mt -79.09 -12.23 60.0 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.522 0.729 . . . . 0.0 111.25 175.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 63.54 24.57 14.08 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.576 1.15 . . . . 0.0 111.027 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.448 ' HB3' HG21 ' A' ' 58' ' ' ILE . 88.3 m . . . . . 0 N--CA 1.47 0.57 0 C-N-CA 125.473 1.509 . . . . 0.0 110.566 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 120.801 0.334 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -138.54 177.96 7.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.088 1.355 . . . . 0.0 108.466 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 HG11 ' A' ' 17' ' ' VAL . 11.1 p -138.17 148.41 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.227 0.537 . . . . 0.0 110.824 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -129.9 105.53 8.05 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.129 1.372 . . . . 0.0 108.037 172.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.0 tp -86.83 105.79 17.27 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 54.74 52.88 11.36 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.266 1.427 . . . . 0.0 110.725 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 74.89 -16.8 0.53 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 125.765 1.626 . . . . 0.0 113.761 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.03 107.71 19.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 75.4 t -69.96 117.49 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.371 0.669 . . . . 0.0 110.874 -176.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.23 119.45 65.59 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 123.853 0.861 . . . . 0.0 109.157 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.33 154.47 74.11 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.421 2.081 . . . . 0.0 112.159 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -59.39 -33.94 71.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.087 0.955 . . . . 0.0 112.115 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.44 1.31 7.21 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.994 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -127.88 -9.82 5.48 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 117.976 -1.011 . . . . 0.0 112.334 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -49.46 -42.33 42.77 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 119.072 0.851 . . . . 0.0 111.685 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -68.09 -41.72 81.42 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.379 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.44 -19.03 60.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.772 0.829 . . . . 0.0 111.812 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.0 m -96.06 115.35 65.51 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.45 169.91 20.98 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.475 2.117 . . . . 0.0 112.832 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.26 104.72 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.802 1.241 . . . . 0.0 108.499 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 p -97.97 166.64 11.35 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.158 0.983 . . . . 0.0 110.678 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 1' ' ' MET . . . -64.22 116.52 6.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.783 0.833 . . . . 0.0 112.003 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.66 26.78 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 119.315 -0.714 . . . . 0.0 114.479 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -74.09 140.52 45.36 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.023 0.912 . . . . 0.0 111.841 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.404 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 42.9 tt0 -89.89 92.56 9.07 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 64.3 mt -96.19 100.91 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.79 0.836 . . . . 0.0 109.861 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -88.92 104.47 16.99 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 26' ' ' CYS . 50.6 mm -78.56 106.69 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 61.1 mt . . . . . 0 C--N 1.323 -0.552 0 C-N-CA 123.298 0.639 . . . . 0.0 110.538 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.466 ' HG2' HG13 ' A' ' 3' ' ' VAL . 1.5 pmm? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.371 0.129 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 44.9 tp -77.86 116.71 18.57 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 173.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.466 HG13 ' HG2' ' A' ' 1' ' ' MET . 32.7 m -120.33 -176.46 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.762 1.225 . . . . 0.0 109.273 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.7 m -126.67 101.65 6.73 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.4 mt -96.29 115.6 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.757 0.823 . . . . 0.0 110.006 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 t30 50.42 52.74 14.21 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.851 1.26 . . . . 0.0 111.243 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.07 -0.8 61.74 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 114.62 -1.173 . . . . 0.0 114.429 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -107.56 109.67 21.38 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.817 0.847 . . . . 0.0 110.155 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -66.32 102.03 0.81 Allowed 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.746 0.784 . . . . 0.0 109.774 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -137.34 136.97 38.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.506 0.722 . . . . 0.0 109.392 -171.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 36.7 tt0 -84.67 130.83 34.66 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.239 0.616 . . . . 0.0 109.595 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.41 177.04 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.713 1.205 . . . . 0.0 108.933 171.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -119.67 7.38 11.05 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.8 m -68.33 112.2 5.07 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 123.441 0.697 . . . . 0.0 110.618 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.97 -16.49 43.91 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.374 0.669 . . . . 0.0 110.728 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.3 t -121.28 141.34 50.99 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.319 1.048 . . . . 0.0 109.432 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.3 t -69.77 -30.19 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 123.535 0.522 . . . . 0.0 110.371 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.74 64.21 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.456 0.702 . . . . 0.0 110.368 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.39 90.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.544 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 53.6 tp -61.77 -54.58 40.43 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.626 0.578 . . . . 0.0 110.888 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.3 mmm -61.57 -32.31 72.39 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.044 0.84 . . . . 0.0 110.905 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -70.03 -40.94 74.87 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.212 0.605 . . . . 0.0 110.887 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.52 -20.77 59.85 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.097 0.559 . . . . 0.0 111.376 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 92.8 mt -87.29 -6.43 58.53 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.056 0.543 . . . . 0.0 110.081 172.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.5 t70 62.03 31.47 17.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.147 1.379 . . . . 0.0 110.564 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.5 t . . . . . 0 CA--C 1.553 1.063 0 C-N-CA 125.223 1.409 . . . . 0.0 109.286 -177.852 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 121.111 0.482 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.1 179.54 9.05 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.82 1.248 . . . . 0.0 108.784 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.459 HG12 ' NE1' ' A' ' 45' ' ' TRP . 7.3 p -147.06 119.09 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.246 0.546 . . . . 0.0 110.299 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -80.32 97.48 7.03 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 171.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.427 HD13 HG12 ' A' ' 56' ' ' ILE . 46.5 tp -92.11 120.49 32.77 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.4 m120 63.45 25.72 14.62 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.69 1.196 . . . . 0.0 110.071 -173.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 74.47 8.31 4.46 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 126.256 1.822 . . . . 0.0 112.644 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -106.04 126.91 52.77 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.49 124.16 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.564 0.746 . . . . 0.0 111.094 -171.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.5 116.69 57.38 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.536 1.135 . . . . 0.0 109.063 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.537 ' HD2' ' HD3' ' A' ' 44' ' ' LYS . 57.4 Cg_endo -70.23 164.26 35.65 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.858 2.372 . . . . 0.0 112.135 173.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -56.53 -43.42 79.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.081 0.952 . . . . 0.0 112.66 -172.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.8 -30.18 74.32 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 123.804 0.69 . . . . 0.0 113.301 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.537 ' HD3' ' HD2' ' A' ' 41' ' ' PRO . 28.2 mtpp -82.01 -25.92 34.28 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.328 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.459 ' NE1' HG12 ' A' ' 33' ' ' VAL . 51.9 m0 -49.19 -36.34 19.43 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 123.76 0.824 . . . . 0.0 111.65 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.73 -54.23 38.62 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.012 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -86.03 2.78 45.12 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.092 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.7 m -108.37 114.67 59.05 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.1 166.12 12.9 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.579 2.186 . . . . 0.0 113.29 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 56' ' ' ILE . 49.1 t -95.17 147.75 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.884 0.873 . . . . 0.0 108.839 172.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 m -123.51 149.16 45.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.848 0.859 . . . . 0.0 110.119 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.29 113.76 3.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.462 0.305 . . . . 0.0 111.243 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.83 39.3 24.95 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.448 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -94.39 164.84 12.84 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.823 0.449 . . . . 0.0 111.386 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -101.15 86.99 3.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.566 0.698 . . . . 0.0 110.204 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.457 HD11 HG13 ' A' ' 50' ' ' VAL . 82.5 mt -86.19 144.2 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.026 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 33.8 tt0 -147.48 136.25 22.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mm -83.29 134.73 26.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.1 mt . . . . . 0 C--N 1.323 -0.546 0 C-N-CA 124.013 0.925 . . . . 0.0 109.543 178.038 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' HG12 ' A' ' 50' ' ' VAL . 23.8 ptp . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 121.064 0.459 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.9 tt -85.43 107.27 17.32 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.484 HG23 HG13 ' A' ' 5' ' ' ILE . 28.6 m -118.69 162.04 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.396 1.079 . . . . 0.0 109.449 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.3 m -94.12 101.52 13.53 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.121 0.569 . . . . 0.0 109.711 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.657 HD13 HD11 ' A' ' 24' ' ' LEU . 69.1 mt -100.02 107.85 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.2 m120 68.26 22.21 8.19 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.917 1.287 . . . . 0.0 112.399 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.17 4.91 66.22 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.455 -0.339 . . . . 0.0 112.66 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -119.99 111.57 18.07 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.143 0.977 . . . . 0.0 108.488 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -60.2 111.28 1.47 Allowed 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.953 0.406 . . . . 0.0 110.287 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -119.94 131.34 55.17 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.626 1.17 . . . . 0.0 108.872 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -80.65 124.42 28.99 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 170.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.43 163.3 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.311 1.044 . . . . 0.0 108.973 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -114.73 -2.22 13.07 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.862 0.465 . . . . 0.0 111.539 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -70.77 117.3 12.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.718 0.407 . . . . 0.0 110.851 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.55 14.27 19.34 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.196 0.998 . . . . 0.0 110.931 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 p -142.38 141.57 32.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.501 1.12 . . . . 0.0 108.702 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.508 HG11 HG11 ' A' ' 33' ' ' VAL . 98.7 t -67.74 -31.73 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 124.027 0.829 . . . . 0.0 112.033 -172.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.5 -45.87 78.14 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.46 0.304 . . . . 0.0 110.521 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -61.29 -38.12 85.63 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.076 0.86 . . . . 0.0 111.092 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.1 tp -62.63 -50.57 70.7 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.902 0.881 . . . . 0.0 111.438 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.5 mtp -72.84 -16.8 61.59 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.65 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.2 m -69.54 -45.84 67.84 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 166.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 22.2 mm-40 -65.89 -30.6 71.23 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.243 0.617 . . . . 0.0 112.217 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.657 HD11 HD13 ' A' ' 5' ' ' ILE . 60.7 mt -99.6 -0.82 39.62 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.634 0.774 . . . . 0.0 111.675 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t70 62.4 25.45 15.18 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.076 1.35 . . . . 0.0 111.503 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.9 m . . . . . 0 CA--C 1.547 0.851 0 C-N-CA 124.434 1.094 . . . . 0.0 110.622 178.232 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 . . . . . 0 C--O 1.237 0.429 0 CA-C-O 121.093 0.473 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.67 134.64 54.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.508 HG11 HG11 ' A' ' 17' ' ' VAL . 11.0 p -106.05 137.92 33.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.43 100.56 8.86 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.419 HD12 HG12 ' A' ' 56' ' ' ILE . 28.5 tp -87.01 108.64 18.94 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 60.39 39.45 18.57 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.232 0.957 . . . . 0.0 110.182 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 68.21 13.87 9.14 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.28 1.432 . . . . 0.0 113.184 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -111.7 116.99 31.67 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.8 t -67.15 126.97 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.247 0.619 . . . . 0.0 111.181 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.7 t -103.8 127.86 28.53 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.544 1.137 . . . . 0.0 108.333 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.68 161.39 33.85 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.947 2.431 . . . . 0.0 111.836 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -59.18 -41.72 89.12 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.476 0.71 . . . . 0.0 112.864 -169.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.45 -29.13 70.81 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 123.373 0.421 . . . . 0.0 112.899 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -88.74 -14.89 36.11 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-O 117.936 -1.031 . . . . 0.0 112.177 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -53.88 -43.37 69.55 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.96 0.8 . . . . 0.0 111.701 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.1 -42.14 85.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.669 0.788 . . . . 0.0 110.432 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -75.77 -21.18 57.65 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.46 1.104 . . . . 0.0 112.445 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 83.8 m -95.0 116.81 66.73 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.27 169.81 16.05 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.409 2.073 . . . . 0.0 112.744 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' SD ' ' A' ' 1' ' ' MET . 98.2 t -121.91 134.62 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 169.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.8 p -128.0 155.69 43.89 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.118 0.967 . . . . 0.0 108.753 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.9 134.08 55.66 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.613 0.571 . . . . 0.0 111.67 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.1 -13.04 57.44 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-O 118.979 -0.901 . . . . 0.0 114.393 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -60.25 137.8 58.05 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -82.43 82.04 8.04 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 62.2 mt -88.58 95.41 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.87 106.13 16.64 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -174.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.8 mt -93.04 100.93 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.539 0.685 . . . . 0.0 109.44 -174.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.1 mt . . . . . 0 C--N 1.325 -0.478 0 C-N-CA 124.286 1.035 . . . . 0.0 110.746 176.834 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.414 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 1.7 pmm? . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.594 0.235 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 9' ' ' GLN . 48.1 tp -89.24 128.15 35.82 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.404 HG23 HG13 ' A' ' 5' ' ' ILE . 6.9 m -140.25 158.33 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.591 1.156 . . . . 0.0 109.325 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -92.29 98.78 11.72 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 62.1 mt -106.61 120.33 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.9 m120 64.01 21.27 12.54 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.692 1.197 . . . . 0.0 111.945 -176.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.75 0.51 78.47 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 119.721 -0.488 . . . . 0.0 114.12 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -115.21 161.11 18.89 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.778 0.789 . . . . 0.0 110.0 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 2' ' ' LEU . 2.0 mp0 -81.6 118.75 23.03 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -127.64 125.75 40.73 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.685 1.194 . . . . 0.0 109.605 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -95.1 113.51 25.21 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.26 157.38 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.697 0.799 . . . . 0.0 110.775 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.15 -2.29 15.0 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.744 0.818 . . . . 0.0 110.607 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 m -60.55 -44.66 95.89 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.76 1.224 . . . . 0.0 112.972 -168.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 75.45 -43.17 0.49 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.245 1.418 . . . . 0.0 113.227 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -97.18 146.51 25.0 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 33' ' ' VAL . 54.9 t -67.91 -31.67 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 123.687 0.617 . . . . 0.0 110.457 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.26 -50.25 72.46 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.668 0.387 . . . . 0.0 110.539 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.84 72.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.602 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.2 tp -68.42 -49.24 61.38 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.794 0.838 . . . . 0.0 111.384 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 92.6 mmm -68.49 -22.49 64.55 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.368 0.667 . . . . 0.0 110.325 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -81.67 -39.39 24.43 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.552 0.341 . . . . 0.0 111.493 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.65 -42.62 98.09 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.696 0.798 . . . . 0.0 110.26 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -88.18 -0.09 56.68 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.983 0.913 . . . . 0.0 111.436 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.0 t70 64.31 20.84 12.33 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.04 1.336 . . . . 0.0 112.437 173.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.4 ' SG ' HG21 ' A' ' 58' ' ' ILE . 56.0 m . . . . . 0 CA--C 1.553 1.09 0 C-N-CA 124.318 1.047 . . . . 0.0 111.884 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.401 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -109.92 153.26 24.76 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 17' ' ' VAL . 9.3 p -105.13 146.01 12.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -126.87 101.83 6.76 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.13 116.92 24.63 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.425 HD22 ' N ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER 65.02 28.44 12.46 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 124.604 1.19 . . . . 0.0 110.276 -172.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 68.92 22.2 7.21 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.473 1.509 . . . . 0.0 112.751 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -114.58 115.79 27.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.932 0.893 . . . . 0.0 108.91 172.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.401 HG13 ' HB1' ' A' ' 32' ' ' ALA . 77.1 t -66.65 120.77 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.906 0.882 . . . . 0.0 112.109 -170.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.436 ' HB ' HG13 ' A' ' 33' ' ' VAL . 91.7 t -95.52 126.6 45.03 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.981 1.312 . . . . 0.0 109.248 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.45 157.19 59.44 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 123.111 2.54 . . . . 0.0 112.475 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.452 ' HA ' ' CE2' ' A' ' 45' ' ' TRP . 74.7 ttt180 -59.05 -40.59 85.59 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.921 0.889 . . . . 0.0 112.695 -171.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.41 -17.97 54.48 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.885 0.741 . . . . 0.0 114.349 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -102.89 -8.28 20.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.452 ' CE2' ' HA ' ' A' ' 42' ' ' ARG . 50.7 m0 -55.35 -37.19 67.15 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 120.991 0.424 . . . . 0.0 111.866 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.21 -50.03 71.88 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.343 1.057 . . . . 0.0 111.445 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.1 2.28 40.14 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.594 0.758 . . . . 0.0 112.515 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.3 m -104.53 122.52 43.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.412 0.685 . . . . 0.0 109.517 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.96 161.36 18.38 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.711 2.274 . . . . 0.0 114.584 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.2 94.59 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.7 p -104.36 142.74 34.03 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -60.03 127.42 31.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.4 1.08 . . . . 0.0 113.319 -167.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.03 12.92 75.78 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-O 119.397 -0.668 . . . . 0.0 114.455 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.96 147.06 25.91 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.869 0.835 . . . . 0.0 111.119 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -84.86 81.75 8.75 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.918 1.287 . . . . 0.0 109.842 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 72.7 mt -88.37 96.43 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.911 0.884 . . . . 0.0 109.158 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 10.4 tp10 -93.65 111.14 22.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.4 HG21 ' SG ' ' A' ' 26' ' ' CYS . 55.7 mt -100.55 104.02 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.728 0 C-N-CA 124.304 1.042 . . . . 0.0 110.389 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.461 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.722 0.296 . . . . 0.0 111.213 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 40.8 tp -90.82 116.51 28.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.178 0.991 . . . . 0.0 110.012 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -129.66 140.6 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.406 0.682 . . . . 0.0 110.495 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 59.9 m -71.33 104.58 3.21 Favored 'General case' 0 C--O 1.216 -0.674 0 C-N-CA 123.915 0.886 . . . . 0.0 110.295 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 46.6 mt -102.32 105.45 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 122.825 0.45 . . . . 0.0 109.955 175.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.8 m120 65.62 31.78 9.64 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.09 1.356 . . . . 0.0 112.308 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.13 1.5 81.77 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.944 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -122.4 115.13 21.74 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.745 0.818 . . . . 0.0 109.112 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 1.2 mp0 -68.9 146.01 53.17 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.101 0.56 . . . . 0.0 110.143 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -150.92 139.57 20.66 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.564 0.346 . . . . 0.0 111.267 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.49 99.91 9.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.572 1.149 . . . . 0.0 109.098 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.3 m -121.61 158.73 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.188 0.995 . . . . 0.0 110.259 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -112.14 9.85 20.21 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.635 0.774 . . . . 0.0 110.075 172.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.0 m -73.37 94.04 2.01 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.576 0.75 . . . . 0.0 110.489 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.77 -3.25 37.24 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.432 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.0 t -129.49 148.69 51.42 Favored 'General case' 0 C--O 1.247 0.958 0 C-N-CA 124.616 1.166 . . . . 0.0 109.62 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.514 HG11 HG11 ' A' ' 33' ' ' VAL . 53.5 t -66.32 -33.37 63.07 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.779 0.832 . . . . 0.0 110.623 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.25 -51.62 68.77 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.5 0.72 . . . . 0.0 111.147 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.74 79.93 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.85 0.719 . . . . 0.0 111.301 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.17 -53.71 18.64 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 123.819 0.699 . . . . 0.0 111.462 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.564 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 65.8 mtp -69.79 -34.34 73.61 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.442 0.297 . . . . 0.0 111.498 -175.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.2 m -68.41 -36.09 78.6 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.523 0.329 . . . . 0.0 110.762 175.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.67 -47.31 84.23 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.204 0.526 . . . . 0.0 110.219 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.7 mt -75.79 -8.14 56.14 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.442 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.0 t70 61.42 54.62 3.08 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.145 1.378 . . . . 0.0 110.384 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.7 m . . . . . 0 CA--C 1.544 0.735 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.801 179.038 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.931 0.396 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.43 -175.26 2.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.762 1.225 . . . . 0.0 108.991 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.564 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.1 p -144.96 156.08 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.163 0.585 . . . . 0.0 110.132 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -132.28 102.16 5.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.954 0.901 . . . . 0.0 109.011 176.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.8 tp -86.66 114.99 23.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 56.52 36.29 27.34 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.078 0.951 . . . . 0.0 110.863 -170.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 74.02 -2.03 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.97 1.708 . . . . 0.0 113.106 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -95.87 122.11 38.31 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 59.0 t -70.3 132.75 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.559 0.744 . . . . 0.0 111.799 -170.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.57 124.44 40.77 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -64.61 154.89 69.82 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.71 2.273 . . . . 0.0 111.703 170.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -64.41 -44.14 92.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.694 0.798 . . . . 0.0 112.202 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.61 -3.99 29.84 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.252 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -113.34 -9.45 13.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.147 0.979 . . . . 0.0 113.033 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -52.04 -39.78 60.08 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 119.011 0.823 . . . . 0.0 111.157 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -71.28 -41.9 69.42 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.956 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.95 -12.31 60.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.403 1.081 . . . . 0.0 112.683 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -105.1 115.15 62.78 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -176.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.51 159.14 32.42 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.602 2.201 . . . . 0.0 112.957 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.484 HG13 HD11 ' A' ' 56' ' ' ILE . 84.9 t -119.06 139.19 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.54 1.136 . . . . 0.0 108.004 174.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.8 p -126.26 165.61 18.65 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.256 1.022 . . . . 0.0 109.206 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.461 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -61.7 129.97 43.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.965 0.906 . . . . 0.0 112.244 -176.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.52 2.05 68.09 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.218 -0.768 . . . . 0.0 114.164 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.31 147.14 44.76 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 117.897 0.848 . . . . 0.0 111.755 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.444 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 4.0 mp0 -94.28 92.39 7.19 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.484 HD11 HG13 ' A' ' 50' ' ' VAL . 3.1 mp -84.93 95.02 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 172.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 36.0 tt0 -96.47 100.39 11.99 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.4 mt -73.95 103.55 2.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.2 mt . . . . . 0 N--CA 1.448 -0.539 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.528 178.562 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptp . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.584 0.231 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 52.4 tp -82.18 114.53 20.76 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.472 ' HA ' ' H ' ' A' ' 53' ' ' GLY . 33.8 m -119.31 -180.0 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.276 1.03 . . . . 0.0 110.57 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.6 m -117.74 100.3 7.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.138 0.575 . . . . 0.0 109.655 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 HD11 ' A' ' 24' ' ' LEU . 69.5 mt -102.41 122.27 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.62 0.768 . . . . 0.0 108.98 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 58.92 30.39 20.13 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.274 1.03 . . . . 0.0 111.927 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.06 -2.74 87.08 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 120.028 -0.318 . . . . 0.0 113.64 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.3 136.0 46.8 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.099 0.96 . . . . 0.0 109.929 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -77.92 113.14 15.54 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -132.1 136.61 47.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.545 1.138 . . . . 0.0 109.512 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.95 131.85 35.36 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 5' ' ' ILE . 27.7 m -133.81 155.26 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.632 0.773 . . . . 0.0 110.449 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -93.63 -43.34 8.72 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.041 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 m -58.83 120.99 10.02 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.857 0.863 . . . . 0.0 112.353 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.54 -0.37 57.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.985 0.914 . . . . 0.0 111.261 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.5 t -116.17 141.39 48.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.384 1.073 . . . . 0.0 108.891 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.64 -33.62 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.497 0.719 . . . . 0.0 110.993 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.73 -53.01 61.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.525 0.33 . . . . 0.0 110.308 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -60.19 -39.45 86.56 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.065 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.2 tp -66.0 -48.1 72.32 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.842 0.457 . . . . 0.0 111.255 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.479 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 83.0 mtp -67.94 -25.68 65.58 Favored 'General case' 0 C--O 1.211 -0.955 0 O-C-N 123.372 0.42 . . . . 0.0 110.238 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.1 m -69.45 -40.95 76.85 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 118.16 0.436 . . . . 0.0 110.343 172.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 18.2 mm-40 -65.93 -37.5 86.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.943 0.497 . . . . 0.0 111.105 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 5' ' ' ILE . 95.5 mt -82.0 -12.86 58.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.02 0.928 . . . . 0.0 111.314 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 63.62 51.13 2.57 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.105 1.362 . . . . 0.0 110.553 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.3 m . . . . . 0 CA--C 1.55 0.947 0 C-N-CA 125.339 1.456 . . . . 0.0 110.443 -178.271 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.0 147.8 52.27 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.207 1.003 . . . . 0.0 109.115 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.479 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 5.6 p -106.82 135.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -116.46 100.98 8.24 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.0 tp -88.71 113.72 24.57 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 56.9 42.85 25.78 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.74 1.275 . . . . 0.0 110.072 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 68.04 21.15 8.89 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.385 1.474 . . . . 0.0 112.328 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -124.59 115.44 20.82 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.804 0.842 . . . . 0.0 108.868 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 58.8 t -63.82 127.96 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.55 0.74 . . . . 0.0 111.144 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.43 ' HB ' HG13 ' A' ' 33' ' ' VAL . 98.4 t -96.02 126.64 43.77 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.401 1.081 . . . . 0.0 109.612 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.38 146.22 68.01 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.44 2.093 . . . . 0.0 112.47 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -48.02 -48.55 32.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.892 1.677 . . . . 0.0 113.315 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.1 -15.65 60.99 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 123.749 0.655 . . . . 0.0 114.561 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -106.68 -10.04 16.28 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 117.922 -1.037 . . . . 0.0 112.34 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -46.8 -40.55 13.92 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 123.646 0.778 . . . . 0.0 112.554 -177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -70.08 -41.01 74.67 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.955 0.902 . . . . 0.0 110.64 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -76.72 -11.91 59.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.595 1.158 . . . . 0.0 111.418 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.0 m -92.78 118.12 67.82 Favored Pre-proline 0 C--O 1.243 0.722 0 C-N-CA 123.515 0.726 . . . . 0.0 109.55 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -82.14 156.73 17.42 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.207 1.938 . . . . 0.0 113.021 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.3 t -96.99 138.64 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.748 1.219 . . . . 0.0 107.867 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.9 m -130.02 139.37 51.03 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.228 1.011 . . . . 0.0 109.461 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.66 114.6 2.82 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.96 0.346 . . . . 0.0 111.392 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 3' ' ' VAL . . . 89.74 20.68 42.82 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-O 119.371 -0.683 . . . . 0.0 114.253 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -84.73 165.69 17.64 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.004 0.902 . . . . 0.0 110.229 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.74 85.5 2.24 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.861 0.464 . . . . 0.0 110.117 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 82.8 mt -88.01 97.32 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 36.6 tt0 -103.99 102.52 12.29 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.211 0.605 . . . . 0.0 109.974 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 64.3 mt -97.88 105.77 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.474 0.739 0 C-N-CA 124.52 1.128 . . . . 0.0 110.508 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 120.718 0.294 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 9' ' ' GLN . 59.2 tp -79.65 119.08 22.1 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.954 0.902 . . . . 0.0 110.324 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.47 162.97 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.344 1.058 . . . . 0.0 109.069 176.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 m -105.02 99.99 9.6 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.64 HD13 HD11 ' A' ' 24' ' ' LEU . 32.9 mt -101.5 108.96 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.732 0.813 . . . . 0.0 109.321 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.4 m120 63.48 22.73 13.36 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.249 1.02 . . . . 0.0 112.999 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.94 8.75 72.1 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.358 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -103.91 131.27 51.3 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.729 0.811 . . . . 0.0 108.834 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.489 ' HB3' HD11 ' A' ' 2' ' ' LEU . 24.9 mt-30 -80.05 113.84 18.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 172.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -137.3 130.56 30.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.146 0.578 . . . . 0.0 110.225 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -82.52 129.52 34.93 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.751 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.99 159.56 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.764 0.826 . . . . 0.0 110.136 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -112.32 -12.69 13.53 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.877 0.871 . . . . 0.0 110.371 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 p -66.16 105.47 1.4 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.128 0.971 . . . . 0.0 110.973 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.95 -17.56 62.07 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.813 0.845 . . . . 0.0 111.748 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.7 t -105.03 143.24 33.49 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.01 0.924 . . . . 0.0 110.097 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 21' ' ' MET . 88.0 t -68.16 -33.63 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 173.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.62 95.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.843 0.457 . . . . 0.0 110.511 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.08 79.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.084 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.1 tp -69.42 -43.13 74.02 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.659 0.599 . . . . 0.0 110.695 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 91.8 mmm -67.44 -29.12 68.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.915 0.486 . . . . 0.0 109.988 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 m -79.99 -29.25 39.46 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.682 0.393 . . . . 0.0 110.663 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -68.48 -37.52 80.2 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.759 0.824 . . . . 0.0 109.931 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.64 HD11 HD13 ' A' ' 5' ' ' ILE . 57.4 mt -98.26 8.62 44.56 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.349 1.06 . . . . 0.0 110.851 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 p30 51.03 23.78 1.63 Allowed 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 125.814 1.646 . . . . 0.0 113.389 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.8 m . . . . . 0 CA--C 1.555 1.14 0 C-N-CA 124.749 1.219 . . . . 0.0 110.655 177.899 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.556 0.693 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.59 168.32 22.3 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.764 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.451 HG13 ' HB ' ' A' ' 40' ' ' VAL . 12.8 p -130.91 147.98 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -126.56 104.96 8.4 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.477 1.111 . . . . 0.0 108.447 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 tp -88.35 109.82 20.29 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 57.06 52.22 9.42 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 124.662 1.226 . . . . 0.0 111.191 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 71.18 -2.1 2.49 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.507 1.523 . . . . 0.0 112.988 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -103.7 110.26 22.28 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.78 0.832 . . . . 0.0 108.943 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 78.0 t -69.92 115.76 9.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 122.896 0.479 . . . . 0.0 110.404 -175.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HB ' HG13 ' A' ' 33' ' ' VAL . 58.4 t -87.23 122.39 70.94 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.23 1.012 . . . . 0.0 108.637 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.9 159.17 53.42 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 122.767 2.311 . . . . 0.0 111.145 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -61.56 -34.05 74.91 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.621 0.576 . . . . 0.0 111.985 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.87 -5.85 21.13 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.792 -0.64 . . . . 0.0 114.066 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -119.46 -6.86 10.24 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 117.655 -1.164 . . . . 0.0 112.827 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -55.86 -46.47 78.21 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 120.132 1.333 . . . . 0.0 111.454 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.51 -39.45 67.61 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.782 0.433 . . . . 0.0 110.108 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.77 -22.37 65.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.713 0.805 . . . . 0.0 112.617 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.5 m -99.56 127.88 32.99 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 123.554 0.742 . . . . 0.0 109.596 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -83.34 167.25 13.79 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.558 2.172 . . . . 0.0 113.429 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 56' ' ' ILE . 67.7 t -115.45 125.59 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.278 1.031 . . . . 0.0 108.37 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.5 p -123.8 160.65 26.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.098 0.559 . . . . 0.0 110.207 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -64.29 142.02 58.57 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.824 1.249 . . . . 0.0 112.588 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.28 -13.2 60.53 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-O 119.71 -0.495 . . . . 0.0 114.01 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.82 145.16 40.86 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.73 0.765 . . . . 0.0 112.049 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -93.14 99.67 12.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.207 1.003 . . . . 0.0 110.127 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 61.6 mt -97.89 97.51 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.901 0.881 . . . . 0.0 108.924 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -96.83 107.11 19.54 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.707 0.803 . . . . 0.0 109.536 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.96 114.84 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.525 HD13 ' H ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.634 0 C-N-CA 123.455 0.702 . . . . 0.0 110.414 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.514 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 24.3 ptp . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.653 0.264 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 36.2 tp -81.49 112.32 18.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.39 165.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.955 0.902 . . . . 0.0 110.087 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.7 m -111.64 100.73 9.21 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.972 0.509 . . . . 0.0 109.871 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.45 HD11 HD11 ' A' ' 20' ' ' LEU . 70.7 mt -108.35 117.8 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 124.109 0.964 . . . . 0.0 109.203 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 65.41 24.49 11.99 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.517 1.127 . . . . 0.0 112.644 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.18 -3.08 84.18 Favored Glycine 0 N--CA 1.47 0.908 0 CA-C-N 116.445 -0.343 . . . . 0.0 113.156 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -105.78 154.97 19.76 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.613 1.165 . . . . 0.0 108.42 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -105.27 136.12 45.38 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.074 0.397 . . . . 0.0 110.07 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -141.3 130.97 24.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.293 1.037 . . . . 0.0 109.503 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.15 124.96 29.68 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.3 m -135.99 161.92 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.212 1.005 . . . . 0.0 110.724 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.82 24.08 5.0 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.781 1.232 . . . . 0.0 108.884 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.3 m -55.98 -48.11 76.44 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.932 1.293 . . . . 0.0 113.705 -171.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 77.02 -50.33 0.55 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.953 1.701 . . . . 0.0 111.701 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -108.19 151.55 25.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.033 0.933 . . . . 0.0 109.301 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.442 ' CG1' HG11 ' A' ' 33' ' ' VAL . 87.6 t -66.43 -24.97 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 O-C-N 124.056 0.848 . . . . 0.0 110.754 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.63 -56.73 15.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.73 0.812 . . . . 0.0 110.512 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.12 -30.32 68.03 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.465 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.45 HD11 HD11 ' A' ' 5' ' ' ILE . 48.3 tp -64.49 -54.74 27.68 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.752 0.821 . . . . 0.0 110.703 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.438 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 97.6 mmm -64.78 -26.43 68.35 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.005 0.522 . . . . 0.0 111.527 -177.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.8 m -75.02 -38.49 61.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.66 0.784 . . . . 0.0 110.936 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.91 -45.13 93.93 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.752 HD13 HD11 ' A' ' 58' ' ' ILE . 48.1 mt -72.65 -12.27 60.97 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.569 1.147 . . . . 0.0 111.828 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 63.62 14.36 8.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.936 1.294 . . . . 0.0 111.626 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.2 m . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 124.886 1.274 . . . . 0.0 109.098 179.23 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 121.516 0.674 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.54 154.3 50.11 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.442 HG11 ' CG1' ' A' ' 17' ' ' VAL . 8.8 p -123.1 150.33 27.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.86 99.32 5.7 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.523 HD12 HG12 ' A' ' 56' ' ' ILE . 18.3 tp -90.08 121.12 31.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.73 23.04 8.73 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.635 1.174 . . . . 0.0 108.734 -170.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.474 ' CE2' ' HB3' ' A' ' 55' ' ' GLU . 59.3 m-85 68.96 3.96 4.28 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.848 1.659 . . . . 0.0 113.059 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -92.63 127.17 38.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.282 0.633 . . . . 0.0 109.39 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.9 t -66.27 114.27 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.748 0.819 . . . . 0.0 111.024 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.417 ' HB ' HG13 ' A' ' 33' ' ' VAL . 80.2 t -87.61 120.41 71.03 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.1 143.36 99.55 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.096 2.531 . . . . 0.0 110.739 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -57.8 -40.07 79.07 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.96 -24.19 62.47 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 123.803 0.689 . . . . 0.0 114.173 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -103.13 2.39 34.53 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.427 ' NE1' HG12 ' A' ' 33' ' ' VAL . 40.9 m0 -50.79 -41.93 57.5 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 118.13 0.423 . . . . 0.0 111.031 175.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.25 -49.42 60.76 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.578 0.751 . . . . 0.0 110.884 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.15 -26.02 67.24 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.826 0.85 . . . . 0.0 111.694 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.2 m -95.52 119.56 65.04 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.73 167.88 23.28 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.856 2.371 . . . . 0.0 113.504 176.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.6 t -104.29 145.76 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.609 1.163 . . . . 0.0 109.305 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.1 m -108.58 148.57 30.12 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.579 0.752 . . . . 0.0 109.683 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 1' ' ' MET . . . -65.67 115.34 5.74 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.735 0.814 . . . . 0.0 110.741 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.86 41.1 73.99 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 123.365 0.415 . . . . 0.0 112.551 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.95 149.03 28.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.084 0.554 . . . . 0.0 110.364 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 37' ' ' TYR . 2.9 mp0 -84.63 81.71 8.74 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 121.854 0.835 . . . . 0.0 109.586 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.523 HG12 HD12 ' A' ' 35' ' ' LEU . 32.4 mt -99.04 153.65 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.729 1.212 . . . . 0.0 109.637 -177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -151.17 125.01 9.12 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.469 0.708 . . . . 0.0 109.14 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.752 HD11 HD13 ' A' ' 24' ' ' LEU . 66.8 mt -80.37 105.36 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.4 mt . . . . . 0 C--O 1.221 -0.44 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.282 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtm . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.62 103.52 9.59 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.64 152.13 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.363 1.065 . . . . 0.0 109.118 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 38.9 m -86.37 106.44 17.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.156 0.582 . . . . 0.0 109.577 176.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 70.2 mt -100.22 106.2 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.986 0.515 . . . . 0.0 110.733 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 t30 66.5 23.61 10.44 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.709 1.204 . . . . 0.0 110.708 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.4 -15.58 62.58 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.354 -174.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -98.18 110.31 22.91 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.38 0.672 . . . . 0.0 109.314 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 18.5 mt-30 -71.94 114.5 10.11 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 120.786 0.326 . . . . 0.0 110.15 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.47 ' NH1' HG12 ' A' ' 12' ' ' VAL . 61.1 ttt-85 -131.23 143.87 50.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.419 1.088 . . . . 0.0 109.265 -176.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.3 137.98 35.74 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.47 HG12 ' NH1' ' A' ' 10' ' ' ARG . 33.1 m -114.81 152.94 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 122.841 0.456 . . . . 0.0 111.261 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.92 -38.43 11.7 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 168.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -66.44 120.05 12.69 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.938 0.895 . . . . 0.0 111.849 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.35 -0.88 52.24 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.787 0.835 . . . . 0.0 111.529 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.7 p -122.14 148.11 45.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.059 0.944 . . . . 0.0 109.093 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.6 t -68.61 -31.43 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 123.478 0.711 . . . . 0.0 111.486 -176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.34 -52.8 63.13 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.896 0.478 . . . . 0.0 110.88 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.63 -30.65 71.67 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.137 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.426 HD22 HG21 ' A' ' 50' ' ' VAL . 36.4 tp -71.16 -44.92 64.55 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 124.0 0.812 . . . . 0.0 111.483 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.8 mmm -70.03 -24.38 63.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.719 0.408 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -74.38 -43.01 58.27 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.764 0.426 . . . . 0.0 110.413 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.12 -37.87 86.76 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.719 1.208 . . . . 0.0 110.895 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.524 HD13 HD11 ' A' ' 58' ' ' ILE . 71.3 mt -88.65 -7.73 55.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.306 1.042 . . . . 0.0 111.367 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.5 t70 59.78 42.68 16.33 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.027 1.331 . . . . 0.0 110.933 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.471 0.615 0 C-N-CA 124.386 1.074 . . . . 0.0 110.769 176.505 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 121.425 0.631 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.02 -177.84 4.88 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.412 1.485 . . . . 0.0 108.226 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.449 HG12 ' NE1' ' A' ' 45' ' ' TRP . 7.9 p -149.8 159.61 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.567 ' HB3' ' HG3' ' A' ' 57' ' ' GLU . . . -133.15 109.86 9.76 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.013 0.525 . . . . 0.0 109.737 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.3 tp -88.59 113.02 23.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 59.48 36.44 23.03 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.154 0.982 . . . . 0.0 110.614 -172.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 72.0 13.18 5.97 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.061 1.344 . . . . 0.0 112.217 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -102.02 112.07 24.58 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.922 0.889 . . . . 0.0 109.247 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.4 t -62.93 111.03 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.557 0 O-C-N 123.921 0.763 . . . . 0.0 110.73 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -90.41 121.36 68.54 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.41 151.84 75.71 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.538 2.159 . . . . 0.0 111.053 173.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -58.24 -38.09 76.18 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.916 0.886 . . . . 0.0 113.053 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.67 3.55 25.83 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 114.567 0.587 . . . . 0.0 114.567 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -121.73 -9.96 8.8 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.882 0.873 . . . . 0.0 112.026 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.449 ' NE1' HG12 ' A' ' 33' ' ' VAL . 40.9 m0 -49.66 -39.69 37.12 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.124 0.57 . . . . 0.0 112.23 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -70.06 -43.07 71.96 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.772 0.829 . . . . 0.0 110.819 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -73.08 -14.59 61.43 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 112.303 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.6 m -100.45 120.37 56.38 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.478 0.711 . . . . 0.0 109.324 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -83.99 166.81 12.88 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.897 2.398 . . . . 0.0 113.278 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.426 HG21 HD22 ' A' ' 20' ' ' LEU . 58.6 t -123.6 129.22 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.019 1.328 . . . . 0.0 107.855 175.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.9 p -125.22 149.53 47.89 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.99 126.88 29.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.842 0.857 . . . . 0.0 111.4 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.56 -4.05 39.89 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 119.564 -0.576 . . . . 0.0 113.358 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -78.11 154.64 31.11 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 117.443 0.622 . . . . 0.0 111.366 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -110.09 90.91 3.45 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.778 0.831 . . . . 0.0 109.387 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 4.0 mp -88.13 97.45 6.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.567 ' HG3' ' HB3' ' A' ' 34' ' ' ALA . 8.2 pt-20 -99.1 125.44 44.63 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.69 0.757 . . . . 0.0 109.231 175.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.524 HD11 HD13 ' A' ' 24' ' ' LEU . 70.2 mt -84.74 126.22 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.453 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.0 mt . . . . . 0 C--N 1.328 -0.366 0 C-N-CA 123.687 0.795 . . . . 0.0 109.724 -177.859 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 47.3 tp -79.11 96.88 5.95 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 52' ' ' ALA . 26.8 m -109.92 139.03 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.41 1.084 . . . . 0.0 109.642 -175.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 8.7 m -84.5 99.66 10.86 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -176.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.47 HD13 HD11 ' A' ' 24' ' ' LEU . 65.9 mt -98.6 108.31 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.626 0.77 . . . . 0.0 109.707 -177.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.506 HD22 ' N ' ' A' ' 6' ' ' ASN . 0.7 OUTLIER 67.66 34.09 4.66 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.9 1.28 . . . . 0.0 110.899 176.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.53 10.16 84.64 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.441 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -125.68 110.99 14.43 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.502 1.121 . . . . 0.0 108.244 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 79.6 mt-30 -66.44 143.89 56.84 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -151.43 128.34 11.0 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.815 1.246 . . . . 0.0 108.595 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.83 116.32 22.1 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.67 155.78 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.286 1.035 . . . . 0.0 109.607 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -109.44 -12.6 14.7 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.846 0.859 . . . . 0.0 109.506 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.2 m -57.46 100.07 0.05 OUTLIER 'General case' 0 C--N 1.353 0.731 0 C-N-CA 124.651 1.18 . . . . 0.0 110.672 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.69 -13.98 60.0 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.631 0.773 . . . . 0.0 111.967 -177.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 t -114.42 142.01 46.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 109.46 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.499 HG11 HG11 ' A' ' 33' ' ' VAL . 94.9 t -69.65 -27.07 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.437 0.695 . . . . 0.0 110.435 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.32 -54.32 42.25 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.79 -31.7 71.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.186 0.594 . . . . 0.0 111.474 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.2 -51.97 46.89 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.491 0.716 . . . . 0.0 111.195 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.54 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 76.4 mtp -75.02 -18.8 60.29 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.782 0.433 . . . . 0.0 111.425 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -67.1 -45.23 77.87 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 166.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -67.1 -41.05 86.92 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.277 1.031 . . . . 0.0 111.613 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.47 HD11 HD13 ' A' ' 5' ' ' ILE . 80.9 mt -80.4 -11.55 59.68 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.835 0.854 . . . . 0.0 110.609 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.3 t70 62.81 35.14 13.94 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.138 1.375 . . . . 0.0 110.817 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.618 ' SG ' HD13 ' A' ' 58' ' ' ILE . 59.8 m . . . . . 0 CA--C 1.545 0.753 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.394 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 121.401 0.619 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HA ' ' HZ2' ' A' ' 45' ' ' TRP . . . -153.29 168.97 24.23 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.272 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.54 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 6.6 p -128.76 139.03 52.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 C-N-CA 124.057 0.943 . . . . 0.0 108.855 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 57' ' ' GLU . . . -108.08 104.19 13.57 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.0 tp -90.11 107.02 18.87 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 173.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.16 37.8 14.16 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.65 1.18 . . . . 0.0 110.42 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 71.98 11.85 6.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.084 1.754 . . . . 0.0 112.86 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.84 109.32 21.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 84.7 t -71.2 122.91 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.127 0.571 . . . . 0.0 109.937 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.47 126.97 48.2 Favored Pre-proline 0 C--O 1.246 0.917 0 C-N-CA 124.293 1.037 . . . . 0.0 109.322 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.81 145.69 59.92 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.087 2.525 . . . . 0.0 112.389 170.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -60.33 -42.19 95.13 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.843 0.857 . . . . 0.0 112.277 -173.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.15 11.7 11.33 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-N 116.317 -0.401 . . . . 0.0 113.14 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -126.32 -6.93 6.44 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.243 1.017 . . . . 0.0 110.611 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.403 ' HZ2' ' HA ' ' A' ' 32' ' ' ALA . 52.5 m0 -54.24 -33.74 59.11 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.19 0.596 . . . . 0.0 111.358 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -71.39 -39.58 71.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.983 0.913 . . . . 0.0 110.471 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.29 -17.9 63.1 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.083 0.953 . . . . 0.0 111.773 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 m -96.41 114.5 64.48 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.981 0.512 . . . . 0.0 109.84 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.74 155.85 53.66 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.214 1.943 . . . . 0.0 112.471 168.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.9 t -101.02 129.33 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -127.17 135.75 51.11 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.116 0.566 . . . . 0.0 109.831 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.417 ' HA ' HG12 ' A' ' 3' ' ' VAL . . . -58.49 133.69 56.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.657 1.183 . . . . 0.0 112.598 -176.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.41 -6.1 71.18 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.351 -0.694 . . . . 0.0 114.372 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.29 164.23 15.02 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 117.872 0.836 . . . . 0.0 112.108 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -97.05 108.57 21.33 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.666 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 73.8 mt -111.38 96.96 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.94 0.896 . . . . 0.0 109.535 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -91.33 145.37 24.7 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.427 0.691 . . . . 0.0 109.242 177.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.618 HD13 ' SG ' ' A' ' 26' ' ' CYS . 99.6 mt -120.81 114.51 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.312 0 C-N-CA 124.498 1.119 . . . . 0.0 108.641 -174.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 120.932 0.396 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' A' ' 9' ' ' GLN . 8.5 tt -85.55 114.57 22.66 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.408 HG23 HG13 ' A' ' 5' ' ' ILE . 9.7 m -132.8 139.46 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.246 1.018 . . . . 0.0 110.568 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.9 m -67.79 100.43 0.93 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 55.7 mt -104.19 104.57 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.44 0.696 . . . . 0.0 109.328 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 62.45 31.43 17.13 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 122.375 1.083 . . . . 0.0 110.28 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.44 -6.52 83.25 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 121.649 -0.657 . . . . 0.0 113.402 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -106.31 105.59 15.7 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.516 ' HB3' HD21 ' A' ' 2' ' ' LEU . 27.0 mt-30 -61.21 107.23 0.72 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.522 ' HB3' HD12 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -118.72 121.53 40.33 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -169.177 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -81.42 112.78 19.0 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.921 0.888 . . . . 0.0 109.031 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.77 169.65 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.59 1.156 . . . . 0.0 109.85 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -129.59 17.77 5.82 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.383 0.673 . . . . 0.0 110.847 175.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.0 p -94.96 108.65 20.71 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.336 0.654 . . . . 0.0 109.311 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 49' ' ' PRO . . . -82.79 -0.38 47.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.813 0.845 . . . . 0.0 112.035 178.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.0 t -110.34 135.62 50.78 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.153 0.981 . . . . 0.0 108.916 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.8 t -68.66 -26.69 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.153 0.581 . . . . 0.0 110.451 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.67 -55.2 18.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.086 0.554 . . . . 0.0 109.999 172.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.2 -30.1 69.15 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.65 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -69.11 -54.66 13.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.786 0.834 . . . . 0.0 110.867 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.58 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 78.8 mtp -70.04 -21.5 63.18 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.3 m -75.18 -37.89 61.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.638 0.375 . . . . 0.0 110.021 171.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.6 -40.92 98.45 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.854 0.861 . . . . 0.0 110.389 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.51 HD11 HD13 ' A' ' 5' ' ' ILE . 64.4 mt -86.89 -3.68 59.1 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.387 -176.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.49 19.67 10.52 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.245 1.418 . . . . 0.0 112.682 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.513 ' SG ' HG21 ' A' ' 58' ' ' ILE . 56.2 m . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 125.018 1.327 . . . . 0.0 111.237 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.995 0.426 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.71 159.67 40.92 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.46 1.104 . . . . 0.0 109.333 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.58 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 11.1 p -118.49 148.01 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.523 0.729 . . . . 0.0 110.103 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' A' ' 57' ' ' GLU . . . -129.55 102.53 6.42 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.625 0.77 . . . . 0.0 110.221 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.49 HD13 HG12 ' A' ' 56' ' ' ILE . 64.3 tp -89.67 123.07 33.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.0 m120 64.38 39.13 7.3 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.555 1.142 . . . . 0.0 111.079 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 66.48 21.31 10.82 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.456 1.502 . . . . 0.0 112.0 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -131.89 123.53 27.67 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.946 0.899 . . . . 0.0 108.66 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 59.4 t -66.12 126.27 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.302 0.641 . . . . 0.0 111.07 -176.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.413 ' HB ' HG13 ' A' ' 33' ' ' VAL . 61.2 t -88.7 125.93 61.41 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.057 0.943 . . . . 0.0 109.085 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.06 146.56 91.11 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.605 2.203 . . . . 0.0 112.031 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -59.78 -39.17 84.01 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.37 -14.64 57.56 Favored Glycine 0 CA--C 1.532 1.095 0 O-C-N 123.752 0.657 . . . . 0.0 113.051 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -104.74 -16.67 14.88 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 117.73 -1.129 . . . . 0.0 112.676 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -46.61 -42.82 16.75 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 118.994 0.815 . . . . 0.0 111.908 -176.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -67.43 -42.72 82.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.566 1.146 . . . . 0.0 112.052 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -90.05 -2.98 58.2 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.917 0.487 . . . . 0.0 112.302 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.3 m -89.53 115.61 64.23 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 96.1 Cg_endo -76.82 153.99 33.76 Favored 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 122.364 2.043 . . . . 0.0 112.785 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.3 t -105.22 119.27 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.561 1.144 . . . . 0.0 108.754 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 p -120.63 148.2 44.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.85 0.86 . . . . 0.0 109.88 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.72 131.81 49.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.139 0.976 . . . . 0.0 112.478 -171.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.62 -0.54 82.97 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-O 119.287 -0.729 . . . . 0.0 114.92 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.46 155.37 24.65 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 117.657 0.728 . . . . 0.0 111.561 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -87.77 92.41 9.1 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.594 1.158 . . . . 0.0 109.177 -173.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 62.1 mt -97.83 97.49 6.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 45.0 mt-10 -93.08 116.77 29.35 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.513 HG21 ' SG ' ' A' ' 26' ' ' CYS . 45.8 mm -98.16 118.1 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 123.169 0.588 . . . . 0.0 109.977 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.431 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 21.3 ptp . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 57.9 tp -79.2 107.11 11.71 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.413 HG21 HD12 ' A' ' 56' ' ' ILE . 27.4 m -110.74 179.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.043 0.937 . . . . 0.0 108.879 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 25.2 m -116.43 110.52 18.75 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -106.76 114.14 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.247 0.619 . . . . 0.0 109.603 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 65.35 26.97 12.04 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.054 1.342 . . . . 0.0 111.645 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.37 3.74 74.86 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.121 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -122.9 114.85 21.01 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.21 1.004 . . . . 0.0 109.232 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.621 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 13.9 pt20 -67.73 130.03 41.73 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.058 0.456 . . . . 0.0 111.193 -178.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 42.6 ttm105 -150.59 141.94 23.32 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.2 1.0 . . . . 0.0 109.045 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -80.82 137.78 36.22 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -124.11 144.71 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.114 0.483 . . . . 0.0 110.187 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -93.28 -23.17 18.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.348 1.059 . . . . 0.0 108.984 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.1 p -76.73 110.15 11.09 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.786 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.49 26.14 2.39 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.752 0.821 . . . . 0.0 110.938 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 57.7 m -146.48 149.41 33.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.917 0.887 . . . . 0.0 109.703 173.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.03 -36.51 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.138 0.975 . . . . 0.0 111.998 -174.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.05 -54.33 39.83 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 120.759 0.314 . . . . 0.0 110.495 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.82 -31.68 69.95 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.442 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.408 HD21 HG21 ' A' ' 56' ' ' ILE . 60.4 tp -67.25 -53.31 31.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.843 0.857 . . . . 0.0 111.135 177.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.518 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 71.5 mtp -69.71 -23.37 63.41 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.155 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.4 m -76.0 -35.22 59.64 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.74 -32.31 70.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.288 0.635 . . . . 0.0 110.762 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.35 2.93 56.04 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.477 0.711 . . . . 0.0 111.963 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 65.14 21.69 12.19 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.646 1.178 . . . . 0.0 111.859 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.62 ' SG ' HG21 ' A' ' 58' ' ' ILE . 60.6 m . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 124.596 1.158 . . . . 0.0 110.628 -177.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -124.9 171.92 9.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.981 0.912 . . . . 0.0 108.65 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.518 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.2 p -135.38 140.33 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -110.73 105.71 14.67 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 170.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.3 tp -92.68 115.37 28.05 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 57.83 37.78 27.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.947 1.299 . . . . 0.0 111.734 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 72.49 30.68 1.89 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.93 1.292 . . . . 0.0 112.193 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -137.38 128.77 28.14 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.718 0.807 . . . . 0.0 109.489 169.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.0 t -72.27 116.76 14.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 123.096 0.559 . . . . 0.0 110.842 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.404 ' HB ' HG13 ' A' ' 33' ' ' VAL . 33.7 t -86.79 120.65 71.86 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.82 155.63 68.03 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.656 2.237 . . . . 0.0 111.302 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -60.14 -32.29 70.88 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.951 0.901 . . . . 0.0 112.808 -173.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.27 -5.22 26.94 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 123.857 0.723 . . . . 0.0 114.502 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -109.06 -25.96 10.41 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.694 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -48.39 -45.69 36.15 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -167.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.49 -47.78 77.63 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.05 0.54 . . . . 0.0 110.371 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.55 -11.34 60.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.298 1.039 . . . . 0.0 112.345 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.6 m -101.6 112.4 65.13 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 98.0 Cg_endo -77.59 171.44 17.51 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.025 1.816 . . . . 0.0 113.081 175.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.3 t -119.32 130.64 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.112 1.365 . . . . 0.0 107.825 172.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.4 p -120.13 156.44 31.05 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.82 0.848 . . . . 0.0 108.932 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -56.21 135.57 53.27 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.593 0.757 . . . . 0.0 111.69 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.15 -16.59 58.06 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.689 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -60.37 127.8 33.56 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.681 0.741 . . . . 0.0 111.991 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -79.82 86.57 5.36 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 3' ' ' VAL . 55.6 mt -89.52 149.73 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.721 1.208 . . . . 0.0 108.878 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 35.2 tt0 -147.33 137.15 22.98 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.62 HG21 ' SG ' ' A' ' 26' ' ' CYS . 36.9 mm -103.31 111.0 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 57.6 mt . . . . . 0 C--O 1.238 0.451 0 C-N-CA 123.747 0.819 . . . . 0.0 110.404 172.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.408 ' HG2' HG13 ' A' ' 3' ' ' VAL . 1.5 pmm? . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 111.23 0.085 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 9' ' ' GLN . 7.7 tt -82.06 113.46 19.95 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.408 HG13 ' HG2' ' A' ' 1' ' ' MET . 27.5 m -109.07 -179.68 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.098 1.359 . . . . 0.0 110.539 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.0 m -129.23 101.97 6.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.202 0.601 . . . . 0.0 109.719 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.9 mt -103.4 120.38 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.609 0.764 . . . . 0.0 109.177 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.62 30.42 18.59 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.917 1.287 . . . . 0.0 112.141 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.07 -1.66 88.68 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.595 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -113.5 132.29 55.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.436 1.094 . . . . 0.0 108.293 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.591 ' HB3' HD21 ' A' ' 2' ' ' LEU . 1.5 mp0 -80.11 121.98 26.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.209 0.604 . . . . 0.0 111.038 -175.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -128.2 145.96 50.87 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.418 1.087 . . . . 0.0 108.138 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 39.9 tt0 -93.12 117.5 30.14 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 173.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -113.61 174.19 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.742 0.817 . . . . 0.0 109.999 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -149.89 18.16 0.89 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.003 0.921 . . . . 0.0 109.642 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.8 m -64.17 -31.54 72.77 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.086 0.954 . . . . 0.0 112.644 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 75.79 -46.69 0.56 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.605 1.562 . . . . 0.0 112.427 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.6 t -103.52 146.92 27.82 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.124 0.97 . . . . 0.0 109.914 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 33' ' ' VAL . 89.6 t -69.03 -30.67 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 123.618 0.767 . . . . 0.0 110.723 175.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.3 -55.81 21.69 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.931 0.492 . . . . 0.0 110.098 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.45 65.28 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 124.341 1.026 . . . . 0.0 111.506 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.73 -59.86 3.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.786 0.834 . . . . 0.0 111.34 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.467 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 81.2 mtp -70.7 -21.35 62.58 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.816 0.446 . . . . 0.0 111.651 -174.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 m -70.01 -43.9 70.43 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.152 0.581 . . . . 0.0 110.122 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -73.63 -31.82 63.72 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.002 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.76 -10.89 59.84 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.532 0.733 . . . . 0.0 110.882 175.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 62.83 33.18 15.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.544 1.138 . . . . 0.0 111.404 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.1 m . . . . . 0 N--CA 1.477 0.878 0 C-N-CA 125.276 1.43 . . . . 0.0 110.001 179.968 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.77 -179.38 3.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.466 0.706 . . . . 0.0 109.525 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.467 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.1 p -140.54 146.14 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.053 0.541 . . . . 0.0 109.666 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -117.51 98.99 6.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.3 tp -90.97 118.86 30.69 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 56.62 33.25 22.43 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.904 0.882 . . . . 0.0 111.465 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 68.97 15.3 8.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.036 1.334 . . . . 0.0 112.185 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -109.24 115.81 30.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 40.7 t -77.17 121.0 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.139 0.576 . . . . 0.0 109.988 -175.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.42 129.54 25.87 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.514 0.725 . . . . 0.0 109.599 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.72 160.07 28.0 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.942 2.428 . . . . 0.0 112.009 174.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -52.87 -43.47 66.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.689 0.795 . . . . 0.0 112.179 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.37 -21.58 48.58 Favored Glycine 0 C--N 1.345 1.065 0 O-C-N 123.81 0.694 . . . . 0.0 114.237 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -103.75 -22.27 13.57 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.357 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -46.64 -42.21 15.93 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 123.623 0.769 . . . . 0.0 112.641 -174.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -61.13 -49.53 76.9 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.971 0.908 . . . . 0.0 111.335 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -77.82 -15.22 59.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.809 0.844 . . . . 0.0 111.923 -176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.5 m -91.18 117.63 67.99 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -83.84 158.3 13.85 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.784 2.323 . . . . 0.0 112.948 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.59 135.93 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.192 0.997 . . . . 0.0 108.311 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.4 m -121.05 147.62 45.27 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.725 0.81 . . . . 0.0 111.232 -168.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.54 114.01 3.66 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.219 0.608 . . . . 0.0 111.334 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.2 32.75 34.39 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 113.137 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.9 p30 -81.24 175.37 10.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.838 0.455 . . . . 0.0 110.891 174.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.06 82.91 1.78 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.629 0.372 . . . . 0.0 110.447 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 75.2 mt -84.82 141.31 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.629 0.772 . . . . 0.0 109.166 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 42.0 tt0 -141.53 112.2 7.12 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.5 mm -77.22 105.44 6.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 CA--C 1.533 0.303 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.206 178.114 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' HG12 ' A' ' 50' ' ' VAL . 17.7 ptp . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 120.973 0.416 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.6 tp -80.05 97.35 6.78 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.01 0.924 . . . . 0.0 108.557 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.7 m -110.84 145.66 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.944 0.897 . . . . 0.0 109.821 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 6.8 m -83.77 99.44 10.28 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 58.6 mt -95.76 108.53 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 60.73 36.07 19.47 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.739 1.215 . . . . 0.0 111.238 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.54 -3.89 86.65 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.519 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -118.04 110.95 18.28 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.055 0.942 . . . . 0.0 108.743 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.544 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 94.5 mt-30 -66.03 118.74 10.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.267 0.627 . . . . 0.0 110.845 -178.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -121.91 139.98 52.98 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.472 1.509 . . . . 0.0 108.768 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -81.87 125.18 30.41 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.81 155.25 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.816 0.847 . . . . 0.0 110.55 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -91.52 -25.64 19.16 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.182 0.593 . . . . 0.0 110.957 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.0 m -70.98 114.99 9.59 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.181 0.592 . . . . 0.0 111.918 -175.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.89 13.04 26.1 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.328 1.051 . . . . 0.0 111.439 173.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.8 t -128.44 138.1 52.15 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.983 1.313 . . . . 0.0 108.403 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 33' ' ' VAL . 76.1 t -68.06 -34.16 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 123.722 0.639 . . . . 0.0 110.839 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.48 -56.68 18.95 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.01 0.524 . . . . 0.0 110.394 174.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.36 75.32 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 124.211 0.944 . . . . 0.0 111.491 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.9 tp -64.32 -55.64 19.9 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 123.732 0.645 . . . . 0.0 110.074 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.541 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 72.0 mtp -69.52 -25.84 64.23 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 122.679 0.392 . . . . 0.0 111.098 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -67.35 -39.57 85.78 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 117.938 0.336 . . . . 0.0 110.549 172.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -69.02 -39.14 79.44 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.081 0.953 . . . . 0.0 110.599 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 81.8 mt -86.93 5.89 34.81 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.067 0.947 . . . . 0.0 111.987 -175.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.3 t70 58.29 44.41 18.68 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.757 1.265 . . . . 0.0 110.868 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 CA--C 1.548 0.873 0 C-N-CA 125.473 1.509 . . . . 0.0 110.473 179.22 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 121.246 0.546 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.71 170.85 15.2 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.456 1.103 . . . . 0.0 108.485 173.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.541 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 9.1 p -130.08 151.71 36.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -125.25 100.42 6.52 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 174.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.2 tp -88.86 108.8 19.73 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 55' ' ' GLU . 50.2 m-20 54.71 47.43 22.51 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.607 1.163 . . . . 0.0 110.034 -173.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 73.44 -9.88 1.12 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.48 1.512 . . . . 0.0 113.252 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -84.22 116.59 23.03 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.9 t -73.76 117.55 17.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 122.925 0.49 . . . . 0.0 110.1 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.4 t -102.04 119.77 55.74 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.079 0.952 . . . . 0.0 108.627 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.53 165.83 29.76 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.105 2.537 . . . . 0.0 112.345 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -53.07 -41.53 64.96 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.818 1.247 . . . . 0.0 113.38 -173.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.67 -21.05 60.15 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 123.853 0.721 . . . . 0.0 113.934 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -109.42 -7.6 15.17 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.01 -0.995 . . . . 0.0 112.088 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -52.27 -40.88 62.32 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.073 0.851 . . . . 0.0 110.616 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.69 -41.39 98.14 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.755 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -84.18 -11.06 57.18 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.375 1.07 . . . . 0.0 112.529 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.8 m -102.36 112.45 65.52 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -76.33 173.86 13.78 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.409 2.072 . . . . 0.0 112.615 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.565 HG12 ' SD ' ' A' ' 1' ' ' MET . 86.4 t -124.69 143.73 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.918 1.287 . . . . 0.0 108.643 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.5 m -142.62 149.39 38.9 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.866 0.866 . . . . 0.0 109.804 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.14 126.58 26.68 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.576 0.75 . . . . 0.0 111.135 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.54 -22.07 17.95 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 119.011 -0.883 . . . . 0.0 114.259 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -69.13 141.92 54.53 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.024 0.912 . . . . 0.0 112.518 -173.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 36' ' ' ASN . 9.9 mp0 -80.52 80.53 6.96 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.751 1.22 . . . . 0.0 109.353 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 63.1 mt -91.03 96.36 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 39.5 tt0 -98.65 106.43 18.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.038 0.935 . . . . 0.0 108.669 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.56 105.06 5.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.235 0.328 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.217 179.92 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.669 -0.123 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 5.0 tt -83.0 122.64 28.57 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.01 145.25 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.098 0.959 . . . . 0.0 110.42 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 18.4 m -78.69 102.1 7.86 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.033 0.533 . . . . 0.0 110.088 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 24.1 mt -101.35 105.61 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.061 0.544 . . . . 0.0 109.947 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 60.41 41.82 15.51 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.514 1.126 . . . . 0.0 110.708 173.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.39 -18.35 57.15 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 114.595 -1.184 . . . . 0.0 114.027 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -108.79 116.39 31.89 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.626 0.77 . . . . 0.0 110.093 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 48.1 mt-30 -70.89 131.49 43.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.857 0.463 . . . . 0.0 109.782 174.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.527 ' NH2' HD21 ' A' ' 24' ' ' LEU . 65.1 ttp85 -152.87 142.9 22.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.34 0.656 . . . . 0.0 109.727 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 38.5 tt0 -83.66 127.05 33.48 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.4 m -120.14 164.15 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.046 0.938 . . . . 0.0 111.069 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -102.89 -1.72 29.09 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.668 1.187 . . . . 0.0 109.744 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.1 m -67.07 99.37 0.65 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 124.304 1.042 . . . . 0.0 111.003 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.69 -14.51 58.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.115 0.566 . . . . 0.0 110.822 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 44.2 t -127.57 154.35 45.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.102 0.961 . . . . 0.0 109.753 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.446 ' O ' ' HG2' ' A' ' 21' ' ' MET . 95.2 t -65.7 -38.56 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.661 0.785 . . . . 0.0 110.774 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.51 95.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.473 0.309 . . . . 0.0 110.882 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.04 80.21 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.708 0.803 . . . . 0.0 111.318 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.476 HD11 HD13 ' A' ' 5' ' ' ILE . 28.1 tp -64.98 -45.94 83.55 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.84 0.713 . . . . 0.0 111.358 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 83.0 mmm -68.17 -24.86 65.02 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.726 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.0 m -74.95 -45.37 42.76 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.935 0.494 . . . . 0.0 110.721 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -57.69 -47.48 82.22 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.805 0.842 . . . . 0.0 110.675 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.527 HD21 ' NH2' ' A' ' 10' ' ' ARG . 80.8 mt -84.47 1.47 45.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.246 -175.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 61.73 20.44 11.37 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.574 1.15 . . . . 0.0 111.119 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.481 ' SG ' HG21 ' A' ' 58' ' ' ILE . 36.1 t . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 124.833 1.253 . . . . 0.0 111.321 -170.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 121.53 0.681 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.83 173.26 12.01 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.464 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG12 ' NE1' ' A' ' 45' ' ' TRP . 14.8 p -139.86 140.48 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.05 0.54 . . . . 0.0 109.834 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.99 100.33 7.48 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.151 0.98 . . . . 0.0 108.52 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 tp -92.56 113.81 26.19 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER 64.29 37.14 8.77 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.365 1.041 . . . . 0.0 110.374 -179.038 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 79.26 -17.04 0.62 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 126.584 1.954 . . . . 0.0 112.741 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -96.52 119.83 35.72 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -171.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 p -67.36 126.54 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.316 0.579 . . . . 0.0 110.756 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.44 119.35 65.48 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.43 156.25 42.39 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.394 2.063 . . . . 0.0 112.485 174.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -60.87 -39.27 88.54 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.089 0.555 . . . . 0.0 111.702 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.89 -19.97 59.38 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 123.72 0.638 . . . . 0.0 113.035 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -99.53 -20.16 16.54 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 117.83 -1.081 . . . . 0.0 111.593 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.425 ' NE1' HG12 ' A' ' 33' ' ' VAL . 39.4 m0 -49.73 -47.3 50.78 Favored 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 119.399 0.999 . . . . 0.0 110.999 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.98 -45.26 78.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.889 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -72.09 -15.16 62.0 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.488 1.115 . . . . 0.0 112.577 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 m -104.52 129.33 25.2 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.369 0.668 . . . . 0.0 110.28 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 54.0 Cg_endo -84.58 174.77 7.51 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.698 2.266 . . . . 0.0 113.267 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.451 HG13 HD11 ' A' ' 56' ' ' ILE . 67.3 t -117.89 126.65 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.603 1.161 . . . . 0.0 108.766 173.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -108.91 145.11 35.91 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.384 1.074 . . . . 0.0 109.027 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.14 118.29 5.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.304 0.642 . . . . 0.0 111.388 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.87 -2.0 31.83 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.53 -0.595 . . . . 0.0 114.055 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.38 131.27 44.54 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.534 0.667 . . . . 0.0 112.156 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -84.77 92.56 8.25 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 39.4 mt -100.33 95.86 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.417 1.087 . . . . 0.0 108.676 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.75 120.3 37.89 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.71 -0.619 . . . . 0.0 110.086 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.481 HG21 ' SG ' ' A' ' 26' ' ' CYS . 76.6 mt -76.32 121.98 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.4 mt . . . . . 0 C--O 1.219 -0.532 0 C-N-CA 123.604 0.762 . . . . 0.0 109.753 177.633 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' HG12 ' A' ' 50' ' ' VAL . 49.5 ttm . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.2 tp -79.62 105.14 10.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.52 0.728 . . . . 0.0 109.51 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.0 m -125.32 139.39 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.294 1.038 . . . . 0.0 109.664 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.5 m -77.03 99.58 5.36 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.524 HD12 ' HD3' ' A' ' 10' ' ' ARG . 50.5 mt -97.55 114.27 34.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 123.148 0.579 . . . . 0.0 109.643 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 55.3 t30 59.87 35.57 21.85 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.671 1.588 . . . . 0.0 111.434 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.39 -3.36 83.85 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.978 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -109.37 130.98 55.48 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 117.464 0.632 . . . . 0.0 110.469 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -69.98 103.02 2.14 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 174.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.524 ' HD3' HD12 ' A' ' 5' ' ' ILE . 53.1 ttt180 -122.17 122.54 39.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.703 0.801 . . . . 0.0 110.113 -173.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -88.43 104.62 16.96 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.48 160.59 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.72 0.808 . . . . 0.0 109.94 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -105.44 -1.35 25.06 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.311 0.644 . . . . 0.0 111.011 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.2 p -77.18 117.28 18.56 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.829 0.852 . . . . 0.0 110.744 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.61 1.73 56.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.954 0.901 . . . . 0.0 111.73 174.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -125.65 142.98 51.23 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.366 1.066 . . . . 0.0 109.58 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.56 -28.23 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.236 0.614 . . . . 0.0 110.39 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.67 -54.41 39.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.759 0.424 . . . . 0.0 110.303 172.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.54 64.77 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.911 0.757 . . . . 0.0 111.679 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.02 -58.93 6.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 172.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.546 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 95.7 mmm -63.43 -32.62 74.12 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.106 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.2 m -66.62 -44.84 80.96 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.057 0.543 . . . . 0.0 110.059 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.95 -31.09 68.64 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.966 0.906 . . . . 0.0 110.382 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.6 mt -91.89 -0.69 57.51 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.754 0.822 . . . . 0.0 111.127 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 63.97 38.81 8.47 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.098 1.359 . . . . 0.0 112.942 171.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 CA--C 1.553 1.091 0 C-N-CA 125.118 1.367 . . . . 0.0 110.832 178.174 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 121.162 0.506 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -127.01 167.31 16.08 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.225 1.01 . . . . 0.0 109.111 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.546 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 8.5 p -133.06 148.21 31.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.41 109.37 11.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.988 0.423 . . . . 0.0 109.916 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.9 tp -88.11 109.28 19.76 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 60.57 51.25 5.2 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 124.755 1.284 . . . . 0.0 110.62 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 72.02 6.74 5.66 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 125.374 1.47 . . . . 0.0 113.671 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -124.5 127.28 47.22 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.129 0.572 . . . . 0.0 109.926 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 p -64.49 135.15 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 124.191 0.932 . . . . 0.0 111.687 -175.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.13 122.48 57.94 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.92 152.61 63.1 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.393 2.062 . . . . 0.0 112.607 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -54.16 -52.53 60.86 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.423 1.089 . . . . 0.0 113.056 -170.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.59 -9.5 61.97 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 116.412 -0.358 . . . . 0.0 113.266 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HD2' ' HB2' ' A' ' 47' ' ' GLU . 54.8 tptt -96.54 -15.44 21.63 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.23 1.012 . . . . 0.0 110.057 -177.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -52.91 -44.41 66.94 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.176 0.591 . . . . 0.0 111.191 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.46 -38.18 80.86 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.002 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HB2' ' HD2' ' A' ' 44' ' ' LYS . 32.8 mt-10 -75.41 -21.41 58.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.796 0.838 . . . . 0.0 112.09 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.0 m -100.3 117.89 62.25 Favored Pre-proline 0 N--CA 1.47 0.544 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.93 165.98 27.56 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.079 1.853 . . . . 0.0 112.604 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' SD ' ' A' ' 1' ' ' MET . 61.7 t -99.79 141.21 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 167.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.9 m -134.44 139.72 45.73 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.09 144.24 56.82 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.692 0.797 . . . . 0.0 111.088 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 -10.98 71.3 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.554 -0.581 . . . . 0.0 112.893 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -87.13 162.45 17.52 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.364 0.602 . . . . 0.0 110.788 174.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -121.06 99.36 6.45 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.835 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 55.8 mt -103.24 153.51 5.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 C-N-CA 124.711 1.204 . . . . 0.0 109.154 -176.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -146.62 139.28 25.18 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 119.26 0.936 . . . . 0.0 109.441 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.1 mt -85.07 121.04 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 84.7 mt . . . . . 0 C--N 1.328 -0.353 0 C-N-CA 123.906 0.883 . . . . 0.0 109.448 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptp . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.5 tp -80.54 100.7 8.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.626 0.77 . . . . 0.0 108.972 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.412 HG11 HG12 ' A' ' 50' ' ' VAL . 17.3 m -123.02 137.33 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.565 0.746 . . . . 0.0 110.515 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 26.5 m -73.44 97.26 2.51 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.455 0.702 . . . . 0.0 109.623 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 62.8 mt -95.17 108.21 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 123.112 0.565 . . . . 0.0 109.629 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 62.85 28.73 16.51 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.244 1.018 . . . . 0.0 111.277 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.56 -6.53 65.31 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 113.84 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -105.47 113.02 26.35 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.712 0.805 . . . . 0.0 109.626 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 47.7 mt-30 -64.78 103.11 0.66 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 173.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -118.7 127.75 53.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.356 1.062 . . . . 0.0 109.795 -170.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -86.08 102.63 14.01 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.876 1.27 . . . . 0.0 109.415 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -105.36 168.9 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.899 0.88 . . . . 0.0 111.064 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -110.57 -4.52 15.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.577 0.751 . . . . 0.0 111.776 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 p -91.71 129.99 37.58 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.581 0.753 . . . . 0.0 111.88 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.46 -6.25 37.7 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.334 1.053 . . . . 0.0 112.557 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 42.5 t -123.52 147.29 47.38 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.108 0.963 . . . . 0.0 109.173 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.3 -34.67 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.145 0.978 . . . . 0.0 111.269 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.73 -52.04 67.1 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 -29.16 69.19 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.9 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.42 -52.89 22.59 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.84 0.856 . . . . 0.0 110.32 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 91.2 mmm -62.94 -34.44 77.47 Favored 'General case' 0 CA--C 1.554 1.1 0 O-C-N 123.72 0.637 . . . . 0.0 109.979 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -70.9 -36.08 72.58 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.238 0.615 . . . . 0.0 110.895 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.73 -35.11 76.71 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.073 0.949 . . . . 0.0 110.433 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.532 HD11 HD13 ' A' ' 5' ' ' ILE . 76.9 mt -93.32 -0.81 56.53 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.885 0.874 . . . . 0.0 112.006 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.3 t70 69.74 15.03 8.09 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.079 0.952 . . . . 0.0 112.189 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.418 ' SG ' HD13 ' A' ' 58' ' ' ILE . 27.6 m -92.48 38.17 1.01 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.331 1.052 . . . . 0.0 111.902 -176.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.1 p -108.38 -8.27 15.66 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -113.22 -173.81 2.33 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.078 0.551 . . . . 0.0 110.72 -174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.83 -103.67 0.35 Allowed Glycine 0 C--N 1.355 1.615 0 O-C-N 123.507 0.504 . . . . 0.0 112.467 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -154.78 86.1 1.12 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.729 0.775 . . . . 0.0 109.596 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -118.3 158.67 24.77 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 171.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.17 160.86 40.79 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.024 1.33 . . . . 0.0 108.491 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.579 HG23 HG23 ' A' ' 56' ' ' ILE . 7.7 p -115.56 136.69 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.291 0.637 . . . . 0.0 109.493 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -118.24 99.89 7.15 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 175.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.1 tp -88.98 107.64 19.14 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 62.3 38.74 13.01 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.114 0.966 . . . . 0.0 110.11 -172.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 72.89 -5.86 1.81 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 125.407 1.483 . . . . 0.0 112.463 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -92.02 111.37 22.88 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -67.65 122.85 19.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 O-C-N 123.516 0.51 . . . . 0.0 111.033 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.445 ' HB ' HG13 ' A' ' 33' ' ' VAL . 60.9 t -90.66 119.23 69.05 Favored Pre-proline 0 C--O 1.247 0.939 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.85 144.93 64.35 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.576 2.184 . . . . 0.0 111.178 171.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -31.33 65.39 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.943 0.777 . . . . 0.0 112.7 -175.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.39 -2.36 41.48 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-O 119.384 -0.675 . . . . 0.0 114.11 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -119.16 -3.64 10.58 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.102 0.961 . . . . 0.0 112.228 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -55.0 -41.03 70.77 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.227 0.611 . . . . 0.0 112.239 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.01 -35.16 66.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.356 0.662 . . . . 0.0 110.817 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.55 -26.64 64.6 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.732 0.813 . . . . 0.0 111.488 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.3 m -97.0 117.58 65.67 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -173.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 84.7 Cg_endo -81.58 161.87 19.3 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 122.388 2.059 . . . . 0.0 111.783 168.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.412 HG12 HG11 ' A' ' 3' ' ' VAL . 13.7 t -90.29 147.15 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 170.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 p -124.09 133.74 53.54 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.736 0.814 . . . . 0.0 109.593 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.15 127.49 32.41 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.703 0.801 . . . . 0.0 111.985 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.83 7.64 74.29 Favored Glycine 0 N--CA 1.472 1.073 0 O-C-N 123.798 0.686 . . . . 0.0 113.637 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.21 167.32 16.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.429 0.691 . . . . 0.0 109.559 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -114.98 101.55 9.12 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.184 0.593 . . . . 0.0 109.939 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.579 HG23 HG23 ' A' ' 33' ' ' VAL . 2.7 mp -97.88 97.83 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 124.37 1.068 . . . . 0.0 108.919 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 41.9 tt0 -91.43 108.92 20.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.328 0.651 . . . . 0.0 109.467 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.418 HD13 ' SG ' ' A' ' 26' ' ' CYS . 68.9 mt -78.13 109.72 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.1 mt -89.93 142.99 27.17 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.198 0.599 . . . . 0.0 110.969 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.7 p -107.65 85.44 2.36 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.39 132.25 42.67 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.988 2.459 . . . . 0.0 113.039 -169.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -74.43 98.12 3.22 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.396 1.078 . . . . 0.0 109.163 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.81 21.13 5.47 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.244 1.018 . . . . 0.0 110.973 -176.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.86 -61.6 5.14 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.64 43.08 3.08 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 112.294 -0.323 . . . . 0.0 112.294 175.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 tt -113.18 119.66 38.55 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -52.06 -33.13 37.7 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.565 1.146 . . . . 0.0 113.739 -176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -71.57 -14.5 62.11 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.627 0.771 . . . . 0.0 111.428 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -49.27 -30.52 7.38 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 124.296 1.039 . . . . 0.0 112.014 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -160.74 118.13 2.42 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -134.83 118.38 16.93 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -59.61 131.6 51.41 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.043 0.537 . . . . 0.0 109.681 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 . . . . . 0 CA--C 1.57 1.725 0 O-C-N 124.539 1.149 . . . . 0.0 110.218 -175.118 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 120.842 0.353 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 47.1 tp -79.02 113.44 17.14 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.606 0.763 . . . . 0.0 109.345 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.2 m -111.04 179.64 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.206 1.002 . . . . 0.0 109.236 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 25.2 m -120.64 101.66 7.89 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 118.775 0.716 . . . . 0.0 110.092 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.56 HD13 HD11 ' A' ' 24' ' ' LEU . 71.5 mt -95.71 117.2 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 123.624 0.769 . . . . 0.0 109.887 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 61.74 22.07 12.69 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.894 1.278 . . . . 0.0 112.567 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.84 1.49 65.5 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-O 120.072 -0.293 . . . . 0.0 113.713 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.78 126.71 50.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.696 0.798 . . . . 0.0 109.8 172.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 42.9 mt-30 -69.84 135.79 50.0 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.971 0.415 . . . . 0.0 111.354 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -146.95 136.4 22.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.402 1.081 . . . . 0.0 108.519 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 45.4 tt0 -81.5 123.0 28.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.468 0.707 . . . . 0.0 109.442 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.92 160.01 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.931 0.892 . . . . 0.0 109.324 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.55 -2.3 9.98 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.713 0.405 . . . . 0.0 111.006 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.5 p -66.21 107.97 2.13 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.604 0.762 . . . . 0.0 110.252 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.93 -19.26 60.2 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.676 0.79 . . . . 0.0 112.874 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.6 p -112.03 150.03 31.21 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 33' ' ' VAL . 72.7 t -67.61 -33.4 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.247 0.619 . . . . 0.0 110.368 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.42 -46.18 90.95 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.973 0.509 . . . . 0.0 110.84 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -59.14 -44.31 92.07 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 124.167 0.917 . . . . 0.0 110.525 177.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 32.8 tp -63.94 -44.45 92.82 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.935 0.772 . . . . 0.0 111.674 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 95.0 mmm -63.31 -28.04 69.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.851 0.46 . . . . 0.0 110.598 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 m -74.56 -39.07 62.52 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.188 0.595 . . . . 0.0 111.496 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 10.6 mm-40 -63.84 -38.86 92.68 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.503 0.668 . . . . 0.0 110.36 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 5' ' ' ILE . 79.4 mt -91.32 -1.87 57.53 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.598 -176.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.19 28.86 14.05 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.829 1.252 . . . . 0.0 113.179 171.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.6 m -115.27 21.25 14.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.47 1.108 . . . . 0.0 110.726 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 t -84.67 62.62 7.46 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 122.531 1.157 . . . . 0.0 110.493 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HB3' ' HD1' ' A' ' 31' ' ' TYR . 19.4 t70 -139.91 158.43 44.1 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.715 -174.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.12 -24.06 76.8 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 114.428 0.531 . . . . 0.0 114.428 -173.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -71.13 -25.37 62.55 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.602 0.361 . . . . 0.0 110.027 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.521 ' HD1' ' HB3' ' A' ' 28' ' ' ASP . 90.2 m-85 -92.09 158.72 16.05 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.756 0.789 . . . . 0.0 110.392 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -133.45 -176.39 4.13 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.937 168.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 17' ' ' VAL . 8.5 p -146.56 158.25 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.52 110.3 10.39 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.193 0.597 . . . . 0.0 110.529 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.405 ' HG ' HD22 ' A' ' 36' ' ' ASN . 56.9 tp -89.31 109.27 20.18 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.405 HD22 ' HG ' ' A' ' 35' ' ' LEU . 50.0 m-80 52.28 65.86 1.38 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.958 1.303 . . . . 0.0 111.866 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 68.43 1.16 2.82 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 124.941 1.296 . . . . 0.0 112.696 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -119.35 116.64 26.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.002 0.921 . . . . 0.0 109.532 -171.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.62 119.87 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 123.764 0.665 . . . . 0.0 111.06 -174.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 48' ' ' THR . 91.8 t -92.52 124.16 59.93 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.064 0.946 . . . . 0.0 108.813 176.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.95 154.7 66.72 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.364 2.043 . . . . 0.0 111.412 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -56.11 -41.38 75.17 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.298 1.039 . . . . 0.0 112.473 -171.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.63 14.17 5.89 Favored Glycine 0 C--N 1.341 0.86 0 N-CA-C 114.361 0.504 . . . . 0.0 114.361 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -17.48 6.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 117.968 -1.015 . . . . 0.0 112.092 173.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.431 ' NE1' HG12 ' A' ' 33' ' ' VAL . 50.3 m0 -46.34 -41.86 14.0 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 123.902 0.751 . . . . 0.0 112.492 -175.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.54 -48.5 77.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.547 1.139 . . . . 0.0 111.327 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.52 -0.48 57.27 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.849 0.86 . . . . 0.0 112.253 -175.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.403 HG21 HG21 ' A' ' 40' ' ' VAL . 91.7 m -96.89 120.85 60.84 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -85.66 146.74 9.48 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.298 1.999 . . . . 0.0 113.636 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 88.9 t -86.87 130.49 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 109.071 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 54' ' ' ASP . 10.6 m -103.99 146.99 27.89 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.767 0.827 . . . . 0.0 110.043 -173.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.97 116.73 8.95 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.321 0.648 . . . . 0.0 110.973 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.91 33.73 49.85 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.612 0.57 . . . . 0.0 112.659 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.538 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 27.8 p30 -83.87 -165.27 1.08 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.686 0.394 . . . . 0.0 110.779 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -134.85 94.66 3.2 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 169.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 37.5 mt -95.04 100.63 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.519 0.727 . . . . 0.0 109.977 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.26 114.1 25.85 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.701 0.801 . . . . 0.0 109.316 177.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.1 mt -77.65 129.85 36.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 90.4 mt -104.93 147.43 27.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.116 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.7 t -141.75 75.72 21.18 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.55 117.75 4.88 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.272 1.981 . . . . 0.0 111.168 -172.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 -57.28 -41.91 80.66 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.222 0.609 . . . . 0.0 109.999 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -71.38 86.49 0.83 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.176 171.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.93 63.63 0.28 Allowed Glycine 0 N--CA 1.474 1.217 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 167.79 -168.82 40.92 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.2 mt 51.39 54.88 10.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.483 1.113 . . . . 0.0 110.843 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -87.5 63.85 7.84 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.336 -172.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -73.61 -44.77 56.23 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.14 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -108.82 80.38 1.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 168.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -70.67 96.31 1.2 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.416 0.627 . . . . 0.0 109.864 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -77.15 106.11 8.66 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.218 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -94.65 142.05 27.9 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 174.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 174.344 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 120.479 0.181 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 9' ' ' GLN . 40.6 tp -86.59 127.42 34.91 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.52 0.728 . . . . 0.0 109.464 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.73 138.02 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 124.528 1.131 . . . . 0.0 109.267 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 28.4 m -78.33 97.71 5.69 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.174 0.443 . . . . 0.0 109.861 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.403 HG12 ' HB ' ' A' ' 56' ' ' ILE . 55.8 mt -94.22 104.25 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 67.0 t30 62.04 36.2 15.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.63 1.172 . . . . 0.0 111.145 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.94 10.83 82.4 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.517 -0.765 . . . . 0.0 113.496 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -130.19 108.88 10.38 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.869 0.867 . . . . 0.0 108.98 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.549 ' HB3' HD11 ' A' ' 2' ' ' LEU . 98.3 mt-30 -64.92 119.77 11.33 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.539 0.736 . . . . 0.0 110.457 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -126.59 158.11 37.13 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.844 0.858 . . . . 0.0 110.327 -177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -97.59 113.79 25.58 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.172 0.989 . . . . 0.0 109.741 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.6 m -120.16 147.25 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.832 0.853 . . . . 0.0 110.85 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -119.01 22.2 12.02 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.74 0.781 . . . . 0.0 109.389 176.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 p -75.97 -49.84 16.56 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.91 1.284 . . . . 0.0 112.418 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 67.21 0.4 2.05 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.676 1.19 . . . . 0.0 113.669 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 39.7 m -154.33 153.6 31.93 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.132 1.373 . . . . 0.0 109.106 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.45 ' CG1' HG11 ' A' ' 33' ' ' VAL . 58.3 t -69.95 -34.36 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 O-C-N 124.297 0.998 . . . . 0.0 112.506 -172.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.23 -53.24 39.48 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 -33.15 70.37 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.137 0.898 . . . . 0.0 111.238 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.653 HD21 HG21 ' A' ' 56' ' ' ILE . 42.0 tp -61.54 -59.88 4.54 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.194 1.398 . . . . 0.0 111.817 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.522 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 60.6 mtp -73.63 -19.92 60.72 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.477 0.485 . . . . 0.0 111.256 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.1 m -70.97 -41.72 70.67 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 121.159 0.504 . . . . 0.0 110.061 168.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.84 -35.96 70.04 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.508 1.123 . . . . 0.0 111.312 -176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.3 mt -80.22 -5.93 56.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.531 0.732 . . . . 0.0 110.707 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.2 t70 65.55 24.62 11.77 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.352 1.461 . . . . 0.0 110.819 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 58' ' ' ILE . 35.0 t -92.75 34.56 1.07 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.609 1.163 . . . . 0.0 111.467 -175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.1 p -118.76 15.39 13.53 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.787 0.835 . . . . 0.0 110.45 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -80.77 0.28 35.47 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.736 0.814 . . . . 0.0 112.702 -175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.68 -151.52 6.6 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -90.54 61.55 4.94 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.426 0.69 . . . . 0.0 109.509 -176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -91.38 156.13 17.98 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.356 0.662 . . . . 0.0 110.935 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.81 175.45 9.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.537 1.135 . . . . 0.0 108.467 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.522 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 6.4 p -134.71 144.2 35.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 123.983 0.913 . . . . 0.0 109.649 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -117.77 100.14 7.4 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.4 tp -97.37 112.01 24.02 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 54.47 55.94 7.45 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.588 1.155 . . . . 0.0 111.49 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 62.86 34.85 14.01 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.434 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -152.06 126.39 9.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.039 0.536 . . . . 0.0 109.898 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.7 t -73.72 126.03 33.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 O-C-N 123.674 0.609 . . . . 0.0 110.38 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.08 117.39 66.8 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.91 152.69 79.67 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 122.579 2.186 . . . . 0.0 111.059 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -61.37 -38.64 87.76 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -167.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.9 -1.71 33.9 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 123.481 0.488 . . . . 0.0 114.118 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -114.44 -9.35 12.74 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.73 0.812 . . . . 0.0 112.156 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -51.47 -41.03 60.62 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 123.396 0.678 . . . . 0.0 111.399 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -70.96 -38.32 72.79 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.468 1.107 . . . . 0.0 111.802 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -77.39 -14.84 59.62 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.1 m -106.27 119.58 51.51 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 88.2 Cg_endo -81.77 167.76 16.37 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.396 2.064 . . . . 0.0 112.316 172.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.464 HG11 HD11 ' A' ' 56' ' ' ILE . 63.0 t -118.73 140.85 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.429 1.092 . . . . 0.0 108.271 171.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.1 m -123.24 154.35 38.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.415 1.086 . . . . 0.0 108.815 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.78 126.93 29.55 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.468 0.707 . . . . 0.0 110.662 175.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 -2.96 52.42 Favored Glycine 0 N--CA 1.472 1.035 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.959 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -76.42 138.72 40.54 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.447 0.624 . . . . 0.0 111.205 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -92.39 110.48 21.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.655 0.782 . . . . 0.0 109.11 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.653 HG21 HD21 ' A' ' 20' ' ' LEU . 56.4 mt -107.26 98.28 6.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.054 0.942 . . . . 0.0 109.829 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 41.3 tt0 -96.67 117.06 30.19 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.448 HG21 ' SG ' ' A' ' 26' ' ' CYS . 75.2 mt -76.3 141.45 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.2 mt -125.23 151.69 45.57 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.457 0.703 . . . . 0.0 110.522 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 64.1 p -122.9 84.6 50.23 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 168.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -65.12 114.97 3.04 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.174 1.916 . . . . 0.0 111.384 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 56.7 ttp180 -156.76 111.32 2.77 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 65.78 8.2 5.09 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.431 1.492 . . . . 0.0 113.052 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.513 ' HA3' ' NE2' ' A' ' 70' ' ' HIS . . . 104.47 10.77 32.76 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.46 -117.92 9.44 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 119.68 -0.511 . . . . 0.0 114.259 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 tt -74.38 -52.44 12.12 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.405 0.682 . . . . 0.0 109.975 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -73.98 140.53 45.58 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.188 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -114.02 -9.66 12.96 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.824 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -114.24 84.17 2.0 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.946 0.899 . . . . 0.0 108.647 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.513 ' NE2' ' HA3' ' A' ' 64' ' ' GLY . 96.7 m-70 -93.64 144.91 24.95 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.25 0.62 . . . . 0.0 110.547 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -122.18 -62.05 1.42 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 172.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -139.47 84.04 1.97 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 169.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 50.3 m80 . . . . . 0 C--O 1.252 1.215 0 C-N-CA 124.902 1.281 . . . . 0.0 109.855 -170.962 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mtp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 9' ' ' GLN . 4.4 tt -79.18 105.22 10.35 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.54 178.02 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.365 1.066 . . . . 0.0 109.021 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.6 m -122.63 100.52 6.96 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.6 mt -95.14 110.04 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.72 0.808 . . . . 0.0 108.982 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.53 HD21 HG13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER 65.23 34.01 8.8 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.166 1.386 . . . . 0.0 110.86 175.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.32 2.52 85.33 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.524 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -115.76 120.2 38.53 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.163 0.585 . . . . 0.0 110.51 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.468 ' HB3' HD21 ' A' ' 2' ' ' LEU . 47.9 mt-30 -64.11 113.65 3.67 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.406 0.683 . . . . 0.0 110.351 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -125.08 133.56 52.84 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.285 1.034 . . . . 0.0 109.965 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -85.18 114.99 22.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.414 1.086 . . . . 0.0 108.993 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.9 m -125.12 168.55 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.445 1.098 . . . . 0.0 109.089 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -124.83 5.53 8.08 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.453 0.701 . . . . 0.0 109.5 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.4 m -78.58 105.21 9.7 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 123.296 0.638 . . . . 0.0 110.576 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.88 2.47 34.21 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.172 0.589 . . . . 0.0 111.106 171.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.7 t -124.52 133.89 53.18 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.431 1.093 . . . . 0.0 109.261 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 33' ' ' VAL . 66.8 t -63.41 -43.05 98.31 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 O-C-N 123.743 0.652 . . . . 0.0 110.046 174.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -50.39 68.49 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 0.0 111.415 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.06 92.11 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 124.047 0.842 . . . . 0.0 111.207 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.0 tp -60.78 -45.94 92.4 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.968 0.792 . . . . 0.0 111.685 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.0 mmm -71.77 -24.31 61.73 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.214 0.606 . . . . 0.0 111.25 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -69.58 -41.07 76.32 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.901 0.481 . . . . 0.0 110.119 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.44 -37.58 77.45 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.085 0.954 . . . . 0.0 111.51 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -82.81 -4.7 58.34 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.563 0.745 . . . . 0.0 111.145 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.2 t70 69.08 12.25 8.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.491 1.116 . . . . 0.0 111.506 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.8 m -95.5 33.52 1.59 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.19 0.996 . . . . 0.0 110.423 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.1 t -125.6 -13.77 6.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.735 0.814 . . . . 0.0 110.304 173.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.76 -68.39 0.34 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.734 0.814 . . . . 0.0 110.694 -175.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.04 -164.92 40.69 Favored Glycine 0 C--N 1.34 0.782 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.936 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -74.5 84.99 2.03 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-O 122.278 1.037 . . . . 0.0 110.154 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -123.69 150.09 44.7 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.415 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -119.69 167.85 11.63 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.698 169.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 17' ' ' VAL . 9.8 p -122.82 156.41 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -131.14 100.86 5.35 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -89.84 108.84 19.94 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 59.71 39.75 20.65 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.763 1.225 . . . . 0.0 109.889 -169.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 73.91 -9.28 1.26 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.99 1.716 . . . . 0.0 113.297 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -77.97 108.94 11.6 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.8 t -67.57 121.72 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 123.6 0.562 . . . . 0.0 109.904 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.482 HG21 HG21 ' A' ' 48' ' ' THR . 67.9 t -105.69 132.56 20.78 Favored Pre-proline 0 C--O 1.245 0.818 0 C-N-CA 124.124 0.97 . . . . 0.0 108.827 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.11 149.83 59.01 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.465 2.11 . . . . 0.0 111.256 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -63.48 -34.2 77.24 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -165.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.96 -29.06 67.12 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 123.384 0.427 . . . . 0.0 112.773 176.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -95.09 -4.21 46.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.718 0.807 . . . . 0.0 112.718 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -57.9 -29.99 65.52 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 118.495 0.589 . . . . 0.0 110.625 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.24 -39.6 82.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.395 1.078 . . . . 0.0 110.888 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -79.47 -24.84 42.1 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.122 0.969 . . . . 0.0 112.131 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.482 HG21 HG21 ' A' ' 40' ' ' VAL . 56.6 m -92.9 110.98 49.24 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.835 0.854 . . . . 0.0 109.464 -171.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -81.03 171.59 13.93 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.8 2.333 . . . . 0.0 112.439 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.405 HG13 HD11 ' A' ' 56' ' ' ILE . 58.0 t -121.85 138.82 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.209 1.004 . . . . 0.0 108.388 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.2 p -128.69 150.85 50.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.567 1.147 . . . . 0.0 108.294 173.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.63 122.39 15.17 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.522 0.729 . . . . 0.0 110.705 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.01 -13.94 19.43 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.191 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -67.18 139.49 57.44 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 117.198 0.499 . . . . 0.0 111.986 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.68 99.45 12.35 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.405 HD11 HG13 ' A' ' 50' ' ' VAL . 62.4 mt -98.3 96.28 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.714 0.805 . . . . 0.0 109.289 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 34.5 tt0 -93.67 119.96 33.34 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.808 0.843 . . . . 0.0 109.726 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.53 HG13 HD21 ' A' ' 6' ' ' ASN . 88.5 mt -87.73 136.42 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 80.0 mt -120.07 152.45 37.53 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.245 1.018 . . . . 0.0 109.763 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 m -126.28 82.7 65.28 Favored Pre-proline 0 C--O 1.243 0.716 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 167.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -61.35 116.4 3.38 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.522 2.148 . . . . 0.0 112.152 -170.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 59.5 72.9 0.5 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.701 1.2 . . . . 0.0 110.603 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -84.08 -40.54 18.17 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.931 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.8 106.86 1.77 Allowed Glycine 0 C--N 1.354 1.53 0 O-C-N 124.079 0.862 . . . . 0.0 112.394 -177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.06 65.33 0.17 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.9 tp -51.46 -41.91 61.22 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.305 1.042 . . . . 0.0 111.258 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -106.06 -40.04 5.79 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.045 0.538 . . . . 0.0 110.309 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -72.89 9.41 1.16 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -53.94 -39.17 65.67 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 123.301 0.64 . . . . 0.0 110.67 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -87.54 95.79 10.16 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 169.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -83.31 -2.76 56.47 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.714 -170.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 85.4 t60 59.03 84.83 0.1 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.302 1.041 . . . . 0.0 110.469 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.8 p80 . . . . . 0 CA--C 1.56 1.331 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -177.562 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.523 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 1.3 pmm? . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.91 0.386 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 tt -79.93 118.56 21.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.0 m -131.0 142.56 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.524 1.129 . . . . 0.0 110.415 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 55' ' ' GLU . 8.3 m -79.75 98.92 7.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.793 0.837 . . . . 0.0 109.437 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.645 HD13 HD11 ' A' ' 24' ' ' LEU . 74.1 mt -104.38 110.77 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.437 HD21 ' HB ' ' A' ' 58' ' ' ILE . 88.9 m-20 64.13 22.42 12.88 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.605 1.162 . . . . 0.0 111.494 -178.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.66 -15.1 64.06 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-O 119.72 -0.489 . . . . 0.0 113.535 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -86.09 133.08 33.91 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 117.401 0.601 . . . . 0.0 109.72 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -75.08 100.16 4.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -105.17 146.2 29.55 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.059 0.944 . . . . 0.0 109.973 -175.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -109.61 104.29 13.29 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 m -113.33 165.14 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.569 0.748 . . . . 0.0 110.156 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -128.1 9.12 6.21 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.661 0.784 . . . . 0.0 109.627 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -57.0 -49.1 76.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.803 1.241 . . . . 0.0 112.799 -170.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 61.78 9.36 2.85 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 124.179 0.992 . . . . 0.0 112.802 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.2 t -162.05 141.48 9.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.152 1.381 . . . . 0.0 108.109 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.462 HG11 HG11 ' A' ' 33' ' ' VAL . 94.6 t -72.05 -33.39 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.335 0.654 . . . . 0.0 111.461 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.88 -53.6 51.7 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.641 0.376 . . . . 0.0 110.275 176.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.65 -44.83 73.59 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.66 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.7 tp -58.81 -56.02 27.59 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.273 1.029 . . . . 0.0 111.886 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.2 mtp -68.95 -19.27 64.17 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.027 0.531 . . . . 0.0 111.2 -175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.7 m -73.27 -46.28 50.8 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.795 0.438 . . . . 0.0 110.663 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -70.1 -34.57 73.3 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.282 1.033 . . . . 0.0 111.604 -175.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.645 HD11 HD13 ' A' ' 5' ' ' ILE . 89.5 mt -79.09 -12.23 60.0 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.522 0.729 . . . . 0.0 111.25 175.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 63.54 24.57 14.08 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.576 1.15 . . . . 0.0 111.027 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.448 ' HB3' HG21 ' A' ' 58' ' ' ILE . 88.3 m -88.98 40.95 1.0 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.473 1.509 . . . . 0.0 110.566 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -138.46 25.48 2.64 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.369 1.067 . . . . 0.0 109.46 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -89.54 85.64 6.55 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.865 0.866 . . . . 0.0 110.112 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.67 -102.11 0.66 Allowed Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.59 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -75.85 77.81 2.77 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.94 0.896 . . . . 0.0 111.076 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.443 ' CE1' HG22 ' A' ' 60' ' ' THR . 27.3 m-85 -141.22 140.08 33.89 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.391 0.676 . . . . 0.0 110.196 174.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -138.54 177.96 7.5 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.088 1.355 . . . . 0.0 108.466 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 HG11 ' A' ' 17' ' ' VAL . 11.1 p -138.17 148.41 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.227 0.537 . . . . 0.0 110.824 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -129.9 105.53 8.05 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.129 1.372 . . . . 0.0 108.037 172.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.0 tp -86.83 105.79 17.27 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 54.74 52.88 11.36 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.266 1.427 . . . . 0.0 110.725 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 74.89 -16.8 0.53 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 125.765 1.626 . . . . 0.0 113.761 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.03 107.71 19.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 75.4 t -69.96 117.49 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.371 0.669 . . . . 0.0 110.874 -176.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.23 119.45 65.59 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 123.853 0.861 . . . . 0.0 109.157 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.33 154.47 74.11 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.421 2.081 . . . . 0.0 112.159 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -59.39 -33.94 71.82 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.087 0.955 . . . . 0.0 112.115 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.44 1.31 7.21 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.994 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -127.88 -9.82 5.48 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 117.976 -1.011 . . . . 0.0 112.334 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -49.46 -42.33 42.77 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 119.072 0.851 . . . . 0.0 111.685 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -68.09 -41.72 81.42 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.379 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.44 -19.03 60.55 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.772 0.829 . . . . 0.0 111.812 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.0 m -96.06 115.35 65.51 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.45 169.91 20.98 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.475 2.117 . . . . 0.0 112.832 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -124.26 104.72 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.802 1.241 . . . . 0.0 108.499 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 p -97.97 166.64 11.35 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.158 0.983 . . . . 0.0 110.678 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 1' ' ' MET . . . -64.22 116.52 6.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.783 0.833 . . . . 0.0 112.003 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.83 18.66 26.78 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 119.315 -0.714 . . . . 0.0 114.479 173.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -74.09 140.52 45.36 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.023 0.912 . . . . 0.0 111.841 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.404 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 42.9 tt0 -89.89 92.56 9.07 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 64.3 mt -96.19 100.91 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.79 0.836 . . . . 0.0 109.861 -177.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -88.92 104.47 16.99 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 26' ' ' CYS . 50.6 mm -78.56 106.69 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 61.1 mt -73.75 141.83 46.29 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.298 0.639 . . . . 0.0 110.538 176.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.443 HG22 ' CE1' ' A' ' 31' ' ' TYR . 81.4 p -119.0 67.84 8.52 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.617 0.767 . . . . 0.0 109.248 171.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -68.25 115.31 3.78 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 121.636 1.557 . . . . 0.0 110.203 -172.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -57.12 -44.8 83.63 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.184 0.994 . . . . 0.0 110.804 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -137.09 153.58 50.52 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.129 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.15 -163.89 35.09 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 112.338 -0.305 . . . . 0.0 112.338 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.8 108.77 0.46 Allowed Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -46.25 -36.31 6.04 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.666 1.186 . . . . 0.0 112.4 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -147.1 167.7 23.45 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 169.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -109.66 85.73 2.16 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.362 0.665 . . . . 0.0 109.308 174.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -75.35 128.06 34.54 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 165.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 35.5 p80 47.87 106.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.583 1.553 . . . . 0.0 111.425 -167.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -36.16 -58.26 0.68 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 125.541 1.536 . . . . 0.0 113.562 -167.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 54.34 93.53 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 O-C-N 124.688 1.243 . . . . 0.0 111.44 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 36.7 p-80 . . . . . 0 CA--C 1.553 1.063 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.996 -175.632 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.466 ' HG2' HG13 ' A' ' 3' ' ' VAL . 1.5 pmm? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.371 0.129 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 44.9 tp -77.86 116.71 18.57 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 173.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.466 HG13 ' HG2' ' A' ' 1' ' ' MET . 32.7 m -120.33 -176.46 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.762 1.225 . . . . 0.0 109.273 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.7 m -126.67 101.65 6.73 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.4 mt -96.29 115.6 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.757 0.823 . . . . 0.0 110.006 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 t30 50.42 52.74 14.21 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.851 1.26 . . . . 0.0 111.243 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.07 -0.8 61.74 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 114.62 -1.173 . . . . 0.0 114.429 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -107.56 109.67 21.38 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.817 0.847 . . . . 0.0 110.155 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -66.32 102.03 0.81 Allowed 'General case' 0 CA--C 1.553 1.084 0 CA-C-O 121.746 0.784 . . . . 0.0 109.774 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -137.34 136.97 38.43 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.506 0.722 . . . . 0.0 109.392 -171.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 36.7 tt0 -84.67 130.83 34.66 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.239 0.616 . . . . 0.0 109.595 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.41 177.04 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.713 1.205 . . . . 0.0 108.933 171.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -119.67 7.38 11.05 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.8 m -68.33 112.2 5.07 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 123.441 0.697 . . . . 0.0 110.618 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.97 -16.49 43.91 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.374 0.669 . . . . 0.0 110.728 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.3 t -121.28 141.34 50.99 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.319 1.048 . . . . 0.0 109.432 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.3 t -69.77 -30.19 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 123.535 0.522 . . . . 0.0 110.371 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.74 64.21 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.456 0.702 . . . . 0.0 110.368 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.39 90.91 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.544 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 53.6 tp -61.77 -54.58 40.43 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.626 0.578 . . . . 0.0 110.888 -178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.3 mmm -61.57 -32.31 72.39 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.044 0.84 . . . . 0.0 110.905 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -70.03 -40.94 74.87 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.212 0.605 . . . . 0.0 110.887 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.52 -20.77 59.85 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.097 0.559 . . . . 0.0 111.376 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 92.8 mt -87.29 -6.43 58.53 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.056 0.543 . . . . 0.0 110.081 172.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.5 t70 62.03 31.47 17.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.147 1.379 . . . . 0.0 110.564 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.5 t -107.38 38.52 2.11 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.223 1.409 . . . . 0.0 109.286 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.445 HG22 ' HZ3' ' A' ' 45' ' ' TRP . 21.5 p -124.06 0.32 8.48 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.713 0.805 . . . . 0.0 112.551 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -81.33 -5.65 58.05 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -170.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.74 -146.64 5.17 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.706 -0.497 . . . . 0.0 112.726 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -77.14 94.6 4.09 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.992 0.901 . . . . 0.0 110.603 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -130.96 171.56 13.06 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.895 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.1 179.54 9.05 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.82 1.248 . . . . 0.0 108.784 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.459 HG12 ' NE1' ' A' ' 45' ' ' TRP . 7.3 p -147.06 119.09 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.246 0.546 . . . . 0.0 110.299 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.514 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -80.32 97.48 7.03 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 171.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.427 HD13 HG12 ' A' ' 56' ' ' ILE . 46.5 tp -92.11 120.49 32.77 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.4 m120 63.45 25.72 14.62 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.69 1.196 . . . . 0.0 110.071 -173.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 74.47 8.31 4.46 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 126.256 1.822 . . . . 0.0 112.644 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -106.04 126.91 52.77 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.49 124.16 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.564 0.746 . . . . 0.0 111.094 -171.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.5 116.69 57.38 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.536 1.135 . . . . 0.0 109.063 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.537 ' HD2' ' HD3' ' A' ' 44' ' ' LYS . 57.4 Cg_endo -70.23 164.26 35.65 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.858 2.372 . . . . 0.0 112.135 173.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -56.53 -43.42 79.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.081 0.952 . . . . 0.0 112.66 -172.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.8 -30.18 74.32 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 123.804 0.69 . . . . 0.0 113.301 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.537 ' HD3' ' HD2' ' A' ' 41' ' ' PRO . 28.2 mtpp -82.01 -25.92 34.28 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.328 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.459 ' NE1' HG12 ' A' ' 33' ' ' VAL . 51.9 m0 -49.19 -36.34 19.43 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 123.76 0.824 . . . . 0.0 111.65 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.73 -54.23 38.62 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.012 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -86.03 2.78 45.12 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.092 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.7 m -108.37 114.67 59.05 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.1 166.12 12.9 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.579 2.186 . . . . 0.0 113.29 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 56' ' ' ILE . 49.1 t -95.17 147.75 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.884 0.873 . . . . 0.0 108.839 172.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 m -123.51 149.16 45.51 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.848 0.859 . . . . 0.0 110.119 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.29 113.76 3.81 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.462 0.305 . . . . 0.0 111.243 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.83 39.3 24.95 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.448 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.5 p30 -94.39 164.84 12.84 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.823 0.449 . . . . 0.0 111.386 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -101.15 86.99 3.14 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.566 0.698 . . . . 0.0 110.204 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.457 HD11 HG13 ' A' ' 50' ' ' VAL . 82.5 mt -86.19 144.2 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 114.418 -1.265 . . . . 0.0 108.026 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 33.8 tt0 -147.48 136.25 22.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mm -83.29 134.73 26.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.1 mt -125.46 149.61 48.08 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.013 0.925 . . . . 0.0 109.543 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.5 p -126.02 89.77 51.64 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 171.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.23 143.9 32.52 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.379 2.052 . . . . 0.0 110.408 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 66.86 23.07 10.06 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.012 0.925 . . . . 0.0 111.305 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -73.29 135.88 44.47 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.971 0.908 . . . . 0.0 111.134 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.2 -18.0 46.59 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-O 119.071 -0.85 . . . . 0.0 112.894 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -49.72 123.34 12.96 Favored Glycine 0 C--N 1.357 1.721 0 C-N-CA 123.278 0.466 . . . . 0.0 113.713 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.0 mt -99.73 20.92 13.23 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.798 0.839 . . . . 0.0 111.536 -172.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.73 93.33 0.52 Allowed 'General case' 0 CA--C 1.556 1.204 0 CA-C-O 122.285 1.04 . . . . 0.0 110.669 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 74.74 -77.19 0.05 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 125.836 1.654 . . . . 0.0 111.457 170.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -141.13 159.62 41.84 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.997 0.519 . . . . 0.0 110.923 -175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -109.21 106.31 16.12 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -79.85 76.04 6.54 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.266 0.555 . . . . 0.0 109.919 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -148.32 173.98 12.49 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.847 1.259 . . . . 0.0 109.402 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.8 p80 . . . . . 0 CA--C 1.561 1.37 0 C-N-CA 123.775 0.83 . . . . 0.0 109.393 -175.623 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' HG12 ' A' ' 50' ' ' VAL . 23.8 ptp . . . . . 0 N--CA 1.477 0.899 0 CA-C-O 121.064 0.459 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.9 tt -85.43 107.27 17.32 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.484 HG23 HG13 ' A' ' 5' ' ' ILE . 28.6 m -118.69 162.04 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.396 1.079 . . . . 0.0 109.449 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.3 m -94.12 101.52 13.53 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.121 0.569 . . . . 0.0 109.711 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.657 HD13 HD11 ' A' ' 24' ' ' LEU . 69.1 mt -100.02 107.85 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.2 m120 68.26 22.21 8.19 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.917 1.287 . . . . 0.0 112.399 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.17 4.91 66.22 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.455 -0.339 . . . . 0.0 112.66 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -119.99 111.57 18.07 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.143 0.977 . . . . 0.0 108.488 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -60.2 111.28 1.47 Allowed 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.953 0.406 . . . . 0.0 110.287 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -119.94 131.34 55.17 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.626 1.17 . . . . 0.0 108.872 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -80.65 124.42 28.99 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 170.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.43 163.3 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.311 1.044 . . . . 0.0 108.973 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -114.73 -2.22 13.07 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.862 0.465 . . . . 0.0 111.539 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.8 m -70.77 117.3 12.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.718 0.407 . . . . 0.0 110.851 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.55 14.27 19.34 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.196 0.998 . . . . 0.0 110.931 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 p -142.38 141.57 32.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.501 1.12 . . . . 0.0 108.702 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.508 HG11 HG11 ' A' ' 33' ' ' VAL . 98.7 t -67.74 -31.73 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 124.027 0.829 . . . . 0.0 112.033 -172.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.5 -45.87 78.14 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.46 0.304 . . . . 0.0 110.521 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -61.29 -38.12 85.63 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 124.076 0.86 . . . . 0.0 111.092 176.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.1 tp -62.63 -50.57 70.7 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.902 0.881 . . . . 0.0 111.438 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 77.5 mtp -72.84 -16.8 61.59 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.65 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.2 m -69.54 -45.84 67.84 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 166.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 22.2 mm-40 -65.89 -30.6 71.23 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.243 0.617 . . . . 0.0 112.217 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.657 HD11 HD13 ' A' ' 5' ' ' ILE . 60.7 mt -99.6 -0.82 39.62 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.634 0.774 . . . . 0.0 111.675 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 t70 62.4 25.45 15.18 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 125.076 1.35 . . . . 0.0 111.503 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.9 m -90.8 14.31 13.94 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.434 1.094 . . . . 0.0 110.622 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.4 t -110.19 -9.57 14.68 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.268 1.027 . . . . 0.0 109.643 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -67.73 -64.96 0.75 Allowed 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.026 0.93 . . . . 0.0 110.499 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.64 -158.43 33.87 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.819 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -90.69 98.29 11.69 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.936 0.495 . . . . 0.0 109.767 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -122.79 148.65 45.12 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.379 0.672 . . . . 0.0 110.177 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -118.67 134.64 54.97 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.508 HG11 HG11 ' A' ' 17' ' ' VAL . 11.0 p -106.05 137.92 33.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.43 100.56 8.86 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.419 HD12 HG12 ' A' ' 56' ' ' ILE . 28.5 tp -87.01 108.64 18.94 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 60.39 39.45 18.57 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.232 0.957 . . . . 0.0 110.182 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 68.21 13.87 9.14 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.28 1.432 . . . . 0.0 113.184 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -111.7 116.99 31.67 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.8 t -67.15 126.97 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.247 0.619 . . . . 0.0 111.181 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.7 t -103.8 127.86 28.53 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.544 1.137 . . . . 0.0 108.333 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.68 161.39 33.85 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.947 2.431 . . . . 0.0 111.836 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -59.18 -41.72 89.12 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.476 0.71 . . . . 0.0 112.864 -169.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.45 -29.13 70.81 Favored Glycine 0 C--N 1.345 1.035 0 O-C-N 123.373 0.421 . . . . 0.0 112.899 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -88.74 -14.89 36.11 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-O 117.936 -1.031 . . . . 0.0 112.177 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -53.88 -43.37 69.55 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 118.96 0.8 . . . . 0.0 111.701 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.1 -42.14 85.1 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.669 0.788 . . . . 0.0 110.432 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -75.77 -21.18 57.65 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.46 1.104 . . . . 0.0 112.445 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 83.8 m -95.0 116.81 66.73 Favored Pre-proline 0 C--O 1.24 0.591 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.27 169.81 16.05 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.409 2.073 . . . . 0.0 112.744 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' SD ' ' A' ' 1' ' ' MET . 98.2 t -121.91 134.62 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 169.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 42.8 p -128.0 155.69 43.89 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.118 0.967 . . . . 0.0 108.753 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.9 134.08 55.66 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.613 0.571 . . . . 0.0 111.67 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.1 -13.04 57.44 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-O 118.979 -0.901 . . . . 0.0 114.393 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -60.25 137.8 58.05 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.183 0.809 . . . . 0.0 113.183 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -82.43 82.04 8.04 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 62.2 mt -88.58 95.41 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.87 106.13 16.64 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -174.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.8 mt -93.04 100.93 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.539 0.685 . . . . 0.0 109.44 -174.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.1 mt -80.1 153.58 28.63 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.286 1.035 . . . . 0.0 110.746 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.1 m -110.23 91.33 11.29 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 167.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.26 136.81 38.42 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.923 2.416 . . . . 0.0 111.797 -173.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -73.44 121.24 20.2 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -67.36 103.34 1.26 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.571 0.748 . . . . 0.0 109.281 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.5 121.37 0.59 Allowed Glycine 0 C--N 1.348 1.25 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.06 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.53 -66.6 3.87 Favored Glycine 0 C--N 1.35 1.351 0 C-N-CA 123.088 0.375 . . . . 0.0 112.347 173.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.98 -60.96 2.74 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.579 0.752 . . . . 0.0 109.296 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -88.01 32.1 0.76 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.269 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -73.84 94.07 2.24 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -94.58 110.43 22.25 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -54.29 -38.27 65.72 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.966 0.906 . . . . 0.0 109.737 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -102.12 80.28 1.97 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.482 168.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -82.21 86.49 6.64 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.936 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 . . . . . 0 CA--C 1.551 1.008 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.237 179.81 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 1.7 pmm? . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.594 0.235 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 9' ' ' GLN . 48.1 tp -89.24 128.15 35.82 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 172.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG23 HG13 ' A' ' 5' ' ' ILE . 6.9 m -140.25 158.33 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 124.591 1.156 . . . . 0.0 109.325 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -92.29 98.78 11.72 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 62.1 mt -106.61 120.33 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.9 m120 64.01 21.27 12.54 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.692 1.197 . . . . 0.0 111.945 -176.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.75 0.51 78.47 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 119.721 -0.488 . . . . 0.0 114.12 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -115.21 161.11 18.89 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.778 0.789 . . . . 0.0 110.0 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 2' ' ' LEU . 2.0 mp0 -81.6 118.75 23.03 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 mmt85 -127.64 125.75 40.73 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.685 1.194 . . . . 0.0 109.605 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -95.1 113.51 25.21 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.26 157.38 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.697 0.799 . . . . 0.0 110.775 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.15 -2.29 15.0 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.744 0.818 . . . . 0.0 110.607 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 m -60.55 -44.66 95.89 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.76 1.224 . . . . 0.0 112.972 -168.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 75.45 -43.17 0.49 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 125.245 1.418 . . . . 0.0 113.227 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -97.18 146.51 25.0 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 172.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 33' ' ' VAL . 54.9 t -67.91 -31.67 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 123.687 0.617 . . . . 0.0 110.457 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.26 -50.25 72.46 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.668 0.387 . . . . 0.0 110.539 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.84 72.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.602 176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.2 tp -68.42 -49.24 61.38 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.794 0.838 . . . . 0.0 111.384 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 92.6 mmm -68.49 -22.49 64.55 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.368 0.667 . . . . 0.0 110.325 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -81.67 -39.39 24.43 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.552 0.341 . . . . 0.0 111.493 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.65 -42.62 98.09 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.696 0.798 . . . . 0.0 110.26 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -88.18 -0.09 56.68 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.983 0.913 . . . . 0.0 111.436 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.0 t70 64.31 20.84 12.33 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.04 1.336 . . . . 0.0 112.437 173.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.4 ' SG ' HG21 ' A' ' 58' ' ' ILE . 56.0 m -83.08 21.39 1.08 Allowed 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.318 1.047 . . . . 0.0 111.884 -178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.473 HG22 ' HZ3' ' A' ' 45' ' ' TRP . 51.4 p -96.85 -31.32 12.66 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.449 0.7 . . . . 0.0 109.875 173.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.09 -60.24 4.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.36 1.064 . . . . 0.0 112.182 -172.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.44 24.27 10.34 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-O 119.588 -0.562 . . . . 0.0 113.759 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 55.5 m80 52.23 64.0 2.02 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.336 1.055 . . . . 0.0 111.376 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -89.75 153.66 20.52 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.401 ' HB1' HG13 ' A' ' 39' ' ' VAL . . . -109.92 153.26 24.76 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.526 HG11 HG11 ' A' ' 17' ' ' VAL . 9.3 p -105.13 146.01 12.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -126.87 101.83 6.76 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.13 116.92 24.63 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.425 HD22 ' N ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER 65.02 28.44 12.46 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 124.604 1.19 . . . . 0.0 110.276 -172.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 68.92 22.2 7.21 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.473 1.509 . . . . 0.0 112.751 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -114.58 115.79 27.74 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.932 0.893 . . . . 0.0 108.91 172.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.401 HG13 ' HB1' ' A' ' 32' ' ' ALA . 77.1 t -66.65 120.77 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.906 0.882 . . . . 0.0 112.109 -170.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.436 ' HB ' HG13 ' A' ' 33' ' ' VAL . 91.7 t -95.52 126.6 45.03 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.981 1.312 . . . . 0.0 109.248 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.45 157.19 59.44 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 123.111 2.54 . . . . 0.0 112.475 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.452 ' HA ' ' CE2' ' A' ' 45' ' ' TRP . 74.7 ttt180 -59.05 -40.59 85.59 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.921 0.889 . . . . 0.0 112.695 -171.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.41 -17.97 54.48 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.885 0.741 . . . . 0.0 114.349 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -102.89 -8.28 20.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.473 ' HZ3' HG22 ' A' ' 27' ' ' THR . 50.7 m0 -55.35 -37.19 67.15 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 120.991 0.424 . . . . 0.0 111.866 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.21 -50.03 71.88 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.343 1.057 . . . . 0.0 111.445 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.1 2.28 40.14 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.594 0.758 . . . . 0.0 112.515 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.3 m -104.53 122.52 43.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 123.412 0.685 . . . . 0.0 109.517 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.96 161.36 18.38 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.711 2.274 . . . . 0.0 114.584 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.2 94.59 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 171.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.7 p -104.36 142.74 34.03 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -60.03 127.42 31.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.4 1.08 . . . . 0.0 113.319 -167.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.03 12.92 75.78 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-O 119.397 -0.668 . . . . 0.0 114.455 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.96 147.06 25.91 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.869 0.835 . . . . 0.0 111.119 175.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -84.86 81.75 8.75 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.918 1.287 . . . . 0.0 109.842 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 72.7 mt -88.37 96.43 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.911 0.884 . . . . 0.0 109.158 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 10.4 tp10 -93.65 111.14 22.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.4 HG21 ' SG ' ' A' ' 26' ' ' CYS . 55.7 mt -100.55 104.02 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.25 177.71 5.25 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.304 1.042 . . . . 0.0 110.389 -174.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.554 ' HB ' ' HA3' ' A' ' 64' ' ' GLY . 21.2 m -106.97 113.95 62.03 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.09 117.58 4.9 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.133 1.888 . . . . 0.0 111.631 -175.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 70.66 115.99 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.59 1.556 . . . . 0.0 111.468 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 67.51 38.13 3.22 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.381 1.072 . . . . 0.0 111.303 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.554 ' HA3' ' HB ' ' A' ' 60' ' ' THR . . . -106.95 -7.15 33.75 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.609 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.26 -40.73 92.25 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 116.874 0.337 . . . . 0.0 112.954 172.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.58 42.4 1.71 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.127 0.971 . . . . 0.0 108.878 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.5 130.06 30.66 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.271 1.028 . . . . 0.0 109.842 175.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -87.75 80.6 7.85 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -56.62 102.52 0.08 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.618 1.167 . . . . 0.0 111.48 -174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -102.65 26.58 7.8 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.29 1.036 . . . . 0.0 109.533 178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -63.11 131.96 50.26 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.313 1.045 . . . . 0.0 109.218 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -53.64 -44.38 69.52 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.268 0.627 . . . . 0.0 111.881 -174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 . . . . . 0 C--O 1.245 0.837 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.128 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.461 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.722 0.296 . . . . 0.0 111.213 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 40.8 tp -90.82 116.51 28.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.178 0.991 . . . . 0.0 110.012 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -129.66 140.6 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.406 0.682 . . . . 0.0 110.495 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 59.9 m -71.33 104.58 3.21 Favored 'General case' 0 C--O 1.216 -0.674 0 C-N-CA 123.915 0.886 . . . . 0.0 110.295 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 46.6 mt -102.32 105.45 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 122.825 0.45 . . . . 0.0 109.955 175.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.8 m120 65.62 31.78 9.64 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.09 1.356 . . . . 0.0 112.308 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.13 1.5 81.77 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.944 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -122.4 115.13 21.74 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.745 0.818 . . . . 0.0 109.112 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 1.2 mp0 -68.9 146.01 53.17 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.101 0.56 . . . . 0.0 110.143 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -150.92 139.57 20.66 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.564 0.346 . . . . 0.0 111.267 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.49 99.91 9.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.572 1.149 . . . . 0.0 109.098 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.3 m -121.61 158.73 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.188 0.995 . . . . 0.0 110.259 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -112.14 9.85 20.21 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.635 0.774 . . . . 0.0 110.075 172.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.0 m -73.37 94.04 2.01 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.576 0.75 . . . . 0.0 110.489 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.77 -3.25 37.24 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.432 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.0 t -129.49 148.69 51.42 Favored 'General case' 0 C--O 1.247 0.958 0 C-N-CA 124.616 1.166 . . . . 0.0 109.62 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.514 HG11 HG11 ' A' ' 33' ' ' VAL . 53.5 t -66.32 -33.37 63.07 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 123.779 0.832 . . . . 0.0 110.623 178.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.25 -51.62 68.77 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.5 0.72 . . . . 0.0 111.147 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.74 79.93 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.85 0.719 . . . . 0.0 111.301 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.17 -53.71 18.64 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 123.819 0.699 . . . . 0.0 111.462 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.564 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 65.8 mtp -69.79 -34.34 73.61 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.442 0.297 . . . . 0.0 111.498 -175.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.2 m -68.41 -36.09 78.6 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.523 0.329 . . . . 0.0 110.762 175.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -62.67 -47.31 84.23 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.204 0.526 . . . . 0.0 110.219 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.7 mt -75.79 -8.14 56.14 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.942 -1.027 . . . . 0.0 111.442 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.0 t70 61.42 54.62 3.08 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.145 1.378 . . . . 0.0 110.384 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 29.7 m -114.06 30.18 7.47 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.801 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -93.54 -16.7 24.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.946 0.499 . . . . 0.0 111.18 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -74.12 176.2 6.78 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.764 0.826 . . . . 0.0 111.465 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.99 -112.68 2.06 Favored Glycine 0 C--N 1.355 1.593 0 O-C-N 123.911 0.757 . . . . 0.0 113.957 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.472 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 88.0 m-70 -147.53 104.62 3.64 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.415 1.486 . . . . 0.0 107.51 169.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -134.51 134.59 41.62 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.024 0.53 . . . . 0.0 109.989 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.43 -175.26 2.72 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.762 1.225 . . . . 0.0 108.991 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.564 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.1 p -144.96 156.08 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.163 0.585 . . . . 0.0 110.132 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -132.28 102.16 5.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.954 0.901 . . . . 0.0 109.011 176.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.8 tp -86.66 114.99 23.82 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 56.52 36.29 27.34 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.078 0.951 . . . . 0.0 110.863 -170.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 74.02 -2.03 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.97 1.708 . . . . 0.0 113.106 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -95.87 122.11 38.31 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 59.0 t -70.3 132.75 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.559 0.744 . . . . 0.0 111.799 -170.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.57 124.44 40.77 Favored Pre-proline 0 CA--C 1.554 1.096 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -64.61 154.89 69.82 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.71 2.273 . . . . 0.0 111.703 170.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -64.41 -44.14 92.17 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.694 0.798 . . . . 0.0 112.202 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.61 -3.99 29.84 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.439 -0.8 . . . . 0.0 113.252 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -113.34 -9.45 13.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.147 0.979 . . . . 0.0 113.033 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -52.04 -39.78 60.08 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 119.011 0.823 . . . . 0.0 111.157 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -71.28 -41.9 69.42 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.956 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.95 -12.31 60.61 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.403 1.081 . . . . 0.0 112.683 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -105.1 115.15 62.78 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -176.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.51 159.14 32.42 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.602 2.201 . . . . 0.0 112.957 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.484 HG13 HD11 ' A' ' 56' ' ' ILE . 84.9 t -119.06 139.19 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.54 1.136 . . . . 0.0 108.004 174.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.8 p -126.26 165.61 18.65 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.256 1.022 . . . . 0.0 109.206 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.461 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -61.7 129.97 43.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.965 0.906 . . . . 0.0 112.244 -176.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.52 2.05 68.09 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.218 -0.768 . . . . 0.0 114.164 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -73.31 147.14 44.76 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 117.897 0.848 . . . . 0.0 111.755 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.444 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 4.0 mp0 -94.28 92.39 7.19 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.484 HD11 HG13 ' A' ' 50' ' ' VAL . 3.1 mp -84.93 95.02 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 172.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 36.0 tt0 -96.47 100.39 11.99 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.4 mt -73.95 103.55 2.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.95 131.4 45.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.528 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.3 p -109.41 86.12 4.1 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 30' ' ' HIS . 28.5 Cg_exo -61.94 117.75 4.6 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.573 2.182 . . . . 0.0 111.57 -177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -65.91 99.96 0.53 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.174 0.99 . . . . 0.0 109.887 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 59.8 77.83 0.3 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.307 1.043 . . . . 0.0 109.654 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.96 92.57 0.2 Allowed Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.605 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.89 -92.76 0.04 OUTLIER Glycine 0 C--N 1.347 1.157 0 O-C-N 123.922 0.424 . . . . 0.0 112.324 -174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 63.7 tp -68.24 99.69 0.94 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.896 0.878 . . . . 0.0 110.224 176.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -58.78 143.42 47.23 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.655 1.182 . . . . 0.0 108.833 169.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -143.06 91.88 2.33 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -172.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -75.2 129.02 36.79 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -61.99 107.5 0.87 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.29 1.036 . . . . 0.0 110.647 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -174.38 131.98 0.37 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.618 1.567 . . . . 0.0 108.798 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -134.07 -176.07 4.06 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.214 1.005 . . . . 0.0 110.129 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.8 m80 . . . . . 0 C--O 1.253 1.274 0 C-N-CA 123.534 0.734 . . . . 0.0 110.299 -177.428 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptp . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.584 0.231 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 52.4 tp -82.18 114.53 20.76 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.472 ' HA ' ' H ' ' A' ' 53' ' ' GLY . 33.8 m -119.31 -180.0 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.276 1.03 . . . . 0.0 110.57 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.6 m -117.74 100.3 7.51 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.138 0.575 . . . . 0.0 109.655 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.555 HD13 HD11 ' A' ' 24' ' ' LEU . 69.5 mt -102.41 122.27 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.62 0.768 . . . . 0.0 108.98 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 58.92 30.39 20.13 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.274 1.03 . . . . 0.0 111.927 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.06 -2.74 87.08 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 120.028 -0.318 . . . . 0.0 113.64 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.3 136.0 46.8 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.099 0.96 . . . . 0.0 109.929 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -77.92 113.14 15.54 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -132.1 136.61 47.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.545 1.138 . . . . 0.0 109.512 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.95 131.85 35.36 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 5' ' ' ILE . 27.7 m -133.81 155.26 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.632 0.773 . . . . 0.0 110.449 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -93.63 -43.34 8.72 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.041 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.3 m -58.83 120.99 10.02 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.857 0.863 . . . . 0.0 112.353 -174.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.54 -0.37 57.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.985 0.914 . . . . 0.0 111.261 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.5 t -116.17 141.39 48.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.384 1.073 . . . . 0.0 108.891 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.64 -33.62 53.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.497 0.719 . . . . 0.0 110.993 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.73 -53.01 61.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.525 0.33 . . . . 0.0 110.308 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -60.19 -39.45 86.56 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.065 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.2 tp -66.0 -48.1 72.32 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.842 0.457 . . . . 0.0 111.255 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.479 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 83.0 mtp -67.94 -25.68 65.58 Favored 'General case' 0 C--O 1.211 -0.955 0 O-C-N 123.372 0.42 . . . . 0.0 110.238 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.1 m -69.45 -40.95 76.85 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 118.16 0.436 . . . . 0.0 110.343 172.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 18.2 mm-40 -65.93 -37.5 86.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.943 0.497 . . . . 0.0 111.105 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 5' ' ' ILE . 95.5 mt -82.0 -12.86 58.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.02 0.928 . . . . 0.0 111.314 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 63.62 51.13 2.57 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.105 1.362 . . . . 0.0 110.553 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.93 35.71 4.78 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.339 1.456 . . . . 0.0 110.443 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.407 HG22 ' HZ3' ' A' ' 45' ' ' TRP . 39.9 p -110.73 -6.46 14.79 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -176.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -115.89 -68.03 0.95 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -167.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.58 64.41 4.25 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-O 119.733 -0.481 . . . . 0.0 114.17 -167.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 56.18 72.56 0.49 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.617 1.167 . . . . 0.0 111.568 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -129.82 144.3 51.24 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.097 0.559 . . . . 0.0 109.925 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.0 147.8 52.27 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.207 1.003 . . . . 0.0 109.115 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.479 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 5.6 p -106.82 135.09 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -116.46 100.98 8.24 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 173.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.0 tp -88.71 113.72 24.57 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 56.9 42.85 25.78 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.74 1.275 . . . . 0.0 110.072 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 68.04 21.15 8.89 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.385 1.474 . . . . 0.0 112.328 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -124.59 115.44 20.82 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.804 0.842 . . . . 0.0 108.868 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 58.8 t -63.82 127.96 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.55 0.74 . . . . 0.0 111.144 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.43 ' HB ' HG13 ' A' ' 33' ' ' VAL . 98.4 t -96.02 126.64 43.77 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.401 1.081 . . . . 0.0 109.612 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.38 146.22 68.01 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.44 2.093 . . . . 0.0 112.47 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -48.02 -48.55 32.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.892 1.677 . . . . 0.0 113.315 -176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.1 -15.65 60.99 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 123.749 0.655 . . . . 0.0 114.561 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -106.68 -10.04 16.28 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 117.922 -1.037 . . . . 0.0 112.34 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.407 ' HZ3' HG22 ' A' ' 27' ' ' THR . 39.0 m0 -46.8 -40.55 13.92 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 123.646 0.778 . . . . 0.0 112.554 -177.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -70.08 -41.01 74.67 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.955 0.902 . . . . 0.0 110.64 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -76.72 -11.91 59.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.595 1.158 . . . . 0.0 111.418 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.0 m -92.78 118.12 67.82 Favored Pre-proline 0 C--O 1.243 0.722 0 C-N-CA 123.515 0.726 . . . . 0.0 109.55 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -82.14 156.73 17.42 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.207 1.938 . . . . 0.0 113.021 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.3 t -96.99 138.64 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.748 1.219 . . . . 0.0 107.867 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.9 m -130.02 139.37 51.03 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.228 1.011 . . . . 0.0 109.461 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.66 114.6 2.82 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.96 0.346 . . . . 0.0 111.392 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 3' ' ' VAL . . . 89.74 20.68 42.82 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-O 119.371 -0.683 . . . . 0.0 114.253 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.2 p-10 -84.73 165.69 17.64 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 118.004 0.902 . . . . 0.0 110.229 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.74 85.5 2.24 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.861 0.464 . . . . 0.0 110.117 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 82.8 mt -88.01 97.32 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 36.6 tt0 -103.99 102.52 12.29 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.211 0.605 . . . . 0.0 109.974 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 64.3 mt -97.88 105.77 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.9 178.14 4.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.52 1.128 . . . . 0.0 110.508 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.0 p -103.53 102.3 29.02 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.271 0.629 . . . . 0.0 109.52 176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.08 133.01 29.53 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.651 2.234 . . . . 0.0 111.183 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -76.87 -29.64 55.9 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.081 0.552 . . . . 0.0 110.51 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 81.25 -62.33 0.19 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.747 1.619 . . . . 0.0 110.628 165.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -82.47 73.0 2.72 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 169.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -54.09 92.56 0.01 OUTLIER Glycine 0 C--N 1.36 1.886 0 C-N-CA 123.783 0.706 . . . . 0.0 114.792 -175.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.1 tp -149.08 2.12 0.57 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.86 0.864 . . . . 0.0 110.363 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.49 -43.91 93.19 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.081 0.952 . . . . 0.0 110.533 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -133.86 171.95 13.46 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.428 1.091 . . . . 0.0 109.354 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -81.16 176.48 9.74 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.093 0.557 . . . . 0.0 109.7 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -71.99 89.46 1.11 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.298 0.639 . . . . 0.0 109.914 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -90.3 85.63 6.27 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.388 0.675 . . . . 0.0 109.971 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 69.59 171.51 0.3 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.27 1.428 . . . . 0.0 111.991 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 74.0 t60 . . . . . 0 C--O 1.249 1.032 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.507 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 120.718 0.294 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.489 HD11 ' HB3' ' A' ' 9' ' ' GLN . 59.2 tp -79.65 119.08 22.1 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.954 0.902 . . . . 0.0 110.324 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.47 162.97 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.344 1.058 . . . . 0.0 109.069 176.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 m -105.02 99.99 9.6 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.64 HD13 HD11 ' A' ' 24' ' ' LEU . 32.9 mt -101.5 108.96 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.732 0.813 . . . . 0.0 109.321 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.4 m120 63.48 22.73 13.36 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.249 1.02 . . . . 0.0 112.999 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.94 8.75 72.1 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.358 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -103.91 131.27 51.3 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.729 0.811 . . . . 0.0 108.834 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.489 ' HB3' HD11 ' A' ' 2' ' ' LEU . 24.9 mt-30 -80.05 113.84 18.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 172.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -137.3 130.56 30.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.146 0.578 . . . . 0.0 110.225 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -82.52 129.52 34.93 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.751 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -134.99 159.56 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.764 0.826 . . . . 0.0 110.136 -177.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -112.32 -12.69 13.53 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.877 0.871 . . . . 0.0 110.371 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 p -66.16 105.47 1.4 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.128 0.971 . . . . 0.0 110.973 -178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.95 -17.56 62.07 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.813 0.845 . . . . 0.0 111.748 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.7 t -105.03 143.24 33.49 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.01 0.924 . . . . 0.0 110.097 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 21' ' ' MET . 88.0 t -68.16 -33.63 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 173.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.62 95.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.843 0.457 . . . . 0.0 110.511 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.08 79.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.084 177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.1 tp -69.42 -43.13 74.02 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.659 0.599 . . . . 0.0 110.695 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 91.8 mmm -67.44 -29.12 68.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.915 0.486 . . . . 0.0 109.988 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 m -79.99 -29.25 39.46 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.682 0.393 . . . . 0.0 110.663 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -68.48 -37.52 80.2 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.759 0.824 . . . . 0.0 109.931 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.64 HD11 HD13 ' A' ' 5' ' ' ILE . 57.4 mt -98.26 8.62 44.56 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.349 1.06 . . . . 0.0 110.851 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 p30 51.03 23.78 1.63 Allowed 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 125.814 1.646 . . . . 0.0 113.389 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.8 m -87.84 20.5 3.03 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.749 1.219 . . . . 0.0 110.655 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 p -95.07 -47.86 6.2 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.562 0.745 . . . . 0.0 109.535 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.22 111.71 13.15 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.602 0.761 . . . . 0.0 110.209 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.98 -172.75 14.37 Favored Glycine 0 C--O 1.242 0.643 0 O-C-N 123.641 0.588 . . . . 0.0 113.119 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -75.78 86.01 2.78 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -138.3 155.69 48.35 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 121.556 0.693 . . . . 0.0 111.202 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.59 168.32 22.3 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.13 -1.396 . . . . 0.0 108.764 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.451 HG13 ' HB ' ' A' ' 40' ' ' VAL . 12.8 p -130.91 147.98 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . . . -126.56 104.96 8.4 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.477 1.111 . . . . 0.0 108.447 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 tp -88.35 109.82 20.29 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 57.06 52.22 9.42 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 124.662 1.226 . . . . 0.0 111.191 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 71.18 -2.1 2.49 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.507 1.523 . . . . 0.0 112.988 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -103.7 110.26 22.28 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.78 0.832 . . . . 0.0 108.943 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 78.0 t -69.92 115.76 9.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 122.896 0.479 . . . . 0.0 110.404 -175.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HB ' HG13 ' A' ' 33' ' ' VAL . 58.4 t -87.23 122.39 70.94 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.23 1.012 . . . . 0.0 108.637 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.9 159.17 53.42 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 122.767 2.311 . . . . 0.0 111.145 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -61.56 -34.05 74.91 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 123.621 0.576 . . . . 0.0 111.985 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.87 -5.85 21.13 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.792 -0.64 . . . . 0.0 114.066 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -119.46 -6.86 10.24 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 117.655 -1.164 . . . . 0.0 112.827 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -55.86 -46.47 78.21 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 120.132 1.333 . . . . 0.0 111.454 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.51 -39.45 67.61 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.782 0.433 . . . . 0.0 110.108 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.77 -22.37 65.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.713 0.805 . . . . 0.0 112.617 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.5 m -99.56 127.88 32.99 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 123.554 0.742 . . . . 0.0 109.596 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -83.34 167.25 13.79 Favored 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.558 2.172 . . . . 0.0 113.429 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 56' ' ' ILE . 67.7 t -115.45 125.59 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.278 1.031 . . . . 0.0 108.37 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.5 p -123.8 160.65 26.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.098 0.559 . . . . 0.0 110.207 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -64.29 142.02 58.57 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.824 1.249 . . . . 0.0 112.588 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.28 -13.2 60.53 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-O 119.71 -0.495 . . . . 0.0 114.01 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.82 145.16 40.86 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.73 0.765 . . . . 0.0 112.049 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -93.14 99.67 12.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.207 1.003 . . . . 0.0 110.127 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 61.6 mt -97.89 97.51 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.901 0.881 . . . . 0.0 108.924 -178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -96.83 107.11 19.54 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.707 0.803 . . . . 0.0 109.536 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.9 mt -94.96 114.84 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.525 HD13 ' H ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -123.38 155.36 37.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.455 0.702 . . . . 0.0 110.414 -176.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.8 p -85.08 146.77 46.19 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.16 132.94 50.4 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.199 1.933 . . . . 0.0 110.589 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.46 78.11 0.19 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.95 1.3 . . . . 0.0 108.201 -168.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -148.22 159.5 43.9 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.889 0.875 . . . . 0.0 109.429 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.09 -126.84 1.94 Allowed Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.34 169.6 22.95 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 117.028 0.414 . . . . 0.0 112.668 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -110.97 10.03 22.21 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.948 0.899 . . . . 0.0 111.0 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.16 109.12 2.93 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 123.931 0.892 . . . . 0.0 110.242 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 58.42 34.67 24.17 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.324 1.05 . . . . 0.0 110.997 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -69.29 91.01 0.52 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.585 0.354 . . . . 0.0 110.55 -175.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -87.11 122.32 30.76 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.142 0.977 . . . . 0.0 109.533 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -72.51 150.42 43.24 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.261 0.624 . . . . 0.0 110.008 177.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -84.22 131.71 34.72 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 174.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 124.375 1.07 . . . . 0.0 108.78 175.906 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.514 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 24.3 ptp . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.653 0.264 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 36.2 tp -81.49 112.32 18.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.39 165.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.955 0.902 . . . . 0.0 110.087 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.7 m -111.64 100.73 9.21 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.972 0.509 . . . . 0.0 109.871 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.45 HD11 HD11 ' A' ' 20' ' ' LEU . 70.7 mt -108.35 117.8 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 124.109 0.964 . . . . 0.0 109.203 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 65.41 24.49 11.99 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.517 1.127 . . . . 0.0 112.644 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.18 -3.08 84.18 Favored Glycine 0 N--CA 1.47 0.908 0 CA-C-N 116.445 -0.343 . . . . 0.0 113.156 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -105.78 154.97 19.76 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.613 1.165 . . . . 0.0 108.42 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -105.27 136.12 45.38 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.074 0.397 . . . . 0.0 110.07 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -141.3 130.97 24.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.293 1.037 . . . . 0.0 109.503 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.15 124.96 29.68 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.3 m -135.99 161.92 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.212 1.005 . . . . 0.0 110.724 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -130.82 24.08 5.0 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.781 1.232 . . . . 0.0 108.884 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.3 m -55.98 -48.11 76.44 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.932 1.293 . . . . 0.0 113.705 -171.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 77.02 -50.33 0.55 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.953 1.701 . . . . 0.0 111.701 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.5 m -108.19 151.55 25.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.033 0.933 . . . . 0.0 109.301 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.442 ' CG1' HG11 ' A' ' 33' ' ' VAL . 87.6 t -66.43 -24.97 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 O-C-N 124.056 0.848 . . . . 0.0 110.754 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.63 -56.73 15.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.73 0.812 . . . . 0.0 110.512 172.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.12 -30.32 68.03 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.465 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.45 HD11 HD11 ' A' ' 5' ' ' ILE . 48.3 tp -64.49 -54.74 27.68 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.752 0.821 . . . . 0.0 110.703 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.438 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 97.6 mmm -64.78 -26.43 68.35 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.005 0.522 . . . . 0.0 111.527 -177.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.8 m -75.02 -38.49 61.51 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.66 0.784 . . . . 0.0 110.936 175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -62.91 -45.13 93.93 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.752 HD13 HD11 ' A' ' 58' ' ' ILE . 48.1 mt -72.65 -12.27 60.97 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.569 1.147 . . . . 0.0 111.828 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 63.62 14.36 8.05 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.936 1.294 . . . . 0.0 111.626 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.2 m -96.92 37.71 1.28 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.886 1.274 . . . . 0.0 109.098 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.9 t -113.47 -28.51 7.51 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.337 0.655 . . . . 0.0 110.512 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -81.09 84.79 6.43 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.106 0.562 . . . . 0.0 110.26 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 134.27 -162.5 24.56 Favored Glycine 0 C--N 1.342 0.896 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.481 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -84.42 80.87 9.07 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.787 0.835 . . . . 0.0 109.381 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -118.86 157.66 27.19 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.516 0.674 . . . . 0.0 110.965 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.54 154.3 50.11 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.442 HG11 ' CG1' ' A' ' 17' ' ' VAL . 8.8 p -123.1 150.33 27.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.86 99.32 5.7 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.523 HD12 HG12 ' A' ' 56' ' ' ILE . 18.3 tp -90.08 121.12 31.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.73 23.04 8.73 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.635 1.174 . . . . 0.0 108.734 -170.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.474 ' CE2' ' HB3' ' A' ' 55' ' ' GLU . 59.3 m-85 68.96 3.96 4.28 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.848 1.659 . . . . 0.0 113.059 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -92.63 127.17 38.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.282 0.633 . . . . 0.0 109.39 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.9 t -66.27 114.27 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.748 0.819 . . . . 0.0 111.024 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.417 ' HB ' HG13 ' A' ' 33' ' ' VAL . 80.2 t -87.61 120.41 71.03 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.1 143.36 99.55 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.096 2.531 . . . . 0.0 110.739 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -57.8 -40.07 79.07 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.96 -24.19 62.47 Favored Glycine 0 CA--C 1.533 1.201 0 O-C-N 123.803 0.689 . . . . 0.0 114.173 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -103.13 2.39 34.53 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.427 ' NE1' HG12 ' A' ' 33' ' ' VAL . 40.9 m0 -50.79 -41.93 57.5 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 118.13 0.423 . . . . 0.0 111.031 175.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -68.25 -49.42 60.76 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.578 0.751 . . . . 0.0 110.884 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.15 -26.02 67.24 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.826 0.85 . . . . 0.0 111.694 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.2 m -95.52 119.56 65.04 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -77.73 167.88 23.28 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.856 2.371 . . . . 0.0 113.504 176.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 50.6 t -104.29 145.76 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.609 1.163 . . . . 0.0 109.305 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.1 m -108.58 148.57 30.12 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.579 0.752 . . . . 0.0 109.683 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 1' ' ' MET . . . -65.67 115.34 5.74 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.735 0.814 . . . . 0.0 110.741 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.86 41.1 73.99 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 123.365 0.415 . . . . 0.0 112.551 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -81.95 149.03 28.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.084 0.554 . . . . 0.0 110.364 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 37' ' ' TYR . 2.9 mp0 -84.63 81.71 8.74 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 121.854 0.835 . . . . 0.0 109.586 178.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.523 HG12 HD12 ' A' ' 35' ' ' LEU . 32.4 mt -99.04 153.65 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.729 1.212 . . . . 0.0 109.637 -177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -151.17 125.01 9.12 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.469 0.708 . . . . 0.0 109.14 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.752 HD11 HD13 ' A' ' 24' ' ' LEU . 66.8 mt -80.37 105.36 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.4 mt -83.39 117.94 23.38 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.2 p -93.56 99.2 3.14 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 170.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.83 117.82 4.63 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.848 2.365 . . . . 0.0 111.972 -171.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -83.92 -50.65 7.85 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.291 -172.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 82.86 -56.61 0.18 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.648 1.579 . . . . 0.0 112.008 171.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.8 75.55 1.26 Allowed Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 175.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.35 121.43 4.4 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -165.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 tt -138.48 109.58 6.82 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -91.73 150.3 21.18 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 170.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -88.32 -12.8 42.44 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.065 0.546 . . . . 0.0 111.712 -175.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 72.42 117.4 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.348 1.459 . . . . 0.0 109.682 -168.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -62.13 137.59 58.28 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.718 0.807 . . . . 0.0 109.989 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -67.57 89.32 0.24 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.984 0.421 . . . . 0.0 110.14 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -74.57 142.01 44.72 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.74 0.816 . . . . 0.0 109.1 173.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.5 p80 . . . . . 0 C--O 1.25 1.125 0 C-N-CA 123.839 0.856 . . . . 0.0 109.23 -179.241 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtm . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.62 103.52 9.59 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.64 152.13 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.363 1.065 . . . . 0.0 109.118 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 38.9 m -86.37 106.44 17.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.156 0.582 . . . . 0.0 109.577 176.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 70.2 mt -100.22 106.2 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 122.986 0.515 . . . . 0.0 110.733 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 t30 66.5 23.61 10.44 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.709 1.204 . . . . 0.0 110.708 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.4 -15.58 62.58 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.354 -174.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -98.18 110.31 22.91 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.38 0.672 . . . . 0.0 109.314 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 18.5 mt-30 -71.94 114.5 10.11 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 120.786 0.326 . . . . 0.0 110.15 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.47 ' NH1' HG12 ' A' ' 12' ' ' VAL . 61.1 ttt-85 -131.23 143.87 50.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.419 1.088 . . . . 0.0 109.265 -176.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.3 137.98 35.74 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.47 HG12 ' NH1' ' A' ' 10' ' ' ARG . 33.1 m -114.81 152.94 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 122.841 0.456 . . . . 0.0 111.261 -178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.92 -38.43 11.7 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 168.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.8 m -66.44 120.05 12.69 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.938 0.895 . . . . 0.0 111.849 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.35 -0.88 52.24 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.787 0.835 . . . . 0.0 111.529 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.7 p -122.14 148.11 45.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.059 0.944 . . . . 0.0 109.093 173.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.6 t -68.61 -31.43 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 123.478 0.711 . . . . 0.0 111.486 -176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.34 -52.8 63.13 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.896 0.478 . . . . 0.0 110.88 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.63 -30.65 71.67 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.137 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.426 HD22 HG21 ' A' ' 50' ' ' VAL . 36.4 tp -71.16 -44.92 64.55 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 124.0 0.812 . . . . 0.0 111.483 -178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 98.8 mmm -70.03 -24.38 63.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.719 0.408 . . . . 0.0 110.681 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.8 m -74.38 -43.01 58.27 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 122.764 0.426 . . . . 0.0 110.413 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.12 -37.87 86.76 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.719 1.208 . . . . 0.0 110.895 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.524 HD13 HD11 ' A' ' 58' ' ' ILE . 71.3 mt -88.65 -7.73 55.86 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.306 1.042 . . . . 0.0 111.367 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.5 t70 59.78 42.68 16.33 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.027 1.331 . . . . 0.0 110.933 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.0 m -121.56 35.91 4.76 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.386 1.074 . . . . 0.0 110.769 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.2 t -120.69 1.91 10.58 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.193 0.597 . . . . 0.0 110.478 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.09 -61.59 2.37 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.833 0.853 . . . . 0.0 112.228 -169.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -116.3 -131.68 4.82 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-O 120.046 -0.308 . . . . 0.0 112.607 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -78.26 87.25 4.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.726 0.811 . . . . 0.0 109.305 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -135.92 152.62 51.18 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.743 0.817 . . . . 0.0 110.925 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.02 -177.84 4.88 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.412 1.485 . . . . 0.0 108.226 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.449 HG12 ' NE1' ' A' ' 45' ' ' TRP . 7.9 p -149.8 159.61 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.567 ' HB3' ' HG3' ' A' ' 57' ' ' GLU . . . -133.15 109.86 9.76 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.013 0.525 . . . . 0.0 109.737 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.3 tp -88.59 113.02 23.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 59.48 36.44 23.03 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.154 0.982 . . . . 0.0 110.614 -172.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 72.0 13.18 5.97 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.061 1.344 . . . . 0.0 112.217 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -102.02 112.07 24.58 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.922 0.889 . . . . 0.0 109.247 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.4 t -62.93 111.03 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.557 0 O-C-N 123.921 0.763 . . . . 0.0 110.73 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -90.41 121.36 68.54 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -68.41 151.84 75.71 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.538 2.159 . . . . 0.0 111.053 173.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -58.24 -38.09 76.18 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.916 0.886 . . . . 0.0 113.053 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.67 3.55 25.83 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 114.567 0.587 . . . . 0.0 114.567 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -121.73 -9.96 8.8 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.882 0.873 . . . . 0.0 112.026 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.449 ' NE1' HG12 ' A' ' 33' ' ' VAL . 40.9 m0 -49.66 -39.69 37.12 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.124 0.57 . . . . 0.0 112.23 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -70.06 -43.07 71.96 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.772 0.829 . . . . 0.0 110.819 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -73.08 -14.59 61.43 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 112.303 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.6 m -100.45 120.37 56.38 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.478 0.711 . . . . 0.0 109.324 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -83.99 166.81 12.88 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.897 2.398 . . . . 0.0 113.278 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.426 HG21 HD22 ' A' ' 20' ' ' LEU . 58.6 t -123.6 129.22 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.019 1.328 . . . . 0.0 107.855 175.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.9 p -125.22 149.53 47.89 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.99 126.88 29.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.842 0.857 . . . . 0.0 111.4 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.56 -4.05 39.89 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 119.564 -0.576 . . . . 0.0 113.358 -176.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -78.11 154.64 31.11 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 117.443 0.622 . . . . 0.0 111.366 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -110.09 90.91 3.45 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.778 0.831 . . . . 0.0 109.387 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 4.0 mp -88.13 97.45 6.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.567 ' HG3' ' HB3' ' A' ' 34' ' ' ALA . 8.2 pt-20 -99.1 125.44 44.63 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.69 0.757 . . . . 0.0 109.231 175.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.524 HD11 HD13 ' A' ' 24' ' ' LEU . 70.2 mt -84.74 126.22 40.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.453 -177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.0 mt -103.35 130.0 50.53 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.687 0.795 . . . . 0.0 109.724 -177.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.408 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 52.4 m -102.48 93.87 4.47 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 163.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.18 115.08 3.99 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 122.518 2.145 . . . . 0.0 111.378 -169.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 60' ' ' THR . 40.7 mtt85 -111.97 -78.99 0.58 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -116.2 84.48 2.13 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.99 -58.86 0.33 Allowed Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.659 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.41 -31.46 59.01 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 112.095 -0.402 . . . . 0.0 112.095 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mp -122.86 88.91 3.01 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 173.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -140.52 -172.57 3.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.22 0.608 . . . . 0.0 110.098 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -134.97 14.31 3.59 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 167.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 57.78 -83.19 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.131 1.372 . . . . 0.0 111.655 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 49.1 m80 63.06 -153.71 0.34 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -169.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -72.41 88.55 1.2 Allowed 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 166.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -163.17 135.98 5.51 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.879 1.272 . . . . 0.0 108.261 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 . . . . . 0 C--O 1.248 0.974 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.663 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 47.3 tp -79.11 96.88 5.95 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 52' ' ' ALA . 26.8 m -109.92 139.03 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.41 1.084 . . . . 0.0 109.642 -175.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 8.7 m -84.5 99.66 10.86 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -176.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.47 HD13 HD11 ' A' ' 24' ' ' LEU . 65.9 mt -98.6 108.31 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 123.626 0.77 . . . . 0.0 109.707 -177.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.506 HD22 ' N ' ' A' ' 6' ' ' ASN . 0.7 OUTLIER 67.66 34.09 4.66 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.9 1.28 . . . . 0.0 110.899 176.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.53 10.16 84.64 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.751 -0.659 . . . . 0.0 113.441 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -125.68 110.99 14.43 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.502 1.121 . . . . 0.0 108.244 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 79.6 mt-30 -66.44 143.89 56.84 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.848 0.356 . . . . 0.0 111.324 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -151.43 128.34 11.0 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.815 1.246 . . . . 0.0 108.595 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.83 116.32 22.1 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.67 155.78 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.286 1.035 . . . . 0.0 109.607 -176.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -109.44 -12.6 14.7 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.846 0.859 . . . . 0.0 109.506 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.2 m -57.46 100.07 0.05 OUTLIER 'General case' 0 C--N 1.353 0.731 0 C-N-CA 124.651 1.18 . . . . 0.0 110.672 177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.69 -13.98 60.0 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.631 0.773 . . . . 0.0 111.967 -177.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 t -114.42 142.01 46.92 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.342 1.057 . . . . 0.0 109.46 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.499 HG11 HG11 ' A' ' 33' ' ' VAL . 94.9 t -69.65 -27.07 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.437 0.695 . . . . 0.0 110.435 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.32 -54.32 42.25 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.79 -31.7 71.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.186 0.594 . . . . 0.0 111.474 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.2 -51.97 46.89 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.491 0.716 . . . . 0.0 111.195 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.54 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 76.4 mtp -75.02 -18.8 60.29 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.782 0.433 . . . . 0.0 111.425 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -67.1 -45.23 77.87 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 166.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -67.1 -41.05 86.92 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.277 1.031 . . . . 0.0 111.613 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.47 HD11 HD13 ' A' ' 5' ' ' ILE . 80.9 mt -80.4 -11.55 59.68 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.835 0.854 . . . . 0.0 110.609 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.3 t70 62.81 35.14 13.94 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.138 1.375 . . . . 0.0 110.817 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.618 ' SG ' HD13 ' A' ' 58' ' ' ILE . 59.8 m -96.36 40.68 1.12 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.295 -1.321 . . . . 0.0 111.394 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.402 HG22 ' HZ3' ' A' ' 45' ' ' TRP . 76.9 p -111.75 6.14 19.57 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.199 0.6 . . . . 0.0 111.781 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.52 109.02 0.62 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.996 0.918 . . . . 0.0 112.42 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.62 -90.72 0.39 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-O 120.047 -0.307 . . . . 0.0 112.553 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -147.7 77.98 1.44 Allowed 'General case' 0 C--N 1.354 0.794 0 CA-C-O 121.552 0.692 . . . . 0.0 109.742 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -93.77 173.68 7.56 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.842 1.257 . . . . 0.0 111.196 175.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HA ' ' HZ2' ' A' ' 45' ' ' TRP . . . -153.29 168.97 24.23 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.272 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.54 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 6.6 p -128.76 139.03 52.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 C-N-CA 124.057 0.943 . . . . 0.0 108.855 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 57' ' ' GLU . . . -108.08 104.19 13.57 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 171.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.0 tp -90.11 107.02 18.87 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 173.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 62.16 37.8 14.16 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.65 1.18 . . . . 0.0 110.42 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 71.98 11.85 6.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.084 1.754 . . . . 0.0 112.86 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.84 109.32 21.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 84.7 t -71.2 122.91 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.127 0.571 . . . . 0.0 109.937 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.47 126.97 48.2 Favored Pre-proline 0 C--O 1.246 0.917 0 C-N-CA 124.293 1.037 . . . . 0.0 109.322 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.81 145.69 59.92 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.087 2.525 . . . . 0.0 112.389 170.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -60.33 -42.19 95.13 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.843 0.857 . . . . 0.0 112.277 -173.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.15 11.7 11.33 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-N 116.317 -0.401 . . . . 0.0 113.14 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -126.32 -6.93 6.44 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.243 1.017 . . . . 0.0 110.611 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.403 ' HZ2' ' HA ' ' A' ' 32' ' ' ALA . 52.5 m0 -54.24 -33.74 59.11 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.19 0.596 . . . . 0.0 111.358 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -71.39 -39.58 71.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.983 0.913 . . . . 0.0 110.471 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.29 -17.9 63.1 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.083 0.953 . . . . 0.0 111.773 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.3 m -96.41 114.5 64.48 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.981 0.512 . . . . 0.0 109.84 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.74 155.85 53.66 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.214 1.943 . . . . 0.0 112.471 168.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.9 t -101.02 129.33 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -127.17 135.75 51.11 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.116 0.566 . . . . 0.0 109.831 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.417 ' HA ' HG12 ' A' ' 3' ' ' VAL . . . -58.49 133.69 56.02 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.657 1.183 . . . . 0.0 112.598 -176.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.41 -6.1 71.18 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-O 119.351 -0.694 . . . . 0.0 114.372 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.29 164.23 15.02 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 117.872 0.836 . . . . 0.0 112.108 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -97.05 108.57 21.33 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.666 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 73.8 mt -111.38 96.96 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 123.94 0.896 . . . . 0.0 109.535 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -91.33 145.37 24.7 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.427 0.691 . . . . 0.0 109.242 177.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.618 HD13 ' SG ' ' A' ' 26' ' ' CYS . 99.6 mt -120.81 114.51 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.96 155.13 50.73 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.498 1.119 . . . . 0.0 108.641 -174.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.7 t -125.22 92.65 46.85 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 123.132 0.573 . . . . 0.0 110.067 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.54 116.83 4.72 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.177 1.918 . . . . 0.0 111.364 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -66.56 -43.04 86.12 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.272 0.629 . . . . 0.0 111.65 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -72.13 -26.56 62.16 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.192 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.59 35.91 3.53 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 116.255 -0.429 . . . . 0.0 113.057 -174.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.18 -115.1 0.29 Allowed Glycine 0 C--N 1.355 1.623 0 C-N-CA 123.048 0.356 . . . . 0.0 113.013 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.4 tp -156.36 80.33 0.97 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.835 0.854 . . . . 0.0 108.751 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -168.04 143.77 3.82 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.609 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -122.88 2.99 9.44 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.159 0.984 . . . . 0.0 109.852 171.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -84.07 45.07 1.06 Allowed 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 121.599 0.714 . . . . 0.0 111.017 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -155.93 116.13 3.7 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.014 1.725 . . . . 0.0 106.893 172.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -139.03 128.3 24.11 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.02 0.928 . . . . 0.0 109.102 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -83.71 -34.44 24.9 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.064 0.545 . . . . 0.0 110.168 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 . . . . . 0 C--O 1.245 0.82 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 168.693 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 120.932 0.396 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' A' ' 9' ' ' GLN . 8.5 tt -85.55 114.57 22.66 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 176.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.408 HG23 HG13 ' A' ' 5' ' ' ILE . 9.7 m -132.8 139.46 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.246 1.018 . . . . 0.0 110.568 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.9 m -67.79 100.43 0.93 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 55.7 mt -104.19 104.57 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.44 0.696 . . . . 0.0 109.328 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 62.45 31.43 17.13 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 122.375 1.083 . . . . 0.0 110.28 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.44 -6.52 83.25 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 121.649 -0.657 . . . . 0.0 113.402 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -106.31 105.59 15.7 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.516 ' HB3' HD21 ' A' ' 2' ' ' LEU . 27.0 mt-30 -61.21 107.23 0.72 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.522 ' HB3' HD12 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -118.72 121.53 40.33 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -169.177 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -81.42 112.78 19.0 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.921 0.888 . . . . 0.0 109.031 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -124.77 169.65 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.59 1.156 . . . . 0.0 109.85 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -129.59 17.77 5.82 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.383 0.673 . . . . 0.0 110.847 175.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.0 p -94.96 108.65 20.71 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.336 0.654 . . . . 0.0 109.311 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 49' ' ' PRO . . . -82.79 -0.38 47.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.813 0.845 . . . . 0.0 112.035 178.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.0 t -110.34 135.62 50.78 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.153 0.981 . . . . 0.0 108.916 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.8 t -68.66 -26.69 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.153 0.581 . . . . 0.0 110.451 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.67 -55.2 18.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.086 0.554 . . . . 0.0 109.999 172.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.2 -30.1 69.15 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.65 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -69.11 -54.66 13.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.786 0.834 . . . . 0.0 110.867 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.58 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 78.8 mtp -70.04 -21.5 63.18 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.3 m -75.18 -37.89 61.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.638 0.375 . . . . 0.0 110.021 171.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -62.6 -40.92 98.45 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.854 0.861 . . . . 0.0 110.389 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.51 HD11 HD13 ' A' ' 5' ' ' ILE . 64.4 mt -86.89 -3.68 59.1 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.387 -176.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 61.49 19.67 10.52 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.245 1.418 . . . . 0.0 112.682 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.513 ' SG ' HG21 ' A' ' 58' ' ' ILE . 56.2 m -87.22 21.0 2.53 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.018 1.327 . . . . 0.0 111.237 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.442 HG22 ' HZ3' ' A' ' 45' ' ' TRP . 10.2 p -100.08 -19.48 16.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.552 1.141 . . . . 0.0 109.706 174.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -89.85 126.85 35.85 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.95 0.9 . . . . 0.0 109.679 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.77 -174.16 51.34 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 112.247 -0.341 . . . . 0.0 112.247 -174.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -84.23 89.1 7.27 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.538 0.685 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -129.07 146.94 50.91 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.445 0.698 . . . . 0.0 110.17 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.71 159.67 40.92 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.46 1.104 . . . . 0.0 109.333 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.58 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 11.1 p -118.49 148.01 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.523 0.729 . . . . 0.0 110.103 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' A' ' 57' ' ' GLU . . . -129.55 102.53 6.42 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.625 0.77 . . . . 0.0 110.221 174.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.49 HD13 HG12 ' A' ' 56' ' ' ILE . 64.3 tp -89.67 123.07 33.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.0 m120 64.38 39.13 7.3 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.555 1.142 . . . . 0.0 111.079 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 66.48 21.31 10.82 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.456 1.502 . . . . 0.0 112.0 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -131.89 123.53 27.67 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.946 0.899 . . . . 0.0 108.66 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 59.4 t -66.12 126.27 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 123.302 0.641 . . . . 0.0 111.07 -176.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.413 ' HB ' HG13 ' A' ' 33' ' ' VAL . 61.2 t -88.7 125.93 61.41 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 124.057 0.943 . . . . 0.0 109.085 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.06 146.56 91.11 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.605 2.203 . . . . 0.0 112.031 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -59.78 -39.17 84.01 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.37 -14.64 57.56 Favored Glycine 0 CA--C 1.532 1.095 0 O-C-N 123.752 0.657 . . . . 0.0 113.051 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -104.74 -16.67 14.88 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 117.73 -1.129 . . . . 0.0 112.676 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.442 ' HZ3' HG22 ' A' ' 27' ' ' THR . 38.3 m0 -46.61 -42.82 16.75 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 118.994 0.815 . . . . 0.0 111.908 -176.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -67.43 -42.72 82.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.566 1.146 . . . . 0.0 112.052 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -90.05 -2.98 58.2 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.917 0.487 . . . . 0.0 112.302 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.3 m -89.53 115.61 64.23 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 96.1 Cg_endo -76.82 153.99 33.76 Favored 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 122.364 2.043 . . . . 0.0 112.785 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.3 t -105.22 119.27 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.561 1.144 . . . . 0.0 108.754 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 p -120.63 148.2 44.22 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.85 0.86 . . . . 0.0 109.88 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.72 131.81 49.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.139 0.976 . . . . 0.0 112.478 -171.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.62 -0.54 82.97 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-O 119.287 -0.729 . . . . 0.0 114.92 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.46 155.37 24.65 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 117.657 0.728 . . . . 0.0 111.561 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -87.77 92.41 9.1 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.594 1.158 . . . . 0.0 109.177 -173.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 62.1 mt -97.83 97.49 6.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 45.0 mt-10 -93.08 116.77 29.35 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -174.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.513 HG21 ' SG ' ' A' ' 26' ' ' CYS . 45.8 mm -98.16 118.1 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.44 165.49 24.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.169 0.588 . . . . 0.0 109.977 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 t -113.09 99.58 49.17 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 123.919 0.887 . . . . 0.0 109.02 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.61 132.7 31.73 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.568 2.179 . . . . 0.0 112.417 -178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 60.08 77.17 0.33 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.743 1.217 . . . . 0.0 109.982 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -145.11 -49.35 0.24 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.096 0.959 . . . . 0.0 108.908 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.31 -55.69 4.37 Favored Glycine 0 C--N 1.349 1.267 0 O-C-N 123.997 0.81 . . . . 0.0 114.41 175.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.94 -28.67 0.18 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.9 mt -83.24 112.35 19.78 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.532 0.733 . . . . 0.0 109.601 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -54.62 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.281 1.032 . . . . 0.0 110.308 171.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -68.74 -33.54 74.09 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.312 0.645 . . . . 0.0 112.004 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -164.35 104.57 0.85 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.5 0.72 . . . . 0.0 109.585 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -141.99 159.24 42.63 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.078 0.951 . . . . 0.0 110.187 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -81.01 84.31 6.5 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.733 0.813 . . . . 0.0 109.963 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -74.95 -50.81 15.46 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.028 173.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 62.3 t60 . . . . . 0 CA--C 1.557 1.226 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.984 175.617 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 21.3 ptp . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 57.9 tp -79.2 107.11 11.71 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.413 HG21 HD12 ' A' ' 56' ' ' ILE . 27.4 m -110.74 179.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.043 0.937 . . . . 0.0 108.879 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 25.2 m -116.43 110.52 18.75 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -106.76 114.14 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.247 0.619 . . . . 0.0 109.603 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 65.35 26.97 12.04 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.054 1.342 . . . . 0.0 111.645 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.37 3.74 74.86 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.121 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -122.9 114.85 21.01 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.21 1.004 . . . . 0.0 109.232 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.621 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 13.9 pt20 -67.73 130.03 41.73 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.058 0.456 . . . . 0.0 111.193 -178.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 42.6 ttm105 -150.59 141.94 23.32 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.2 1.0 . . . . 0.0 109.045 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -80.82 137.78 36.22 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.7 m -124.11 144.71 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.114 0.483 . . . . 0.0 110.187 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -93.28 -23.17 18.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.348 1.059 . . . . 0.0 108.984 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.1 p -76.73 110.15 11.09 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.786 176.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.49 26.14 2.39 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.752 0.821 . . . . 0.0 110.938 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 57.7 m -146.48 149.41 33.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.917 0.887 . . . . 0.0 109.703 173.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.2 t -70.03 -36.51 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.138 0.975 . . . . 0.0 111.998 -174.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.05 -54.33 39.83 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 120.759 0.314 . . . . 0.0 110.495 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.82 -31.68 69.95 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.442 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.408 HD21 HG21 ' A' ' 56' ' ' ILE . 60.4 tp -67.25 -53.31 31.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.843 0.857 . . . . 0.0 111.135 177.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.518 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 71.5 mtp -69.71 -23.37 63.41 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.155 -176.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.4 m -76.0 -35.22 59.64 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.74 -32.31 70.78 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.288 0.635 . . . . 0.0 110.762 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.35 2.93 56.04 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.477 0.711 . . . . 0.0 111.963 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 65.14 21.69 12.19 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.646 1.178 . . . . 0.0 111.859 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.62 ' SG ' HG21 ' A' ' 58' ' ' ILE . 60.6 m -92.78 36.92 1.01 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.596 1.158 . . . . 0.0 110.628 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.0 t -139.94 -9.49 1.18 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.91 0.484 . . . . 0.0 111.585 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -64.39 -37.44 87.53 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.052 0.541 . . . . 0.0 111.648 -175.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -113.98 -128.95 4.78 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -117.47 102.06 8.9 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.613 1.165 . . . . 0.0 109.078 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -130.4 156.67 44.34 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.233 1.013 . . . . 0.0 109.411 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -124.9 171.92 9.79 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.981 0.912 . . . . 0.0 108.65 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.518 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.2 p -135.38 140.33 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -110.73 105.71 14.67 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 170.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.3 tp -92.68 115.37 28.05 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 57.83 37.78 27.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.947 1.299 . . . . 0.0 111.734 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 72.49 30.68 1.89 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.93 1.292 . . . . 0.0 112.193 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -137.38 128.77 28.14 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.718 0.807 . . . . 0.0 109.489 169.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.0 t -72.27 116.76 14.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 C-N-CA 123.096 0.559 . . . . 0.0 110.842 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.404 ' HB ' HG13 ' A' ' 33' ' ' VAL . 33.7 t -86.79 120.65 71.86 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.82 155.63 68.03 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.656 2.237 . . . . 0.0 111.302 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -60.14 -32.29 70.88 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.951 0.901 . . . . 0.0 112.808 -173.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.27 -5.22 26.94 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 123.857 0.723 . . . . 0.0 114.502 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -109.06 -25.96 10.41 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.694 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -48.39 -45.69 36.15 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -167.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.49 -47.78 77.63 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.05 0.54 . . . . 0.0 110.371 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -75.55 -11.34 60.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.298 1.039 . . . . 0.0 112.345 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.6 m -101.6 112.4 65.13 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 98.0 Cg_endo -77.59 171.44 17.51 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.025 1.816 . . . . 0.0 113.081 175.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.3 t -119.32 130.64 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.112 1.365 . . . . 0.0 107.825 172.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.4 p -120.13 156.44 31.05 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.82 0.848 . . . . 0.0 108.932 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 1' ' ' MET . . . -56.21 135.57 53.27 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.593 0.757 . . . . 0.0 111.69 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.15 -16.59 58.06 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.689 176.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -60.37 127.8 33.56 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.681 0.741 . . . . 0.0 111.991 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -79.82 86.57 5.36 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 173.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 3' ' ' VAL . 55.6 mt -89.52 149.73 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.721 1.208 . . . . 0.0 108.878 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 35.2 tt0 -147.33 137.15 22.98 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.62 HG21 ' SG ' ' A' ' 26' ' ' CYS . 36.9 mm -103.31 111.0 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 57.6 mt -79.45 137.28 37.18 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.747 0.819 . . . . 0.0 110.404 172.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.8 m -112.43 87.33 9.31 Favored Pre-proline 0 C--O 1.243 0.718 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 169.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.47 114.43 2.88 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.404 2.069 . . . . 0.0 111.213 -175.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.8 tpp85 -155.38 -0.72 0.15 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.235 0.614 . . . . 0.0 110.663 -174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -135.8 8.02 3.26 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.481 1.112 . . . . 0.0 110.198 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.41 154.29 21.71 Favored Glycine 0 C--N 1.348 1.223 0 C-N-CA 123.225 0.441 . . . . 0.0 112.109 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.647 ' HA3' ' HB3' ' A' ' 68' ' ' HIS . . . -70.0 123.94 13.52 Favored Glycine 0 C--N 1.342 0.875 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt -66.63 -54.49 22.77 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.38 0.672 . . . . 0.0 110.57 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -86.14 -39.37 16.77 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.821 173.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.647 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 26.4 t60 -65.04 91.3 0.09 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.316 1.046 . . . . 0.0 109.899 176.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -93.8 160.37 14.78 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.213 0.605 . . . . 0.0 109.917 176.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.1 m170 -70.53 125.14 25.97 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.078 0.551 . . . . 0.0 109.701 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -66.44 -19.84 65.9 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.922 0.489 . . . . 0.0 112.21 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -96.98 -69.08 0.77 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.829 0.851 . . . . 0.0 109.131 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.2 t60 . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.421 178.673 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' HG2' HG13 ' A' ' 3' ' ' VAL . 1.5 pmm? . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 111.23 0.085 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' A' ' 9' ' ' GLN . 7.7 tt -82.06 113.46 19.95 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.408 HG13 ' HG2' ' A' ' 1' ' ' MET . 27.5 m -109.07 -179.68 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.098 1.359 . . . . 0.0 110.539 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.0 m -129.23 101.97 6.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.202 0.601 . . . . 0.0 109.719 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.9 mt -103.4 120.38 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.609 0.764 . . . . 0.0 109.177 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 61.62 30.42 18.59 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.917 1.287 . . . . 0.0 112.141 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.07 -1.66 88.68 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.595 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -113.5 132.29 55.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.436 1.094 . . . . 0.0 108.293 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.591 ' HB3' HD21 ' A' ' 2' ' ' LEU . 1.5 mp0 -80.11 121.98 26.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.209 0.604 . . . . 0.0 111.038 -175.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -128.2 145.96 50.87 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.418 1.087 . . . . 0.0 108.138 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 39.9 tt0 -93.12 117.5 30.14 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 173.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.8 m -113.61 174.19 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.742 0.817 . . . . 0.0 109.999 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -149.89 18.16 0.89 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.003 0.921 . . . . 0.0 109.642 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.8 m -64.17 -31.54 72.77 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.086 0.954 . . . . 0.0 112.644 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 75.79 -46.69 0.56 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.605 1.562 . . . . 0.0 112.427 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.6 t -103.52 146.92 27.82 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.124 0.97 . . . . 0.0 109.914 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 33' ' ' VAL . 89.6 t -69.03 -30.67 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 123.618 0.767 . . . . 0.0 110.723 175.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.3 -55.81 21.69 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.931 0.492 . . . . 0.0 110.098 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.45 65.28 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 124.341 1.026 . . . . 0.0 111.506 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.73 -59.86 3.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.786 0.834 . . . . 0.0 111.34 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.467 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 81.2 mtp -70.7 -21.35 62.58 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.816 0.446 . . . . 0.0 111.651 -174.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 m -70.01 -43.9 70.43 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.152 0.581 . . . . 0.0 110.122 171.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -73.63 -31.82 63.72 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.002 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.76 -10.89 59.84 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.532 0.733 . . . . 0.0 110.882 175.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 62.83 33.18 15.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.544 1.138 . . . . 0.0 111.404 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.1 m -106.15 37.44 2.28 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.276 1.43 . . . . 0.0 110.001 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.2 t -130.85 23.31 4.98 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 122.125 -0.359 . . . . 0.0 111.412 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.404 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . 3.0 m-20 -57.57 -63.94 1.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.406 1.082 . . . . 0.0 111.339 -176.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.81 -104.96 0.57 Allowed Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.421 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -85.15 81.14 8.97 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.532 0.733 . . . . 0.0 110.051 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 28' ' ' ASP . 76.8 m-85 -136.52 123.27 21.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.536 1.134 . . . . 0.0 108.339 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.77 -179.38 3.67 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.466 0.706 . . . . 0.0 109.525 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.467 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 7.1 p -140.54 146.14 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.053 0.541 . . . . 0.0 109.666 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -117.51 98.99 6.69 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.3 tp -90.97 118.86 30.69 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 56.62 33.25 22.43 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.904 0.882 . . . . 0.0 111.465 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 68.97 15.3 8.86 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.036 1.334 . . . . 0.0 112.185 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -109.24 115.81 30.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' ALA . 40.7 t -77.17 121.0 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.139 0.576 . . . . 0.0 109.988 -175.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.42 129.54 25.87 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.514 0.725 . . . . 0.0 109.599 -173.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.72 160.07 28.0 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.942 2.428 . . . . 0.0 112.009 174.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.5 mtt-85 -52.87 -43.47 66.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.689 0.795 . . . . 0.0 112.179 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.37 -21.58 48.58 Favored Glycine 0 C--N 1.345 1.065 0 O-C-N 123.81 0.694 . . . . 0.0 114.237 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -103.75 -22.27 13.57 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.357 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -46.64 -42.21 15.93 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 123.623 0.769 . . . . 0.0 112.641 -174.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -61.13 -49.53 76.9 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.971 0.908 . . . . 0.0 111.335 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -77.82 -15.22 59.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.809 0.844 . . . . 0.0 111.923 -176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.5 m -91.18 117.63 67.99 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -83.84 158.3 13.85 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.784 2.323 . . . . 0.0 112.948 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.59 135.93 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.192 0.997 . . . . 0.0 108.311 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.4 m -121.05 147.62 45.27 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.725 0.81 . . . . 0.0 111.232 -168.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.54 114.01 3.66 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.219 0.608 . . . . 0.0 111.334 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.2 32.75 34.39 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.268 -0.424 . . . . 0.0 113.137 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.9 p30 -81.24 175.37 10.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.838 0.455 . . . . 0.0 110.891 174.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -114.06 82.91 1.78 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.629 0.372 . . . . 0.0 110.447 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 75.2 mt -84.82 141.31 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.629 0.772 . . . . 0.0 109.166 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 42.0 tt0 -141.53 112.2 7.12 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.5 mm -77.22 105.44 6.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -79.06 137.99 37.78 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.206 178.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.5 p -117.52 84.3 18.61 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 167.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.49 116.39 3.38 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.281 1.987 . . . . 0.0 112.229 -177.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -166.15 -79.55 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.404 1.082 . . . . 0.0 108.347 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 71.14 -75.45 0.08 Allowed 'General case' 0 C--N 1.368 1.372 0 C-N-CA 125.576 1.55 . . . . 0.0 110.441 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.79 -164.05 35.81 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 115.869 -0.605 . . . . 0.0 114.077 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.94 77.64 0.79 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.1 mt 62.11 81.23 0.2 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.775 1.23 . . . . 0.0 110.688 -172.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.78 133.69 25.92 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.566 1.146 . . . . 0.0 111.403 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -79.5 91.89 5.2 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.293 0.637 . . . . 0.0 110.716 -171.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -116.51 -0.93 12.33 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.285 1.034 . . . . 0.0 109.372 170.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 65.56 99.29 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.833 1.253 . . . . 0.0 111.033 -177.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -63.2 128.02 33.94 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.307 0.643 . . . . 0.0 110.711 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -80.14 80.85 6.5 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.148 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 . . . . . 0 CA--C 1.548 0.897 0 CA-C-N 114.86 -1.063 . . . . 0.0 108.869 -174.889 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' HG12 ' A' ' 50' ' ' VAL . 17.7 ptp . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 120.973 0.416 . . . . 0.0 110.654 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.6 tp -80.05 97.35 6.78 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.01 0.924 . . . . 0.0 108.557 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.7 m -110.84 145.66 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.944 0.897 . . . . 0.0 109.821 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 6.8 m -83.77 99.44 10.28 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 58.6 mt -95.76 108.53 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -177.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 60.73 36.07 19.47 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.739 1.215 . . . . 0.0 111.238 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.54 -3.89 86.65 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.519 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -118.04 110.95 18.28 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.055 0.942 . . . . 0.0 108.743 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.544 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 94.5 mt-30 -66.03 118.74 10.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.267 0.627 . . . . 0.0 110.845 -178.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -121.91 139.98 52.98 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.472 1.509 . . . . 0.0 108.768 176.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -81.87 125.18 30.41 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.81 155.25 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.816 0.847 . . . . 0.0 110.55 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -91.52 -25.64 19.16 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.182 0.593 . . . . 0.0 110.957 -178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.0 m -70.98 114.99 9.59 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.181 0.592 . . . . 0.0 111.918 -175.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.89 13.04 26.1 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.328 1.051 . . . . 0.0 111.439 173.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.8 t -128.44 138.1 52.15 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.983 1.313 . . . . 0.0 108.403 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 33' ' ' VAL . 76.1 t -68.06 -34.16 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 123.722 0.639 . . . . 0.0 110.839 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.48 -56.68 18.95 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.01 0.524 . . . . 0.0 110.394 174.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.36 75.32 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 124.211 0.944 . . . . 0.0 111.491 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.9 tp -64.32 -55.64 19.9 Favored 'General case' 0 C--N 1.35 0.607 0 O-C-N 123.732 0.645 . . . . 0.0 110.074 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.541 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 72.0 mtp -69.52 -25.84 64.23 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 122.679 0.392 . . . . 0.0 111.098 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -67.35 -39.57 85.78 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 117.938 0.336 . . . . 0.0 110.549 172.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -69.02 -39.14 79.44 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.081 0.953 . . . . 0.0 110.599 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 81.8 mt -86.93 5.89 34.81 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.067 0.947 . . . . 0.0 111.987 -175.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.3 t70 58.29 44.41 18.68 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.757 1.265 . . . . 0.0 110.868 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.2 m -123.59 18.6 9.6 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.473 1.509 . . . . 0.0 110.473 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.8 t -99.89 25.53 7.23 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.562 0.696 . . . . 0.0 110.077 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.92 -25.18 68.03 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.148 0.979 . . . . 0.0 111.415 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.55 -43.26 1.69 Allowed Glycine 0 C--N 1.347 1.176 0 O-C-N 123.549 0.531 . . . . 0.0 112.082 176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -86.4 1.62 50.6 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.991 0.516 . . . . 0.0 111.065 -176.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -89.05 156.4 18.87 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.738 0.815 . . . . 0.0 109.617 174.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.71 170.85 15.2 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.456 1.103 . . . . 0.0 108.485 173.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.541 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 9.1 p -130.08 151.71 36.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . . . -125.25 100.42 6.52 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 174.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.2 tp -88.86 108.8 19.73 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 55' ' ' GLU . 50.2 m-20 54.71 47.43 22.51 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.607 1.163 . . . . 0.0 110.034 -173.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 73.44 -9.88 1.12 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.48 1.512 . . . . 0.0 113.252 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -84.22 116.59 23.03 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.9 t -73.76 117.55 17.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 122.925 0.49 . . . . 0.0 110.1 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 63.4 t -102.04 119.77 55.74 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.079 0.952 . . . . 0.0 108.627 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.53 165.83 29.76 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.105 2.537 . . . . 0.0 112.345 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -53.07 -41.53 64.96 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.818 1.247 . . . . 0.0 113.38 -173.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.67 -21.05 60.15 Favored Glycine 0 CA--C 1.535 1.282 0 O-C-N 123.853 0.721 . . . . 0.0 113.934 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -109.42 -7.6 15.17 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.01 -0.995 . . . . 0.0 112.088 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -52.27 -40.88 62.32 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 119.073 0.851 . . . . 0.0 110.616 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.69 -41.39 98.14 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.755 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -84.18 -11.06 57.18 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.375 1.07 . . . . 0.0 112.529 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.8 m -102.36 112.45 65.52 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -176.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -76.33 173.86 13.78 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.409 2.072 . . . . 0.0 112.615 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.565 HG12 ' SD ' ' A' ' 1' ' ' MET . 86.4 t -124.69 143.73 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.918 1.287 . . . . 0.0 108.643 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.5 m -142.62 149.39 38.9 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.866 0.866 . . . . 0.0 109.804 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.14 126.58 26.68 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.576 0.75 . . . . 0.0 111.135 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.54 -22.07 17.95 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-O 119.011 -0.883 . . . . 0.0 114.259 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -69.13 141.92 54.53 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.024 0.912 . . . . 0.0 112.518 -173.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 36' ' ' ASN . 9.9 mp0 -80.52 80.53 6.96 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.751 1.22 . . . . 0.0 109.353 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 63.1 mt -91.03 96.36 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 34' ' ' ALA . 39.5 tt0 -98.65 106.43 18.7 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.038 0.935 . . . . 0.0 108.669 179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.56 105.06 5.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.6 mt -80.58 143.83 32.88 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.217 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.4 p -111.83 92.18 16.94 Favored Pre-proline 0 C--O 1.246 0.913 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 160.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.33 127.78 23.36 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.339 2.693 . . . . 0.0 112.475 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -59.47 -48.36 81.96 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 124.349 1.031 . . . . 0.0 109.988 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -92.6 87.47 5.94 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 167.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.03 0.22 17.09 Favored Glycine 0 N--CA 1.467 0.729 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.181 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.32 116.64 2.86 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.8 tp -71.8 90.29 1.09 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.253 1.021 . . . . 0.0 110.85 -171.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -59.63 -53.8 53.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.892 0.877 . . . . 0.0 112.525 -173.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -65.72 100.68 0.56 Allowed 'General case' 0 CA--C 1.558 1.259 0 CA-C-O 122.09 0.948 . . . . 0.0 110.439 177.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -148.72 96.59 2.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.803 1.241 . . . . 0.0 108.594 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -174.78 30.92 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.551 1.14 . . . . 0.0 110.547 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -123.45 35.12 4.93 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.892 0.477 . . . . 0.0 111.22 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.7 m80 66.64 38.08 4.14 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.38 1.072 . . . . 0.0 111.838 176.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 . . . . . 0 CA--C 1.554 1.129 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.2 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.669 -0.123 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 11' ' ' GLU . 5.0 tt -83.0 122.64 28.57 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.01 145.25 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.098 0.959 . . . . 0.0 110.42 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 9' ' ' GLN . 18.4 m -78.69 102.1 7.86 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.033 0.533 . . . . 0.0 110.088 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 24.1 mt -101.35 105.61 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.061 0.544 . . . . 0.0 109.947 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 60.41 41.82 15.51 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.514 1.126 . . . . 0.0 110.708 173.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.39 -18.35 57.15 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 114.595 -1.184 . . . . 0.0 114.027 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -108.79 116.39 31.89 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.626 0.77 . . . . 0.0 110.093 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 48.1 mt-30 -70.89 131.49 43.83 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.857 0.463 . . . . 0.0 109.782 174.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.527 ' NH2' HD21 ' A' ' 24' ' ' LEU . 65.1 ttp85 -152.87 142.9 22.28 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.34 0.656 . . . . 0.0 109.727 178.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 2' ' ' LEU . 38.5 tt0 -83.66 127.05 33.48 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.4 m -120.14 164.15 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.046 0.938 . . . . 0.0 111.069 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -102.89 -1.72 29.09 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.668 1.187 . . . . 0.0 109.744 171.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.1 m -67.07 99.37 0.65 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 124.304 1.042 . . . . 0.0 111.003 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.69 -14.51 58.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.115 0.566 . . . . 0.0 110.822 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 44.2 t -127.57 154.35 45.3 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.102 0.961 . . . . 0.0 109.753 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.446 ' O ' ' HG2' ' A' ' 21' ' ' MET . 95.2 t -65.7 -38.56 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.661 0.785 . . . . 0.0 110.774 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.51 95.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.473 0.309 . . . . 0.0 110.882 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.04 80.21 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.708 0.803 . . . . 0.0 111.318 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.476 HD11 HD13 ' A' ' 5' ' ' ILE . 28.1 tp -64.98 -45.94 83.55 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.84 0.713 . . . . 0.0 111.358 177.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 83.0 mmm -68.17 -24.86 65.02 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.726 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.0 m -74.95 -45.37 42.76 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.935 0.494 . . . . 0.0 110.721 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -57.69 -47.48 82.22 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.805 0.842 . . . . 0.0 110.675 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.527 HD21 ' NH2' ' A' ' 10' ' ' ARG . 80.8 mt -84.47 1.47 45.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.728 -1.124 . . . . 0.0 112.246 -175.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 61.73 20.44 11.37 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.574 1.15 . . . . 0.0 111.119 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.481 ' SG ' HG21 ' A' ' 58' ' ' ILE . 36.1 t -94.08 10.59 33.06 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.833 1.253 . . . . 0.0 111.321 -170.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -100.05 -27.03 13.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.985 0.514 . . . . 0.0 110.395 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.75 -61.59 2.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.008 0.923 . . . . 0.0 112.53 -174.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.65 -167.14 31.56 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.989 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -86.57 63.63 8.09 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.361 0.664 . . . . 0.0 110.357 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -106.53 170.52 7.88 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.125 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.83 173.26 12.01 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.464 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG12 ' NE1' ' A' ' 45' ' ' TRP . 14.8 p -139.86 140.48 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.05 0.54 . . . . 0.0 109.834 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.99 100.33 7.48 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.151 0.98 . . . . 0.0 108.52 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 tp -92.56 113.81 26.19 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER 64.29 37.14 8.77 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.365 1.041 . . . . 0.0 110.374 -179.038 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 79.26 -17.04 0.62 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 126.584 1.954 . . . . 0.0 112.741 -175.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -96.52 119.83 35.72 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -171.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 p -67.36 126.54 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.316 0.579 . . . . 0.0 110.756 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.9 t -95.44 119.35 65.48 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.43 156.25 42.39 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.394 2.063 . . . . 0.0 112.485 174.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -60.87 -39.27 88.54 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.089 0.555 . . . . 0.0 111.702 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.89 -19.97 59.38 Favored Glycine 0 C--N 1.346 1.098 0 O-C-N 123.72 0.638 . . . . 0.0 113.035 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -99.53 -20.16 16.54 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 117.83 -1.081 . . . . 0.0 111.593 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.425 ' NE1' HG12 ' A' ' 33' ' ' VAL . 39.4 m0 -49.73 -47.3 50.78 Favored 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 119.399 0.999 . . . . 0.0 110.999 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.98 -45.26 78.2 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.889 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -72.09 -15.16 62.0 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.488 1.115 . . . . 0.0 112.577 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 m -104.52 129.33 25.2 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.369 0.668 . . . . 0.0 110.28 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 54.0 Cg_endo -84.58 174.77 7.51 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.698 2.266 . . . . 0.0 113.267 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.451 HG13 HD11 ' A' ' 56' ' ' ILE . 67.3 t -117.89 126.65 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.603 1.161 . . . . 0.0 108.766 173.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.3 m -108.91 145.11 35.91 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.384 1.074 . . . . 0.0 109.027 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.14 118.29 5.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.304 0.642 . . . . 0.0 111.388 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.87 -2.0 31.83 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.53 -0.595 . . . . 0.0 114.055 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -69.38 131.27 44.54 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.534 0.667 . . . . 0.0 112.156 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -84.77 92.56 8.25 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 169.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 39.4 mt -100.33 95.86 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.417 1.087 . . . . 0.0 108.676 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.75 120.3 37.89 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.71 -0.619 . . . . 0.0 110.086 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.481 HG21 ' SG ' ' A' ' 26' ' ' CYS . 76.6 mt -76.32 121.98 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.4 mt -112.63 142.51 45.14 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.604 0.762 . . . . 0.0 109.753 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 m -116.16 87.64 20.13 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.74 166.13 30.43 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.6 2.2 . . . . 0.0 112.642 -165.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.8 mtt-85 -62.84 86.92 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.812 0.845 . . . . 0.0 111.709 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 173.44 -61.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 -170.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.65 -14.44 50.06 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.208 170.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.5 15.71 44.41 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 123.001 0.334 . . . . 0.0 113.026 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.2 mt -90.57 100.05 12.96 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.268 1.027 . . . . 0.0 108.413 174.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.6 81.29 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.702 0.801 . . . . 0.0 111.321 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -150.78 145.51 25.79 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -62.15 87.8 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -168.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -87.68 -25.29 23.56 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.944 1.298 . . . . 0.0 109.386 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -139.01 146.27 40.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.359 1.064 . . . . 0.0 110.825 -175.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -179.64 -46.82 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.188 1.395 . . . . 0.0 109.286 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 76.2 t60 . . . . . 0 CA--C 1.552 1.03 0 C-N-CA 124.851 1.26 . . . . 0.0 109.267 -174.11 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' HG12 ' A' ' 50' ' ' VAL . 49.5 ttm . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.2 tp -79.62 105.14 10.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.52 0.728 . . . . 0.0 109.51 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.0 m -125.32 139.39 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.294 1.038 . . . . 0.0 109.664 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.5 m -77.03 99.58 5.36 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.524 HD12 ' HD3' ' A' ' 10' ' ' ARG . 50.5 mt -97.55 114.27 34.27 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 123.148 0.579 . . . . 0.0 109.643 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 55.3 t30 59.87 35.57 21.85 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.671 1.588 . . . . 0.0 111.434 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.39 -3.36 83.85 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.978 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -109.37 130.98 55.48 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 117.464 0.632 . . . . 0.0 110.469 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -69.98 103.02 2.14 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 174.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.524 ' HD3' HD12 ' A' ' 5' ' ' ILE . 53.1 ttt180 -122.17 122.54 39.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.703 0.801 . . . . 0.0 110.113 -173.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -88.43 104.62 16.96 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -106.48 160.59 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.72 0.808 . . . . 0.0 109.94 176.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -105.44 -1.35 25.06 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.311 0.644 . . . . 0.0 111.011 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.2 p -77.18 117.28 18.56 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.829 0.852 . . . . 0.0 110.744 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.61 1.73 56.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.954 0.901 . . . . 0.0 111.73 174.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.2 t -125.65 142.98 51.23 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.366 1.066 . . . . 0.0 109.58 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.56 -28.23 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.236 0.614 . . . . 0.0 110.39 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.67 -54.41 39.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.759 0.424 . . . . 0.0 110.303 172.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.54 64.77 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.911 0.757 . . . . 0.0 111.679 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.4 tp -62.02 -58.93 6.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 172.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.546 ' SD ' ' HB ' ' A' ' 33' ' ' VAL . 95.7 mmm -63.43 -32.62 74.12 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.106 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.2 m -66.62 -44.84 80.96 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.057 0.543 . . . . 0.0 110.059 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -69.95 -31.09 68.64 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.966 0.906 . . . . 0.0 110.382 -176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.6 mt -91.89 -0.69 57.51 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.754 0.822 . . . . 0.0 111.127 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 63.97 38.81 8.47 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.098 1.359 . . . . 0.0 112.942 171.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.5 m -118.82 27.24 9.01 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.118 1.367 . . . . 0.0 110.832 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 p -96.51 20.49 10.58 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.665 0.786 . . . . 0.0 110.865 175.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.37 -36.61 80.72 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.468 0.707 . . . . 0.0 110.892 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.31 -55.92 0.68 Allowed Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.165 177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -78.48 14.08 1.38 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.538 0.735 . . . . 0.0 112.501 -177.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -108.04 150.41 27.19 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.546 0.738 . . . . 0.0 109.808 174.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . . . -127.01 167.31 16.08 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.225 1.01 . . . . 0.0 109.111 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.546 ' HB ' ' SD ' ' A' ' 21' ' ' MET . 8.5 p -133.06 148.21 31.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.41 109.37 11.36 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.988 0.423 . . . . 0.0 109.916 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.9 tp -88.11 109.28 19.76 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 60.57 51.25 5.2 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 124.755 1.284 . . . . 0.0 110.62 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 72.02 6.74 5.66 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 125.374 1.47 . . . . 0.0 113.671 175.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -124.5 127.28 47.22 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.129 0.572 . . . . 0.0 109.926 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 p -64.49 135.15 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 124.191 0.932 . . . . 0.0 111.687 -175.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.13 122.48 57.94 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.92 152.61 63.1 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.393 2.062 . . . . 0.0 112.607 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -54.16 -52.53 60.86 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.423 1.089 . . . . 0.0 113.056 -170.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.59 -9.5 61.97 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 116.412 -0.358 . . . . 0.0 113.266 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HD2' ' HB2' ' A' ' 47' ' ' GLU . 54.8 tptt -96.54 -15.44 21.63 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.23 1.012 . . . . 0.0 110.057 -177.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -52.91 -44.41 66.94 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.176 0.591 . . . . 0.0 111.191 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -68.46 -38.18 80.86 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.002 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HB2' ' HD2' ' A' ' 44' ' ' LYS . 32.8 mt-10 -75.41 -21.41 58.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.796 0.838 . . . . 0.0 112.09 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.0 m -100.3 117.89 62.25 Favored Pre-proline 0 N--CA 1.47 0.544 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.93 165.98 27.56 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.079 1.853 . . . . 0.0 112.604 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.507 HG12 ' SD ' ' A' ' 1' ' ' MET . 61.7 t -99.79 141.21 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 167.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.9 m -134.44 139.72 45.73 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.09 144.24 56.82 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.692 0.797 . . . . 0.0 111.088 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 -10.98 71.3 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 119.554 -0.581 . . . . 0.0 112.893 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -87.13 162.45 17.52 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.364 0.602 . . . . 0.0 110.788 174.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -121.06 99.36 6.45 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.835 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 5' ' ' ILE . 55.8 mt -103.24 153.51 5.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 C-N-CA 124.711 1.204 . . . . 0.0 109.154 -176.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -146.62 139.28 25.18 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 119.26 0.936 . . . . 0.0 109.441 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.1 mt -85.07 121.04 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 84.7 mt -91.32 125.91 36.24 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 123.906 0.883 . . . . 0.0 109.448 176.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 63' ' ' GLN . 65.7 p -108.95 87.46 4.62 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 173.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.37 121.68 9.77 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.115 2.543 . . . . 0.0 112.363 -169.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 72.4 -3.04 2.41 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.358 1.463 . . . . 0.0 112.842 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.453 ' HB2' ' HB ' ' A' ' 60' ' ' THR . 79.5 mm-40 -100.77 158.05 16.25 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.032 0.933 . . . . 0.0 110.645 -174.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.52 -79.53 1.9 Allowed Glycine 0 C--N 1.341 0.832 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -174.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.8 122.11 2.24 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-O 119.05 -0.861 . . . . 0.0 111.002 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.4 mt -56.47 -72.5 0.08 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.722 0.809 . . . . 0.0 111.716 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 46.89 58.14 5.01 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.571 1.169 . . . . 0.0 111.452 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -40.28 99.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 124.514 1.134 . . . . 0.0 112.76 -172.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -57.71 110.51 0.91 Allowed 'General case' 0 C--N 1.358 0.968 0 CA-C-N 114.722 -1.127 . . . . 0.0 110.14 -172.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -74.19 107.7 6.53 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -68.58 -40.81 80.39 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.334 0.654 . . . . 0.0 111.009 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 74.75 -60.33 0.52 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.985 1.714 . . . . 0.0 111.902 -177.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 79.3 t60 . . . . . 0 CA--C 1.558 1.276 0 C-N-CA 124.649 1.18 . . . . 0.0 109.317 -173.525 . . . . . . . . 0 0 . 1 stop_ save_